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Abstract 
The degradation of RNA is a ubiquitous phenomenon critical to many biological 
processes. The eukaryotic exosome complex is a major source of 3’-5’ 
exoribonuclease activity and is required for multiple RNA processing and 
degradation pathways. To modulate the recognition and fate of RNA substrates, 
the exosome recruits a number of additional cofactors. This study focuses on the 
function and relationships between the proteins Rrp6, Rrp47, Rex1 and Mpp6 that 
function in nuclear RNA quality control mechanisms, 3’-end processing of stable 
RNAs and the degradation of cryptic unstable transcripts (CUTs). The function of 
Rrp6 is largely dependent on the physical interaction with Rrp47 and the 
expression levels of either protein are mutually dependent on this physical 
interaction. The function of Rrp6/Rrp47 is redundant with Mpp6-dependent or 
Rex1-dependent processes. This is supported by the synthetic lethal interactions 
between rrp6∆ and rrp47∆ mutants with loss of function mpp6 or rex1 mutant. 
However, the molecular basis of these interactions is not clear. To investigate if 
Rrp47 can function when physically divorced from Rrp6, a novel approach was 
used to separate the Rrp6/Rrp47 complex in vivo whilst maintaining stable 
expression of Rrp47. Segregated Rrp47 was shown to be functional when 
combined with mpp6∆ or rex1∆ mutants. However, segregating C-terminal 
truncated Rrp47 protein from Rrp6 caused a block in growth in mpp6∆ and rex1∆ 
mutants. RNA analysis reveals a block in 3’ maturation of box C/D snoRNAs in 
conditional rex1 rrp47 mutants and a strong accumulation of RNA surveillance 
targets in conditional mpp6 rrp47 mutants. These findings provide insight into the 
basis of synthetic lethal interactions and highlight specific redundant pathways. 
Finally, whilst these studies validate the role of Mpp6 in RNA surveillance 
pathways, little is known about the protein itself. Mutational analysis is employed 
to identify and characterise the functional regions of the Mpp6 protein. This 
identifies crucial regions required for function in vivo including residues that may 
be required for association with the exosome and associated sub-complexes.  
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Abbreviat ions, units and nomenclature 
 
Abbreviations and units used throughout this study are listed below. The mention 
of yeast throughout the text refers to Saccharomyces cerevisiae unless otherwise 
stated. Nomenclature used in this study is compliant with guidelines for S. 
cerevisiae compiled by the Committee of Genetic Nomenclature (“Saccharomyces 
cerevisiae,” 1998). Yeast wildtype genes are written in upper case and italicised 
(e.g. MPP6), mutant alleles are in lower case and italicised (e.g. mpp6) and 
proteins being with a capital letter followed by lower case (e.g. Mpp6).  
 
Abbreviat ions used in this study.   
 
5’FOA 5’fluoroorotic acid  
ATP  adenosine triphosphate  
CIP  calf-intestinal alkaline phosphatase  
CTD  C-terminal domain 
CUT  cryptic unstable transcript 
DEPC diethylpyrocarbonate 
DMSO dimethyl sulfoxide 
dNTP  deoxyribonucleotide triphosphate  
ds  double stranded  
DTT  dithiothreitol 
Endo  endonuclease  
EPPCR error-prone polymerase chain reaction  
ETS  external transcribed spacer 
Exo  exonuclease 
gDNA  genomic DNA  
GST  glutathione-S-transferase  
GTC  guanidine thiocynate 
HCl  hydrochloric acid  
His  histidine  
IPTG  isopropyl β-D-1-thigalactopyranoside  
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ITS  internal transcribed spacer  
mRNA messenger RNA 
MW  molecular weight  
ncRNA non-coding RNA 
NTD  N-terminal domain  
OD  optical density  
ORF  open reading frame  
Ori  origin of replication  
PCR  polymerase chain reaction  
PEG  polyethyleneglycol 
PMSF phenylmethylsulphonylfluoride   
PNK  polynucleotide kinase  
poly(A) polyadenylated 
poly(U) polyuridylated  
RBD  RNA binding domain  
RNA pol DNA dependent RNA polymerase  
RNase ribonuclease  
RNP  ribonucleoprotein  
rDNA  ribosomal DNA 
rRNA  ribosomal RNA  
SD  synthetic dextrose medium  
SDM  site directed mutagenesis  
SDS  sodium dodecyl sulphate  
SGal  synthetic galactose medium  
snoRNA small nucleolar RNA  
snRNA small nuclear RNA  
ss  single stranded  
SUT  stable uncharacterised transcript  
TAP  tandem affinity purification  
TCA  trichloroacetic acid  
TEMED  N,N,N′,N′-Tetramethylethylenediamine 
Tm  melting temperature  
tRNA  transfer RNA 
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TS  temperature sensitive 
UTR  untranslated region  
UV  ultraviolet  
v/v  percentage volume per volume   
w/v  percentage weight per volume  
WT  wildtype 
XUT  Xrn1-sensitive unstable transcript 
ZnK  zinc-knuckle 
zz  protein A tag  
 
Units used in this study 
 
bp  base pair   
CFU  colony forming units  
cpm  counts per minute 
Da  daltons  
g  gram 
g  g-force (relative centrifugal force)   
kb  kilobase  
kDa  kiladalton  
l   litre  
mg  milligram 
ml  millilitre  
mM  millimolar 
ng  nanogram  
nM   nanomolar 
pmol  picomolar 
rpm  revolutions per minute  
S  Svedberg 
U  units (of enzyme)  
µg  microgram 
µM  micromolar  
µ l    microlitre 
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Chapter 1: Introduction  
 
1.1 RNA degradation in Eukaryotes 
 
RNA degradation is a necessary activity, key to the maintenance of stable cellular 
transcriptomes and is ubiquitous to all kingdoms of life. As with all biomolecules, 
RNA transcripts exist in a constant state of flux and require a high level of dynamic 
control for all aspects of RNA metabolism. All characterised classes of RNA are 
transcribed as long precursor molecules and undergo processing reactions to 
generate mature transcripts. Surveillance and quality control mechanisms purge 
the cell of aberrant RNA molecules to prevent disruption to cellular processes. 
Furthermore, RNAs are degraded as part of natural turnover pathways and 
contributes to the recycling of nucleotides. For coding transcripts, RNA turnover 
acts as part of a number of mechanisms to control gene expression levels 
(Houseley and Tollervey, 2009; Jackowiak et al., 2011; Parker, 2012).  
These productive and destructive degradation pathways require the function of 
three classes of cellular RNase enzymes: endonucleases that cleave RNA 
internally, 5’-3’ exonucleases that degrade from the 5’ end of RNA, and 3’-5’ 
exonucleases that act on the 3’ end. As with many biological systems, a large 
degree of redundancy exists between RNases and degradation pathways. With 
the advent of high-throughput technologies combined with classical techniques, it 
has become apparent that there is a large functional overlap between RNases. 
This suggests that multiple enzymes are synergistic in the recognition of the same 
target RNA (Houseley and Tollervey, 2009). Redundant pathways serve to make 
RNA degradation pathways more robust and fundamentally enhance the overall 
efficiency.  
 
 
1.1.1. The eukaryotic exosome complex  
 
A major source of 3’-5’ exonuclease activity in eukaryotes is provided by the RNA 
exosome complex (Allmang et al., 1999b; Mitchell et al., 1997). The exosome 
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plays key roles in both processing and degradation pathways of all characterised 
RNA species in the cytoplasm and nucleus of eukaryotic and archeal cells 
(Chlebowski et al., 2013). The complex itself is composed of a non-catalytic 
barrel-like core of nine essential polypeptides (EXO9) that associates with Rrp44 
and Rrp6 proteins to provide ribonuclease activity. Rrp44 provides both 
endonuclease and 3’-5’ exonuclease activity and is found in both cytoplasmic and 
nuclear exosome complexes known together as EXO10 (Lorentzen et al., 2008; 
Mitchell et al., 1997). Rrp6 is related to bacterial RNaseD and provides additional 
exonuclease activity to the nuclear exosome in yeast (Allmang et al., 1999b; 
Briggs et al., 1998). The complex is ubiquitous in all eukaryotes studied so far and 
shows a large degree of homology to related structures in bacteria and archaea 
(Lykke-Andersen et al., 2009).  
 
The exosome complex is a critical component of all eukaryotic cells with functions 
linked to roles ranging from ribosome biogenesis to gene silencing. Whilst a 
degree of functional redundancy exists within various components of the exosome 
and associated factors, all components of the EXO10 complex are essential for 
viability (Allmang et al., 1999b; Mitchell et al., 1997). A small number of diseases 
have been associated with the human exosome, namely the rare autoimmune 
disease polymyositis scleroderma in which patients develop antibodies against 
PM/Scl-75 and PM/Scl-100 (homologs of EXO10 components Rrp45 and Rrp6 
respectively) (Allmang et al., 1999b; Gelpi et al., 1990). It was recently shown that 
germline mutations in the Rrp44-related DIS3L2 are linked to Perlman syndrome 
of overgrowth and a predisposition Wilm’s tumor development (Astuti et al., 2012). 
Additionally, whole-genome sequencing revealed a high frequency of mutations in 
the Rrp44-homolog hDIS3 allele in patients with multiple myeloma (MM), a lethal 
neoplastic disease (Chapman et al., 2011).  
 
In addition to processing and degradation of major classes of RNA transcripts, the 
exosome was shown to contribute to the rapid suppression of a hidden layer of 
intergenic pervasive transcription. Such non-coding RNAs were termed cryptic 
unstable transcripts (CUTs) and are shown to accumulate in exosome mutants 
(Arigo et al., 2006; Thiebaut et al., 2006; Wyers et al., 2005). Whilst the role of 
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CUTs is still relatively unknown, a few studies have recently reported possible 
functions in gene regulation (Camblong et al., 2007; Castelnuovo et al., 2013; 
Martens et al., 2005).  
 
With multiple functions and a wide array of RNA substrates, the exosome complex 
requires a high level of modulation to control the fate of target transcripts. Multiple 
processing and degradation pathways are achieved through the physical and 
functional association with various co-factors and complexes. These auxiliary 
factors have been widely characterised and studied in relation to the activation of 
the exosome. However, the mechanisms that govern substrate recognition and 
targeting to various exosome-dependent pathways are yet to be fully understood.  
 
 
1.1.2. Functions of the eukaryotic exosome  
 
The catalytic activities of the nuclear and cytoplasmic exosome target all classes 
of RNA in eukaryotes and play key roles in multiple pathways involving RNA 
processing and degradation. The modulation of such activities is due to 
compartmentalization in the nucleolus, nucleoplasm and cytoplasm along with 
physical and function associations with a variety of co-factors and complexes. The 
eukaryotic exosome has been shown to be involved in 3’ end processing of stable 
RNAs, cytoplasmic turnover of mRNAs, and in nuclear and cytoplasmic RNA 
surveillance pathways for coding and non-coding RNAs including CUTs. 
 
All characterised classes of stable RNAs are generated from longer precursor 
transcripts that undergo exonuclease and/or endonuclease processing to 
generate mature RNA. The eukaryotic exosome was originally identified in yeast as 
a processing complex with 3’-5’ exonuclease activity involved in the 3’ end 
processing of the 5.8S rRNA component of mature ribosomes (Mitchell et al., 
1997). Subsequent analyses reported that exosome activity was required for the 
3’ maturation of snRNA and snoRNAs (Allmang et al., 1999a; van Hoof et al., 
2000a). Mature 5.8S rRNA is processed from the 7S pre-rRNA molecule which 
itself is derived from a 35S pre-rRNA polycistronic precursor transcribed by RNA 
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polymerase I. The exonuclease activity of Rrp44, a catalytic subunit of both 
nuclear and cytoplasmic exosomes, processes the 3’ end of 7S rRNA to produce 
the 5.8S + 30 species (5.8S rRNA extended by 30nt at the 3’ end) (Mitchell et al., 
1996). The accumulation of extended 5.8S transcripts is characteristic of exosome 
and Rrp6 mutants (Briggs et al., 1998; Mitchell et al., 2003, 1997). The 5.8S + 30 
rRNA is processed to 6S rRNA species by Rrp6 which is subsequently exported 
to the cytoplasm for final maturation steps involving the cytoplasmic nuclease 
Ngl2 (Thomson and Tollervey, 2010). The 3’ +30 species is accumulated in rrp6∆ 
mutants. However, mature 5.8S rRNA is still generated, most likely due to 
redundant exonuclease pathways (Briggs et al., 1998). The Rex1, Rex2 and Rex3 
exonucleases were shown to have redundant functions in 3’- end 5.8S 
maturation. Double rex1∆ rex2∆ and triple rex1∆ rex2∆ rex3∆ mutants exhibited 
an accumulation of the 6S pre-rRNA species (van Hoof et al., 2000b). This 
suggests that the 3’ maturation of 5.8S rRNA could utilize multiple pathways 
involving various exonucleases to generate mature transcripts. Interestingly, loss 
of function rex1 mutants are synthetic lethal with rrp6∆ alleles suggesting a level of 
functional redundancy in the processing of shared substrates (Peng et al., 2003; 
van Hoof et al., 2000b).  
 
The 3’ ends of pre-snRNAs and pre-snoRNAs were also shown to require the 
function of the exosome and associated co-factors (Allmang et al., 1999a; 
Costello et al., 2011; Mitchell et al., 2003; van Hoof et al., 2000a). Exosome and 
rrp6∆ mutants accumulate 3’ extended pre-snRNA and pre-snoRNA transcripts 
that are polyadenylated (Allmang et al., 1999a; van Hoof et al., 2000a). 
Transcriptional termination of snoRNA genes occurs at a proximal 
Nrd1/Nab3/Sen1 (NNS) dependent site I and a distal, failsafe mRNA 
cleavage/polyadenylation site II (Steinmetz and Brow, 2003; Steinmetz et al., 
2006). Normal productive snoRNA production proposed to be mediated by NNS-
dependent termination at site I followed by polyadenylation and subsequent 3’-
end trimming by Rrp6 (Grzechnik and Kufel, 2008). The function of Rrp6 in pre-
rRNA processing and 3’-end formation of snRNA and snoRNAs is dependent on 
physical and function interactions with the exosome-associated cofactor Rrp47. 
Loss of Rrp47 in yeast resembles RNA processing and degradation phenotypes 
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observed in rrp6∆ strains. (Costello et al., 2011; Feigenbutz et al., 2013b; Mitchell 
et al., 2003; Stead et al., 2007).  
 
In the cytoplasm the exosome complex has only been reported to act on mRNA 
transcripts, functioning in normal mRNA turnover and in the degradation of 
aberrant transcripts as part mRNA surveillance pathways.  
The turnover of mRNAs in yeast can occur via two pathways, both involving an 
initial shortening of the poly(A) tail by deadenylases and followed by either 5’-3’ or 
3’-5’ exonucleolytic degradation. The removal of the 5’ cap by decapping 
enzymes Dcp1 and Dcp2 leaves the mRNA susceptible to 5’-3’ degradation by 
the Xrn1 exonuclease (Beelman et al., 1996; Dunckley and Parker, 1999; Hsu and 
Stevens, 1993). Deadenylation can also lead to a 3’-5’ degradation pathway 
involving the cytoplasmic exosome (Anderson and Parker, 1998; van Hoof et al., 
2000c). In yeast, the former 5’-3’ pathway is considered to be the major pathway 
in mRNA turnover whereas the later exosome-dependent pathway plays a minor 
role. The catalytic activity of the cytoplasmic exosome is provided by the essential 
protein, Rrp44 which possess both exo- and endonuclease activities 
(Dziembowski et al., 2007; Lebreton et al., 2008; Mitchell et al., 1997). A loss of 
Rrp44 exonuclease activity leads to the accumulation of mRNA decay 
intermediates and is synthetic lethal with the loss of Xrn1 (Dziembowski et al., 
2007; Schneider et al., 2009).  
The cytoplasmic exosome associates with the SKI (Superkiller) complex 
composed of the DExH-box helicase Ski2 along with Ski3 and Ski8 (Anderson and 
Parker, 1998; Synowsky and Heck, 2008). The SKI and cystoplasmic exosome 
complexes are physically coupled via the GTPase protein Ski7 via independent 
regions in the N-terminus (Araki et al., 2001). Defects in SKI genes inhibit mRNA 
3’-5’ decay pathways and are synthetic lethal with xrn1∆ mutants. These results 
suggest that that the SKI complex works in concert with the cytoplasmic exosome 
in 3’-5’ mRNA decay pathways that are redundant with the 5’-3’ decapping 
pathway (Johnson and Kolodner, 1995; Mitchell and Tollervey, 2003). The role of 
the SKI complex in cytoplasmic turnover is relatively unknown although a recent 
crystal structure of the complex suggests that RNA substrates are channeled 
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through the helicase domain of Ski2 into the central channel of EXO9 to reach the 
exonuclease site in Rrp44 (Halbach et al., 2013).  
 
The removal of aberrant mRNA transcripts in RNA surveillance pathways is a 
critical process to maintain the integrity of protein-coding gene transcripts. Such 
aberrant mRNAs need to be distinguished from normal coding RNAs through 
surveillance mechanisms and target faulty transcripts for rapid degradation. The 
cytoplasmic exosome contributes to the degradation of aberrant mRNAs in 
nonsense-mediated decay (NMD), non-stop decay (NSG) and no-go decay (NGD) 
pathways (Doma and Parker, 2006; Mitchell and Tollervey, 2003; Takahashi et al., 
2003; van Hoof et al., 2002). Transcripts that contain premature termination 
codons (PTCs), due to transcriptional errors or post-transcriptional processing, are 
targeted to NMD pathways. As with normal mRNA turnover, two NMD pathways 
exist in yeast. The major 5’-3’ NMD pathway involves decapping followed by rapid 
5’-end degradation involving Xrn1 (Muhlrad and Parker, 1994). The cytoplasmic 
exosome, in cooperation with the SKI complex, was also shown to be required for 
a secondary 3’-5’ degradation pathway of PTC-containing transcripts (Mitchell 
and Tollervey, 2003). Exosome mutants have been shown to stabilise mRNA 
transcripts that lack stop codons (Frischmeyer et al., 2002; van Hoof et al., 2002). 
In such cases, translating ribosomes read through the mRNA and stalls at the 3’ 
poly(A) tail of the transcript. Ski7 is proposed to recognize stalled ribosome and 
co-recruit the SKI complex and cytoplasmic exosome resulting in rapid 
degradation of the aberrant transcript. The C-terminal domain of Ski7 is 
homologous to translation factors eEF1A and eRF3 and it has been suggested 
that this domain interacts with the stalled ribosome (Araki et al., 2001; van Hoof et 
al., 2002). The no-go decay pathway is induced by stalling of the ribosome at 
structured elements within mRNAs during translation (Doma and Parker, 2006). 
The NGD model proposes that transcripts undergo endonucleolytic cleavage that 
releases 5’ and 3’ mRNA fragments. The 3’-fragment is degraded by the 5’-3’ 
exonuclease Xrn1 whereas the 5’-fragment is degraded through co-operation 
between the SKI complex and the cytoplasmic exosome (Doma and Parker, 
2006).  
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In addition to RNA surveillance and quality control of coding mRNAs in the 
cytoplasm, the exosome complex is responsible for targeted 3’-5’ degradation of 
coding and non-coding pre-RNA species in the nucleus. Defective RNA 
precursors are the result of mutation or errors in RNA transcription and 
processing. The nuclear exosome recruits a plethora of co-factors and complexes 
to specifically target aberrant transcripts derived from RNA polymerase I, II and III 
in distinct pathways whilst allowing normal RNAs to undergo normal maturation. 
Analogous to redundant 3’ and 5’ degradation pathways in the cytoplasm, the 
exonuclease Rat1 functions in 5’-3’ RNA surveillance pathways in the nucleus 
(Fang et al., 2005). Recent advances in high-throughput transcriptome and 
microarray analysis have revealed key factors in RNA surveillance and their target 
transcripts. However, the mechanisms that distinguish between normal and 
aberrant transcripts are still poorly understood.  
 
The activity of the nuclear exosome is dependent on additional proteins and 
complexes including the Trf4/Air2/Mtr4 (TRAMP) polyadenylation complex, the 
Nrd1/Nab3/Sen1 (NNS) complex and the nuclear RNA binding proteins Rrp47 and 
Mpp6 (Chlebowski et al., 2013). The nuclear exosome possesses an additional 
catalytic component from the physical and functional association with Rrp6, a 
RNaseD-related 3’-5’ exonuclease (Burkard and Butler, 2000).  
The TRAMP complex plays a key role in targeting aberrant ncRNAs for 
degradation in yeast. TRAMP complexes are typically comprised of the poly(A) 
polymerase Trf4, either of two zinc-knuckle RNA binding proteins Air1 or Air2 and 
the putative RNA helicase Mtr4. (LaCava et al., 2005; Vanácová et al., 2005; 
Wyers et al., 2005). TRAMP adds short 3’ oligo(A) tails to RNA substrates to target 
for degradation by the nuclear exosome complex and/or Rrp6. The addition of 
short single stranded RNA is suggested to present a more favorable substrate for 
the exosome-associated exonucleases Rrp44 and Rrp6. (LaCava et al., 2005). 
Targets of the TRAMP complex encompass transcripts from all three RNA 
polymerases including hypermodified pre-tRNAiMet, aberrant 23S pre-rRNA, 3’ 
truncated 5S (5S*), unspliced pre-tRNAs, read-through snoRNAs and cryptic-
unstable transcripts. All aforementioned transcripts are stabilised in both TRAMP 
and exosome mutants suggesting a functional coupling between the two 
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complexes in RNA surveillance and degradation pathways (Allmang et al., 1999a; 
Copela et al., 2008; Grzechnik and Kufel, 2008; Kadaba et al., 2006; LaCava et 
al., 2005; Neil et al., 2009; Wlotzka et al., 2011; Wyers et al., 2005).  
 
A novel class of non-coding RNA species derived from pervasive Pol II 
transcription of intergenic regions was identified in a transcriptome-wide analysis 
of rrp6∆ cells (Wyers et al., 2005). These ncRNAs, termed cryptic unstable 
transcripts (CUTs), were shown to be virtually undetectable in wild-type cells 
suggesting that they are targeted for rapid degradation by the exosome. CUTs 
were shown to be 3’ polyadenylated with a high level of heterogeneity and appear 
as a smear in northern blot hybridisation analysis (Arigo et al., 2006; Thiebaut et 
al., 2006; Wyers et al., 2005). It was demonstrated that CUTs are polyadenylated 
by Trf4 as part of the TRAMP complex, which targets transcripts for subsequent 
degradation by the exosome (Wyers et al., 2005). A detailed analysis of the model 
CUT NEL025c revealed that the Nrd1/Nab3/Sen1 (NNS) complex is involved in 
transcriptional termination of CUTs and triggers subsequent degradation involving 
TRAMP and the exosome. A depletion of Nrd1 or Nab3 results in the 
accumulation of 3’-extended read-through transcripts including snoRNAs and 
CUTs (Arigo et al., 2006; Thiebaut et al., 2006). The loss of exosome-associated 
cofactors Rrp47 and Mpp6 result in the stabilisation of NEL025c and other cryptic 
transcripts suggesting a role in ncRNA surveillance pathways in concert with the 
NNS complex, TRAMP, Rrp6 and EXO10 (Milligan et al., 2008).   
Various genome-wide transcriptome analyses have reported pervasive intergenic 
transcription in many eukaryotes including humans, budding and fission yeast, 
fruit flies and plants (Bertone et al., 2004; David et al., 2006; Dutrow et al., 2008; 
Li et al., 2006; Stolc et al., 2004). High resolution mapping of the pervasive 
transcriptome revealed subclasses of intergenic transcripts (Neil et al., 2009; Xu et 
al., 2009). In addition to CUTs, stable-annotated transcripts (SUTs) are defined as 
intergenic transcripts that are observed in both wildtype and rrp6∆ cells. This 
suggests that SUTs are not ubiquitously degraded by the exosome. In addition to 
exosome-dependent degradation involving Rrp6 and Rrp47, SUTs are primarily 
degraded in the cytoplasm through NMD pathways involving decapping enzymes 
Dcp1/2 and the 5’-3’ exonuclease Xrn1 (Marquardt et al., 2011). Transcriptome-
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wide analysis of rrp6∆, rrp44exo-and rrp44endo- mutants reported that both catalytic 
subunits of the nuclear exosome are involved in the degradation of previously 
annotated CUTs and SUTs and show a large degree of substrate overlap (David et 
al., 2006; Gudipati et al., 2012b; Neil et al., 2009; Xu et al., 2009). Inactivation of 
the endonuclease domain of Rrp44 did not significantly stabilise CUT and SUT 
transcripts however double rrp44exo-endo-mutants showed a greater accumulation in 
comparison to the single rrp44exo- mutant (Gudipati et al., 2012b).  
 
The function(s) of CUTs and SUTs, if any, are still relatively unknown. A growing 
number of pervasive ncRNAs have been shown to have possible regulatory 
functions to control gene expression. The expression of SER3, a gene involved in 
serine and glycine biosynthesis, is modulated by the SRG1 SUT transcribed from 
the intergenic regulatory region of the SER3 allele. SRG1 was initially identified in a 
transcriptome wide screen for CUTs but was subsequently shown to be primarily 
degraded in the cytoplasmic by Xrn1 (Davis and Ares, 2006; Martens et al., 2004; 
Thompson and Parker, 2007). A high level of transcription of the SRG1 SUT was 
observed when cells were grown in rich medium. The constant transcription of 
SRG1 was postulated to prevent the binding of transcription factors to initiate 
SER3 transcription thereby repressing SER3 (Martens et al., 2005, 2004). The 
transcription of the PHO84 gene was shown to decrease in rrp6∆ cells and it was 
subsequently revealed that a CUT was generated in the antisense direction 
downstream of the PHO84 ORF (Camblong et al., 2007). Instead of transcriptional 
silencing through RNAi-like mechanisms, it has been suggested that the act of 
antisense CUT/SUT transcription itself silences sense transcription. The antisense 
transcript recruits the Hda1/2/3 histone deacetylase complex resulting in PHO84 
silencing through chromatin rearrangement. Persistent antisense transcription may 
therefore act as a buffering system to prevent sense transcription until a threshold 
of sense activation signals is reached (Camblong et al., 2007; Castelnuovo et al., 
2013).  
 
The understanding of pervasive transcription and the reasoning behind this 
seemingly wasteful process is still in its infancy. The nuclear exosome complex 
plays a key role in the rapid turnover of unstable ncRNAs in concert with Rrp47, 
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Mpp6, the NNS complex and TRAMP. Whilst it is known that these protein 
complexes are required for CUT turnover, the mechanisms involved are yet to be 
elucidated.  
 
 
1.1.3 Composit ion of the eukaryotic core-exosome complex 
 
The eukaryotic exosome complex shares common functional and structural 
features with evolutionary related structures such as the archeal exosome and 
bacterial PNPase and RNase PH. These complexes are comprised of multiple 
subunits that oligomerize to form a ring-like structure with a central channel which 
can accommodate single-stranded RNA (Harlow et al., 2004; Ishii et al., 2003; Liu 
et al., 2006; Lorentzen et al., 2005; Shi et al., 2008).  
Bacterial RNase PH is composed of a homohexamer of PH subunits that form a 
pseudo-ring structure with three-fold symmetry (Figure 1.1.A) (Harlow et al., 2004; 
Ishii et al., 2003). In a similar manner, PNPase forms a pseudo-hexameric ring 
through oligomerisation of three PNPase units comprised of two RNase PH-like 
domains, an S1 RNA binding domain and a KH domain (Figure 1.1.B) (Shi et al., 
2008). Crystal structures of exosome complexes from archeal thermophiles S. 
solfataricus, A. fulgidus and P. abyssi reveal a pseudo-hexameric ring composed 
of three Rrp41/Rrp42 heterodimers which share sequence identity with RNase PH 
proteins. The ring-like structure is capped by three copies of Rrp4 and/or Csl4, 
which contain S1 domains. Rrp4 also contains a KH domain akin to PNPase 
domains (Figure 1.1.C) (Lorentzen et al., 2005). 
The crystal structure of a reconstituted eukaryotic exosome (EXO9) revealed many 
similarities to the archeal exosome (Liu et al., 2006). The complex is composed of 
a six membered pseudo-ring structure composed three-heterodimeric pairs of 
RNase PH related proteins (Rrp41-Rrp45, Rrp43-Rrp46 and Mtr3-Rrp42). Three 
S1/KH containing proteins (Rrp4, Rrp40 and Csl4) form an asymmetric trimeric, 
capped structure on top of the PH ring (Figure 1.1.D). The complex forms a 
narrow channel of ~10-12 Å which allows unstructured ssRNA to thread through 
the complex (Liu et al., 2006; Makino et al., 2013a). Both PNPase and  
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Figure 1.1. Conserved architecture of evolutionary related exonuclease complexes. 
Cartoon representation of bacterial RNase PH (A), bacterial PNPase (B), the archaeal 
exosome (C) and the eukaryotic exosome core (D). Subunits containing phosphorolytic and 
hydrolytic exoribonuclease active sites are marked with a cross. 
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the archeal exosome contain active sites in the central pore of the respective 
complexes that catalyse phosphorylytic 3’-5’ exonuclease activity (Lorentzen et 
al., 2005; Nurmohamed et al., 2009). Surprisingly, the eukaryotic EXO9 complex 
does not possess any exonuclease activity. This is because most residues critical 
for RNA binding, phosphate and cation coordination have not been conserved 
over evolution (Dziembowski et al., 2007; Liu et al., 2006). Catalytic activity of the 
core-exosome is provided through physical and function association with Rrp44 
(also known as Dis3) which possesses both 3’-5’ exonuclease and endonuclease 
activities (Dziembowski et al., 2007; Lebreton et al., 2008; Liu et al., 2006; 
Schaeffer et al., 2009; Schneider et al., 2009).The N-terminal PIN domain of 
Rrp44 physically interacts with the bottom of EXO9 complex with PH-like proteins 
Rrp41 and Rrp45 to form the EXO10 complex (Figure 1.2.A,B) (Makino et al., 
2013a; Schneider et al., 2009). The catalytically active EXO10 complex is 
ubiquitously found in both the nucleus and cytoplasm of all eukaryotes (Lorentzen 
et al., 2008; Mitchell et al., 1997). In addition, the nuclear exosome recruits Rrp6, 
a RNase D related protein which provides additional 3’-5’ exonuclease activity 
(Briggs et al., 1998; Mitchell et al., 1997). A crystal structure of EXO10 in complex 
with a fragment of Rrp6 shows that the C-terminal region of the protein physical 
interacts with the cap region of the core-exosome complex (Makino et al., 2013a) 
 
The barrel-like architecture of the exosome can also be likened to structure of the 
proteasome complex, which is comprised of four seven-membered stacked rings. 
Although both complexes are functionally unrelated and act on different 
substrates, it is interesting to recognize the exosome and proteasome complex as 
examples of convergent evolution to a common architecture. The similarities 
between bacterial PNPase, RNase PH, archeal and eukaryotic exosome are more 
likely due to divergent evolution (Groll et al., 1997; Lorentzen and Conti, 2006).  
 
Various in vitro studies propose that single-stranded RNA is threaded through the 
S1/KH capped structure and down the channel of the PH ring to reach the 
exonuclease active site of Rrp44 docked on the bottom of the complex (Bonneau 
et al., 2009; Malet et al., 2010). A 2.8 Å resolution crystal structure of EXO10 plus  
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Figure 1.2. The eukaryotic EXO10 complex. (A) Structural arrangement of S1/KH and PH 
subunits (EXO9) plus Rrp44 (EXO10) to form the eukaryotic exosome core complex. The 
cartoon representation is based on the x-ray structure of the 11 subunit nuclear exosome 
complex shown in (B) and coloured respectively (Makino et al. 2013) (PDB=4IFD). (C) 
RNA is proposed to be channeled through the central channel of EXO9 to reach the 
exonuclease active site of Rrp44. Exonuclease and endonuclease sites are marked with 
a cross and diamond, respectively. 
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Rrp6CT in complex with RNA revealed the binding path of ssRNA through the 
channel of EXO9 (Makino et al., 2013a). The structure reveals that RNA  
is threaded into the channel after unwinding at the entry pore composed of the 
cap proteins Rrp4 and Rrp40. Subsequent base-stacking and base flipping 
mechanisms interact with the substrate to move the RNA though the capped 
structure into the internal channel and exit EXO9 to reach the exonuclease domain 
of Rrp44 (Figure 1.2.C). All components of EXO9 contribute to RNA binding 
through the complex to traverse a 110-Å path between the entrance pore and 
Rrp44 (Makino et al., 2013a) 
 
All constituents of the EXO9 complex are essential for viability in yeast. However, 
catalytic subunits Rrp44 and Rrp6 are able to bind RNA and retain catalytic 
activity in the absence of EXO9 (Allmang et al., 1999b; Dziembowski et al., 2007; 
Januszyk et al., 2011; Liu et al., 2006; Mitchell et al., 1997). This raises questions 
regarding the functions of the core-exosome complex other than as a scaffold. 
The exonuclease activity of Rrp44 in vitro is decreased when in complex with 
EXO9 suggesting that the exosome core exerts a much needed layer of control 
(Bonneau et al., 2009; Liu et al., 2006; Wasmuth and Lima, 2012). It has long 
been proposed that the recruitment of various cofactors and complexes allows 
modulation of exosome activity to process a wide variety of RNA substrates. Two 
recent independent analyses propose that the central channel of EXO9 is 
important in the modulation of both exonuclease and endonuclease functions of 
cytoplasmic and nuclear exosomes (Karolina Drążkowska, Rafał Tomecki, Krystian 
Stoduś, Katarzyna Kowalska, Mariusz Czarnocki-Cieciura, 2013; Wasmuth and 
Lima, 2012). Mutants with occlusions in the PH central channel resulted in loss of 
catalytic function of Rrp44 and Rrp6 exonucleases in vitro and caused a loss of 
viability in vivo. Interestingly, occlusion mutants also caused an inhibition of Rrp44 
endonuclease activity in vitro suggesting that the active site of the PIN domain is 
access via the central channel. This does not corroborate with recent structural 
studies which shows no access between the channel and the PIN domain which 
appears to be exposed to the solvent (Karolina Drążkowska, Rafał Tomecki, 
Krystian Stoduś, Katarzyna Kowalska, Mariusz Czarnocki-Cieciura, 2013; Makino 
et al., 2013a; Wasmuth and Lima, 2012). The channel occlusion data also 
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proposes that RNA substrates can pass through the EXO9 cap structure and exit 
through possible side channels between the S1/KH protein cap and the PH 
protein ring. However, the mechanism by which EXO9 can select a path for either 
exonuclease is yet to be resolve (Wasmuth and Lima, 2012) .  
 
 
1.2. Catalyt ic components of the eukaryotic exosome 
 
1.2.1 Rrp44 (Ribosomal RNA-processing protein 44)  
 
The core structure of the yeast exosome contains 9 subunits, 6 of which share 
20-30% identity with bacterial 3’-5’ exonucleases. However, unlike bacterial and 
archeal homologs, the eukaryotic core-exosome does not process catalytic 
activity (Liu et al., 2006; Mitchell et al., 1997). Enzymatic activity is provided 
through the association with Rrp44 (also known as Dis3 or Mtr17). Rrp44 
possesses both 3’-5’ exonuclease and endonuclease activity and is present in 
both cytoplasmic and nuclear exosome complexes. (Dziembowski et al., 2007; 
Lebreton et al., 2008; Liu et al., 2006; Schneider et al., 2009). The catalytic activity 
of Rrp44 as part of the exosome complex has been implicated in processing and 
degradation pathways of all classes of RNAs (Section 1.1.2).  
 
Rrp44 is an essential 113kDa protein that shares homology with members of the 
bacterial RNase II family of hydrolytic 3’-5’ exonucleases (Mitchell et al., 1997). 
Similar to E. coli RNase II, Rrp44 contains two N-terminal cold shock RNA-binding 
domains (CSD1 and CSD2 respectively), a central exoribonuclease (RNB) domain 
and a C-terminal S1 RNA binding domain (Frazão et al., 2006; Schneider et al., 
2007). Additionally, Rrp44 contains a N-terminal PIN (Pilus-forming N-terminus) 
domain that harbors endonuclease activity and is required to physically tether the 
protein to the core-exosome (Figure 1.3.) (Schneider et al., 2007). A conserved  
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Figure 1.3 Domain organisation and structural arrangement of Rrp44. (A) Schematic 
representation of Rrp44 domain architecture as defined by Pfam (http://pfam.xfam.org/). 
Rrp44 contains an N-terminal CR3 domain (residues 1-84), a PIN catalytic domain 
harboring endonuclease activity (84-235), two cold shock RNA binding domains (CSD1 
235-400, CSD2 400-474), a RNB catalytic domain harboring exonuclease activity 
(474-909) and a C-terminal S1 RNA binding domain (909-1001). (B) Structure 
representation of Rrp44 based on EM and X-ray crystallography data (Wang et al. 2007; 
Bonneau et al. 2009; Makino et al. 2013). Exonuclease and endonuclease containing 
domains are marked with a cross and diamond, respectively. 
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CR3 motif (cysteine-rich domain with three cysteines) N-terminal to the PIN 
domain is suggested to cluster with a conserved histidine residue and co-ordinate 
a divalent cation. Mutations in the CR3 motif leads to impaired catalytic activity 
and a reduced interaction with the core exosome suggesting that this region is 
important for structural integrity of Rrp44 (Schaeffer et al., 2012). The crystal 
structure of Rrp44 has been determined in three reports including co-complexes 
with RNA, a Rrp44-Rrp41-Rrp45 complex and more recently the structure of an 
11-subunit exosome core containing EXO9, Rrp44 and the C-terminus of Rrp6 
was solved (Bonneau et al., 2009; Lorentzen et al., 2008; Makino et al., 2013a). 
Combining results from structural and in vitro studies, it has been suggested that 
substrate RNA is threaded through the central channel of the core exosome to 
reach the exonuclease domain of Rrp44 (Bonneau et al., 2009; Malet et al., 2010).  
 
The PIN domain is found in over 300 proteins from bacteria, archaea and eukarya 
domains. The endonuclease active site contains four highly conserved basic 
residues (D91E120D171D198) that co-ordinate two divalent cations that are essential 
for catalytic activity in vitro (Schneider et al., 2009). In addition to endonucleolytic 
activity, the PIN domain physically connects Rrp44 to the RNase PH proteins on 
the exosome core (Rrp41, Rrp45) (Bonneau et al., 2009; Makino et al., 2013a; 
Schneider et al., 2009). Yeast strains lacking either exonuclease or endonuclease 
activity (Rrp44exo- or Rrp44endo- respectively) are viable whereas double Rrp44exo-, 
endo- mutants are lethal (Dziembowski et al., 2007; Schneider et al., 2009, 2007). 
Structural studies have revealed that the endonuclease site in the PIN domain is 
exposed to outer solvent and does not require channeling through the exosome 
core. (Bonneau et al., 2009; Schneider et al., 2009). Whilst Rrp44 has a wide 
range of characterised substrate targets, those specific to endonuclease activity 
are relatively unknown. In vivo northern blot analysis of Rrp44endo- mutants shows 
an accumulation of the 5’ETS fragment produced during 35S rRNA processing 
(Schneider et al., 2009). The endonuclease can cleave circular and linear ssRNA 
but is unable to process dsRNA substrates in vitro (Schaeffer et al., 2009).  
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The exoribonuclease (RNB) domain of Rrp44 shares many features with motifs in 
bacterial RNase II and RNase R and is responsible for the 3’-5’ processive 
exonuclease activity of the core-exosome (Dziembowski et al., 2007; Frazão et al., 
2006; Lorentzen et al., 2008; Mitchell et al., 1997). Catalytic activity is dependent 
on four highly conserved aspartate residues that co-ordinate two magnesium ions 
that hydrolytically cleave the backbone of RNA substrates. The loss of Rrp44 is 
lethal in yeast yet surprisingly mutations in the conserved Asp residues abolishes 
catalytic activity but are tolerated (Dziembowski et al., 2007; Liu et al., 2006; 
Schaeffer et al., 2009; Schneider et al., 2007). The exonuclease active site is 
buried within the protein and requires substrates with ssRNA overhangs of at least 
7nt long to enter a narrow cavity formed by the CSD1, CSD2 and S1 RNA binding 
domains. This cavity forms a clamp structure similarly observed in bacterial RNase 
II. The clamp architecture holds substrates in place whilst the exonuclease attacks 
the 3’ ends of ssRNA and degrades in a processive manner, releasing nucleoside 
5’-monophosphates and leaving a short product of a few nucleotides long. 
(Lorentzen et al., 2008; Wang et al., 2007; Zuo et al., 2006). In contrast to 
RNaseII, Rrp44 is able to degrade structured substrates in vitro as long as there is 
a single-stranded 3’ overhang of at least 4 nucleotides. Longer 3’ overhangs are 
more efficiently degraded (Dziembowski et al., 2007; Lorentzen et al., 2008). This 
suggests that the processive nature of the enzyme is able to unwind structured 
RNA upon capture in the clamp channel prior to subsequent degradation.  
Crystal structure analysis of the core-exosome plus Rrp44 reveal that the central 
channel formed by EXO9 feeds into the exoribonucleolytic channel of Rrp44 and 
RNA substrates are threaded through. This requires an unstructured ssRNA 
overhang of at least 31-33nt to be able to pass through the exosome core to 
reach the active site of Rrp44. (Bonneau et al., 2009; Makino et al., 2013a; Malet 
et al., 2010). An alternative, more direct, route has been proposed where RNA can 
bypass the core-exosome channel and access the exonuclease domain of Rrp44 
directly. This secondary route is theorized to be accessible with much shorter 3’ 
ssRNA overhangs and could possibly be a pathway for the degradation of highly 
structured substrates (Bonneau et al., 2009; Makino et al., 2013a; Wang et al., 
2007) 
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The exosome complex has been shown to function in the degradation and 
processing of a multitude of coding and non-coding RNAs produced from all three 
RNA polymerases (Allmang et al., 2000; Kadaba et al., 2004; van Hoof et al., 
2000a; Wlotzka et al., 2011). Catalytic activity can be attributed to three units; the 
endonuclease domain of Rrp44 and the exonuclease domains of both Rrp44 and 
Rrp6. Determining the specific targets of each catalytic unit is challenging due to 
levels of redundancy and co-operation within the exosome and other 
exonucleases.  
Novel high-resolution, transcriptome-wide analyses of rrp6Δ, rrp44exo- and 
rrp44endo- mutants have recently identified a broad range of exosome substrates 
(Gudipati et al., 2012b). Both Rrp44 and Rrp6 appear to have overlapping targets 
yet distinct functions suggesting a level of co-operation between each catalytic 
unit. This dataset proposes that Rrp44 and Rrp6 both function in the degradation 
of CUTs and SUTs whereas Rrp44 has a more specific role in pre-tRNA 
degradation and the turnover of intro-containing mRNAs. In addition to the 
turnover of CUTs and SUTs, Rrp6 was proposed to play a specific role in pre-
snRNA and snoRNA degradation. This is consistent with previous observations of 
accumulated 3’-extended pre-snRNA and snoRNA species in rrp6Δ strains 
(Allmang et al., 1999a; Gudipati et al., 2012b; van Hoof et al., 2000a).  
In vivo protein-RNA crosslinking and analysis of cDNAs (CRAC) was applied to 
Rrp44 and Rrp6 along with catalytic mutants to identify target substrates 
(Schneider et al., 2012). Transcriptome-wide binding profiles identified associated 
substrates from all classes of RNA in accordance to previous analysis. 
Interestingly, disruption of the endonuclease domain (Rrp44endo-) did not appear to 
alter substrate binding significantly. However, the Rrp44exo-°mutant showed a 
strong enrichment of characterised exosome substrates including CUTs, SUTs, 
snRNAs and snoRNAs. Strikingly, almost 40% of observed crosslinks in the 
Rrp44exo- mutant were products of RNA Pol III transcription including 5S rRNA and 
U6 snRNA. A large amount of crosslinked transcripts were shown to be 
oligoadenylated, which implies that they had been targeted for degradation. 
Parallel CRAC analyses using Trf4, a component of the TRAMP complex, revealed 
strong overlaps in oligoadenylated substrates which corroborates previous studies 
suggesting co-operation between TRAMP-dependent polyadenylation and 
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exosome-degradation (Houseley and Tollervey, 2006; LaCava et al., 2005; 
Schneider et al., 2012; Vanácová et al., 2005; Wyers et al., 2005). CRAC analysis 
also revealed a strong overlap of substrates between Rrp6 and Rrp44. This level 
of functional redundancy may explain the synthetic lethality between rrp6∆ and 
rrp44exo- mutants. The Tollervey lab proposes a model for strong co-operation 
between the endonuclease domain of Rrp44 with the exonuclease domains of 
Rrp44 and Rrp6. Endonucleolytic cleavage events would provide favorable free 3’ 
ends for Rrp6, Rrp44 or other cellular exonucleases such as Rex1. In rrp44exo- 
mutants, endonuclease activity would still provide substrates for degradation by 
Rrp6 or other exonucleases, albeit less efficiently (Schneider et al., 2012). 
 
 
1.2.2 Rrp6 (Ribosomal RNA-processing protein 6)  
 
Rrp6 is a member of the DEDD superfamily of 3’-5’ exonucleases which also 
includes bacterial RNaseD (Zuo and Deutscher, 2001). In addition to Rrp44, Rrp6 
provides catalytic activity to the exosome but differs in its exclusive association 
with the nuclear exosome (Allmang et al., 1999b). Deletion of RRP6 is not and 
cause slow growth phenotypes at 30°C and no growth at 37°C (Briggs et al., 
1998). The loss of core exosome components is lethal; therefore rrp6Δ strains are 
a useful tool for the understanding of exosome-mediated processing and 
degradation of all classes of RNA. The characterisation of cryptic unstable 
transcripts (CUTs) was carried out in rrp6Δ strains as a tool to maintain stable 
expression of unstable intergenic transcripts (Wyers et al., 2005). Rrp6 interacts 
physically and functionally with a small nuclear RNA binding protein called Rrp47. 
The expression levels of either protein are mutually dependent on this physical 
interaction with Rrp47 being more sensitive to the loss of Rrp6 (Costello et al., 
2011; Feigenbutz et al., 2013a, 2013b; Garland et al., 2013; Stead et al., 2007) 
 
The human homolog or Rrp6, PM-Scl100, was initially identified as a protein for 
which antibodies were found in patients suffering from polymitosis, sclerderma or 
an overlap of the two diseases (Alderuccio, 1991; Ge et al., 1992). 
Immunoprecipitation experiments revealed PM-Scl100 to be associated with large 
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complexes of 11-16 proteins (Gelpi et al., 1990; Reimer et al., 1986). Rrp6 was 
initially identified in yeast through genetic screening where rrp6 mutants showed 
suppression of a temperature sensitive pap1-1 mutation. Subsequent cloning and 
sequencing of the RRP6 locus revealed significant homology to Pm-Scl100 
(Briggs et al., 1998).  
 
Rrp6 comprises 733 amino acids and has a molecular weight of ~84kDa. The 
protein contains an N-terminal PMC2NT domain (Staub et al., 2004), an 
exonuclease domain, two HRDC (Helicase RNaseD C-terminal) domains 
(Midtgaard et al., 2006) and a bipartite nuclear localisation signal (NLS) at the C-
terminus (Figure 1.4.A) (Briggs et al., 1998).  
 
The N-terminal PMC2NT (N-terminal domain in 3’-5’-exonucleases like 
Polymyositis autoantigen 2) domain of Rrp6 (Rrp6NT) interacts physically with the 
N-terminal Sas10/C1D domain of the RNA binding protein Rrp47, a small nuclear-
specific exosome associated co-factor (Stead et al., 2007). Normal expression 
levels of Rrp47 are strongly dependent on the physical interaction with Rrp6NT with 
protein levels decreased by 90% in the absence of Rrp6 (Feigenbutz et al., 2013b; 
Stead et al., 2007). The PMC2NT domain is found in eukaryotic Rrp6 homologs 
but not in bacterial RNaseD (Carpousis, 2002). Although crystal structures of Rrp6 
have been solved, these unfortunately do not include the N-terminal regions of the 
protein (Makino et al., 2013a; Midtgaard et al., 2006). Protein structure prediction 
programs suggest the N-terminus to be largely α-helical in nature. Partial crystal 
structures confirm four short α-helices between residues 132 and 210 (Kelley and 
Sternberg, 2009; Midtgaard et al., 2006; Stead et al., 2007). The PMC2NT 
domain alone is sufficient to bind Rrp47 in vitro, yet inclusion of the α-helices 
downstream of the PMC2NT domain increases the efficiency of the pulldown 
(Stead et al., 2007).  
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Figure 1.4. Domain structure of Rrp6 and organisation of EXO11 complex. (A) Schematic 
representation of Rrp6 domain architecture as defined by Pfam. Rrp6 contains an N-terminal 
PMC2NT domain (residues 13-102), four α-helices (132-210), a catalytic exonuclease (EXO) 
domain (283-381), a HRDC domain (438-505) and a C-terminal nuclear localisation signal 
(NLS). The exosome binding region of Rrp6 is defined between residues 518-693. (B) X-ray 
structure of the eukaryotic EXO9 complex plus Rrp44 and the C-terminal region of Rrp6 
(Rrp6CT) from Makino et al (2013) (PDB=4IFD). The C-terminus of Rrp6 (Green) physically 
interacts with Csl4, Mtr3 and Rrp43 of the core exosome complex (EXO9) (C) Cartoon 
representation of the EXO11 complex. Exonuclease and endonuclease containing domains are 
marked with a cross and diamond, respectively. 
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The exonuclease domain of Rrp6 contains three motifs conserved between 
homologs in model organisms termed ExoI, ExoII and ExoIII respectively (Burkard 
and Butler, 2000). The DEDD family of proteins are characterised by an Asp-Glu-
Asp-Asp motif in the catalytic residues of the exonuclease active site. These 
residues co-ordinate two divalent cations that are involved in the activation of a 
water molecule to attack the terminal phosphodiester bond of the target nucleic 
acid (Steitz and Steitz, 1993). Rrp6 was shown to require both Mn2+ and Zn2+ 
cations to form protein-ribonucleotide complexes through systematic 
crystallographic analysis of cation binding (Midtgaard et al., 2006). Mutations in 
critical aspartate or glutamate residues lead to a loss of catalytic function. The 
RRP6 gene was originally cloned by complementation of a catalytic rrp6-1 allele 
that harbors a D238N mutation (Briggs et al., 1998; Burkard and Butler, 2000).  
 
Rrp6 contains two HRDC (Helicase RNaseD C-terminal) domains that fold into 
characteristic 5-α-helical structures. First identified in the RecQ family of proteins, 
the HRDC domain was characterised as a putative nucleic acid binding domain 
(Morozov et al., 1997). Crystal structures of Rrp6 peptides have only included the 
N-terminal-end HRDC1 domain which folds almost undistinguishable to the 
homologous domain found in bacterial RNaseD (Midtgaard et al., 2006; Zuo et al., 
2005). The RNA binding properties of the HRDC domains in Rrp6 have not been 
demonstrated experimentally. Crystal structures revealed the position of the 
HRDC1 domain to be stabilised by a conserved aspartic acid residue (D457) in 
concordance with a homologous D232 in RNaseD. RNA analysis in a D457A 
mutant shows a retarded function for 3’-maturation of 5.8S rRNA and snoRNA yet 
the turnover of 5’ETS and polyadenylated snoRNAs was not affected. This 
suggests that the position of the HRDC1 domain is important for the 3’-end 
processing function of Rrp6 but is not important for RNA degradation most likely 
in concert with the core exosome and Rrp44 (Midtgaard et al., 2006; Phillips and 
Butler, 2003). Deletion of either or both HRDC domains in Rrp6 results in the loss 
of association with the core-exosome complex. HRDC2, but not HRDC1 deletions 
in Rrp6 allow normal 3’-end processing of pre-5.8S rRNA and pre-snoRNAs but 
are unable to degrade 5’ETS. This demonstrated that Rrp6 functions 
independently of the core-exosome in 3’-end processing but still requires the core 
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exosome and co-operative activity with Rrp44 for the turnover of degradation 
substrates (Callahan and Butler, 2008). Rrp6 has since been shown to 
allosterically stimulate the function of Rrp44 (Wasmuth and Lima, 2012) and will be 
discussed below.   
 
The C-terminal region of Rrp6 contains two putative nuclear localisation signals 
(NLS). Biofractionation experiments initially revealed Rrp6 to be associated with 
only the nuclear fraction of exosome complexes. This was corroborated by 
immunofluorescence analysis revealing Rrp6 was localized to the nucleus (Allmang 
et al., 1999b; Briggs et al., 1998). Deletion of the NLS region of Rrp6 results in 
mis-localisation to the cytoplasm (Phillips and Butler, 2003). More recently it has 
been shown that Rrp6 is imported into the nucleus via the importin complex 
involving the Srp1/Kap95 heterodimer (the yeast homologs of importins α and β) 
(Feigenbutz et al., 2013b). Mass spec analysis of Rrp6 pulldowns were shown to 
contain Srp1 and Kap95 proteins and corroborated in a later study (Feigenbutz et 
al., 2013b; Synowsky et al., 2009). Interestingly, the Rrp6-associated co-factor 
Rrp47 was not found to be associated with the Rrp6/Srp1 complex suggesting 
that Rrp47 is localised to the nucleus independent of Rrp6 before the assembly of 
the Rrp6/Rrp47 homodimer (Feigenbutz et al., 2013b). Additionally, the C-
terminus of Rrp6 (Rrp6CT) is required for contact with the core exosome complex. 
A recent crystal structure of EXO10 in complex with Rrp6CT shows that this region 
interacts with the Csl4 subunit of the S1/KH cap along with Mtr3 and Rrp43 
subunits that make up the PH ring of EXO9 (Figure 1.4.B-C) (Makino et al., 2013a) 
 
1.2.3. Specif ic functions of Rrp6 in RNA maturation and degradation  
 
The initial identification and characterisation of yeast Rrp6 showed that catalytic 
rrp6-1 mutants resulted in the accumulation of a 5.8S rRNA species extended at 
the 3’ end by 30 nucleotides dubbed 5.8S + 30. This phenotype correlated with a 
20 fold decrease in mature levels of 5.8S compared to wildtype levels suggesting 
a block in 3’-end processing (Briggs et al., 1998). However, the majority of pre-
5.8S rRNA molecules are correctly processed to mature 5.8S suggesting a level of 
redundancy via alternative pathways. Rrp6 trims the 5.8S + 30 rRNA species, 
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generated from the 7S rRNA by exosome-dependent processing, to 6S rRNA 
which undergoes final 3’-end maturation by Ngl2 after export to the cytoplasm 
(Briggs et al., 1998; Mitchell et al., 1997, 1996; Thomson and Tollervey, 2010). 
The 3’ extended 5.8S + 30 rRNA is also accumulated in yeast cells lacking Rrp47 
and a similar phenotype was observed in mammalian cells depleted of the human 
homolog C1D (Mitchell et al., 2003; Schilders et al., 2007; Stead et al., 2007). This 
suggests a key requirement of Rrp47 is to aid Rrp6 in efficient 3’-end processing 
rRNA precursors. The mechanism by which Rrp47 promotes Rrp6 catalytic 
activity is still poorly understood.  
 
In addition to the maturation of ribosomal RNA, Rrp6 function has been ascribed 
to the 3’-end processing of snoRNAs and snRNA precursor transcripts. Northern 
blot analysis of snoRNAs and snRNAs in rrp6Δ cells showed a slowed migration 
suggesting a block in the final steps of processing. Pre-snoRNA and some 
snRNAs are transcribed as 3’ extended precursors that undergo initial 3’-5’ 
trimming by Rrp44 as part of the core-exosome before release and undergoing 
the final precise 3’-maturation by Rrp6 (Allmang et al., 1999a; van Hoof et al., 
2000a). Rrp6 is still able to function in 3’-end processing of 5.8S, snoRNAs and 
snRNAs independently of association with the core exosome complex but is 
dependent on the physical interaction with Rrp47 (Callahan and Butler, 2008; 
Mitchell et al., 2003; Stead et al., 2007).  
 
The surveillance and degradation of aberrant ncRNAs, rRNA processing 
intermediates and products of pervasive intergenic transcription is key in 
maintaining a stable transcriptome in eukaryotes. Rrp6 and the core-exosome 
have been shown to be major contributors in many surveillance and degradation 
pathways in concert with additional co-factors and complexes. As Rrp6 is a non-
essential component of the nuclear exosome, rrp6Δ strains have allowed the 
identification and characterisation of a myriad of RNA degradation substrates.  
 
In the absence of Rrp6, cells not only show rRNA processing defects but also 
accumulate byproducts of processing such as the excised spacer fragment 
extending from the 5’ end to the A0 cleavage site of the 35S polycistronic pre-
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rRNA transcript (5’ external transcribed spacer, 5’ETS). The 5’ETS processing 
byproduct is also accumulated in core exosome mutants suggesting a co-
operative or redundant pathway for 5’ETS degradation (Allmang et al., 1999a, 
1999b; de la Cruz et al., 1998).  
 
As mentioned above, Rrp6 is required for the final steps of 3’-end maturation of 
snoRNA and some snRNAs. A block in the processing of snRNA and snoRNAs 
results in the accumulation of short 3’ extended transcripts as observed in rrp6Δ 
mutants (Allmang et al., 1999a). Additionally, rrp6, rrp47 and core exosome 
mutants were shown to accumulate a smaller amount of longer 3’-polyadenylated 
snoRNA and snRNAs. This phenotype was also observed upon the loss of an 
ATP-dependent RNA helicase, Mtr4 (Allmang et al., 1999a; de la Cruz et al., 1998; 
Mitchell et al., 2003; van Hoof et al., 2000a). Polyadenylation of other ncRNAs 
were reported such as pre-rRNA, rRNA and a hypermodified aberrant pre-tRNAiMet 
(Kadaba et al., 2004; Kuai et al., 2004). The stabilisation of defective tRNAiMet was 
observed in mutations in a putative poly(A) polymerase, Trf4. Likewise, tRNAiMet 
was stabilised in the absence of Rrp6 or conditional rrp44 mutants (Kadaba et al., 
2004). This suggested that Trf4-dependent polyadenylation of ncRNAs leads to 
degradation by the exosome and Rrp6. Both Trf4 and Mtr4 were identified to be 
components of the nuclear polyadenylation TRAMP complex comprised of the 
poly(A) polymerase Trf4, zinc knuckle RNA binding protein Air2 and the RNA 
helicase Mtr4. (LaCava et al., 2005; Vanácová et al., 2005). The components of 
the TRAMP complex will be discussed further below. Rrp6, Rrp44 and TRAMP 
complexes work in concert to play an essential role in the turnover of non-coding 
RNAs.  
 
Transcriptome-wide analysis of yeast strains lacking Rrp6 identified 
polyadenylated non-coding RNAs in agreement with previous observations. 
Additionally, a novel class of polyadenylated RNA pol II transcripts derived from 
intergenic regions was identified and later termed as cryptic unstable transcripts 
(CUTs). Polyadenylation of CUTs is almost completely dependent on the activity of 
Trf4 as part of the TRAMP complex (Wyers et al., 2005). The use of rrp6Δ and 
TRAMP mutant strains has been widely reported as a tool to stabilise and 
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characterise cryptic unstable transcripts (Camblong et al., 2007; Davis and Ares, 
2006; Uhler et al., 2007; Wyers et al., 2005; Xu et al., 2009).  
 
Whilst the role of Trf4 and Rrp6 in polyadenylation and subsequent degradation of 
CUTs was clear, the mechanism for initial targeting was relatively unknown. 
Through ChIP analysis it was revealed that Nrd1 and Nab3 proteins are localised 
to chromosomal regions expressing CUTs (Arigo et al., 2006). Nrd1 and Nab3 
have previously been shown to be involved in 3’-end formation of snRNAs and 
snoRNAs coupled to transcriptional termination in concert with RNA Pol II and the 
RNA helicase Sen1 collectively known as the NNS (Nrd1/Nab3/Sen1) complex 
(Conrad et al., 2000; Steinmetz and Brow, 1996; Steinmetz et al., 2001). In nrd1 
and nab3 mutants, 3’-extended snoRNA transcripts are accumulated due to 
errors in transcriptional termination. The resulting transcripts read through the 
normal Nrd1-dependent termination point and extend into neighboring coding 
regions before termination at an mRNA cleavage/polyadenylation site. In addition 
to sn- and snoRNAs, 3’-extended read-through transcripts that arise from the well 
characterised NEL025c CUT locus were accumulated in conditional nrd1 and 
nab3 mutants (Arigo et al., 2006; Thiebaut et al., 2006). Two classes of NEL025c 
transcript were characterised in the Libri and Corden labs; a series of short, 
polyadenylated NEL025cS transcripts and a longer NEL025cL transcript. The 
shorter species were shown to be polyadenylated by Trf4 as part of the TRAMP 
complex and are stabilised in exosome mutants including rrp6Δ strains. The 
NEL025cL species accumulates in conditional nrd1 and nab3 mutants and is 
polyadenylated by Pap1. This supports a model of alternative transcription 
termination of CUTs where shorter RNAs from Nrd1/Nab3-dependent termination 
are polyadenylated by Trf4 as targets for exosome-dependent degradation. 
Longer transcripts are generated from a loss of Nrd1/Nab3-dependent termination 
and read through into downstream genes before terminated at the canonical 
mRNA cleavage/polyadenylation site (Arigo et al., 2006; Thiebaut et al., 2006; 
Wyers et al., 2005). This model along with other data suggests that the 
exosome/Rrp6/TRAMP and NNS complexes couple transcriptional termination, 
polyadenylation and rapid turnover of CUTs as part of a major RNA surveillance 
complex. However, the mechanisms that govern substrate recognition for either 
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productive or destructive generation of RNA PolII transcripts are still relatively 
unknown. 
It has been suggested that exosome-associated cofactors that possess RNA 
binding activity such as Rrp47, Mpp6 and the Air1/2 proteins may function to 
differentiate substrate recognition to target transcripts for processing or 
degradation pathways coupled with TRAMP, Nrd1/Nab3 and the core-exosome 
or Rrp6 (Milligan et al., 2008; Mitchell et al., 2003; Schmidt et al., 2012). The 
mechanisms underlying this putative substrate recognition are poorly 
characterised and further investigation is required.  
 
1.3. Exosome associated co-factors 
 
The nuclear exosome complex must distinguish a wide array of RNA substrates 
for a number of separable functions in vivo. The nuclease activities of Rrp44 and 
Rrp6 require regulation to prevent ubiquitous RNA degradation. The physical 
association of Rrp44 to the catalytically inert EXO9 significantly decreases 
enzymatic activity (Liu et al., 2006; Wasmuth and Lima, 2012). Further modulation 
of Rrp6 and Rrp44 is achieved through the association with small nuclear proteins 
Rrp47 and Mpp6 in addition to larger complexes such as Trf4/Air2/Mtr4 (TRAMP) 
and Nrd1/Nab3/Sen1 (NNS). These co-factors are proposed to be required for 
recognition of substrates in order to recruit the exosome for productive or 
degradative functions.  A summary of exosome components and cofactors is 
detailed in Figure 1.5 and Table 1.1.   
 
 
1.3.1 Rrp47 (Ribosomal RNA-processing protein 47)  
 
The yeast protein Rrp47 (also known as Lrp1 and yC1D) is a nuclear-specific 
exosome-associated co-factor that can bind RNA and DNA (Kumar et al., 2002; 
Mitchell et al., 2003; Stead et al., 2007). Along with its putative human homolog 
C1D, Rrp47 was implicated as a DNA binding protein involved in double strand  
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Figure 1.5. Summary of exosome associated co-factors in S. cerevisiae. 
The yeast core exosome (EXO9) associates with a number of distinct co-
factors and complexes in both the nucleus and cytoplasm. Co-factors 
depicted have been identified to be functionally and/or physically 
associated with EXO9. 
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Complex/co-factors! Yeast 
protein!
Location ! Human homolog! Description/role!
Core Exosome (EXO9)! Rrp41! n + c! hRrp41! RNasePH domain, non-catalytic core 
exosome component!
Rrp42! n + c! hRrp42! RNasePH domain, non-catalytic core 
exosome component!
Mtr3! n + c! hMtr3! RNasePH domain, non-catalytic core 
exosome component!
Rrp43! n + c! hRrp43! RNasePH domain, non-catalytic core 
exosome component!
Rrp45! n + c! hRrp45! RNasePH domain, non-catalytic core 
exosome component!
Rrp46! n + c! hRrp46! RNasePH domain, non-catalytic core 
exosome component!
Rrp4! n + c! hRrp4! S1/KH domain, non-catalytic core 
exosome component!
Rrp40! n + c! hRrp40! S1/KH domain, non-catalytic core 
exosome component!
Csl4! n + c! hCsl4! S1/KH domain, non-catalytic core 
exosome component!
Catalytic subunits! Rrp44! n + c! Dis3, Dis3L, 
Dis3L2!
RNaseII-related 3’-5’ exonuclease, 
putative endonuclease !
Rrp6! n! PM/Scl-100! RNaseD-related 3’-5’ exonuclease!
TRAMP complex! Trf4! n! ?PAPD5 + POLS! Non-canonical poly(A) polymerase!
Trf5! n! ?PAPD5 + POLS! Non-canonical poly(A) polymerase!
Air1! n! ?ZCCHC7! ZnK RNA binding protein !
Air2! n! ?ZCCHC7! ZnK RNA binding protein !
Mtr4! n! hMtr4 (SKIV2L2)! DExH RNA helicase !
NNS complex! Nrd1! n! ?! RNA binding and RNA pol II CTD binding!
Nab3! n! ?! RNA binding !
Sen1! n! Senataxin! Type I 5’-3’ ATP-dependent DNA/RNA 
helicase!
SKI complex ! Ski2! c! hMtr4 (SKIV2L2)! DExH RNA helicase !
Ski3! c! hSki3! Ski complex component!
Ski8! c! hSki8! Ski complex component!
Co-factors ! Rrp47! n! C1D! RNA/DNA binding protein!
Mpp6! n! MPP6! RNA binding protein !
Ski7! c! ?! Bridges SKI and exosome complexes, 
putative GTPase!
Table 1.1. Summary of Exosome components and associated proteins in yeast. Proteins are 
subcategorized into known complexes. Characterised human homologs are shown.‘?’ indicates 
that sequence homologs have not been identified or have not been confirmed. Location refers to 
subcellular localisation of proteins, either in the nucleus (n) and/or the cytoplasm (c). 
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break repair of DNA (Erdemir et al., 2002; Nehls et al., 1998; Yavuzer et al., 1998). 
Rrp47 was identified as an exosome-associated protein through pulldown 
experiments using Rrp44 and subsequent mass spectrometry (Mitchell et al., 
2003). Both Rrp47 and C1D associate physically and functionally with the nuclear  
exosome component Rrp6 (PM-Scl-100 in humans) and the stability of Rrp47 
expression is dependent on the physical interaction with Rrp6 (Feigenbutz et al., 
2013b; Schilders et al., 2007; Stead et al., 2007). Loss-of function rrp47 mutants 
exhibit RNA phenotypes similar to observations in rrp6Δ mutants suggesting a 
requirement for the processing of 5.8S rRNA, snoRNAs, snRNAs and the 
degradation of cryptic unstable transcripts (CUTS) (Arigo et al., 2006; Costello et 
al., 2011; Milligan et al., 2008; Mitchell et al., 2003). Yeast strains lacking Rrp47 
are synthetic lethal with a loss of the exosome co-factor Mpp6 (Milligan et al., 
2008) or the 3’-5’ exonuclease Rex1 (Peng et al., 2003).  
 
Rrp47 is a small basic protein with a molecular weight of 21kDa. With a lack of 
published structural information, secondary structure prediction analysis suggests 
that the first ~120 residues of the protein are to be generally α-helical in nature 
whereas the C-terminus is thought to be highly disordered and unstructured 
(Kelley and Sternberg, 2009). The N-terminus (residues 10-89) contains the 
bioinformatically-defined Sas10 domain found in the Sas10/C1D family of proteins 
(Pfam: PF04000) (Figure 1.6.A). This family includes the U3 ribonucleoprotein 
components Utp3 (also known as Sas10) and Lcp5 (Dragon et al., 2002; 
Wiederkehr et al., 1998), Rrp47 and its human homolog C1D (Mitchell et al., 2003) 
and the human initial factor 4e binding protein Neuroguidin (Jung et al., 2006). 
Functional studies of the Rrp47 protein reveal that residues 10-100, 
encompassing the Sas10/C1D domain, are critical for the protein function in vivo 
(Costello et al., 2011).  
 
Rrp47 and Rrp6 interact physically through their N-terminal Sas10/C1D and 
PMC2NT domains respectively (Figure 1.6.B). This interaction is critical to the 
stability of Rrp47 in vivo as the loss of Rrp6 causes a strong decrease in 
expression levels of Rrp47 protein through proteasome degradation (Costello et 
al., 2011; Feigenbutz et al., 2013b; Stead et al., 2007). Recombinant Rrp47 can  
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Figure 1.6. Domain architecture of Rrp47. (A) Schematic representation of Rrp47 
domain architecture as defined by Pfam. Rrp47 contains an N-terminal Sas10/C1D 
domain (residues 10-89) and a conserved lysine rich region at the C-terminus 
(162-184). The N-terminus (1-120) is predicted to be α-helical where as the C-
terminus (121-184) is predicted to be unstructured using bioinformatics tools. (B) 
Model schematic of Rrp47/Rrp6 interaction. The N-terminal Sas10/C1D domain of 
Rrp47 physical interacts with the N-terminal PMC2NT domain of Rrp6. 
Rrp6!
PMC2NT!
Rrp47
!
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form homodimers in vitro and can form heterodimers with the N-terminus of Rrp6 
(Rrp6NT) in a 1:1 stoichiometry. Although Rrp47 and Rrp6 ultimately form a 
heterodimer in the nucleus in vivo, both proteins are independently imported into 
to the nucleus with Rrp6 transported via the importin complex (Feigenbutz et al., 
2013b). These results suggest that Rrp47 is initially expressed as a homodimer in 
the cytoplasm and is dissociated following import to the nucleus to form the 
functional Rrp6/Rrp47 homodimer.   
 
Rrp47 has been shown to bind nucleic acids in vitro with a preference for 
structured substrates (Stead et al., 2007). However, the protein does not possess 
any characterised RNA or DNA binding domains and therefore may possess a 
novel nucleic acid binding mechanism. It was initially thought that the highly basic 
lysine-rich C-terminus of Rrp47 provided an ideal region for RNA binding. 
Biochemical analysis revealed that RNA binding in vitro is dependent on both the 
C-terminal basic residues along with residues in the N-terminus (Costello et al., 
2011).  
 
The exact molecular function of Rrp47 is still to be elucidated entirely. Yeast 
strains lacking Rrp47 show defects in RNA processing and degradation pathways. 
These phenotypes closely resemble those seen in rrp6 mutants such as the 
accumulation of pre-rRNA intermediates (including 5.8S+30, 27SA2, 23S and 35S 
rRNA species), a block in 3’-end Box C/D snoRNA maturation, the stabilisation of 
cryptic unstable transcripts (CUTs) and the accumulation of RNA surveillance 
targets including the 5’-external transcribed spacer region of 35S rDNA (5’ETS) 
(Costello et al., 2011; Garland et al., 2013; Milligan et al., 2008; Mitchell et al., 
2003; Peng et al., 2003).  
 
Taking together the RNA binding properties of Rrp47, the physical interaction 
between Rrp47 and Rrp6 and the similarities in RNA phenotypes upon the loss of 
either protein, it was suggested that Rrp47 might promote substrate binding to 
Rrp6 thus acting in RNA recruitment for Rrp6 dependent processing or 
degradation (Costello et al., 2011; Mitchell et al., 2003; Stead et al., 2007).  
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1.3.2 Mpp6 (M-phase phosophoprotein 6)  
 
Yeast Mpp6 is a small, basic, exosome-associated RNA binding co-factor that 
shares many features with Rrp47. The human homolog, MPP6, was initially 
identified as a nuclear-specific protein in interphase cells that is subsequently 
targeted for MPF2-kinase-dependent phosphorylation during M-phase of the cell 
cycle (Matsumoto-Taniura et al., 1996). Both yeast Mpp6 and human MPP6 have 
been shown to co-purify with exosome complexes (Chen et al., 2001; Krogan et 
al., 2006; Milligan et al., 2008). MPP6 was found to be associated with exosome 
complexes that contained the Rrp6 homolog PM-Scl100 but lacked the Rrp44 
homolog Dis3 (Chen et al., 2001).  
 
Yeast Mpp6 was originally identified in a genetic screen for synthetic lethal 
interactions with the loss of Rrp47 or Air1, a zinc-knuckle protein component of 
the TRAMP complex (Milligan et al., 2008). Additionally, mpp6∆ alleles were 
shown to be synthetic lethal with a loss of Rrp6. This suggests that Mpp6 does 
not function redundantly with Rrp47 to promote substrate recognition for Rrp6-
dependent processing or degradation. The Tollervey lab proposed the model that 
Mpp6 acts to target RNAs to the core-exosome for Rrp44-dependent 
exonuclease activity (Milligan et al., 2008). Mammalian MPP6 shows physical 
interactions with PM-Scl100 (Rrp6 in yeast) and hMtr4, a 3’-5’ ATP-dependent 
helicase and part of the TRAMP complex (Schilders et al., 2007). Taken with the 
knowledge of the synthetic lethality between mpp6∆ and air1∆ alleles and the 
association of MPP6 with exosome complexes lacking Dis3 (Rrp44), an alternative 
model is that Mpp6 promotes functional coupling between Rrp6 and the TRAMP 
complex (Butler and Mitchell, 2011).  A more recent study of the targeted 
degradation of aberrant mRNPs by Rrp6-dependent quality control pathways 
shows that Mpp6 is co-transcriptionally recruited along with Rrp47 and 
components of the TRAMP complex (Trf4/5 and Air2) to aberrant mRNPs 
(Stuparevic et al., 2013). Subsequent degradation of aberrant mRNPs is 
suggested to be generally dependent on Rrp6 catalytic activity and not Rrp44. 
Although no physical interaction between Mpp6 and Rrp6/Rrp47 has been 
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shown, it could be possible that Mpp6 recruits Rrp6 indirectly, possibly through 
the TRAMP complex.  
 
Whilst Rrp47 shows a preference for binding of structured RNAs, Mpp6 was 
shown to bind unstructured pyrimidine-rich RNA sequences such as poly(U) RNA 
(Milligan et al., 2008; Schilders et al., 2007, 2005; Stead et al., 2007). Mpp6 
contains no annotated RNA binding motifs and therefore represents a novel RNA 
binding protein. The physical association of Mpp6 to the exosome is independent 
of its ability to bind RNA as shown in tandem affinity purification experiments 
treated with RNaseA (Milligan et al., 2008). The C-terminus of Mpp6 is enriched 
with basic residues similar to the lysine-rich region of Rrp47. This could possible 
contribute to RNA binding through electrostatic attraction. However, in the case of 
Rrp47; both the basic C-terminus and the N-terminus were shown to contribute to 
RNA binding (Costello et al., 2011). There is no detailed structural data available 
for Mpp6. Primary sequence analysis reveals no presence of any annotated 
domain structures and secondary structure prediction software reveals 
inconclusive results yet suggests that the protein is highly disordered (Section 5.1, 
Kelley & Sternberg 2009). Sequence homology reveals two conserved motifs 
shared between Mpp6 homologs in model organisms (Milligan et al., 2008). These 
motifs will be discussed in further detail in Chapter 5.   
 
The role of Mpp6 in RNA degradation has been poorly studied since its discovery. 
Whilst the physical and functional interactions between Rrp47 and Rrp6 have 
been thoroughly investigated (Costello et al., 2011; Feigenbutz et al., 2013a, 
2013b; Stead et al., 2007), it is unknown how Mpp6 directly interacts with 
exosome complexes and how it stimulates targeted degradation of RNA 
surveillance substrates.  
 
 
1.3.3. The TRAMP complex (Trf4/Air2/Mtr4 Polyadenylat ion complex)  
 
TRAMP complexes are composed of a non-canonical poly(A) polymerase Trf4 or 
Trf5, a zinc-knuckle RNA-binding protein Air1 or Air2 and the putative RNA 
! 36!
helicase Mtr4. (Houseley and Tollervey, 2006; LaCava et al., 2005; Vanácová et 
al., 2005; Wyers et al., 2005). In a pathway completely distinct from the productive 
3’-tail polyadenylation of mRNAs, the TRAMP complex functions to oligoadenylate 
ncRNA substrates for Rrp6 and core-exosome dependent processing and 
degradation. The TRAMP complex has been implicated in the 3’-end maturation 
of non-coding RNAs (snRNA and snoRNAs) and coding-RNAs (mRNAs). 
Additionally, TRAMP has been shown to be required for the turnover of functional 
mRNAs, aberrant ncRNAs and the rapid degradation of pervasive RNA PolII-
generated cryptic unstable transcripts (Ciais et al., 2008; Grzechnik and Kufel, 
2008; Vanácová et al., 2005; Wyers et al., 2005). Although a large number of 
TRAMP targets have been reported, it is still relatively unknown how the TRAMP 
complex is able to distinguish RNA substrates to target for constructive or 
destructive pathways involving the exosome.  
 
 
1.3.4. Composit ion of TRAMP complexes 
 
The TRAMP complex was originally identified through yeast two-hybrid analysis 
using Mtr4 as bait after previous studies identified the protein to be required for 3’ 
end formation of 5.8S in yeast (de la Cruz et al., 1998; LaCava et al., 2005). 
Tandem affinity purification of interacting proteins revealed distinct complexes 
distinguished by the presence of Trf4 or Trf5 termed TRAMP4 and TRAMP5 
respectively (Houseley and Tollervey, 2006; LaCava et al., 2005). The assembly of 
the TRAMP4 complex is dependent on bridging interactions with Air2. Mtr4 
interacts with the N-terminus of Air2 and Trf4 is bound via a zinc-knuckle domain 
at the C-terminus of Air2 (Holub et al., 2012) (Figure 1.7). Although many crystal 
structures have been reported for the individual components of the TRAMP 
complex, a complete structure has yet to be solved (Hamill et al., 2010; Holub et 
al., 2012; Weir et al., 2010). Trf4 and Trf5 share 58% identity and double trf4∆ 
trf5∆ mutants are synthetic lethal (Castaño et al., 1996) Analogously, Air1 and Air2 
are 45% identical and double air1∆ air2∆ mutants have a very strong growth 
defect (Inoue et al., 2000). Despite the obvious similarities between Trf4 and Trf5, 
TRAMP4 and TRAMP5 complexes have been reported to show different substrate  
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Figure 1.7. Structural composition of the TRAMP complex. Cartoon model of the 
arrangement of Air2/1, Trf4/5 and Mtr4 to form the TRAMP complex in yeast. Mtr4 
interacts with the N-terminus of Air2 whereas Trf4 interacts with zinc-knuckles 
(ZnK) 4 and 5 at the C-terminus of Air2. The structure of Mtr4 is based on x-ray 
crystallography data (PDB = 2XGJ) whereas Trf4 and Air2 arrangements are based 
from a partial structure (PDB = 3NYB). 
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specificities (Houseley and Tollervey, 2006; Houseley et al., 2007; Roth et al., 
2009). Likewise, the Air proteins have been shown to control the recognition of 
different classes of target substrates (Schmidt et al., 2012; Stuparevic et al., 
2013). 
 
 
1.3.4.1 Trf4/Trf5 (DNA topoisomerase I-related function 4/5)  
 
Trf4, along with Trf5, was originally identified as a DNA polymerase in a genetic 
screen for mutations that are synthetic lethal with DNA topoisomerase 1 
 
(Castaño et al., 1996). Further analysis reported that Trf4 and the S. pombe 
homolog Cid13 exhibit poly(A) polymerase activity in vitro and that Trf4 associates 
with poly(A) binding protein Pab1 (Ho et al., 2002; Saitoh et al., 2002; Vanácová et 
al., 2005). A link between Trf4 and the exosome was reported in studies showing 
that the activities of Rrp44, Rrp6 and Trf4 were required for the degradation of an 
aberrant pre-tRNAiMet substrate (Kadaba et al., 2004).  
Tandem affinity purification and mass spectrometry analysis revealed that Trf4 and 
Trf5 were the catalytic components part of a heterogenic polyadenylation protein 
complex comprised with Air1/2 and Mtr4 proteins. However, in vitro 
polyadenylation activity of Trf4 was only active with the addition of either Air1 or 
Air2 proteins suggesting a minimal active Trf4/5-Air1/2 complex (Vanácová et al., 
2005). An independent report from the Tollervey lab identified the TRAMP 
complex initially through yeast-two hybrid analysis using Mtr4 as bait and more 
comprehensive analysis through tandem-affinity purification (LaCava et al., 2005). 
In contrast to related S. pombe and C. elegans cytoplasmic poly(A) polymerases 
(Cid13 and gld-2 respectively), Trf4 and Trf5 proteins were shown to be 
exclusively located in the nucleus (Huh et al., 2003; Kwak et al., 2004; Walowsky 
et al., 1999; Wang et al., 2000).  
 
Trf4 and Trf5 proteins share 57% of identical sequence and 72% of similar 
sequences. The homology between the two proteins are suggested to have arisen 
due to the ancient whole genome-duplication event in Saccharomyces cerevisiae 
(Castaño et al., 1996; Kellis et al., 2004). Both Trf4 and Trf5 share characteristic  
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Figure 1.8. Domain architecture of Trf4/5 and Air2/1 proteins. (A) Trf4 and Trf5 
share 57% identity. The N-terminal regions contain a Nucleotidyl Transferase 
domain (Residues 192-297 in Trf4 and 190-300 in Trf5) that provides poly(A) 
polymerase activity. The C-terminus contains a conserved Central domain which 
shares homology with Polβ family RNA Polymerases (297-481 in Trf4 and 
300-484 in Trf5). The Air2 interacting region in Trf4 has been mapped to a 
conserved surface of the central domain. (B) Air2 and Air1 share 48% identity. 
Both proteins contain five Zinc Knuckle RNA binding domains (ZnK1 61-78, ZnK2 
79-98, ZnK3 99-116, KnK4 121-143, ZnK5 162-179 in Air2). The N-terminal 
region of Air2 interacts with Mtr4 (residues 1-60). ZnK 4,5 and linker region are 
required for the interaction with Trf4 (121-179). 
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domain structure with canonical poly(A) polymerases such as Pap1, Cid13 and 
Gld-2. The N-terminal regions contain the catalytic domain bearing three highly 
conserved aspartate residues and a characteristic strand-loop motif. Additionally 
Trf proteins contain a Central domain that contains a short nucleotide recognition 
motif (Figure 1.8.A). In contrast to Pap1, Trf4 and Trf5 lack any characterised 
RNA-binding domains (Vanácová et al., 2005). The physical association with 
Air1/2 RNA binding proteins most likely contributes to RNA recognition. This 
model is corroborated by the observation that poly(A) polymerase activity of Trf4 in 
vitro requires the presence of Air1 or Air2 proteins (Vanácová et al., 2005; Wyers 
et al., 2005). A crystal structure of a Trf4/Air2 sub-complex lacking Mtr4 shows 
that the fourth and fifth zinc-knuckle domains of Air2 interact physically with a 
conserved surface in the central domain of Trf4 (Hamill et al., 2010). Although no 
structure exists for Trf4 complexes with Mtr4, it is presumed that the two proteins 
interact independently of the Air1/2 proteins as Trf4/5 co-precipitates Mtr4 in the 
absence of Air1 or Air2 (LaCava et al., 2005).  
 
Polyadenylated RNA species, such as rRNAs, snRNAs, snoRNAs and CUTs, have 
been shown to increase in EXO9 and exosome-related mutants (Allmang et al., 
1999a; Kuai et al., 2004; Mitchell et al., 2003; van Hoof et al., 2000a; Wyers et al., 
2005). These species were subsequently shown to be polyadenylated by Trf4 and 
Trf5 but not by the canonical poly(A) polymerase Pap1 (Houseley and Tollervey, 
2006; Wyers et al., 2005). It is proposed that Trf4 and Trf5 function to 
polyadenylate RNA substrates as part of the TRAMP complex to enhance 
processing or degradation pathways involving the nuclear exosome and Rrp6 
(Egecioglu et al., 2006; LaCava et al., 2005; Vanácová et al., 2005; Wyers et al., 
2005).  
 
To distinguish from stable mRNA polyadenylation by Pap1, in vitro studies 
reported that Trf4/5 proteins add 10-50nt poly(A) tails to substrates in comparison 
to longer 60-80nt tails added by Pap1 (Egecioglu et al., 2006; Houseley and 
Tollervey, 2006; Kadaba et al., 2004; LaCava et al., 2005). However, more recent 
studies have shown that Mtr4 modulates poly(A) length to much shorter lengths of 
4nt and complements a global analysis study on RNA surveillance targets in yeast 
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which reports poly(A) lengths of 3-5nt (Jia et al., 2011; Wlotzka et al., 2011). The 
general model for exosome activation due to polyadenylation by Trf4/5 is that the 
addition of unstructured poly(A) tails to RNA targets will make the transcripts more 
favourable to be recognised by the exosome. However, Trf4/5-dependent 
polyadenylation is not required for all substrates activated by TRAMP. This could 
be due to the helicase activity of Mtr4, which may unwind structured RNA to 
provide a more favourable substrate for exosome-dependent pathways. 
Nevertheless, a recent study has revealed that the polyadenylation activity of Trf4 
can enable the helicase activity of Mtr4 to unwind substrates that otherwise could 
not be separated (Jia and Wang, 2012).  
These findings fit a model of co-ordinated activity between Trf4/5 and Mtr4; Mtr4 
modulates polyadenylation of substrates by Trf4 to ~4nt, Trf4-generated poly(A) 
tails aid in Mtr4-dependent unwinding and Trf4/Air1 directly stimulates the activity 
of Mtr4 (Jia and Wang, 2012; Jia et al., 2011).  
 
TRAMP substrates fall into two categories of degradation targets and processing 
targets. The former group include hypermodified tRNAs, pre-rRNA processing 
intermediates, CUTs and aberrant RNAs (Allmang et al., 2000; Kadaba et al., 
2006, 2004; Vanácová et al., 2005; Wyers et al., 2005). TRAMP dependent 
maturation targets include pre-rRNAs, snRNAs and snoRNAs (Allmang et al., 
1999a; Houseley and Tollervey, 2006; Kuai et al., 2004). Trf4 and Trf5 dependent 
polyadenylation has been attributed to both processing and degradation 
pathways yet the mechanism to distinguish substrates is still relatively unknown. 
Microarray analysis of trf4∆ and trf5∆ showed little overlap in altered transcripts 
suggesting TRAMP4 and TRAMP5 complexes have distinct roles (San Paolo et al., 
2009). It is more likely that the RNA binding proteins Air1 and Air2 confer 
substrate specificity. TRAMP4 complexes preferentially bind Air2 whilst TRAMP5 
has only been shown to bind Air1 (Houseley and Tollervey, 2006; LaCava et al., 
2005; Vanácová et al., 2005; Wyers et al., 2005). Air1 and Air2 proteins have 
recently been reported to show certain specificities and will be discussed below 
(Schmidt et al., 2012) 
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1.3.4.2 Air/Air2 (arginine methyl-transferase-interacting RING f inger 
protein 1/2) 
 
The Air1 and Air2 proteins are putative RNA binding proteins bearing five zinc-
knuckle (ZnK) motifs (also known as RING finger motifs). As with TRF4 and TRF5 
genes, the AIR1 and AIR2 alleles are thought to be an artefact of the whole 
genome duplication event in S. cerevisiae and share 45% identity (Inoue et al., 
2000; Kellis et al., 2004). As part of the TRAMP polyadenylation complex, the 
Air1/2 proteins are suspected to be involved in substrate recognition to allow the 
complex to precisely polyadenylate and unwind targets for processing or 
degradation pathways. The mechanism by how TRAMP complexes distinguish 
substrates is still to be fully determined.  
 
Both Air1 and Air2 contain five adjacent CXXCXXXXHXXXXC  (CCHC) zinc knuckle (ZnK) 
domains that have been suggested to be involved in either RNA or protein binding 
(Figure 1.8.B). The domains are highly similar, sharing 67% identity and 80% 
similarity (Fasken et al., 2011; Inoue et al., 2000; LaCava et al., 2005; Vanácová et 
al., 2005). A crystal structure of Trf4 complexed with a fragment of Air2 revealed 
the zinc knuckles 4 and 5 (ZnK4 and ZnK5) interact with the central domain of Trf4 
(Hamill et al., 2010). In vivo functional analysis of the ZnK domains in Air1 and Air2 
revealed that ZnK4 and ZnK5 mutants exhibit TS growth phenotypes and are 
impaired in interactions with Trf4 (Fasken et al., 2011). This study also identified a 
highly conserved IWRXY linker region between ZnK4 and ZnK5 that is critical for 
Trf4 interaction. In vivo northern blot analysis of Air1 ZnK4+5 and IWRXY mutants 
revealed a strong accumulation of CUTs and pre-snoRNAs (Fasken et al., 2011). 
An independent analysis distinguished individual roles for the ZnK domains in Air2. 
ZnK4 was shown to have a key role in RNA binding and CUT recognition along 
with providing interactions with Trf4 whereas ZnK5 was shown to only be involved 
in Trf4 interaction (Holub et al., 2012).  
 
The RNA binding properties of Air1 and Air2 were originally assumed due to the 
enhanced polyadenylation activity of recombinant Trf4 with the addition of Air2 
(Hamill et al., 2010). In vitro binding assays reported that Air2 binds unstructured 
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RNA with a strong affinity whereas no binding to structured RNA substrates could 
be detected (Holub et al., 2012).  
 
Due to a large degree of similarity, it was assumed that Air1 and Air2 were 
functionally redundant in TRAMP complexes. However further investigation 
revealed differential TRAMP complexes; TRAMP4 preferentially contains Air2 but 
has been shown to co-precipitate with Air1 whereas TRAMP5 only appears to 
contain Air1 (Houseley and Tollervey, 2006; LaCava et al., 2005; Vanácová et al., 
2005; Wyers et al., 2005). The presence of different TRAMP complexes is most 
likely related to the multiple functions of the TRAMP complex in recognising 
different classes of substrates. Phenotypic analysis and RNA deep sequencing 
identified differential substrate specificities due to the presence of either Air protein 
(Schmidt et al., 2012). Air2 was shown to preferentially target polyadenylation of 
snoRNAs for subsequent degradation by Rrp6 and the exosome. It was also 
shown that Air2 plays a role in regulation of mRNAs involved in iron transport and 
carbon metabolism. Air1 was reported to be required for the stable copy number 
of the endogenous 2µ plasmid in concert with Rrp6 (Schmidt et al., 2012). 
Although non-redundant specific functions for each Air protein have been 
reported, the mechanisms behind this are yet to be understood.  
 
 
1.3.4.3. Mtr4 (mRNA transport protein 4)  
 
The putative 3’-5’ RNA helicase, Mtr4 (also known as Dob1), was initially identified 
in a screen identifying mRNA transport mutants and later shown to be a co-factor 
to the nuclear exosome required for 5.8S rRNA maturation (Kadowaki et al. 1994; 
de la Cruz et al. 1998; van Hoof et al. 2000). Mtr4 was identified as part of the 
TRAMP complex through yeast-two hybrid interactions and mass spectrometry 
analysis of co-IPs (LaCava et al., 2005; Vanácová et al., 2005; Wyers et al., 2005). 
In addition to its association with TRAMP complexes, Mtr4 can function 
independently of TRAMP, a feature that is supported by an excess of cellular Mtr4 
in comparison to other TRAMP components (Ghaemmaghami et al., 2003; 
LaCava et al., 2005; van Hoof et al., 2000a). Mtr4 is a member of the DEXD/H-box 
! 44!
ATPase family of helicase proteins along with Ski2 that shares sequence identity 
(Anderson and Parker, 1998). Additionally, Mtr4 has been shown to be essential 
for growth in yeast (Liang et al., 1996). It has been reported that Mtr4 functions as 
an exosome co-factor in the processing of structured RNAs such as 5.8S rRNA 
(de la Cruz et al., 1998; Kadaba et al., 2004; LaCava et al., 2005; van Hoof et al., 
2000a) and also functions with the TRAMP complex in processing and 
degradation of a wide range of substrates in concert with the exosome and Rrp6. 
The helicase activity of Mtr4 is thought to be required to unwind structured 
substrates to aid in recognition by the exosome and is stimulated by the 
polyadenylation activity of Trf4/5-Air1/2 complexes (Houseley and Tollervey, 2006; 
LaCava et al., 2005; Lebreton and Séraphin, 2008; Vanácová et al., 2005; Wyers 
et al., 2005).  
 
Mtr4 shares 38% sequence identity with Ski2, another member of the DEXH 
helicase family. However, the 110kDa Mtr4 is considerably larger than other 
helicases from this family (de la Cruz et al., 1998). Mtr4 comprises two canonical 
RecA domains (RecA1 and RecA2) that form the helicase core, a winged-helix 
(WH) domain and a C-terminal Helical bundle (Figure 1.9.A) (Jackson et al., 2010; 
Weir et al., 2010). The protein also features a large arched KOW domain inserted 
between the WH domain that shows structural similarities to a motif found in a 
variety of ribosomal proteins and a bacterial transcription factor NusG (Kyrpides et 
al., 1996). The KOW domain forms an arm and fist-like structure that is not found 
in related DEXH helicases (Figure 1.9.B) (Jackson et al., 2010; Weir et al., 2010). 
Removal of the KOW arch domain results in slow-growth phenotypes, 5.8S 
processing defects similar to rrp6Δ mutants, reduces RNA binding and is unable 
to efficiently activate the exosome in vitro to process hypermodified tRNAiMet 
(Holub et al., 2012; Jackson et al., 2010; Weir et al., 2010). Although individual 
crystal structures of Mtr4 have been solved, these have been independent of 
association with TRAMP components. However, mutational analysis revealed that 
the N-terminus of Air2 is required for the interaction with Mtr4 and was not 
required for the Trf4-Air2 interaction (Holub et al., 2012).   
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Figure 1.9. Domain architecture and structure of Mtr4. (A) Mtr4 contains a N-
terminal domain (residues 80-143), two RecA domains (RecA1 150-320, RecA2 
326-575), a Winged helix (WH) structure (575-615 and 876-900) separated by a 
stalk/KOW insertion domain (615-876) and a C-terminal Helical bundle domain 
(912-1073). The RecA2, WH2 and helical bundle domains are required for 
interaction with the Trf4/Air2 heterodimer (Holub et al. 2012). (B) X-ray crystal 
structure of Mtr4 from Weir et al (2010). Image was generated using PyMol and 
coloured by domain to match A (PDB = 2XGJ). The Stalk/KOW domains form a 
characteristic protruding structural unit from the central helicase core. 
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The function of the helicase activity of Mtr4 is presumed to unwind structured RNA 
and/or displace any associated protein complexes in order to present the 
exosome with a more favourable substrate (Houseley and Tollervey, 2009; 
Lebreton and Séraphin, 2008). Additionally, it has been proposed the hydrolysis of 
ATP by Mtr4 may be used to feed RNA substrates through the exosome core 
channel in a comparable mechanism to proteasome-associated ATPases (Makino 
et al., 2013b; Smith et al., 2007; van Hoof and Parker, 1999). Mutations in the 
helicase domain have been shown to result in the accumulation of pre-5.8S rRNA, 
5’ETS and hypermodified tRNAiMet substrates; all of which are processed or 
degraded by  
the exosome and Rrp6. These mutations did not affect TRAMP stability of 
polyadenylation activity therefore suggesting that Mtr4 acts independently of Trf4-
dependent polyadenylation (Allmang et al., 1999a; de la Cruz et al., 1998; Holub 
et al., 2012; Jackson et al., 2010). In vitro analysis has shown that Mtr4 can 
unwind RNA substrates with a high degree of secondary structure (Vanácová et 
al., 2005). As mentioned above, Mtr4 has been shown to modulate the nucleotide 
length of Trf4-generated poly(A) tails to 3-5 nt (Jia et al., 2011). These results 
suggest a mechanism by which Mtr4 regulates the polyadenylation of RNA targets 
by Trf4. Short poly(A) tails enhance the unwinding by Mtr4 to provide an 
accessible substrate for exosome activity. The unwinding activity may also serve 
to disassemble any RNP complexes associated with the transcript.  
 
 
1.3.5 TRAMP-dependent targeting to the nuclear exosome  
 
The TRAMP complex acts as a layer of control for RNA processing and 
degradation by the nuclear exosome. The ability to recognise and target specific 
substrates for differential pathways is a critical role needed to govern the 
exonuclease activity of Rrp44 and Rrp6. The TRAMP complex is proposed to 
function to recognise, polyadenylate and unwind RNA transcripts to provide a 
favourable substrate for the exosome and Rrp6. However, the mechanism by 
which TRAMP is able to distinguish substrates for productive or destructive 
processing is still poorly understood. The ability to modulate recognition may be 
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attributed to properties of components within the complex or due to the 
association with various co-factors. One proposed candidate is the exosome-
associated RNA binding protein Mpp6 (Butler and Mitchell, 2011). In humans 
MPP6 physically associates with Rrp6 and Mtr4 homologs (PM-Scl100 and hMtr4 
respectively) (Schilders et al., 2007). Additionally, mpp6∆ mutations are synthetic 
lethal with air1∆, rrp47∆ and rrp6∆ suggesting a possible redundant coupling 
between Rrp6 and TRAMP complexes (Butler and Mitchell, 2011; Milligan et al., 
2008).  
  
 
1.3.6 The NNS (Nrd1/Nab3/Sen1) complex 
 
The NNS complex, comprised of RNA binding proteins Nrd1, Nab3 and the 
putative nucleic acid helicase Sen1, plays an essential role in RNA quality control 
pathways through transcriptional termination and recruitment of RNA surveillance 
factors (Steinmetz et al., 2001). The NNS complex is involved in the transcriptional 
termination of RNA PolII transcripts coupled to TRAMP activity for the maturation 
of snRNAs, snoRNAs and some mRNAs (Carroll KL, Pradhan DA, Granek JA, 
Clarke ND, 2004; Ciais et al., 2008; Grzechnik and Kufel, 2008; Steinmetz et al., 
2001). Additionally, NNS and TRAMP activity terminate and degrade cryptic 
unstable transcripts derived from pervasive intergenic transcription (Arigo et al., 
2006; Thiebaut et al., 2006) 
 
Nrd1 (Nuclear pre-mRNA Down-regulation protein 1) is an essential protein of 
63kDa that features an N-terminal domain that allows interaction with the C-
terminus of the large subunit of RNA PolII (CID, CTD interacting domain), an RNA 
recognition motif and a Nab3-interacting region (Figure 1.10.A) (Conrad et al., 
2000; Vasiljeva et al., 2008a). The CTD of RNA PolII contains tandem heptameric 
repeats (TSPTSPS) that associate with various co/post-transcriptional factors. 
Differential binding to the CTD is modulated by phosphorylation at serine residues 
2, 5 and 7 (TSPTSPS). In vitro analysis has shown that Nrd1 preferentially binds 
Ser5 phosphorylated CTD domain of RNA PolII whereas in vivo analysis shows  
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Figure 1.10. Domain architecture of Nrd1, Nab3 and Sen1. (A) Nrd1 contains an N-
terminal RNA PolII CTD binding (CID) domain (residues 1-140), a RE/RS (argenine-
glutamate/argenine-serine) rich region (245-265), a RNA binding motif (RRM) 
(340-410) and a P/Q (proline/glutamine)-rich region (500-575). The Nab3 interacting 
region is mapped to between residues 169 and 244. (B) Nab3 contains an N-
terminal D/E (Aspartate/Glutamate)-rich region (residues 1-194), a RNA binding motif 
(RRM) (329-404) and a P/Q (Proline/Glutamine)-rich region (575-802). The Nrd1 
interaction region is mapped to between residues 204 and 248. (C) Sen1 contains a 
Type I ATP-dependent DNA/RNA Helicase domain (residues 1327-1656)
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Nrd1 to co-localise with the Ser7 phosphorylated form (Buratowski, 2009; Kim et 
al., 2010; Vasiljeva et al., 2008a).  
 
The N-terminus of Nrd1, downstream of the CID, interacts physically with a 
second RNA binding protein, Nab3 (Nuclear polyadenylated RNA-binding protein 
3), a 90kDa RNA binding protein shown to be essential in yeast (Conrad et al., 
2000). Nab3 contains a C-terminal domain rich in acidic residues (D/E-rich), a 
central RNA recognition motif and an essential Proline/Glutamine-rich C-terminus 
with no characterised function (Figure 1.10.B) (Carroll et al., 2007; Conrad et al., 
2000). The RNA-recognition motifs (RRMs) of Nrd1 and Nab3 have been reported 
to recognise GUAA/G and UCUU motifs as binding sites respectively (Carroll KL, 
Pradhan DA, Granek JA, Clarke ND, 2004; Hobor et al., 2011; Lunde et al., 2011).  
 
The essential and highly conserved Type I 5’-3’ ATP-dependent DNA/RNA 
helicase Sen1 (Splicing endonuclease protein 1) interacts with the Nrd1/Nab3 
heterodimer through physical association with Nab3 but shows no direct 
interaction with Nrd1 (Nedea et al., 2008; Ursic et al., 2004; Winey and 
Culbertson, 1988). Although Sen1 is essential in yeast, sen1 mutants bearing N-
terminal deletions are viable with slow growth phenotypes. The N-terminus of 
Sen1 is involved in interactions with the CTD of RNA PolII whilst the C-terminal 
region contains the essential helicase domain (Figure 1.10.C) (Nedea et al., 2008; 
Ursic et al., 2004).  
 
In yeast, the NNS complex is involved in productive pathways to generate mature 
snRNA and snoRNA transcripts and in destructive surveillance pathways to 
degrade pervasive intergenic-transcribed CUTs (Arigo et al., 2006; Grzechnik and 
Kufel, 2008; Kim et al., 2006; Steinmetz et al., 2001; Thiebaut et al., 2006). The 
RRM domains of Nrd1 and Nab3 have been reported to recognise specific RNA 
motifs in the 3’UTR regions of PolII transcripts (GUAA/G and UCUU respectively). 
These sequences are commonly found downstream of snRNA and snoRNA genes 
(Carroll KL, Pradhan DA, Granek JA, Clarke ND, 2004; Steinmetz and Brow, 
1996, 1998). Binding of Nrd1/Nab3 has been suggested to stimulate the 
recruitment of the TRAMP complex and the exosome. Transcriptional termination  
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Figure 1.11. Nrd1-dependent termination of Pol II transcripts. Model of 
transcriptional termination of RNA Pol II transcripts (snRNAs, snoRNAs, CUTs) by 
the NNS complex. Nrd1 and Sen1 interact with Ser5 phosphorylated CTD of RNA 
Pol II. The RRM domains of Nrd1 and Nab3 bind specific RNA motifs that trigger 
transcriptional termination. The NNS complex recruits the TRAMP and exosome 
complexes for subsequence 3’-end processing by multiple rounds of 
polyadenylation and exonucleolytic trimming. This generates mature RNPs in the 
case of snRNAs and snoRNAs or complete degradation in the case of CUTs. 
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by the NNS is followed by polyadenylation and subsequent 3’ end processing by 
the nuclear exosome (Figure 1.11) (LaCava et al., 2005; Perumal and Reddy, 
2002; Vanácová et al., 2005; Vasiljeva and Buratowski, 2006; Wyers et al., 2005). 
Mutations in Nrd1, TRAMP and exosome components lead to an observable 
accumulation of 3’ extended snRNAs and snoRNAs.  In rrp6∆ mutants, two 
populations of 3’ extended heterogeneous snR13, U14 and snR50 snoRNAs are 
observed to accumulate (Allmang et al., 1999a; Mitchell et al., 2003; van Hoof et 
al., 2000a; Vasiljeva and Buratowski, 2006). Subsequent analysis revealed that 
termination of snoRNAs is carried out by two complexes and in two distinct 
regions; a proximal NNS-dependent termination region (site I) and a distal “failsafe” 
mRNA 3’ processing region (siteII) (Grzechnik and Kufel, 2008; Steinmetz and 
Brow, 2003). Both termination events are coupled to polyadenylation which leads 
to subsequent processing by the nuclear exosome and Rrp6 in the case of NNS-
dependent termination, or degradation by the exosome and surveillance factors in 
the case of “failsafe” termination (Grzechnik and Kufel, 2008).  
 
The discovery of pervasive transcription of intergenic regions has encouraged 
intense investigation into the nature of unstable-ncRNAs including cryptic unstable 
transcripts (CUTs). Originally identified in rrp6Δ strains, CUTs are rapidly degraded 
by the exosome in wildtype cells (Gudipati et al., 2012a; Schneider et al., 2012; 
Wyers et al., 2005). Like snoRNAs, CUTs are transcribed by RNA Pol II, have a 
defined 5’ end and heterogeneous Trf4-dependent polyadenylated 3’ ends. In the 
absence of Trf4, populations of non-polyadenylated CUTs are accumulated 
(Wyers et al., 2005). Transcriptional termination of CUTs is also dependent on the 
NNS complex in yeast (Arigo et al., 2006; Thiebaut et al., 2006). Many CUTs have 
been reported to contain Nrd1/Nab3 recognition motifs that recruit the NNS 
complex to trigger transcriptional termination. The NNS also stimulates the 
recruitment of the TRAMP complex and the exosome for subsequent Trf4-
dependent polyadenylation and rapid degradation by Rrp44 and Rrp6 (Arigo et al., 
2006; Thiebaut et al., 2006; Wyers et al., 2005). The well-characterised CUT, 
NEL025c, was shown to exist in two forms in exosome mutants. Shorter, 
heterogeneous transcripts were shown to be polyadenylated by Trf4 (NEL025S) 
and a longer species were dependent on Pap1 polyadenylation (NEL025cL) 
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(Thiebaut et al., 2006; Wyers et al., 2005). As with snoRNAs, these two species 
are due to termination events at either a proximal NNS-dependent region (site I) or 
a distal mRNA cleavage/polyadenylation site II. Depletion of Nrd1 in rrp6Δ mutants 
leads to a decrease in site I NEL025cS and subsequent increase in longer read-
through transcripts terminating at site II (Thiebaut et al., 2006).  
 
The NNS complex has been well characterised as part of RNA surveillance 
pathways in yeast as a level of quality control. With physical and functional 
connections to the TRAMP complex and the nuclear exosome, the action of the 
NNS can generate stable snRNA and snoRNA transcripts. Additionally, the NNS is 
well characterised in its role of termination of pervasive transcription and 
stimulation of rapid degradation by the exosome and Rrp6.   
 
 
1.3.7. Rex1 (RNA exonuclease 1)  
 
The 3’-5’ exonuclease activity of the nuclear exosome is attributed to the 
exonuclease domain of Rrp44 and/or the exosome-associated Rrp6 (Allmang et 
al., 1999b; Mitchell et al., 1997). Rex1 (also known as Rnh70 and Rna82) is a 
member of the DEDDh superfamily of exoribonucleases along with Rrp6 (Ozanick 
et al., 2009; Zuo and Deutscher, 2001). Although Rex1 is localised to the nucleus, 
no physical association with the exosome complexes has been reported (Frank et 
al., 1999). Yeast rex1Δ strains accumulate 5S rRNA extended by ~3nt and show 
defects in processing of tRNAs (Ozanick et al., 2009; van Hoof et al., 2000b). 
Rex1 was initially characterised along with related 3’ exonucleases Rex2 and Rex3 
(van Hoof et al., 2000b). It was reported that Rex1 and Rex2 function redundantly 
in the 3’ processing of 5.8S rRNA. Single mutants were shown to have no effect 
on 5.8S pre-cursors yet a rex1∆ rex2∆ double mutant showed an accumulation of 
6S pre-rRNA species as initially reported in exosome mutants (Mitchell et al., 
1996; van Hoof et al., 2000b). Yeast strains bearing rex1Δ alleles are synthetic 
lethal with rrp6Δ and rrp47Δ alleles (Costello et al., 2011; Peng et al., 2003; van 
Hoof et al., 2000b). Both rrp6Δ and rex1Δ strains show defects in 3’-end 
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processing of stable RNAs and the synthetic lethality genetic interaction may 
suggest redundancy in RNA substrate maturation.  
 
 
1.4 Functional redundancy and synthetic lethal interactions 
 
Functional redundancy is common within many biological systems and acts as a 
failsafe layer of ‘genetic buffering’ to protect the cell against the failure of one 
component or pathway(Kafri et al., 2009). The loss of function of two proteins 
independently may have little or no effect on the cell whereas the simultaneous 
loss of function may have a more dramatic and possible lethal impact. It has been 
widely documented that mutations in many exosome or exosome-related 
components result in similar phenotypes (Allmang et al., 1999a; LaCava et al., 
2005; Milligan et al., 2008; Mitchell et al., 2003; van Hoof et al., 2000a; Vasiljeva 
and Buratowski, 2006). Corroborating this, recent transcriptome-wide analyses 
revealed a large degree of substrate overlap for the catalytic activities of both 
Rrp44 and Rrp6 as part of the nuclear exosome (Gudipati et al., 2012b; Schneider 
et al., 2012). Genetic redundancy is likely mirrored in synthetic lethal interactions. 
The functional overlap between Rrp44 and Rrp6 is supported by the synthetic 
lethality observed in rrp6∆ rrp44exo- mutants (Lebreton et al., 2008).  
 
The exosome associated co-factor Rrp47 has been shown to interact directly with 
Rrp6 and function to promote Rrp6-dependent processes (Costello et al., 2011; 
Feigenbutz et al., 2013b; Mitchell et al., 2003; Stead et al., 2007). A second 
cofactor, Mpp6 is still relatively uncharacterised in terms of physical and functional 
interactions. It has been proposed that Rrp6-dependent processes are 
functionally redundant with Mpp6-related activities. This is supported by synthetic 
lethality observed in rrp6∆ mpp6∆ and rrp47∆ mpp6∆ mutants. It was therefore 
proposed that Mpp6 functions to stimulate the catalytic activity of Rrp44 (Milligan 
et al., 2008). An alternative model is that Mpp6 promotes the functional couple 
between Rrp6 and the TRAMP complex. This is supported by the synthetic 
lethality in mpp6∆ air1∆ mutants and physical interactions reported between 
human MPP6, PM-Scl100 and hMtr4 (Mpp6, Rrp6 and Mtr4 in yeast) (Milligan et  
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Figure 1.12. Synthetic lethal interactions between non-essential exosome 
co-factors. Generated from reported genetic interactions between null 
alleles. Data was obtained from BioGRID (http://thebiogrid.org/) or from 
observations during this study. Red connectors between two null alleles 
signifies that the double null mutant is synthetic lethal.  
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al., 2008; Schilders et al., 2007). A summary of synthetic lethal genetic 
interactions between exosome-related components is depicted in Figure 1.12. 
 
 
1.5. Aims of this study 
 
As described above, the eukaryotic exosome functions in a wide array of essential 
biological processes including RNA processing and RNA surveillance. It is still 
unclear how the complex is able to distinguish between transcripts from all 
characterised classes of RNA and discriminate between downstream productive 
or destructive processes. It is widely known that the exosome recruits a number of 
co-factors and additional complexes to distinguish the outcome of RNA 
substrates. Whilst the identification of these auxiliary factors has been widely 
documented, it is still generally unknown how exosome associate co-factors 
control the function of the exosome. This study aims to investigate the role of 
these additional proteins in RNA surveillance and processing pathways involving 
the nuclear exosome and the relationship between their individual functions.  
 
The main aim of this work address the function of three proteins, Rrp6, Rrp47 and 
Mpp6. The relationship between Rrp6 and Rrp47 is investigated in Chapter 3 and 
4. These proteins interact physically and functionally in RNA degradation 
processes and the stability of either protein is sensitive to this connection. These 
analyses look at the effects of separating the Rrp6/Rrp47 complex in vivo using a 
novel method and addressing the individual functions of either protein.  
 
Mpp6 has been reported to associate with the nuclear exosome complex and is 
involved in RNA surveillance activities. However, little is known about the protein 
itself. Chapter 5 attempts to identify and characterise the functional regions of the 
Mpp6 protein through mutational analysis.  
 
Finally, work throughout this study aims to address the redundant functions of 
these co-factors and provide insight into synthetic lethal interactions found in 
combined mutants.  
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Chapter 2: Mater ia ls and Methods  
 
2.1 Materials 
 
2.1.1. Reagents and enzymes  
 
All general reagents used throughout this study were of molecular biology grade 
and purchased from Melford (Melford Laboratories Ltd., Ipswich, UK), Sigma 
(Sigma-Aldrich Co., St Louis, MO, USA), Fisher (Thermo Fisher Scientific., 
Waltham, MA, USA), VWR (VWR International LLC., Radnor, PA, USA) and 
Geneflow (Geneflow Ltd., Lichfield, Staffordshire, UK) as stated in the text. Water 
for stock solutions, buffers, media and other general uses was filtered through a 
Milli-Q 4 Bowl reagent grade water system (Millipore., Billerica, MA, USA). 
Enzymes were purchased from NEB (New England Biolabs., MA, USA), 
Fermentas (Fermentas International Inc., Canada), Promega (Promega Inc., 
Madison, WI, USA) and Roche (Roche Diagnostics Ltd., Surrey, UK) unless 
otherwise stated in the text.  
 
2.1.2. Bacterial strains 
 
E. coli strains XL1-Blue, DH5α (Stratagene., La Jolla, California, USA) and KC8 
(Clontech., Mountain View, California, USA) were used for molecular cloning, 
plasmid recovery and amplification. For expression of recombinant proteins the E. 
coli strain BL21 (DE3) pLysS (Stratagene) was used. Genotypes of 
aforementioned strains are stated in Table 2.1   
 
2.1.3. Bacterial growth   
 
Bacterial strains were grown at 37°C unless otherwise stated. Liquid cultures were 
incubated in appropriate selective media (see Table 2.2) with sufficient aeration. All 
glassware and media were sterilised by autoclaving at 126°C, 121 psi for 20 
minutes. Non-autoclavable components, such as IPTG, were sterilised by filtration 
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through 0.2 µm Minisart filters (Sartorius Stedim Biotech., Goettingen, Germany).  
Bacterial stocks were stored in 15% glycerol at -80°C.  
 
2.1.4. Yeast strains 
 
Unless otherwise stated, S. cerevisiae was the sole yeast used in this study. 
A list of background strains used in this study is described in Table 2.5   
 
2.1.5. Yeast growth 
 
Yeast strains were grown in appropriate media (see Table 2.2) at 30°C unless 
otherwise stated. Liquid cultures were incubated in sterilised glassware with 
sufficient aeration. Strains were stored on solid media plates or slants at 4°C for 
short-term storage or in 25% glycerol at -80°C for long-term storage.  
 
Table 2.1. E. col i strains used during this study.  
Strain Genotype Source 
XL1-Blue 
RecA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 
lac [F’ proAB lacIqZ∆M15 Tn10 (Tetr)] Stratagene 
DH5α 
fhuA2 Δ(argF-lacZ)U169 phoA glnV44 Φ80 Δ(lacZ) 
M15 gyrA96 recA1 relA1 endA1 thi-1 hsdR17 Stratagene 
KC8 
hsdR leuB600 trpC9830 pyr::Tn5 hisB463 
lacDeltaX74 strA galU galK 
Clontech 
BL21 (DE3) 
pLysS 
F– dcm ompT hsdS(rb-mb-) gal λ(DE3) [pLysS 
Camr] Stratagene 
 
 
Table 2.2. Media recipes used during this study.  
Percentages given indicate weight per volume (w/v). For solid media, 2% Bacto-
agar (BD., Becton Dickinson and Company, Sparks, MD, USA) was added prior to 
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autoclaving. Antibiotics/drugs were supplemented as necessary according to 
Table 2.4.  
LB 
(Lysogeny 
Broth)  
1% Tryptone (Melford), 0.5% Yeast Extract (Melford), 1% NaCl 
(Fisher).  
M9 Minimal 
Media  
1 X M9 Salts (3.4 mM Na2HPO4, 2.2 mM KH2PO4, 0.85 mM NaCl, 
0.95 mM NH4Cl). Amino acids and bases were supplemented as 
required from 100 X stocks, described in Table 2.3, prior to 
autoclaving. To cooled media 2 mM MgSO4, 0.4% v/v Glucose and 
100 µm CaCl2 were added.  
YPD 2% Peptone, 1% Yeast Extract, 2% Glucose 
YPGal 2% Peptone, 1% Yeast Extract, 2% Galactose 
Yeast 
Minimal 
Media  
0.17% Yeast Nitrogen Base without amino acids (Melford), 0.5% 
Ammonium Sulphate, 2% Glucose. Amino acids and bases were 
supplemented as required from 100 X stocks prior to autoclaving 
(Table 2.3).  
5’FOA 
Minimal 
Media  
0.17% Yeast Nitrogen Base without amino acids, 0.5% Ammonium 
Sulphate, 2% Glucose. All amino acids and bases were 
supplemented from 100 X stocks. 5’-Fluoroortic Acid (Melford) was 
filter-sterilised to a final concentration of 1 mg/ml into cooled media 
after autoclaving.  
 
 
Table 2.3. Weights of L-Amino Acids and Bases used to generate 
100 X stocks.  
 
100 X stock solutions were made up individually from solid reagents (Sigma) and 
stored at -20°C. Adenine and Tyrosine (*) required the addition of 20 mM and 30 
mM NaOH respectively to neutralise pH.  
 
Amino Acid/Base Abbreviation Mass per litre (g) 
Adenosine hemisulphate* Ade 2 
Argenine monohydrochloride Arg 2 
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Histidine monohydrochloride His 2 
Leucine Leu 6 
Lysine monohydrochloride Lys 3 
Methionine Met 2 
Phenyalanine Phe 5 
Threonine Thr 20 
Tryptophan Trp 2 
Tyrosine* Tyr 3 
Uracil Ura 2 
 
 
Table 2.4. Antibiot ic/drug concentrations used in this study.  
 
Ant ib iot ic Abbreviat ion Source Stock Preparat ion 
Final 
Concentrat ion 
Ampicillin Sodium 
Salt 
Amp Melford 1000 X 
4 g in 50 ml 
ethanol 
80 µg/ml 
Chloramphenicol  Chl Sigma 1000 X 
250 mg in 10 
ml ethanol 
25 µg/ml 
Kanamycin A 
Monosulphate 
(from S. 
kanamyceticus)  
Kan Sigma 1000 X 
2.5 g in 50 ml 
sterile water 
50 µg/ml 
G418 Disulphate 
Salt (Geneticin) 
Kan Sigma 50 X 
100 mg in 10 
ml sterile 
water  
200 µg/ml 
Hygromycin B 
(from S. 
hygroscopicus) 
Hyg Sigma 50 X 
100 mg in 10 
ml sterile 
water 
200 µg/ml 
5’-Fluoroorotic 
Acid 
5’FOA Melford 50 X 
100 mg in 1 
ml DMSO 
2 mg/ml 
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Table 2.5. S. cerevisiae strain backgrounds used in this study.  
 
Strain  Genotype Source 
BMA38 Mata/Matα ade2-1/ade2-
1 his3-∆200/his3-∆200 
leu2-3,112/leu2-3,112 
trp1-1/trp1-1 ura3-
1/ura3-1 can1-100/can1-
100  
Laboratory stock (Baudin 
et al., 1993) 
BY4741 Mata his3∆1 leu2∆0 
met15∆0 ura3∆0  
Euroscarf (University of 
Frankfurt, Germany) 
(Brachmann et al., 1998) 
W303 Mata/Matα ade2-1/ade2-
1 his3-11,15/his3-11,15 
leu2-3,112/leu2-3,112 
trp1-1/trp1-1 ura3-
1/ura3-1 can1-100 can1-
100 
Laboratory stock 
(Rothstein, 1983) 
158 Mata ade2-1 his3-∆200 
leu2-3,112 trp1-1 ura3-1 
can1-100 rrp6∆::TRP1 
Laboratory stock  
RS453 Mata/Matα ade2-1/ade2-
1 his3-11/his3-11 leu2-
3/leu2-3 trp1-1/trp1-1 
ura3-52/ura3-52 can1-
100/can1-100  
Laboratory stock 
(Thomas and Rothstein, 
1989) 
575 Mat1 ade2-1 his3-∆200 
leu2-3,112 trp1-1 ura3-1 
can1-100 
Laboratory stock  
SC0000 Mata ade2 arg4 leu2-
3,112 trp1-189 ura3-52 
Euroscarf (University of 
Frankfurt, Germany) 
(Gavin et al., 2006) 
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2.1.6. Media  
 
Media background recipes are given in Table 2.2.  
 
2.1.6.1. Bacterial Media 
 
Sterilised antibiotics were used to select for bacterial strains expressing plasmids 
harboring the respective antibiotic resistant gene. Stocks were prepared at 1000 X 
concentrations by mixing the appropriate amount of antibiotic (shown in Table 2.4) 
in 50% v/v ethanol or dissolved in sterile MP H2O before storage at -20°C. 
Antibiotics were added to sterile media following autoclaving after sufficient 
cooling.  
 
2.1.6.2. Yeast Media 
 
Amino acid dropout yeast minimal media (YMM) was used to select for strains 
harboring plasmid constructs containing selectable markers. A full list of amino 
acid supplements is described in Table 2.3 
Minimal Raffinose- or Galactose-based media was prepared as described for 
YMM substituting Glucose with 2% Raffinose (Sigma) or Galactose (Sigma) 
respectively.  
Antibiotics were supplemented to rich media (YPD) to select for deletion strains 
harboring Kanamycin (kanMX4) or Hygromycin B (hphMX4) resistance alleles. 
Antibiotics were filter sterilised from 50 X concentrated stocks, detailed in Table 
2.4, into cooled media after autoclaving.  
 
2.1.7. Buffers and solut ions  
 
All buffers and solutions were made from distilled water filtered through a Milli-Q 4 
Bowl reagent grade water system (MP H2O) and sterilised by autoclaving at 
126°C, 121 psi for 20 minutes or filter sterilised though 0.2 µm Minisart filters 
(Sartorius Stedim). Recipes for buffer preparation are described in Table 2.6. All 
buffers and solutions were stored at room temperature unless otherwise stated. 
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Buffers as part of commercial kits were used according to the manufacturer’s 
instructions unless otherwise stated.  
 
Table 2.6. Buffers and solut ions used in this study.  
 
Buffer/Solution Preparation  
1 X TE Buffer 10 mM Tris-HCl (pH 8.0), 1 mM EDTA 
(pH 8.0)  
1 X TBE (Tris/Borate/EDTA) running 
buffer  
90 mM Tris, 90 mM Boric acid, 2 mM 
EDTA (pH 8.0)  
1 X TGS (Tris/Glycine/SDS) running 
buffer  
2.5 mM Tris, 19.2 mM Glycine, 0.1% 
w/v SDS  
1 X TBS (Tris-buffered saline)  10 mM Tris-HCl (pH 7.4), 150 mM NaCl  
1 X SSPE Buffer  150 mM NaCl, 9 mM NaH2PO4 , 1 mM 
EDTA, pH adjusted to 7.4 using NaOH 
10 X MOPS Buffer  200 mM MOPS (pH 7.0), 50 mM NaAc, 
10 mM EDTA. Filter sterilised.  
6 X DNA Loading Dye 30% v/v Glycerol, 0.25% w/v 
Bromophenol Blue, 0.25% w/v Xylene 
cyanole  
2 X Protein Loading Dye  160 mM Tris-HCl (pH 6.8), 10% v/v β-
mercaptoethanol, 2% v/v SDS, 10% 
Glycerol, 0.05% w/v Bromophenol Blue  
2 X RNA Loading Dye 95% v/v Formamide, 20 mM EDTA, 
0.05% Bromophenol Blue, 0.05% w/v 
Xylene cyanole  
1 X Glyoxal Loading Dye  50% v/v DMSO, 1 M Glyoxal, 1 X 
MOPS buffer, 10% v/v Glycerol, 20 
µg/ml Ethidium Bromide, 0.025% w/v 
Bromophenol Blue, 0.025% Xylene 
cyanole  
Western Blot Transfer Buffer 20% v/v Methanol, 0.5 X TGS, 0.05% 
v/v SDS  
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TMN150 Lysis Buffer 10 mM Tris-HCl (pH 7.6), 5 mM MgCl2, 
150 mM NaCl 
HEPES Extraction Buffer  50 mM HEPES (pH 7.4), 50 mM KCl, 5 
mM MgCl2, 10% v/v Glycerol. Filter 
sterilised and stored at 4°C. PMSF was 
added to 2 mM prior to use.  
GTC Mix  6.1 M Guanidine thiocyanate (GTC), 15 
mM EDTA (pH 8.0), 75 mM Tris-HCl 
(pH 8.0), 3% v/v Sarkosyl, 1.5% v/v β-
mercaptoethanol 
NaAc Mix 10 mM Tris-HCl (pH 8.0), 100 mM 
Sodium Acetate (pH 5.0), 1 mM EDTA 
(pH 8.0)  
ECL Solution 1 2.5 mM Luminol (Sigma), 400 µM p-
coumaric acid (Sigma), 100 mM Tris-
HCl (pH 8.7). Stored at 4°C  
ECL Solution 2 5.4 mM H2O2, 100 mM Tris HCl (pH 
8.7). Stored at 4°C 
Alkaline Lysis Solution I 25 mM Tris-HCl (pH 8.0), 50 mM 
Glucose, 10 mM EDTA (pH 8.0)  
Alkaline Lysis Solution II 0.2 M NaOH, 1% v/v SDS  
Alkaline Lysis Solution III 3 M Potassium Acetate, 11.5% v/v 
Acetic Acid. Solution was pre-chilled on 
ice prior to use.  
DEPC H1O 0.1% Diethylpyrocarbonate (DEPC) in 
MP H1O. Incubated overnight at 22°C 
before autoclaving.  
Northern Blot Stripping Buffer 0.1% v/v SSPE, 0.1% v/v SDS 
50 X Denhardt’s Solution  0.04% w/v Ficoll, 0.04% w/v 
Polyvinylpyrrolidone, 0.04% w/v BSA. 
Stored at -20°C for short term storage 
and -80°C for long term storage.  
Oligo-Hybridisation Buffer  6 X SSPE, 5 X Denhardt’s Solution, 
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0.2% v/v SDS. Made using DEPC 
treated MP H2O  
Formamide Oligo-Hybridisation Buffer  50% v/v Formamide, 5 X SSPE, 5 X 
Denhardt’s Solution, 0.1% v/v SDS, 
200 µg/ml Herring sperm DNA 
LiT Buffer 10 mM Tris-HCl (pH 7.6), 1 mM EDTA 
(pH 8.0), 100 mM Lithium acetate (pH 
7.5)  
Western Blot Blocking Buffer 10% w/v dried, skimmed mlik powder 
(Marvel, Premier International Foods 
Ltd. Lincs, UK) in 1 X TBS.  
STET 8% w/v Sucrose, 50 mM Tris-HCl (pH 
8.0), 50 mM EDTA (pH 8.0), 5% v/v 
Triton X-100 
Neutralisation Buffer 1.5 M NaCl, 0.5 M Tris, pH adjusted to 
7.4 using HCl  
Breaking Buffer  10 mM Tris-Hcl (pH 8.0), 1 mM EDTA 
(pH 8.0), 100 mM NaCl. 1% v/v SDS, 
2% Triton X-100  
Alkaline Lysis Extraction Buffer  0.2 M NaOH, 0.2% v/v β-
mercaptoethanol. Stored at 4°C 
TfbI Solution 10 mM KAc, 100 mM RbCl2, 10 mM 
CaCl2, 50 mM MnCl2, 15% v/v Glycerol, 
pH adjusted to 5.8 using 0.2 M Acetic 
Acid.  
TfbII Solution  10 mM MOPS, 75 mM CaCl2, 10 mM 
RbCl2, 15% v/v Glycerol, pH adjusted to 
6.5 using 0.5 M KOH 
 
2.1.8. Plasmids 
 
All plasmids used or constructed during this study (unless otherwise stated) are 
described in Table 2.8. Vector backbones are detailed in Table 2.7.  
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Table 2.7. Backbone plasmids used in this study 
 
Plasmid  Descript ion Source/Reference 
pRSET-b 
E. coli expression vector, ampicillin 
resistance, T7 promoter. For 
generating recombinant, N-terminal, 
His(6)-tagged fusion proteins.  
Invitrogen (Schoepfer, 
1993) 
 
pGEX-2T 
E. coli expression vector, ampicillin 
resistance, tac promoter. For 
generating recombinant, N-terminal 
GST fusion proteins. 
Amersham (Smith and 
Johnson, 1988) 
pRS313 
Yeast/E. coli shuttle single-copy 
vector, ampicillin resistance, HIS3 
selection marker.  
(Sikorski and Hieter, 
1989) 
pRS314 
Yeast/E. coli shuttle single-copy 
vector, ampicillin resistance, TRP1 
selection marker. 
(Sikorski and Hieter, 
1989) 
pRS415 
Yeast/E. coli shuttle single-copy 
vector, ampicillin resistance, LEU2 
selection marker. 
(Sikorski and Hieter, 
1989) 
pRS425 
Yeast/E. coli shuttle multi-copy 
vector, ampicillin resistance, LEU2 
selection marker. 
(Sikorski and Hieter, 
1989) 
pRS316 
Yeast/E. coli shuttle single-copy 
vector, ampicillin resistance, URA3 
selection marker. 
(Sikorski and Hieter, 
1989) 
pRS426 
Yeast/E. coli shuttle multi-copy 
vector, ampicillin resistance, URA3 
selection marker. 
(Sikorski and Hieter, 
1989) 
p44 
Yeast/E. coli shuttle single-copy 
vector, ampicillin resistance, URA3 
selection. For generating N-terminal 
(Mitchell et al., 1996) 
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zz-tagged fusion proteins driven by 
the RRP4 promoter.   
pEG(KT)  
Yeast 2µ high copy number vector, 
ampicillin resistance, URA3 & leu2-d 
selection. For generating Gal1/10 
driven GST fusion proteins.  
(Mitchell et al., 1993)  
pTL26 
Yeast/ E. coli shuttle single-copy 
vector, ampicillin resistance, HIS3 
selection. For generating Gal1/10 
driven proteins.  
Euroscarf  (Lafontaine 
and Tollervey, 1996)  
pET24b[GB1] 
E. coli expression vector, kanamycin 
resistance, T7 promoter. For 
generating N-terminal GB1 & His(6) 
fusion proteins.  
A gift from G.Hautbergue 
(University of Sheffield)  
(Hautbergue et al., 2008) 
pBS1479 
Yeast / E. coli shuttle vector, 
ampicillin resistance, TRP1 selection. 
For generating C-terminal TAP-
tagged fusion proteins.   
(Rigaut et al., 1999) 
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p426 
p425 
p280 
p263 
p262 
p198 
p44 
Plasm
id 
N
um
ber 
pRS313[rrp47∆C] 
pRS313[RRP47] 
pEG(kt)[rrp6∆212-721] 
pRS416[zz-RRP6] 
pRS314[RRP47] 
pEG(kt) 
pRS416[zz] 
C
om
position  
Untagged rrp47∆C yeast 
expression construct under RRP47 
prom
oter. (HIS3) 
Untagged Rrp47 yeast expression 
construct under RRP47 prom
oter. 
(HIS3) 
2µ yeast vector for high level 
expression of GST-Rrp6
NT . Driven 
by G
AL1/10 prom
oter. (URA3, leu2-
d) 
zz-Rrp6 yeast expression construct. 
Driven by the RRP4 prom
oter. 
(URA3) 
Untagged Rrp47 yeast expression 
construct. Driven by the RRP47 
prom
oter. (TRP1) 
2µ yeast vector for high level 
expression of GST-fusion peptides 
under the control of the G
AL 1/10 
prom
oter. (URA3, leu2-d) 
For construction of N-term
inal 
tagged zz-fusion proteins in yeast. 
Driven by RRP4 prom
oter. (URA3) 
D
escription  
P.J. M
itchell (University of Sheffield) 
P.J.M
itchell (University of Sheffield)  
J.A. Stead (Stead et al., 2007) 
P.J. M
itchell (University of Sheffield)  
R.M
. Jones (University of Sheffield)  
(M
itchell et al., 1993) 
P.J. M
itchell (University of Sheffield) (M
itchell et 
al., 1996) 
Source/C
onstruction  
Table 2.8. Plasm
ids used/constructed in this study.  
Plasm
id num
bers refer to the lab nom
enclature reference system
. Plasm
ids are prefixed with a lower case ‘p’ and num
bered chronologically. 
Yeast selection m
arkers are indicated in brackets.  
!
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p599 
p593 
p532 
p530 
p514 
p432 
p430 
p428 
pRS415[zz-M
PP6] 
pRS416[zz-M
PP6] 
pRS426[NEL025c] 
pRS425[NEL025c] 
pRS313[GAL::zz-RRP6] 
pRS313[zz-rrp6, L197X] 
pRS313[zz-rrp6-1] 
pRS313[zz-RRP6] 
zz-M
pp6 yeast expression 
construct. Driven by RRP4 
prom
oter. (LEU2) 
zz-M
pp6 yeast expression 
construct. Driven by RRP4 
prom
oter. (URA3) 
2µl NEL025c yeast expression 
construct. (URA3) 
2µl NEL025c yeast expression 
construct. (LEU2) 
zz-Rrp6 yeast expression construct. 
Under control of the G
AL1/10 
prom
oter. (HIS3)  
zz-Rrp6
NT  yeast expression 
construct. Driven by RRP4 
prom
oter. (HIS3) 
zz-rrp6-1 yeast expression 
construct. Driven by RRP4 
prom
oter. (HIS3) 
zz-Rrp6 yeast expression construct. 
Driven by RRP4 prom
oter. (HIS3) 
This study: Bam
HI/SalI fragm
ent from
 p593 
subcloned into pRS415 
This study: o597 + o598 PCR on wildtype 
genom
ic DNA cloned into p44 using EcoR1 and 
HindIII 
M
. Feigenbutz (University of Sheffield) (Garland 
et al., 2013) 
M
. Feigenbutz (University of Sheffield) (Garland 
et al., 2013) 
M
. Turner (University of Sheffield) 
P.J.M
itchell (University of Sheffield) 
P.J. M
itchell (University of Sheffield) 
P.J.M
itchell (Univeristy of Sheffield)  
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p667 
p666 
p665 
p664 
p603 
p602 
p601 
p600 
pRS415[zz-
m
pp6_G111A_R112A_F1
15A] 
pRS415[zz-
m
pp6_F20A_M
21A] 
pRS415[zz-
m
pp6_M
18A_K19A] 
pRS415[zz-
m
pp6_L11A_S12A_V15A] 
pRS425[zz-M
PP6] 
pRS425[zz-RRP6] 
pEG(kt)[Rrp6∆212-721, 
ura3-] 
pEG(kt)[ura3-] 
zz-m
pp6 yeast expression 
construct with 
G111A_R112A_F115A 
substitutions. (LEU2) 
zz-m
pp6 yeast expression 
construct with F20A_M
21A 
substitutions. (LEU2) 
zz-m
pp6 yeast expression 
construct with M
18A_K19A 
substitutions. (LEU2) 
zz-m
pp6 yeast expression 
construct with L11A_S12A_V15A 
substitutions. (LEU2) 
2µ zz-M
PP6 yeast expression 
construct. Driven by RRP4 
prom
oter. (LEU2) 
2µ zz-RRP6 yeast expression 
construct. Driven by RRP4 
prom
oter. (LEU2)  
2µ yeast vector for high level 
expression of GST-Rrp6
NT . Driven 
by G
AL1/10 prom
oter. (leu2-d) 
2µ yeast vector for high level 
expression of GST-fusion peptides 
under the control of the G
AL 1/10 
prom
oter.  (leu2-d) 
This study: SDM
 on p599 using o764 + o765 
This study: SDM
 on p599 using o762 + o763 
This study: SDM
 on p599 using o760 + o761 
This study: SDM
 on p599 using o758 + o759 
This study: Bam
HI/SalI fragm
ent of p593 
subcloned into pRS425.  
This study: XhoI/SacI fragm
ent of p263 
subcloned into pRS425.  
This study: URA3 allele of p280 disrupted by 
ApaI/StuI digestion, treatm
ent with Klenow 
fragm
ent followed by blunt end ligation.  
This study: URA3 allele of p198 disrupted by 
ApaI/StuI digestion , treatm
ent with Klenow 
fragm
ent followed by blunt end ligation.  
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p698 
p697 
p686 
p685 
p671 
p670 
p669 
p668 
pRS415[zz-m
pp6_D43N] 
pRS415[zz-m
pp6_S42P] 
pRS415[zz-m
pp6_N33D] 
pRS415[zz-m
pp6_M
18I] 
pRS313[rrp47∆C-TAP, 
TRP1] 
pRS313[RRP47-
TAP,TRP1] 
pRS415[zz-m
pp6_K169X] 
pRS415[zz-m
pp6_D130X] 
zz-m
pp6 yeast expression 
construct with a D43N substitution. 
(LEU2) 
zz-m
pp6 yeast expression 
construct with a S42P substitution. 
(LEU2) 
zz-m
pp6 yeast expression 
construct with a N33D substitution. 
(LEU2)  
zz-m
pp6 yeast expression 
construct with a M
18I substitution. 
(LEU2)  
Rrp47∆C-TAP yeast expression 
construct. Driven by RRP47 
prom
oter. (HIS3, TRP1) 
Rrp47-TAP yeast expression 
construct. Driven by RRP47 
prom
oter. (HIS3, TRP1) 
zz-m
pp6 yeast expression 
construct with a K169X m
utation. 
(LEU2) 
zz-m
pp6 yeast expression 
construct with a D130X m
utation. 
(LEU2) 
This study: SDM
 on p599 using o858 + o859 
This study: SDM
 on p599 using o854 + o855 
This study: SDM
 on p599 using o850 + o851 
This study: SDM
 on p599 using o846 + o847 
This study: o777 + o879 PCR on pBS1479 was 
ligated with SalI linearised p425 by in vivo 
recom
bination in yeast.  
This study: o878 + o879 PCR on pBS1479 was 
ligated with SalI linearised p425 by in vivo 
recom
bination in yeast.  
This study: SDM
 on p599 using o766 + o767 
This study: SDM
 on p599 using o844 + o845 
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p691 
p690 
p689 
pRS415[zz-m
pp6_E146K] 
pRS415[zz-m
pp6_Y66H] 
pRS415[zz-m
pp6_L63P] 
zz-m
pp6 yeast expression 
construct with a E146K 
substitution. (LEU2) 
zz-m
pp6 yeast expression 
construct with a Y66H substitution. 
(LEU2) 
zz-m
pp6 yeast expression 
construct with a L63P substitution. 
(LEU2) 
This study: SDM
 on p599 using o848 + o849 
This study: SDM
 on p599 using o856 + o857  
This study: SDM
 on p599 using o852 + o853 
!
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2.1.9. Ol igonucleotides  
 
All oligonucleotides were purchased from Operon (Eurofins MWG Operon., 
Ebersberg, Germany) and were already purified and dephosphorylated. Oligos 
were typically diluted to a working stock concentration of 5 µM in DEPC treated 
H2O. Tables 2.9, 2.10, 2.11 and 2.12 describe oligonucleotides used in this study 
categorized by usage. All sequences are written 5’-3’.  
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O
ligo N
um
ber 
Sequence 
D
escription/U
se 
o236 
GCGTTGTTCATCGATGC 
To detect 5.8S rRNA, com
plem
entary to B1S boundary in 5.8S rRNA 
o237 
TGAGAAGGAAATGACGCT 
To detect 5.8S + 30nt rRNA, com
plem
entary to the 5.8S/ITS2 boundary 
o238 
TCACTCAGACATCCTAGG 
To detect U14 snoRNA, com
plem
entary to 108-126 nt from
 the 5’ end 
o240 
CACCGTTACTGATTTGGC 
To detect snR13 snoRNA, com
plem
entary to 68-86 nt from
 the 5’ end 
o242 
AAGGACCCAGAACTACCTTG 
To detect SCR1 RNA, com
plem
entary to 295-315 nt from
 the 5’ end  
o243 
GAGAGGTTACCTATTATTA 
To detect snR38 snoRNA, com
plem
entary to 51-70 nt form
 the 5’ end 
o274 
CGCTGCTCACCAATGG 
To detect 5’ETS, com
plem
entary to 5’ETS 278 nt downstream
 of A
0  
o319 
GCTCTTTGCTCTTGCC 
To detect 20S pre-rRNA, com
plem
entary between D and A
2   
o405 
CATGGCTTAATCTTTGAGAC 
To detect 18S rRNA, com
plem
entary to 34-54 nt downstream
 of A
1  
o406 
CTCCGCTTATTGATATGC 
To detect 25S rRNA, com
plem
entary to 41-59 nt downstream
 of C
1  
o443 
TTCGGTTTCTCACTCTGGGGTAC 
To detect U3 snoRNA, com
plem
entary to 102-125 nt from
 the 5’ end 
o494 
CTGCTGCAAATTGCTACCTC 
To detect snR50 snoRNA, com
plem
entary to 13-23 nt from
 the 5’ end 
o517 
ATCTCTGTATTGTTTCAAATTGACCAA 
To detect U6 snRNA, com
plem
entary to 27-54 nt downstream
 from
 the 5’ end 
o717 
TGTTACCTCTGGGCCC 
To detect 27SA
2 pre-rRNA, com
plem
entary to ITS1 between A
2  and A
3  
o809 
GGCTTCTACAGAACAAGTTGTATCGAAATGATTGTTGGCGAC 
To detect NEL025c CUTs 
o815 
GATGTAAGAGAACAAGTGAACAGTGAACAGTGAACAGTGGGGACA 
To detect IGS1-R CUTs 
o820 
ACTTGTCAGACTGCCATT 
Com
plem
entary to the 3’ end of U3 snoRNA 
o821 
GGTCAGATAAAAGTAAAAAAAGGTACG 
Com
plem
entary to the 3’ end of snR13 snoRNA 
o822 
AGATTGCAGCACCTGAGTTTC 
Com
plem
entary to the 3’ end of 5S rRNA  
o925 
CTACTCGGTCAGGCTC 
To detect 5S rRNA, com
plem
entary to 64-80 nt from
 the 5’ end 
! Table 2.9. O
ligonucleotides used for N
orthern Probes in this study  
Oligo Num
ber refers to the lab nom
enclature reference system
.  
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O
ligo 
N
um
ber 
Sequence 
D
escription/U
se 
o758 
GTGCTAACAATGGTGTCACTGGCAAAGCCGCTAGTAGAGCCATGAATATGAAGTTTATGAAATTT 
(+) To generate L11A, S12A, 
V15A substitutions in M
pp6 
o759 
AAATTTCATAAACTTCATATTCATGGCTCTACTAGCGGCTTTGCCAGTGACACCATTGTTAGCAC 
(-) To generate L11A, S12A, 
V15A substitutions in M
pp6 
o760 
TGGCAAACTCTCTAGTAGAGTCATGAATGCGGCGTTTATGAAATTTGGTAAGACGGATGAC 
(+) To generate M
18A, K19A 
substitutions in M
pp6 
o761 
GTCATCCGTCTTACCAAATTTCATAAACGCCGCATTCATGACTCTACTAGAGAGTTTGCCA 
(-) To generate M
18A, K19A 
substitutions in M
pp6 
o762 
ACTCTCTAGTAGAGTCATGAATATGAAGGCTGCGAAATTTGGTAAGACGGATGACGAAGAG 
(+) To generate F20A, M
21A 
substitutions in M
pp6 
o763 
CTCTTCGTCATCCGTCTTACCAAATTTCGCAGCCTTCATATTCATGACTCTACTAGAGAGT 
(-) To generate F20A, M
21A 
substitutions in M
pp6 
o764 
CGAAAACCTGAGGGTGTGATAAGTGCGGCAAAAACCGCTGGCGATAATTCTGATGATAGT 
(+) To generate G111A, R112A, 
F115A substitutions in M
pp6 
o765 
ACTATCATCAGAATTATCGCCAGCGGTTTTTGCCGCACTTATCACACCCTCAGGTTTCG 
(-) To generate G111A, R112A, 
F115A substitutions in M
pp6 
o766 
GACCTAGATAAATTATTTAAGGATAGCATCTAGAAGAAAAAGACCAACCATAATGGTAAAAAT 
(+) To generate a K169X 
truncation in M
pp6 
o767 
ATTTTTACCATTATGGTTGGTCTTTTTCTTCTAGATGCTATCCTTAAATAATTTATCTAGGTC 
(-) To generate a K169X 
truncation in M
pp6 
o844 
GGTGGTTCCAGGAAGAGAAAGTTCTAGGAAGGCGAACAAAATGAAGAC 
(+) To generate a D130X 
truncation in M
pp6 
o845 
GTGTTCATTTTGTTCGCCTTCCTAGAACTTTCTCTTCCTGGAACCAC 
(-) To generate a D130X 
truncation in M
pp6 
o846 
CAAACTCTCTAGTAGAGTCATGAACATCAAGTTTCTGAAATTTGGTAAGAC 
(+) To generate a M
18I 
substitution in M
pp6 
Table 2.10. O
ligonucleotides used for site-directed m
utagenesis in this study.  
+/- denotes forward or reverse prim
ers respectively.  
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o847 
GTCTTACCAAATTTCATAAACTTGATGTTCATGACTCTACTAGAGAGTTG 
(-) To generate a M
18I 
substitution in M
pp6 
o848 
GAAGACGAGAAAAGGGATGCTAAGGATAAAAAGTTTACAGGGAGCC 
(+) To generate an E146K 
substitution in M
pp6 
o849 
GGCTCCCTGTAAACTTTTTATCCTTAGCATCCCTTTTCTCGTCTTC 
 
(-) To generate an 
E146K substitution in M
pp6 
o850 
CGGATGACGAAGAGAGTTCAGATTCCAATACGCCGTCTAATATC 
(+) To generate a N33D 
substitution in M
pp6 
o851 
GATATTAGACGGCGTATTGGAATCTGAACTCTCTTCGTCATCCG 
(-) To generate a N33D 
substitution in M
pp6 
o852 
GTCTGGATGACTCAGCGTGGGATCCAAATAGCTACAAAGATGA 
(+) To generate a L63P 
substitution in M
pp6 
o853 
TCATCTTTGTAGCTATTTGGATCCCACGCTGAGTCATCCAGAC 
(-) To generate a L63P 
substitution in M
pp6 
o854 
CAATACGCCGTCTAATATCAATCCGGATGTGGAACCTATAGAGC 
(+) To generate a S42P 
substitution in M
pp6 
o855 
GCTCTATAGGTTCCACATCCGGATTGATATTAGACGGCGTATTG 
(-) To generate a S42P 
substitution in M
pp6 
o856 
CTGGATGACTCAGCGTGGGACCTCAATAGTCATAAAGATGATTT 
(+) To generate a Y66H 
substitution in M
pp6 
o857 
AAATCATCTTTATGACTATTGAGGTCCCACGCTGAGTCATCCAG 
(-) To generate a Y66H 
substitution in M
pp6 
o858 
CGCCGTCTAATATCAACTCTAACGTGGAACCTATAGAGCAGAAAG 
(+) To generate a D43N 
substitution in M
pp6 
o859 
CTTTCTGCTCTATAGGTTCCACGTTAGAGTTGATATTAGACGGCG 
(-) To generate a D43N 
substitution in M
pp6 
!
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Oligo 
Number  
Sequence Description/Use 
o778 GGCAAAGCCGCTAGTAG 
To screen for L11A, S12A, V15A 
substitutions in Mpp6 
o779 ATGAATGCGGCGTTTAT 
To screen for M18A, K19A 
substitutions in Mpp6 
o780 AGAAGGCTGCGAAATT 
To screen for F20A, M21A 
substitutions in Mpp6 
o781 ATAAGTGCGGCAAAAAC 
To screen for G131A, R132A, 
F135A substitutions in Mpp6 
o860 AGAAGTTCTAGGAAGGCG 
To screen for D130X truncations 
in Mpp6 
o861 GTCATGAACATCAAGTTTATG 
To screen for M18I substitutions 
in Mpp6 
o862 AGGATAAAAAGTTTACAGGG 
To screen for E146K 
substitutions in Mpp6 
o863 AGAGTTCAGATTCCAATACG 
To screen for N33D substitutions 
in Mpp6 
o864 GTGGGATCCAAATAGCTAC 
To screen for L63P substitutions 
in Mpp6 
o865 ATCAATCCGGATGTGG 
To screen for S42P substitutions 
in Mpp6 
o866 CCTCAATAGTCATAAAGATGATT 
To screen for Y66H substitutions 
in Mpp6 
o867 CAACTCTAACGTGGAACC 
To screen for D43N substitutions 
in Mpp6 
 
 
 
 
 
 
 
Table 2.11. Ol igonucleotides used for Southern probes in this 
study.  
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O
ligo 
N
um
ber 
Sequence 
 
D
escription 
 
o68 
 
ATTAACCCTCACTAAAGGG 
 
(+) PCR prim
er to am
plify from
 the 
T3 prom
oter  
 
o191 
 
AAACTCGAGGAACTGACTACTGA 
 
(+) Outlying PCR prim
er to am
plify 
RRP47 alleles 
 
o192 
 
AAAGAGCTCAAACTTTCGCTGG 
 
(-) Outlying PCR prim
er to am
plify 
RRP47 alleles 
 
o468 
CTGGGATCCATGATACACGATGCAGG 
 
(+) Outlying PCR prim
er to am
plify 
REX1 alleles 
 
o512 
 
ATGGCAACCCTACGAGTAA 
 
(-) Outlying PCR prim
er to am
plify 
REX1 alleles 
 
o594 
 
CGCGAATTCTCTCGAATCTACACG 
 
(+) PCR prim
er with EcoR1 site to 
am
plify M
PP6 alleles 
 
o595 
 
CCTGCTCCCATTACAG 
 
(+) Outlying PCR prim
er to am
plify 
M
PP6 alleles 
 
o597 
 
ACGGAATTCAATGAGTGCTAACAATGG 
 
(+) PCR prim
er with EcoRI site to 
am
plify from
 the initiation site of 
M
PP6 alleles 
 
o598 
 
CGCAAGCTTGGCGTGCATGAGACG 
 
(-) PCR prim
er with HinDIII site to 
am
plify M
PP6 alleles 
 
Table 2.12. O
ligonucleotides used for PC
R and m
olecular cloning during this study 
+/- denotes forward or reverse prim
ers respectively.  
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o599 
 
ACAAACAGATTCAAAGGG 
 
(-) Outlying PCR prim
er to am
plify 
M
PP6 alleles 
 
o774 
 
CGAAAGTAGACAACAAATTC 
 
(+) PCR prim
er to am
plify zz-tagged 
alleles.  
 
o877 
 
CAGGCAGAGCAAGAAAAAGCTAAGAATATCATTTCCAATGTTTTGGACTCCATGGAAAAGAGAAG 
 
(+)PCR prim
er to am
plify TAP-tag and 
TRP1 m
arker from
 pBS1479. 
Contains regions of hom
ology to 
target product to the RRP47 locus to 
generate a rrp47DC-TAP allele 
 
o878 
 
AAAAGTAAAAGATTGGATAAAGTTGGAAAAAAGAAAGGAGGGAAGAAGTCCATGGAAAAGAGAAG 
 
 (+)PCR prim
er to am
plify TAP-tag and 
TRP1 m
arker from
 pBS1479. 
Contains regions of hom
ology to 
target product to the RRP47 locus to 
generate a rrp47-TAP allele 
  
o879 
 
TATAAGCATTTTTGCATTTGTGCTCTCACATCACCTTTAATCTACGACTCACTATAGGG 
 
(-) PCR prim
er to am
plify TAP-tag and 
downstream
 TRP1 m
arker from
 
pBS1479. Contains regions of 
hom
ology to target downstream
 of the 
RRP47 locus.  
 
!
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2.1.10 Antibodies  
Antibodies used in this study are described in Table 2.13. Bracketed names 
describe the abbreviations frequently used in this text and figures. Antibodies were 
stored at -80°C for long-term storage and either -20°C or 4°C as stated for short-
term storage.  
 
Table 2.13. Antibodies used in this study.  
 
Name Concentrat ion used 
Incubation 
per iod Storage Source 
Mouse anti-penta-
his (α-His) 1:10,000 2 hours -20°C QIAGEN 
Rabbit anti-
Glutathione-S-
Transferase (α-
GST) 
1:14,000 2 hours -20°C SIGMA 
Peroxidase/anti-
Peroxidase (α-
PAP) 
1:10,000 2 hours -20°C SIGMA 
Mouse anti-
Phosphoglycerate 
Kinase 1 (α-PGK1) 
1:10,000 2 hours 4°C Invitrogen 
Rabbit anti-Rrp4 
(α-Rrp4) 1:10,000 2 hours -20°C 
P.J.Mitchell (University of 
Sheffield) 
Rabbit anti-Rrp6 
(α-Rrp6) 1:5,000 2 hours -20°C 
A kind gift from David 
Tollervey (Wellcome Trust 
Centre for Cell Biology, 
Edinburgh) 
Rabbit anti-Rrp47 
(α-Rrp47) 1:5,000 2 hours -20°C 
P.J.Mitchell (University of 
Sheffield) 
Rabbit anti-Sba1 
(α-Sba1) 1:20,000 1 hour -20°C 
A kind gift from Stephan 
Wilson (University of 
Sheffield) 
Goat anti-Rabbit 
Peroxidase 
(GARPO) 
1:10,000 1 hour -20°C SIGMA 
Rabbit anti-Mouse 
Peroxidase 
(RAMPO) 
1:20,000 1 hour -20°C SIGMA 
Goat anti-Mouse 
Peroxidase (GAM) 1:10,000 1 hour 4°C Bio-Rad 
 
! 80!
2.2. Methods 
 
2.2.1. Generating competent E. col i  cel ls: The Rubidium Chloride 
method 
 
Saturated pre-cultures of appropriate E. coli strains (listed in Table 2.1) were 
diluted 100-fold into 100 ml LB media and grown at 37°C to an OD550 of 0.48. 
Cells were harvested by centrifugation at 3,200 x g at 4°C for 5 minutes and 
pellets were re-suspended in 40 ml TfbI solution. Following 10 minutes incubation 
on ice, cells were harvested as before and re-suspended in 5 ml TfbII solution 
before a further 15 minutes incubation on ice. Aliquots of 100 µl were snap-frozen 
in liquid nitrogen and stored at -80°C before use.  
 
2.2.1.1. Determination of E. col i competency 
 
Competent cells generated as above were routinely tested for their degree of 
competency by their transformation efficiency. An aliquot of cells was transformed 
as described in section 2.2.2 with 0.1 ng pUC18 DNA (Agilent), plated onto 
selective media and incubated for 16 hours. Transformation efficiency was 
calculated by the number of colony forming units per µg of pUC18 DNA (CFU/µg 
pUC18 DNA).  
 
E. coli cells with a transformation efficiency of 105-107 CFU/µg pUC18 DNA were 
used for plasmid transformations. Cells with efficiencies of 107-109 CFU/µg pUC18 
DNA were used for procedures that required a higher degree of competency such 
as molecular cloning or SDM transformations.  
 
2.2.2. Transformation of competent E. col i cel ls 
 
Competent E. coli cells were regularly transformed with varying nanogram 
quantities of DNA depending on the application. Cells were thawed on ice for 10 
minutes before addition of transforming DNA and incubating for a further 15 
minutes on ice. The cells were subjected to a heat-shock at 42°C for 1.5 minutes 
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followed by 2 minutes on ice before recovery at 37°C with the addition of 1ml LB 
media for 40 minutes. Following recovery, cells were centrifuged at 16,000 x g for 
1 minute, re-suspended in LB media and plated onto selective media.  
 
2.2.3. Isolat ion of plasmid DNA from E. col i   
 
Plasmids were routinely extracted from transformed E. coli cells. Strains harboring 
plasmids were isolated from single colonies growing on solid LB media 
supplemented with appropriate antibiotics. Single colonies were used to inoculate 
5ml LB media plus antibiotics and were grown to saturation overnight at 37°C with 
sufficient agitation. Cells were harvested at 16,300 x g for 1 minute and any 
supernatant was removed. Pellets were either used immediately or stored at -
20°C for up to 1 week.  
 
2.2.3.1 Alkal ine lysis method 
 
Based on method originally described by Birnboim & Doly (Birnboim and Doly, 
1979). Cell pellets from 1.5 ml saturated pre-culture were re-suspended in 100 µl 
Alkaline lysis Solution I and 200 µl of Alkaline lysis solution II was added. After 
incubating on ice for 5 minutes, 150 µl of Alkaline lysis solution III was added 
before centrifugation at 16,300 x g for 10 minutes. The resulting supernatant was 
added to an equal volume of phenol/chloroform, briefly vortexed and centrifuged 
for 5 minutes. The aqueous phase was transferred to a fresh tube and mixed with 
2 volumes of 100% ethanol and precipitated for 20 minutes at room temperature. 
Nucleic acids were pelleted by centrifugation for 20 minutes and washed with 200 
µl 70% (v/v) ethanol. Pellets were air dried before re-suspending in 19 µl MP H2O 
followed by the addition of 1 µg RNaseA. Plasmid mini-preps were routinely 
checked by agarose gel electrophoresis (see section 2.2.10) using 1 µl of sample.  
 
2.2.3.2. Spin Miniprep Kit method 
 
Plasmid preparations using E.Z.N.A.® Plasmid Miniprep Kit (Omega, Omega Bio-
Tek Inc., Georgia, USA) were routinely used for lab stocks and sequencing. Cell 
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pellets were prepared as described above, re-suspended in chilled buffer provided 
by the manufacturer and plasmid DNA was isolated as per the manufacture’s 
instructions.  
 
2.2.4. Polymerase Chain Reaction (PCR)  
 
PCR reactions were performed using Taq DNA polymerase (GoTaq®, Promega) 
unless otherwise stated. Thermocycling reactions were carried out using a Cleaver 
TC32/80 (Cleaver Scientific LTD., Warwickshire, UK) or a Techne TC312 (Techne., 
Cambridge, UK) thermocycler. PCR volumes ranged from 20-100 µl depending on 
the application. Two-step PCR was routinely used as a general protocol to 
optimize annealing.   
Typical reaction mix:  
 
 30.5 µl MP H2O  
 10 µl   5 x GoTaq® Reaction Buffer (includes MgCl2)  
5 µl  2 mM dNTP mix 
1 µl   Oligonucleotide primer A (5 µM stock)  
1 µl   Oligonucleotide primer B (5 µM stock)  
1 µl  Template DNA (~10 ng)  
1.25 U Taq DNA Polymerase  
 
Typical thermocycler settings for two-step PCR:  
 
  95°C   2 mins 
  95°C  30 secs 
  45°C  1 min 
  50°C  1 min 
  72°C   3 mins 
  72°C   5 mins 
  4°C  Hold 
 
30 cycles  
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PCR reaction products were regularly verified by agarose gel electrophoresis (see 
Section 2.2.10) and subjected to PCR cleanup (Section 2.2.9) or gel purification 
(Section 2.2.11) depending on the downstream application.  
 
2.2.5. Colony PCR 
 
Alleles were directly screened from yeast colonies without the need to isolate and 
purify DNA. Freshly growing cells were collected from solid media and added 
directly to a 50 µl PCR mix solution as described in Section 2.2.4 in place of the 
template DNA. A two-step PCR thermocycling program was used as described 
above with the addition of a 10-minute initial denaturation step. Cellular debris and 
other PCR contaminants were removed using a commercial PCR cleanup kit as 
described in section 2.2.8.  
 
2.2.6. Error-prone PCR (EPPCR)  
 
A variation on the PCR reaction was used to introduce random mutations into 
alleles to generate a mutant library. Cumulative rounds of PCR were performed on 
template DNA using GoTaq DNA Polymerase (Promega) that lacks proofreading 
activity.  
 
The initial PCR product was generated using ~10 ng plasmid DNA harboring the 
gene of interest as a template. Outlying primers were designed to amplify the gene 
and flanking sequences. Reaction mixes of 100 µl (prepared in the same relative 
amounts as described in section 2.2.4) were split into 10 µl aliquots and PCR 
reactions were run in parallel before pooling the resulting products.   
 
PCR products were purified by ethanol precipitation as described in Section 2.2.8. 
DNA was confirmed by agarose gel electrophoresis and approximately quantified 
in relation to GeneRuler 1 kb DNA ladder bands (Thermo Scientific). A 10 ng 
aliquot from the primary round (1°) of EPPCR was used for a subsequent 
secondary round (2°) of PCR as described above. This process was repeated for 
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5 rounds of EPPCR to generate 5 libraries (1°-5°) with cumulative degrees of 
nucleotide mis-incorporation for use in downstream applications.  
 
 
2.2.7. Site-Directed Mutagenesis (SDM)  
 
Site-Directed Mutagenesis was used to introduce nucleotide substitutions in 
plasmid expression constructs in order to generate specific mutations in the 
subsequent gene products. Briefly, two complementary oligonucleotides 
containing the desired mutation were used to amplify the appropriate plasmid 
DNA through a thermocycling reaction using Pfu Turbo high fidelity DNA 
polymerase. The QuickchangeTM Site-Directed Mutagenesis I Kit (Stratagene) was 
used with slight variations to the manufacturers instructions. 
 
Reaction mix:  
  15.5 µl  H2O  
  2.5 µl   10 X Reaction Buffer 
  1 µl   Plasmid DNA (50-100 ng)  
  2.5 µl   Oligonucleotide Primer A  
  2.5 µl   Oligonucleotide Primer B  
  0.5 µl  dNTP Mix 
  2.5 U   Pfu DNA polymerase 
 
Thermocycler conditions:  
 
  95°C  2 mins 
  95°C  30s 
  55°C  1 min 
  68°C  12 mins 
  68°C  10 mins 
  4°C  Hold 
 
30 cycles  
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After amplification, 20 U DpnI was added to digest methylated and 
hemimethylated parental plasmid at 37°C for 1 hour. A 10 µl aliquot was used to 
transform competent E. coli cells as described in section 2.2.2.  
 
2.2.8. Ethanol precipitat ion of DNA  
 
PCR products were precipitated to remove enzyme contaminants and excess 
dNTPs. To a standard 50 µl PCR reaction, NaAc pH 5.0 was added to a final 
concentration of 300mM after thermocycling. Nucleic acids were precipitated with 
the addition of 2 x volumes 100% ethanol and incubated at -20°C for 1 hour 
followed by centrifugation at 16,300 x g for 20 minutes. Pelleted DNA was 
washed with 70% (v/v) ethanol and centrifuged for a further 5 minutes. The 
supernatant was removed and DNA was air dried at room temperature before re-
suspending in 50 µl TE buffer. DNA was confirmed by agarose gel 
electrophoresis.   
   
2.2.9. PCR cleanup 
 
Colony PCR DNA products were routinely purified for sequencing or downstream 
applications using an E.Z.N.A® Cycle-Pure Kit (Omega) with variations on the 
manufacturer’s protocol. After thermocycling, cellular debris was pelleted by 
centrifugation at 16,300 x g for 2 minutes and the supernatant was transferred to 
a fresh tube. Buffer CP was added to 4 x volumes and the protocol was followed 
as described by the manufacturer’s instructions.  
 
 
2.2.10. Agarose gel electrophoresis of DNA  
 
DNA was routinely separated by electrophoresis on 1% (w/v) agarose gels. High-
resolution agarose (Geneflow) was dissolved in 0.5X TBE by microwaving. 
Agarose solutions were cooled to ~65°C and Ethidium bromide was added to a 
final concentration of 0.1 µg/µl. Gels were cast in a Bio-Rad gel caster and run at 
76 V in a Mini-Sub Cell GT Agarose Gel Electrophoresis system (Bio-Rad, Bio-Rad 
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Laboratories., Munchen, Germany) using 0.5 X TBE as a running buffer. Prior to 
loading, samples were mixed with 6 X DNA Loading Buffer. DNA was visualized 
using a Syngene G:Box Gel Documentation UV transilluminator (Syngene, 
Synoptics., Cambridge, UK) and captured using GeneSnap software. 
Quantification was carried out using GeneTools software as described by the 
manufacturer’s instructions.  
 
2.2.11. Purif ication of DNA from agarose gels 
 
After separation of DNA by agarose gel electrophoresis, DNA fragments were 
excised from the gel using a scalpel. A hand-held UV lamp was used to visualize 
the DNA whilst minimizing UV exposure where possible. DNA fragments were 
purified from agarose using an E.Z.N.A® Gel Extraction Kit (Omega) according to 
the manufacture’s instructions. DNA was eluted from the column in 20-50 µl of TE 
buffer heated to 70°C. Eluted DNA was confirmed by agarose gel electrophoresis.  
 
2.2.12. Restr ict ion digest of DNA  
 
DNA was digested using commercial enzymes provided by NEB and Promega 
according to the manufacturer’s instructions. Digests were carried out in total 
volumes ranging 20-50 µl, using 100-500 ng of DNA for analytical digests and 
several micrograms of DNA for molecular cloning purposes. Typically, digests 
were carried out at 37°C for either 2-4 hours or 16 hours for analytical and 
preparative digestions respectively. Analysis of restriction digests was carried out 
using agarose gel electrophoresis as described in Section 2.2.10 and DNA 
fragments were routinely purified from agarose as described in Section 2.2.11.  
 
2.2.13 Alkal ine Phosphatase digestion of DNA 
 
Calf-Intestinal Phosphatase (CIP) (Roche) was used to catalyse the removal of 5’ 
phosphate groups from digested DNA to prevent self-ligation during molecular 
cloning.  
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Restriction digestion of DNA was carried out as described in Section 2.2.12 
before adding 1 U CIP (1 U/µl) and incubating at 37°C for 1 hour. The sample was 
diluted 4 X using MP H2O and NaAc pH 5.0 was added to a final concentration of 
300 mM. An equal volume of phenol/chloroform was added before briefly 
vortexing and centrifuged at 16,300 x g for 5 minutes. The aqueous phase was 
transferred to a fresh tube and DNA precipitated with 2 volumes 100% (v/v) 
ethanol at -20°C for 1 hour. DNA was recovered by centrifugation at 16,3000 x g 
for 20 minutes before washing with 70% (v/v) ethanol and centrifugation for a 
further 5 minutes. The supernatant was removed before air-drying at room 
temperature. DNA was dissolved in a final volume of 50 µl.  
 
2.2.14. Klenow fragment treatment of DNA 
 
The Klenow fragment of DNA polymerase I from E. coli was used to fill in receded 
3’ ends of restriction digested DNA for blunt end ligation.  
After restriction digestion of DNA (Section 2.2.12), 10 U of Klenow fragment 
(Fermentas) and dNTPs (to 200 µM) were added before incubating at 37°C for 10 
minutes. The enzyme was heat-inactivated at 65°C for 5 minutes and DNA was 
purified by gel electrophoresis as described in Section 2.2.11.  
 
 
2.2.15 in vitro DNA l igation 
 
Ligation of DNA molecules with complementary overhanging sequences or blunt 
ends was routinely carried out as part of molecular cloning using T4 DNA ligase 
(Promega).  
Typical ligation mix:  
 
 ~200 ng purified, digested vector DNA 
 3 X molar equivalent purified, digested insert DNA 
 2 µl T4 Ligase Buffer  
 0.5 U T4 DNA Ligase  
 Volume to 20 µl with MP H2O 
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Ligation reactions were left at room temperature overnight before addition of a 
further 0.5 U ligase and incubating for 4-6 hours. 10 µl of the ligation mixture was 
used to transform competent E. coli as described in Section 2.2.2.  
 
2.2.16. 5’-end radiolabel l ing of Ol igonucleotides 
 
Short oligonucleotide probes were used to detect the presence of DNA or RNA 
molecules on Southern or Northern blots respectively. Nucleic acid probes were 
designed to be complementary to the desired target. Oligonucleotides were 
radiolabelled at the 5’-hydroxal group with γ[32P]-ATP (PerkinElmer, PerkinElmer., 
MA, USA) using T4 Polynucleotide Kinase (PNK) (Promega) 
 
Typical labeling reaction mix:  
 
 10 µl   DEPC H2O 
 1.5 µl   10 X PNK Reaction Buffer  
 1 µl  DNA Oligonucleotide (5pmols/µl)  
 5 U   PNK 
 2 µl  γ[32P]-ATP (~6 pmol total) 
 
Reaction mixes were incubated at 37°C for 30-45 minutes before heat-inactivation 
at 65°C for 5 minutes. Labeled probes were diluted in oligo-hybridisation buffer 
and filter sterilised by passing through a 0.2 µm filter before use in 
Northern/Southern blot hybridisation.  
 
2.2.17. Southern Blott ing 
 
As originally described by Southern (Southern et al, 1975). DNA separated by 
agarose gel electrophoresis was transferred using the ‘turbo-blot’ procedure.  
After electrophoresis, gels were soaked in 0.4 M NaOH for 15 minutes with gentle 
agitation. Excess NaOH was rinsed thoroughly with MP H2O before soaking in 
neutralisation buffer for 15 minutes. The gel was washed thoroughly as previously 
! 89!
mentioned before a final soak in 10 X SSPE for 15 minutes. Nucleic acids were 
transferred to Hybond-N+ membrane (GE Healthcare, GE Healthcare Life 
Sciences., Buckinghamshire, UK) overnight by capillary action in 10X SSPE using 
reservoir pressure. After transfer, DNA was cross-linked to membranes using 
1200 joules/cm2 UV light at a distance of ~10 cm.  
 
Southern blots were probed using γ[32P]-ATP labeled oligonucleotides prepared as 
described in Section 2.2.16. Blots were hybridised overnight at 37°C with gentle 
agitation. Excess probe was decanted from the blot before being washed 3 x with 
2 X SSPE at room temperature followed by a 30-minute incubation at 37°C. Blots 
were wrapped in saran wrap and placed under phosphor storage screens 
(Kodak). Exposures were scanned using a Personal Molecular Imager FX machine 
(Bio-Rad) and non-saturated images were obtained using the ImageJ64 program 
(NIH).  
 
2.2.18. Genomic DNA extraction from yeast 
 
Yeast genomic DNA (gDNA) was isolated in order to confirm alleles by PCR 
analysis or for amplification of genes for downstream applications.  The method is 
based on the protocol originally described in (Cryer et al., 1975).  
 
Yeast strains were grown to saturation in 50 ml of appropriate medium before 
harvesting at 3,200 x g for 5 minutes. Cell pellets were washed in 5 ml MP H2O 
before spinning for a further 5 minutes. The supernatant was removed and the cell 
pellet was re-suspended in 1 ml breaking buffer and 1 ml phenol/chloroform. An 
equal volume of glass beads were added and cells were lysed by vortexing for 5 
minutes. A further 4 ml of phenol/chloroform was added along with 4 ml TE buffer, 
the mixture was briefly vortexed and centrifuged for 5 minutes at 3,200 x g. The 
aqueous layer was removed to a fresh falcon tube and DNA was precipitated with 
2 x volumes of 100% ethanol at -20°C for one hour. Samples were centrifuged for 
20 minutes at 3,200 x g and re-suspended in 2 ml TE buffer. RNA was digested 
with the addition of 30 µg RNaseA and incubating at 37°C for 30 minutes.  A 
further 5 ml 100% ethanol was added with 25 µl NH4Ac and the mixture was 
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centrifuged for 20 minutes at 3,200 x g. The pellet was washed with 70% (v/v) 
ethanol before re-suspending in 500 µl TE buffer. DNA was re-precipitated 3 times 
with 1 volume isopropanol, pelleting by centrifugation at 16,300 x g and re-
suspended in 0.5 ml TE buffer. Genomic DNA was air dried and dissolved in a final 
volume of 100 µl TE buffer.  
 
2.2.19 Yeast Transformation  
 
Yeast transformations were performed with variations on methods previously 
described (Schiestl and Gietz, 1989). Different methods were used depending on 
the desired efficiency of transformation.  
 
2.2.19.1. Yeast Colony Transformation 
 
For low yield, plasmid transformations (~102 cfu per µg Transforming DNA), yeast 
colonies were isolated from plates for transformation.  
 
Several yeast colonies were picked from freshly growing selective media and re-
suspended in 1 ml MP H2O before pelleting at 16,300 x g for 1 minute. The cells 
were washed in 1 ml TE buffer and 1 ml LiT buffer consecutively before re-
suspending in LiT buffer (50 µl per transformant). For each transformation, 50 µl of 
cells were mixed with 1 µg transforming DNA, 50 µg denatured- single-stranded 
herring sperm carrier DNA (Roche) and 100 µl sterile 40% (w/v) PEG4000 in LiT 
buffer. The mixture was incubated for 30 minutes at room temperature before 
adding 15 µl DMSO and heat-shocked at 42°C for 15 minutes. Cells were 
harvested and washed in 1 ml TE buffer before re-suspending in 100 µl TE buffer 
and plating onto selective media.  
 
2.2.19.2. Yeast pre-culture Transformation 
 
Alternatively to colony transformation, yeast cells were harvested from overnight 
liquid cultures grown in selective media.  
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1 ml of liquid cultures were pelleted by centrifugation at 16,300 x g for 1 minute 
before following the protocol described in section 2.2.19.1.  
 
2.2.19.3. High-eff iciency Yeast Transformation 
 
For transformation of SDM plasmids, DNA libraries or genomic integrations, a 
high-efficiency transformation method was used.  
 
A saturated overnight culture of the recipient strain was used to inoculate 50 ml 
YPD media to an OD600 of 0.1 and grown at 30°C with constant shaking to an 
OD600 of 0.5. Cells were harvested by centrifugation at 3,200 x g for 5 minutes, 
washed in 5 ml TE buffer and 5 ml LiT buffer concurrently and re-suspended in 
500 µl LiT buffer. An aliquot of 100 µl cell suspension was used per transformation 
and was added to 50 µl LiT buffer containing 1 µg transforming DNA, 50 µg 
carrier DNA and 300 µl freshly prepared PEG4000 (40% w/v in LiT buffer). The 
mixture was incubated at room temperature for 30 minutes before the addition of 
50 µl DMSO and heat-shocked at 42°C for 15 minutes. Cells were pelleted and 
washed in 1 ml TE buffer before re-suspending in 100 µl TE buffer and plating to 
the appropriate selective media.   
 
2.2.20. Plasmid recovery from Yeast 
Plasmid DNA was isolated from yeast strains using an E.Z.N.A® Yeast Plasmid kit 
(Omega) and amplified by transforming into KC8 E. coli. This allowed selection of 
plasmids using yeast auxotrophic markers and was ideal for recovery from yeast 
strains containing multiple plasmids bearing different auxotrophic markers.   
 
Yeast strains were grown to saturation in YPD or selective minimal media before 
harvesting 3 ml of culture by centrifugation at 3,200 x g for 5 minutes. Cell pellets 
were used immediately or stored at -20°C. Cells were re-suspended in SE 
buffer/β-mercaptoethanol/lyticase solution as provided by the manufacturer and 
DNA was extracted according to the manufacturer’s instructions. DNA was eluted 
from the column matrix in 30 µl elution buffer (10 mM Tris pH 8.5). 10 µl of DNA 
eluate was used to transform competent KC8 E. coli and selected on appropriate 
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drop out minimal M9 media. Isolated colonies were grown to saturation in LB 
media supplemented with the appropriate antibiotic before isolating plasmid DNA 
as described in section 2.2.3.  
 
2.2.21. Yeast Repl ica Plat ing 
 
Yeast colonies were routinely tested for the ability to grow on different selective 
media by replica plating.  
 
Strains were grown on a master plate for 2-3 days at 30°C before pressing 
colonies onto a sterile velveteen disk. The disk was imprinted onto secondary 
selective media to transfer colonies and strains were incubated for a further 2-3 
days at 30°C.  
 
2.2.22. Spot Growth Tests 
 
Yeast strains were compared for their relative growth in various different 
conditions by spotting onto selective media plates.  
 
Strains were inoculated into 5ml of appropriate selective medium and grown to 
saturation over 1-2 days. Values for OD600 were measured and normalised for 1/1 
samples. Ten-fold serial dilutions were made in sterile MP H2O and 4 µl aliquots 
were spotted onto appropriate media. Strains were grown at various temperatures 
depending on the desired results.  
 
2.2.23. Preparation of Protein Lysates from Yeast 
 
2.2.23.1. Physical lysis method  
 
Cells were grown in selective media at 30°C to an OD600 of 0.5-1.5 and harvested 
by centrifugation at 3,200 x g for 5 minutes and washed in 5 ml TE buffer. Pellets 
were either used immediately or stored at -80°C.  
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Cells were re-suspended in TMN150 buffer (2 ml/litre culture) and an equal volume 
of glass beads was added along with 2 mM PMSF. The cells were vortexed 10 
times for 30 seconds with 1 minute rests on ice between beatings. Lysates were 
transferred to a 1.5 ml eppendorf tube and clarified at 15,000 x g for 20 minutes 
at 4°C.  
 
Protein concentration was determined by measurement of OD280 and OD260 using 
a 6305 Genova Spectrophotometer (Jenway, Bibby Scientific., Stone, UK). Protein 
lysates were analysis by SDS-PAGE (described in Section 2.2.26).  
 
2.2.23.2. Alkal ine Lysis method 
 
Protocol as described in (Motley et al., 2012) originally based on methods 
described in (von der Haar, 2007)  
 
Yeast strains were grown in selective media before 10 ml cells at an OD600 of 1.0 
were harvested by centrifugation at 3,200 x g for 5 minutes. The cells were 
washed in TE buffer and pellets were either stored at -80°C or used immediately.  
 
Cell pellets were re-suspended in 500 µl cold Yeast Protein Alkaline Lysis Buffer 
and incubated on ice for 10 minutes. Trichloroacetic acid (TCA) was added to a 
final concentration of 5% (v/v) and incubated on ice for 10 minutes before 
centrifugation at 13,000 x g for 5 minutes in a cooled centrifuge. The pellet was 
re-suspended in 10 µl Tris HCl pH 9.4 before adding 90 µl 2 x SDS Protein 
Loading Dye and boiling the samples for 5 minutes at 95°C.  
Protein lysates were stored at -20°C. Prior to use, the sample was cleared by 
centrifugation at 16,300 x g for 1 minute. Typically 10 µl (equivalent to 1 OD cells) 
was used for SDS-PAGE analysis as described in Section 2.2.26).  
 
2.2.24 Purif ication of Tagged Proteins from Yeast 
 
Endogenous TAP-tagged fusion proteins or plasmid-borne zz-tagged fusion 
constructs were used to isolate proteins from yeast and for pulldown analysis.  
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Yeast lysates were prepared as described in Section 2.2.23.1. However, the cells 
were lysed in HEPES Extraction Buffer in place of TMN150. A Bio-Rad Poly-Prep 
Chromatography Column (Bio-Rad) was washed with HEPES Extraction Buffer 
before adding 50 µl IgG Sepharose beads (GE Healthcare) and equilibrating with 
further HEPES Extraction Buffer. Clarified yeast protein lysates were incubated 
with the washed beads and passed through the column 10-15 times. The beads 
were washed thoroughly in HEPES Extraction Buffer followed by HEPES Wash 
Buffer.  
 
Retained proteins were eluted either by boiling in 2 x SDS Loading Dye or 
incubating with 0.5 M Acetic Acid. Eluates from acid washing were concentrated 
by the addition of 10% (v/v) 2-butanol, vortexing and centrifugation at 16,300 x g 
for 5 minutes. The upper phase was removed and the process was repeated until 
~50-100 µl of the lower phase remained. The samples were lyophilized in a 
Savant Speedvac SC 110A Concentrator (Thermo) before dissolving the pellet in 
100 µl 2 x SDS Loading Dye and incubating at 95°C for 5 minutes.  
 
Purified proteins were analysed by SDS-PAGE and Western Blotting (described in 
sections 2.2.26 and 2.2.28 respectively).  
 
2.2.25 Glycerol gradient ultracentr i fugation  
 
Native yeast lysates were prepared by physical lysis and subjected to glycerol 
gradient ultracentrifugation through 12 ml 10-30% glycerol gradients prepared in 
HEPES extraction buffer.  
  
Yeast cells were grown in 400 ml of appropriate media at 30°C to an OD600 of 1.0-
1.5 before harvesting by centrifugation at 3,200 x g for 5 minutes. Cell pellets 
were washed in 5 ml TE buffer and centrifuged for a further 5 minutes before 
immediate use or storage at -80°C.  
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Cells were lysed by physical lysis (described in section 2.2.23.1) in cold HEPES 
Extraction Buffer. An equal volume of glass beads was added along with PMSF to 
a final concentration of 2 mM. Cells were vortexed for 10 x 30 second intervals 
interpolated with 1 minute incubations on ice.  Lysates were clarified by 
centrifugation at 16,300 x g for 20 minutes.  
 
Gradients were prepared by under-laying using a Beckman Model 385 former 
(Beckman-Coulter, Beckman Coulter UK LTD, High Wycombe, UK). The outer 
chamber was filled with 6 ml HEPES extraction buffer containing 30% v/v glycerol 
and mixed in the outlet chamber containing 6 ml HEPES extraction buffer 
containing 10% v/v glycerol before under-laying into 12 ml Beckman 
ultracentrifugation SW41 tubes.  
 
Gradient tubes were weighed and calibrated using HEPES extraction buffer before 
loading 400 µl clarified yeast cell lysate on the top of the gradient. 
Ultracentrifugation was carried out in a Beckman-Optima LE-80X Ultracentrifuge 
using a SW41 rotor at 36,000 rpm for 24 hours at 4°C. Gradients were 
fractionated manually from the top of the gradient using a pipette into 18 x 680 µl 
fractions. Fractions were analysed by colloidal gel staining of SDS PAGE gels to 
compare resolution of whole cell lysates through gradients.  
 
Proteins were precipitated from fractions by the addition of TCA to 20% v/v and 
incubating on ice for 30 minutes before centrifugation at 16,300 x g for 20 
minutes. Precipitated proteins were washed in 1ml acetone before centrifugation 
at 16,300 x g for 5 minutes. Pellets were dried before re-suspending in 100 µl 2 x 
SDS Loading Dye and denaturing at 90°C for 5 minutes. Samples were analysed 
by SDS-PAGE followed by western blotting.  
 
2.2.26. SDS-PAGE Analysis of Proteins  
 
Proteins were routinely separated according to their electrophoretic mobility by 
Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresis (SDS-PAGE) as 
originally described in (Shapiro et al., 1967). Acrylamide concentrations varied 
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from 8-15% (v/v) depending on the size of the protein(s) of interest. Typically, 
samples were run on a 12% Polyacrylamide gel using an Owl P81 Single Sided 
Vertical Electrophoresis System (Thermo-Fisher Scientific) or a Mini-Protean Cell 
electrophoresis system (BioRad). Larger SDS-PAGE gels were run in a Protean II 
electrophoresis system (BioRad).  
 
12% SDS-PAGE Gel mixes;  
 
Resolving fraction (10 ml);  
  
3.0 ml  40% (w/v) 37.5:1 Acrylamide:Bis-Acrylamide (National 
Diagnostics Inc, Charlotte NC, USA)  
2.8 ml  1.5 M Tris HCl pH 8.7  
4 ml  MP H2O  
100 µl  10% (w/v) SDS  
100 µl  10% (w/v) Ammonium Persulphate (APS)  
10 µl  Tetramethylethylenediamine (TEMED) (Sigma) 
 
Stacking fraction (3 ml);  
 
350 µl  40% (w/v) Acrylamide 38:1 Bis-Acrylamide 
350 µl  1 M Tris HCl pH 6.8  
2.235 ml  MP H2O  
30 µl 10% (w/v) SDS 
30 µl 10% (w/v) APS 
5 µl TEMED 
 
 
Prior to loading, protein samples were denatured by boiling in 2 X SDS Loading 
Dye at 90°C for 5 minutes. Proteins were separated in 1 X TGS at 65 V through 
the stacking fraction and was raised to 115 V once the dye front reached the 
resolving fraction. Gels were typically run until the bromophenol blue dye reached 
the end of the resolving fraction.  
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SDS-PAGE gels were typicaly used for colloidal staining (Section 2.2.27) or 
subjected to Western Blot analysis (Section 2.2.28).  
 
2.2.27. Coomassie staining of SDS-PAGE gels 
 
To visualize proteins fractionated by SDS-PAGE, gels were incubated in 10 ml 
Instant Blue (Expedeon) after electrophoresis for 1 hour with gentle agitation 
followed by washing in MP H2O to remove excess stain. Gels were visualized 
using a Syngene G:Box Gel Doc System using the GeneSnap software.  
 
2.2.28. Western Blott ing 
 
SDS-PAGE gels were routinely subjected to Western Blot analysis in order to 
detect specific proteins of interest.  
 
Following electrophoresis as described in section 2.2.26, proteins were 
transferred to Hybond-C nitrocellulose membrane (GE Healthcare) by 
electroblotting in Western Blot Transfer Buffer at 15 V overnight using a HSI, TE 
Series Transphor Electrophoresis Unit (HSI, Hoefer Scientific Instruments, San 
Francisco, USA).  
 
Membranes were washed in TBS before staining with 10 ml Ponceau S solution 
(Thermo Scientific) to confirm protein transfer. Ponceau solution was removed by 
washing 3 times in TBS before incubating the membrane in Western Blot Blocking 
solution for 1 hour at room temperature with gentle agitation. Membranes were 
washed 3 times in TBS for 5-minute intervals before incubating with the relevant 
primary antibody (see Table 2.13 for concentration and incubation times of 
antibodies). Following a further 3 washes in TBS, membranes were incubated with 
the appropriate secondary antibody coupled to horseradish peroxidase (HRP). 
Excess antibody was removed with 3 further washes in TBS. A mixture of equal 
volumes of ECL solutions 1 and 2 was applied to the membrane and incubated at 
room temperature for 1 minute with gentle agitation. Immunofluorescence was 
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visualized primarily using a CCD camera as part of a Syngene G:Box Gel Doc 
System and captured using the GeneSnap software following the manufacturer’s 
instructions. For larger Western Blots, membranes were wrapped in saran wrap 
after ECL incubation before being exposed to film (Kodak, Kodak Ltd., Herts, UK) 
and developed using a Compact X4 Developer (XOgraph, XOgraph Imaging 
Systems Inc., Gloucs, UK).  
 
 
2.2.29. RNA Extraction from Yeast  
 
Total RNA was extracted from Yeast using a variation on the guanidine 
thiocyanate/hot phenol method of extraction (T. Maniatis, E. F. Fritsch, 1982) with 
adaptations from a later study (Tollervey and Mattaj, 1987).  
 
Cells of the appropriate strain were grown in 50 ml of selective media to an OD600 
of 0.5 before harvesting at 3,200 x g for 5 minutes followed by washing in TE 
buffer and pelleting for a further 5 minutes. Cells were either used immediately or 
stored at -80°C until needed.  
To the cell pellet, 1 ml of sterile DEPC treated glass beads were added along with 
0.5 ml GTC mix and 0.5 ml phenol pH 4.0 before vortexing for 5 minutes. A further 
1.5 ml GTC mix and 1.5 ml phenol pH 4.0 was added and briefly vortexed before 
incubating at 65°C for 10 minutes. The mixture was cooled on ice for 10 minutes 
before the addition of 2 ml chloroform and 1 ml NaAc mix. The aqueous phase 
was separated by centrifugation at 3,200 x g for 5 minutes before re-extracting 
with the addition of 2.5 ml phenol/chloroform pH 4.5 before centrifugation for a 
further 5 minutes. Nucleic acids were precipitated from the aqueous phase by the 
addition of 2 volumes of 100% (v/v) ethanol and incubating at -80°C overnight.  
 
Precipitated RNA was pelleted by centrifugation at 3,200 x g for 20 minutes 
before washing with 70% (v/v) ethanol and air dried for 10 minutes at room 
temperature. Pellets were re-suspended in a final volume of 100 µl DEPC H2O.  
RNA concentration (in µg/µl) was calculated by measuring the OD260 of diluted 
samples and assuming that 1 OD240 ~ 40µg. Typically a 160-fold dilution was used 
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and the OD260 value was multiplied by 6.4 to obtain the concentration. Samples 
were prepared by mixing with an equal volume of 2X RNA Loading Buffer and 
denatured at 65°C for 5 minutes before use or stored at -80°C.  
 
2.2.30. Acrylamide gel electrophoresis of RNA  
 
RNA samples were fractionated on 8% polyacrylamide (19:1), TBE buffered-gels 
containing 50% (w/v) urea. Gels were run in 0.5 X TBE using an EV200 Large 
Format PAGE Unit Gel Unit (Engineering and Design Plastics Ltd., Cambridge, 
UK).  
Typically 5 µg total RNA was prepared in a total volume of 4 µl to which an equal 
volume of 2 X RNA loading buffer was added. Samples were denatured at 65°C 
for 5 minutes before loading. Gels were run overnight at 65 V until the Xylene 
Cyanole dye front reached the end of the gel. Fractionated RNA was stained by 
incubating the gel in Ethidium bromide diluted to 0.1 µg/ml in 0.5 X TBE for 15 
minutes with gentle agitation before visualizing on a UV transilluminator.  
 
2.2.31. Agarose gel electrophoresis of RNA  
 
RNA was fractionated on 1.2% (w/v) agarose, MOPS buffered-gels in order to 
probe for pre-rRNA and mRNA species by northern blotting.  
 
Aliquots of 10 µg total RNA were lyophilized in a Savant SpeedVac SC100A Plus 
Concentrator (Thermo Scientific) before dissolving in 15 µl Glyoxal loading dye 
(see Table 2.6) and denaturing for 1 hour at 55°C. Gels were prepared with 1.2% 
(w/v) agarose in 1 X MOPS buffer using DEPC treated MP H2O and run in 1 X 
MOPS buffer in a OWL A1 Large Gel System (Thermo Scientific). Fractionated 
RNA was visualized on a UV transilluminator before transfer and northern blot 
analysis.  
 
2.2.32. Northern Blott ing  
Northern blotting was performed based on original techniques described by 
Alwine et al (Alwine et al., 1977) and Littlehales (Littlehales, 1989).  
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Total RNA fractionated by polyacrylamide gel electrophoresis was transferred to 
Hybond-N+ membranes (GE Healthcare) by electroblotting at 10 V overnight in 
0.5 X TBE.  RNA separated by agarose gel electrophoresis was transferred to 
Hybond-N+ membranes by capillary action using the ‘turbo-blot’ procedure 
described in Section 2.2.17. Transferred RNA was cross-linked to membranes 
using 1200 joules/cm2 UV light at a distance of ~10 cm. Membranes with RNA 
transferred from agarose gels were washed in 20 mM Tris HCl pH 8.0 at 65°C for 
15 minutes to remove any excess glyoxal.  
 
Membranes were incubated in 50 ml Oligo-hybridisation buffer for 1 hour at 37°C 
prior to hybridisation overnight with radiolabeled probes prepared as described in 
2.2.16. Excess probe was decanted before washing three times for 1 minute in 6 
X SSPE at room temperature before incubating at 37°C for 30 minutes. 
Membranes were wrapped in Saran wrap before placing under phosphor storage 
screens (Kodak) and analysed using a Personal Molecular Imager FX machine 
(BioRad). Non-saturated images were obtained using ImageJ64 software (NIH).  
 
Radiolabelled probes were stripped from blots by incubating with 250 ml boiled 
Northern blot stripping buffer for 1 hour with strong agitation.   
 
2.2.33. Bioinformatics 
 
Yeast genome sequences were obtained from the Saccharomyces Genome 
Database (SGD) (http://www.yeastgenome.org). Bioinformatics tools and software 
were used extensively throughout this study and are referenced in the text.  
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Chapter 3: Resolving the Rrp6/Rrp47 complex in v ivo  using 
the DECOID approach 
 
3.1 Introduction 
 
The degradation of RNA is a fundamental biological process required for both 
productive and destructive pathways to maintain a stable transcriptome (Section 
1.1). The RNA exosome complex harbors both endonuclease and 3’-5’ 
exonuclease activities and functions in many fundamental degradation processes 
(Section 1.1.2). Rrp44 and Rrp6 associate with the exosome core (EXO9) to 
provide catalytic activity in the nucleus (Section 1.2). Whilst Rrp6 is not essential in 
yeast, rrp6∆ alleles are synthetic lethal in combination with rrp44exo- mutants and 
both proteins have overlapping functions in RNA processing and surveillance 
(Gudipati et al., 2012b; Schneider et al., 2012). With a wide array of RNA 
substrates for a multitude of degradation processes, the exosome requires the 
function of accessory factors to modulate its activity (Section 1.3).  
 
The nuclear RNA binding protein Rrp47 (also known as Lrp1) functions in concert 
with Rrp6 in processing and degradation pathways. In the absence of Rrp47, 
most Rrp6-dependent processes are impeded (Mitchell et al., 2003). The N-
terminal Sas10/C1D domain of Rrp47 (Rrp47NT) physically interacts with the N-
terminal PMC2NT domain of Rrp6 (Rrp6NT). This interaction is essential for the 
normal expression levels of Rrp47 in vivo. In rrp6∆ or rrp6∆NT mutants, Rrp47 
levels are reduced to ~15% compared to wildtype cells (Feigenbutz et al., 2013b; 
Stead et al., 2007). Conversely in the absence of Rrp47, Rrp6 expression levels 
are reduced in cells grown in minimal media, but not to the extent as the loss of 
Rrp47 in rrp6∆ mutants (Feigenbutz et al., 2013a). Yeast rrp47∆ and rrp6∆ 
mutants are synthetic lethal in with the loss of Mpp6, another nuclear RNA binding 
protein, or the RNaseD related exonuclease Rex1 (Milligan et al., 2008; Peng et 
al., 2003). Like Rrp6, Rex1 functions in 3’-end processing of stable RNAs yet 
does not physically associate with the exosome (Ozanick et al., 2009; van Hoof et 
al., 2000b).  
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The C-terminus of Rrp47 is highly basic and is required for RNA binding in vitro. 
However, rrp47∆C alleles encoding the N-terminal Sas10/C1D domain are still 
functional in vivo and are able to complement the synthetic lethality of rrp47∆ 
rex1∆ mutants (Costello et al., 2011). The C-terminus of Rrp47 was also reported 
to be required for the physical interaction with box C/D snoRNP proteins Nop56 
and Nop58 and rrp47∆C mutant show defects in the final stages of box C/D 
snoRNA maturation (Costello et al., 2011). Taken together, it has been proposed 
Rrp47 functions to aid in substrate recruitment to Rrp6 through its RNA binding 
properties. Additionally, as further discussed in Chapter 4, Rrp47 functions to 
maintain stable expression of Rrp6 (Feigenbutz et al., 2013a).  
 
In this chapter, the effects of physically separating Rrp47 proteins from Rrp6-
containing complexes were investigated. Rrp47 is unstable in the absence of the 
physical interaction with the N-terminal PMC2NT domain of Rrp6 (Rrp6NT). To 
overcome this limitation, an overexpression system was used to induce 
expression of Rrp6NT and titrate Rrp47 out of functional complexes with Rrp6. This 
successfully divorces the Rrp6/Rrp47 homodimer whilst maintaining stable 
expression of Rrp47. This novel approach is referred to as DECOID (decreased 
expression of complexes by overexpression of interacting domains).  
These results show that Rrp47 is functional when physically separated from the 
catalytic and exosome binding domains of Rrp6. The ability to function 
independent from Rrp6 is impaired upon deletion of the C-terminal region of 
Rrp47. Conditional mpp6 rrp47 and rex1 rrp47 mutants were generated using the 
DECOID approach. Overexpression of Rrp6NT in mpp6∆ rrp47∆C and rex1∆ 
rrp47∆C strains resulted in a conditional block in growth. RNA analyses revealed a 
widespread loss of RNA surveillance in the mpp6 rrp47 mutant and a specific 
defect in snoRNA maturation in the rex1 rrp47 mutant. This data supports the 
model that Rrp47 functions in substrate recognition prior to processing or 
degradation by Rrp6 and that these functions are redundant with pathways 
involving Rex1 or Mpp6. 
3.1.1. A functional assay to screen for mpp6 and rrp47 al leles 
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A plasmid shuffle assay was developed to screen for loss of function mutations in 
Mpp6 or Rrp47 proteins. The plasmid shuffle and sectoring assays are well 
characterised as methods for testing genetic complementation of alleles using 
yeast centromeric plasmids (Elledge and Davis, 1988). These screens can be used 
to test for complementation of essential alleles or for synthetic lethal genetic 
interactions.  
 
Yeast strains lacking Mpp6 are viable and have no strong growth or temperature 
sensitive phenotype.  However, mpp6Δ alleles are synthetic lethal in combination 
with rrp47Δ, rrp6Δ or air1Δ alleles (Milligan et al., 2008).  The viability of a mpp6∆ 
rrp47∆ double mutant can be complemented by the maintenance of a 
centromeric plasmid bearing either MPP6 or RRP47 alleles.  The use of yeast 
shuttle vectors containing auxotrophic markers allows for selection or 
counterselection of plasmids in order to test for complementation of synthetic 
lethality.  
 
A strain lacking the gene of interest is transformed with a URA3 plasmid bearing a 
functional copy of the allele. The second gene is disrupted in the resulting strain 
and the double mutant is therefore reliant on the functional allele on the URA3 
maintenance plasmid for cell viability. This strain can be used to introduce 
plasmids bearing mutated alleles and test for complementation of the synthetic 
lethality by counterselection of the original maintenance plasmid on media 
containing 5-Floroorotic Acid (5’FOA). The use of 5’FOA is a common technique 
to cure yeast strains of plasmids containing URA3 markers. 5’FOA is converted to 
the toxic 5-flurouracil in strains expressing the URA3 allele coding for oritine-5-
monophosphate decarboxylase (ODCase) involved in uracil biosynthesis.  
 
For this study, an mpp6Δ rrp47Δ plasmid shuffle assay was constructed in order 
to test plasmids bearing mutated mpp6 or rrp47 alleles (summarised in Figure 
3.1). The aim was to create a double knockout strain complemented with a 
wildtype copy of MPP6 on a plasmid containing a URA3 marker. The resulting  
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Figure 3.1. A functional assay to test for complementation of mpp6∆ rrp47∆ synthetic 
lethality. Schematic for a mpp6∆ rrp47∆ plasmid shuffle assay in yeast. A mpp6∆ rrp47∆ 
strain bearing a wildtype copy of MPP6 on a URA3 plasmid can be used to test 
functionality of mpp6 alleles on a LEU2 plasmid by selection of transformants on minimal 
media containing 5’FOA. If the second plasmid contains a functional mpp6 allele, cells 
are able to lose the URA3 plasmid and are viable on 5’FOA media (upper route). 
However, if the second plasmid is unable to complement the mpp6∆ rrp47∆ synthetic 
lethality, the URA3 plasmid is retained resulting in the production of toxic 5-flurouracil 
and cells lose viability (lower route).
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strain can be transformed with a second plasmid bearing mutant copies of mpp6 
or rrp47 and LEU2 or HIS3 selectable markers respectively. If the second plasmid 
coded for a functional copy of either gene, this would allow for the loss of the  
 
 
URA3 expressing plasmid and strains would be viable on media containing 5’FOA. 
However, if the second plasmid coded for a non-functional allele, the strain would 
have to maintain the URA3 plasmid to complement the synthetic lethality but as a 
result would be toxic to the cells. Such strains would be unable to grow on 5’FOA. 
The mpp6∆ rrp47∆ plasmid shuffle strain was used extensively for these studies.  
 
3.2. Results 
 
3.2.1. Generation of a tagged Mpp6 yeast expression construct 
 
A URA3 centromeric yeast plasmid expressing Mpp6 was created to serve as a 
maintenance plasmid in the plasmid shuffle strain.  The presence of the URA3 
marker served as a tool to counterselect the plasmid on media containing 5’FOA. 
A fusion protein bearing two copies of the z domain of protein A from 
Staphylococcus aureus (Nilsson et al., 1987) was constructed in order to detect 
the expression of the protein by western blotting using available antibodies.  
 
The wildtype MPP6 ORF was amplified from genomic DNA isolated from a 
wildtype strain (P364) by PCR using o597 and o598. The primers introduced 
EcoR1 restriction site at the initiation codon of the MPP6 ORF and a HindIII site 
~430nt downstream of the stop codon. The PCR product of 998bp was cloned 
by ligation into EcoR1/HindIII cut p44 (pRS416[zz]), a yeast expression construct 
containing a zz-tag under the control of the RRP4 promoter and bearing a URA3 
marker (Mitchell et al., 1996). Ligated plasmids were transformed into E. coli and 
recovered before screening by restriction digests using EcoR1/HindIII (Figure 3.2. 
A)   
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Figure 3.2. Generation of a tagged Mpp6 yeast expression construct. (A) Restriction digest 
screen of pRS416[zz-MPP6] constructs. The yeast MPP6 ORF was amplified from gDNA from a 
wildtype strain by PCR using o597 + o598 and cloned into p44 (pRS416[zz]) using EcoR1 and 
HindIII restriction sites. Candidate plasmids (lanes 4-5) were screened by EcoR1/HindIII 
restriction digestion and confirmed by sequencing. (B) Western blot analysis of zz-Mpp6 protein 
expression. An mpp6∆ yeast strain was transformed with a plasmid encoding a zz-Mpp6 fusion 
protein under control of the RRP4 promoter. An empty vector was transformed in parallel. Cells 
were lysed under denaturing conditions and analysed by SDS PAGE and western blotting. 
Lysates prepared from a endogenous mpp6-TAP tagged strain were analysed in parallel to 
compare expression levels. Mpp6 fusion proteins were detected with the PAP antibody (upper 
panel). An antiserum against Pgk1 was used as a loading control (lower panel). Expression levels 
of Mpp6 fusion proteins are given below the figures and are the average of three independent 
biological replicas. Values are expressed relative to the endogenous Mpp6-TAP protein. 
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To test for the expression of a zz-fusion peptide, the resulting plasmid (p593) was 
transformed into an mpp6Δ yeast strain (P548, Euroscarf, University of Frankfurt, 
Germany) and selected for growth on minimal media lacking uracil (SD-ura). The 
mpp6Δ strain was also transformed with an empty URA3 containing vector as a 
negative control. Protein lysates were prepared by alkaline lysis and the tagged 
zz-Mpp6 fusion protein was visualised by western blot analysis using the PAP 
antibody (Figure 3.2. B). The migration of the  
zz-Mpp6 fusion protein corresponds to the estimated molecular weight of 
~35kDa. No detectable fusions peptides were observed in lysates prepared from 
strains bearing the empty vector (lane 2). The steady state expression level of the 
zz-Mpp6 fusion protein was compared to levels of an endogenous C-terminal TAP 
tagged fusion peptide under the control of the MPP6 promoter. The plasmid-
borne zz-Mpp6 fusion protein is expressed ~3-fold greater than the Mpp6-TAP 
protein. Due to the nature of the plasmid construct, zz-Mpp6 is under the control 
of the RRP4 promoter rather than the endogenous MPP6 promoter. A global 
analysis of protein expression in yeast previously reported that Rrp4 and Mpp6 
peptides are expressed at roughly 4840 and 1350 molecules per cell respectively 
(Ghaemmaghami et al., 2003). This translates to a 3.5:1 ratio of Rrp4:Mpp6 and 
roughly corresponds to the relative quantified values of zz-Mpp6:Mpp6-TAP in 
Figure 3.2. B.   
 
To show that overexpression of Mpp6 has no detrimental effect on cell growth, 
the relative growth rates of strains expressing increased levels of Mpp6 protein 
were compared. Growth rates of isogenic wildtype, mpp6∆ and mpp6∆ strains 
expressing zz-Mpp6 from either a centromeric or 2µ plasmids were compared by 
spot growth assays on minimal- or rich-based media (Figure 3.3). The growth 
rates of all strains were comparable. Overexpression of Mpp6 showed no evident 
effect on growth in both minimal- and rich-based media.  
 
3.2.2. Construction of an mpp6Δ rrp47Δ plasmid shuff le strain 
 
In section 3.2.1, an mpp6Δ strain was transformed with a yeast expression shuttle 
plasmid encoding a zz-Mpp6 fusion protein. To generate an mpp6∆ rrp47∆  
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Figure 3.3. Overexpression of Mpp6 does not affect cell growth. Spot growth 
assays of isogenic wildtype (WT), mpp6∆ and mpp6∆ strains bearing an empty 
vector (pRS415), a centromeric plasmid encoding zz-mpp6 (p599) and a 2µ plasmid 
encoding zz-mpp6 (p603). Strains were grown in minimal medium and normalised 
by optical density (600nm). 10-fold serial dilutions were spotted onto solid minimal 
(MM) and rich (YPD) medium. Plates were incubated for 2 days at 30˚C before 
photographing. 
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plasmid shuffle strain in yeast the endogenous RRP47 locus was disrupted by 
transposing an rrp47∆ deletion cassette into the aforementioned strain. The MPP6 
locus in the mpp6Δ parental strain was disrupted by a KanMX4 deletion cassette 
(Wach et al., 1994), therefore the RRP47 disruption would require a different 
marker for selection.  
 
Genomic DNA was extracted from a strain harboring an rrp47Δ allele disrupted by 
the hygromycin B resistance gene, hphMX4  (P913, Garland et al. 2013). PCR 
was used to amplify the rrp47∆::hphMX4 deletion cassette using primers 
complementary to sequences 500bp upstream and downstream of the RRP47 
ORF (o191 + o192). The rrp47∆ deletion cassette was used to transform the 
mpp6∆ strain complemented by plasmid borne zz-Mpp6 expression and selected 
on media containing hygromycin. The successful disruption of the RRP47 locus 
was confirmed by PCR using outlying RRP47 primers (o191 + o192) (Figure 3.4. 
A-B). The disruption of RRP47 and viability of resulting transformants also 
confirms that the zz-mpp6 allele is functional in yeast and complements the 
mpp6∆ rrp47∆ synthetic lethality.  
 
The resulting mpp6∆ rrp47∆ plasmid shuffle strain (P1232) was assayed for the 
ability to lose the URA3 maintenance plasmid encoding zz-Mpp6 through 5’FOA 
counterselection. The zz-mpp6 allele was first subcloned into a centromeric 
plasmid bearing a LEU2 allele (pRS415) before transforming into the mpp6∆ 
rrp47∆ plasmid shuffle strain. A parallel transformation was carried out using an 
empty LEU2 vector. Transformants were selected on minimal medium lacking 
uracil and leucine before assaying for growth on minimal medium containing 
5’FOA (Figure 3.4. C). Strains bearing LEU2 plasmids encoding zz-Mpp6 were 
able to grow on media containing 5’FOA whereas strains transformed with an 
empty LEU2 vector were not viable. The resulting strains viable on 5’FOA were 
tested for growth on minimal media lacking uracil to confirm the loss of the URA3 
plasmid. Strains passaged over 5’FOA were no longer viable on media lacking 
uracil confirming that the URA3 plasmid had been lost.  
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Figure 3.4. Validation of a mpp6∆ rrp47∆ plasmid shuffle assay. (A) Schematic of outlying 
MPP6 and RRP47 primers (B) PCR analysis of mpp6∆ rrp47∆ plasmid shuffle strain. A 
mpp6∆::kanMX4 strain was transformed with a zz-MPP6 construct before disruption of the 
RRP47 locus using a rrp47∆::hphMX4 allele. Double mpp6∆ rrp47∆ mutants were screened 
by PCR using outlying MPP6 and RRP47 primer pairs (o595 + o599 and o191 + o192 
respectively). PCR was carried out on isogenic wildtype, mpp6∆ and rrp47∆ genomic DNA in 
parallel for comparison. (C) Spot growth assay to validate the plasmid shuffle assay. A mpp6∆ 
rrp47∆ plasmid shuffle strain was transformed with a LEU2 centromeric plasmid encoding 
wildtype zz-mpp6 and an empty LEU2 vector. Transformants were grown to saturation in 
selective medium and normalised by optical density (600nm). Ten-fold serial dilutions were 
spotted onto solid glucose (SD-ura-leu) and 5’FOA media. Plates were incubated for 3 days 
at 30˚C before photographing. 
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These results describe the successful generation of an mpp6∆ rrp47∆ plasmid 
shuffle strain to be used as a method to assay for functionality of mpp6 or rrp47 
alleles in vivo. The mitotic maintenance of the URA3 maintenance plasmid 
encoding a functional copy of MPP6 was disrupted by transformation with a 
secondary LEU2 plasmid encoding zz-Mpp6 and growth on media containing 
5’FOA. This provides a conditional assay to test for complementation of mpp6∆ 
rrp47∆ synthetic lethality using plasmids bearing mpp6 or rrp47 alleles.  
 
 
3.2.3. RRP47 and rrp47ΔC al leles complement the mpp6Δ rrp47Δ 
synthetic lethal ity 
 
The plasmid shuffle assay, described in section 3.2.2 allows for testing plasmids 
bearing mpp6 or rrp47 alleles for functionality by complementation of a double 
mpp6∆ rrp47∆ mutant using 5’FOA to counterselect against a maintenance 
plasmid bearing MPP6 and URA3 alleles.  
 
A C-terminal truncation of Rrp47, encoding the N-terminal 120 residues, has 
previously been shown to complement the synthetic lethality of rrp47Δ rex1Δ in a 
similar plasmid shuffle assay. The N-terminus of Rrp47 contains the 
bioinformatically defined Sas10/C1D domain that interacts physically with the N-
terminal PMC2NT domain of Rrp6. The N-terminus of Rrp47 alone is functional in 
the absence of Rex1, however recombinant protein analyses report that the 
protein is unable to bind RNA in vitro (Costello et al., 2011).  
 
To assay if the N-terminus of Rrp47 is sufficient to complement the mpp6Δ rrp47Δ 
synthetic lethality, centromeric HIS3 plasmids encoding for RRP47 and rrp47ΔC 
were transformed into the mpp6Δ rrp47Δ plasmid shuffle strain. Resulting 
transformants were assayed for complementation by growth on media containing 
5’FOA to counterselect the URA3 maintenance plasmid encoding zz-Mpp6 (Figure 
3.5). Strains bearing plasmids containing RRP47 and rrp47∆C alleles were able to 
complement the mpp6∆ rrp47∆ synthetic lethality and were viable on 5’FOA  
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Figure 3.5. The rrp47ΔC allele complements the mpp6Δ rrp47Δ synthetic lethality.
A plasmid shuffle assay. Centromeric plasmids encoding the full length RRP47 gene 
(p425), the rrp47ΔC allele (p426) and an empty vector (pTL26) were transformed into a 
mpp6Δ rrp47Δ strain complemented a zz-MPP6 allele on a URA3 vector. 
Transformants were assayed for the loss of the URA3 plasmid by streaking out onto 
glucose-based minimal media containing 5’FOA. 
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media. Strains transformed with an empty HIS3 vector (pTL26) were unable to 
grow on media containing 5’FOA.  
 
The complementation assay revealed that the N-terminus of Rrp47 is sufficient to 
complement the synthetic lethality of an mpp6Δ rrp47Δ strain. The N-terminal 
Sas10/C1D domain of Rrp47 has been reported to interact physically with Rrp6 to 
form a heterodimer and this interaction is required for the stability of the Rrp47 
protein in vivo (Feigenbutz et al., 2013b). The function of Rrp6 is partially 
dependent on its interaction with Rrp47 but the mechanisms behind this are 
unclear (Stead et al., 2007).  
 
 
3.2.4. Using the DECOID strategy to resolve the Rrp6/Rrp47 complex 
in vivo.  
 
The expression of Rrp47 is dramatically reduced in rrp6Δ mutants or strains 
lacking the N-terminal PMC2NT domain of Rrp6 (Stead et al., 2007). Because this 
interaction has a profound effect on the stability of Rrp47, it was presumed that 
RNA processing and degradation function of Rrp6 and Rrp47 was dependent on 
this physical association. It has been suggested that Rrp47 acts to promote the 
exonuclease activity of Rrp6 in vivo through substrate recognition from RNA 
binding activity (Costello et al., 2011; Mitchell et al., 2003; Stead et al., 2007). 
However, it was unclear whether the physical association of Rrp47 to Rrp6 was 
critical for its function in RNA processing and degradation pathways. As Rrp47 is 
degraded by the proteasome in the absence of Rrp6, analyses of rrp6∆ mutants 
are not ideal to address this question.  
 
Previous work (established by M. Turner, M. Feigenbutz and P. Mitchell) 
developed a novel strategy to separate the physical interaction between the 
Rrp6/Rrp47 heterodimer complex. This employs an overexpression system to 
induce expression of the N-terminal PMC2NT domain of Rrp6 (Rrp6NT) in order to 
titrate Rrp47 out of complexes with Rrp6 (Garland et al., 2013). We refer to this 
approach as DECOID (decreased expression of complexes by overexpression of  
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Figure 3.6. Summary of the DECOID technique to 
separate Rrp47 from Rrp6. (A) Schematic 
representation of domain architecture of Rrp6 and 
Rrp47 as defined by Pfam (http://
pfam.sanger.ac.uk/). Rrp6 contains an N-terminal 
PMC2NT domain (residues 13-102), four α-helices 
(132-210), a catalytic exonuclease domain 
(213-281), a HRDC domain (438-505) and a C-
terminal nuclear localisation signal (NLS). Rrp47 
contains an N-terminal Sas10/C1D domain 
(residues 10-89) and a lysine-rich basic C-
terminus. (B) Model for the physical separation of 
Rrp47 from Rrp6 by the overexpression of the N-
terminal PMC2NT domain of Rrp6 (Rrp6NT) from an 
inducible source. The excess Rrp6NT protein 
titrates Rrp47 from Rrp6 complexes to form 
Rrp47/Rrp6NT heterodimers. 
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interacting domains). A summary of the technique using the separation of Rrp47 
and Rrp6 as an example is depicted in Figure 3.6. This approach would 
theoretically mimic the Rrp47/Rrp6 interaction through binding to the exogenously 
expressed Rrp6NT and prevent the degradation of Rrp47 in the absence of its 
normal binding partner. Overexpression of a GAL-inducible GST-Rrp6NT fusion 
protein was shown to effectively segregate Rrp47 from full-length Rrp6-containing 
complexes through glycerol gradient ultracentrifugation and pull-down assays 
(Garland et al., 2013) 
 
Certain limitations of the DECOID technique must be considered. The possibility 
that residual amounts of Rrp47 protein remain bound to Rrp6 cannot be formally 
discounted. During the initial development of the method, it was shown that ~4% 
of Rrp47 remained bound to Rrp6 after induction of GST-Rrp6NT when compared 
to amounts bound after induction of a GST control. This was considered to be an 
efficient titration of Rrp47 from Rrp6. Additionally, by overexpressing a decoy 
protein, the possibility of off-target effects must be considered. It may be 
conceivable that overexpressed GST-Rrp6NT may interact or disrupt non-intended 
targets. However, overexpressing GST-Rrp6NT in an rrp47∆ strain showed no 
effect on growth in comparison to equivalent GST controls. With no Rrp47 in the 
cell, the decoy protein will have no target. Additionally, overexpression of GST-
Rrp6NT in an rrp47∆ mutant showed no additive RNA processing or degradation 
phenotypes in comparison to a GST control (Garland et al., 2013). Furthermore, 
the N-terminal PMC2NT domain of Rrp6 has no reported function than to interact 
with Rrp47 in previous analyses.  
 
Loss of Rrp47 function is synthetic lethal with mpp6∆ or rex1∆ alleles (Milligan et 
al., 2008; Peng et al., 2003). Surprisingly, segregation of Rrp47 from Rrp6 was 
tolerated in mpp6∆ and rex1∆ strains suggesting that Rrp47 is still functional 
when independent of full length Rrp6. Overexpression of the GST-Rrp6NT protein 
in mpp6∆ and rex1∆ strains induced slow growth phenotypes in comparison to 
cells overexpressing the GST domain.  
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3.2.5. Overexpression of Rrp6NT does not complement the mpp6∆ 
rrp47∆ synthetic lethal ity.  
 
Induction of GST-Rrp6NT expression in mpp6∆ and rex1∆ mutants caused slow 
growth phenotypes in comparison to induction of the GST domain. Conversely, 
GST-Rrp6NT overexpression caused no change in growth rate in rrp47∆ strains 
(Garland et al., 2013). This suggests that Rrp47 is functional yet impaired upon 
GST-Rrp6NT induction.  
 
Plasmid shuffle assays were carried out to test that overexpression of the Rrp6NT 
domain does not negate the requirement for Rrp47. The mpp6∆ rrp47∆ plasmid 
shuffle strain was transformed with 2µ plasmids encoding GAL-induced GST and 
GST-Rrp6NT proteins. Transformants were assayed for growth on minimal media 
containing 5’FOA to counterselect the URA3 maintenance plasmid encoding  
wildtype MPP6. Strains expressing GST and GST-Rrp6NT were unable to grow on 
5’FOA media whereas strains transformed with plasmids encoding wildtype MPP6 
allowed growth (Figure 3.7.) This shows that the overexpression of Rrp6NT does 
not suppress the mpp6∆ rrp47∆ synthetic lethality and that growth defects 
observed in mpp6∆ single mutants are not due to dominant-negative effects of 
Rrp6NT induction.  
 
3.2.6. Yeast mpp6Δ rrp47ΔC and rex1Δ rrp47ΔC al leles are sensit ive 
to Rrp6NT overexpression  
 
In Section 3.2.3, a C-terminal truncation of Rrp47, encompassing the 
bioinformatically defined Sas10/C1D domain, was shown to complement the 
mpp6∆ rrp47∆ synthetic lethality through a plasmid shuffle assay. Additionally, the 
rrp47∆C allele was previously shown to complement the rex1∆ rrp47∆ synthetic 
lethality through a similar plasmid shuffle assay (Costello et al., 2011). The 
DECOID strategy was employed to assay if the Rrp47∆C protein was functional 
when divorced from Rrp6 by overexpression of the Rrp6NT protein in mpp6∆ and 
rex1∆ strains.  
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Figure 3.7. Overexpression of Rrp6NT does not complement the mpp6Δ rrp47Δ 
synthetic lethality. A plasmid shuffle assay. A mpp6Δ rrp47Δ strain maintained by a 
URA3 plasmid encoding zz-MPP6 was transformed with 2-micron plasmids encoding 
GAL::GST (p198) and GAL::GST-Rrp6NT (p280). Centromeric vector (pRS415) and zz-
MPP6 (p599) control plasmids were transformed in parallel. Transformants were 
assayed for the ability to lose the URA3 maintenance plasmid by streaking onto 
galactose media containing 5’FOA. 
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Figure 3.8. Yeast mpp6Δ rrp47ΔC and rex1Δ rrp47ΔC strains are sensitive to Rrp6NT 
overexpression. Plate growth assays of yeast strains on permissive glucose-based medium 
and non-permissive galactose-based medium. (A) Growth of mpp6∆ rrp47∆C strains bearing 
plasmids encoding either GAL-regulated GST or GST-Rrp6NT. (B) Growth of rex1∆ rrp47∆C 
strains bearing plasmids encoding either GAL-regulated GST or GST-Rrp6NT. (C) Spot growth 
assays of mpp6∆ rrp47∆C and rex1∆ rrp47∆C strains bearing plasmids encoding GAL-
regulated GST or GST-Rrp6NT. Strains were grown to saturation in permissive raffinose-based 
medium and normalised by optical density (600nm). Ten-fold serial dilutions were spotted 
onto solid glucose- or galactose based minimal medium. Plates were photographed after 3 
days incubation at 30˚C. 
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Yeast mpp6∆ rrp47∆ and rex1∆ rrp47∆ strains harboring plasmids encoding 
Rrp47∆C were transformed with 2µ plasmids encoding GST or GST-Rrp6NT under 
the control of the GAL1/10 promoter (Stead et al., 2007). Transformants were 
assayed for growth on glucose- and galactose-based media (Figure 3.8. A-C). 
Strikingly, induction of the GST-Rrp6NT domain caused a significant reduction in 
growth in both mpp6∆ rrp47∆C and rex1∆ rrp47∆C mutants whereas induction of 
the GST domain allowed for viability on galactose-based media. This suggests 
that the C-terminus of Rrp47 is required for Rrp6-independent functions that are 
redundant with pathways involving Mpp6 and Rex1.  
 
The C-terminus of Rrp47 was previously shown to not be required for protein 
function yet is necessary for RNA binding in vitro. Additionally, the C-terminus is 
required for interactions with snoRNP proteins Nop56 and Nop58 and C-terminal 
deletion mutants show defects in the maturation of Box C/D snoRNAs (Costello et 
al., 2011).  
 
3.2.7. Rrp47 and Rrp47ΔC proteins are stabi l ised by Rrp6NT  
 
The stability of Rrp47 is sensitive to the physical interaction with the N-terminus of 
Rrp6. In the absence of Rrp6, steady state expression levels of Rrp47 are reduced 
to ~15 % compared to wildtype cells (Costello et al., 2011; Feigenbutz et al., 
2013b). Separating full length Rrp47 from Rrp6 in wildtype, mpp6∆ and rex1∆ 
strains allowed for viability. However, divorcing Rrp47∆C from Rrp6 results in a 
conditional lethal growth phenotype in mpp6∆ and rex1∆ strains. This suggests 
that the C-terminus of Rrp47 is required for Rrp6-independent functions that are 
redundant with Mpp6- and Rex1-dependent pathways. One possibility is that the 
physical separation of Rrp47∆C and Rrp6 though Rrp6NT overexpression results in 
the destabilisation of Rrp47∆C protein expression.  
 
To check for expression levels of Rrp47 and Rrp47ΔC proteins, C-terminal TAP-
tagged fusion constructs were generated through homologous recombination 
cloning in yeast. PCR was carried out on pBS1479 to amplify the TAP-tag, 
consisting of two IgG binding domains (zz) from S. aureus protein A and a 
calmodulin binding peptide separated by a TEV cleavage site, along with a TRP1  
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Figure 3.9. Rrp47 and Rrp47ΔC protein expression is stabilised by Rrp6NT in 
rrp6Δ mutants. Western blot analysis of Rrp47 and Rrp47ΔC protein expression 
in rrp6Δ strains. Yeast rrp6∆ rrp47∆ strains harboring GAL-inducible GST or 
GST-Rrp6NT constructs were transformed with plasmids encoding C-terminal 
TAP tagged Rrp47 and Rrp47∆C fusion proteins. Strains were grown in 
raffinose- (R) or galactose- (G) based minimal medium. Log phase cells were 
harvested and lysed under denaturing conditions before analysis by SDS PAGE 
and western blotting. Rrp47 and Rrp47ΔC fusion proteins were detected with 
the PAP antibody (upper panel). An antiserum against Sba1 was used as a 
loading control (lower panel). 
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marker (Puig et al., 2001). Primers were designed to amplify the TAP tag and 
introduce regions of homology to target the tag the RRP47 locus to generate 
RRP47-TAP and rrp47ΔC-TAP alleles (o878 + o879 and o877 + o879 
respectively). A plasmid bearing the wildtype RRP47 allele (p425) was linearised 
downstream of the ORF by digestion using SalI and co-transformed with the PCR 
products into rrp6Δrrp47Δ strains either harboring the GAL::GST-rrp6NT construct 
(p280) or GAL::GST (p198). Transformants were isolated on selective medium and 
screened for positive clones by western blot analysis. Rrp47-TAP and Rrp47ΔC-
TAP proteins were detected using the PAP antibody. Plasmids harboring RRP47-
TAP and rrp47ΔC-TAP alleles were recovered from yeast and sequenced to 
confirm the junction between the ORF and the TAP-tag.  
Lysates were prepared from rrp6∆ strains expressing either full length Rrp47 or 
truncated Rrp47∆C proteins before and after induction of GST-Rrp6NT protein or 
GST control in raffinose- and galactose-based media respectively. Raffinose is 
used as a non-inducing/non-repressing neutral carbon source. This allows for 
rapid induction of proteins under control of the GAL promoter upon shift to 
synthetic galactose-based medium.  Steady state expression levels of TAP-
tagged Rrp47 proteins were analysed by western blotting using the PAP antibody 
(Figure 3.9). As reported in previous analyses (Feigenbutz et al., 2013b), the 
expression level of Rrp47 was increased in the rrp6∆ mutant upon expression of 
the GST-Rrp6NT (Figure 3.9, compare lanes 5 and 6). Furthermore, the expression 
of the Rrp47∆C protein was increased comparably upon expression of GST-
Rrp6NT protein (lanes 7-8). Induction of the GST control showed no significant 
effect on the expression levels of Rrp47 or Rrp47∆C proteins (lanes 1-4). These 
results show that both the full length Rrp47 and the truncated Rrp47ΔC protein 
are stable in complex with the Rrp6NT protein in the absence of full length Rrp6.  
 
A possible explanation for the loss of growth observed in mpp6∆ rrp47∆C and 
rex1∆ rrp47∆C mutants upon Rrp6NT expression is that the stability of Rrp47∆C 
proteins is compromised in the absence of Mpp6 or Rex1. To address this, the 
expression levels of full-length and C-terminally truncated Rrp47 proteins were 
analysed in mpp6∆ and rex1∆ mutants. Plasmids encoding C-terminal TAP-
tagged Rrp47 and Rrp47∆C (described above) were transformed into mpp6∆  
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Figure 3.10. Rrp47 and Rrp47ΔC proteins are stable in mpp6∆ and rex1∆ 
mutants. Western blot analysis of Rrp47 and Rrp47∆C protein expression in 
mpp6∆ (A) and rex1∆ (B) strains. Plasmids encoding C-terminal TAP-tagged 
fusion proteins of wildtype Rrp47 (p670) or the C-terminal truncation Rrp47∆C 
(p671) were transformed into yeast mpp6∆ rrp47∆ and rex1∆ rrp47∆ plasmid 
shuffle strains bearing URA3 maintenance plasmids encoding wildtype MPP6 
and RRP47 alleles respectively. Cells were passaged over media containing 
5’FOA to purge the strains of the URA3 maintenance plasmid. Cells were lysed 
under denaturing conditions and analysed by SDS PAGE and Western blotting. 
Rrp47 and Rrp47ΔC fusion proteins were detected with the PAP antibody 
(upper panel). An antiserum against Sba1 was used as a loading control (lower 
panel). Expression levels of Rrp47 proteins are given below the figures and are 
the average of three independent biological replicas. Values are expressed 
relative to the corresponding wildtype Rrp47 proteins in each strain. 
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rrp47∆ and rex1∆ rrp47∆ plasmid shuffle strains. As shown in Section 3.2.3 and 
Costello et al. 2011, both RRP47 and rrp47∆C alleles are able to complement the 
mpp6∆ rrp47∆ and rex1∆ rrp47∆ synthetic lethality. Transformants were viable on 
media containing 5’FOA and recovered strains were validated for the loss of the 
URA3 maintenance plasmid encoding wildtype MPP6 or RRP47 alleles. Lysates 
were prepared from the resulting mpp6∆ and rex1∆ strains harboring plasmids 
encoding Rrp47-TAP and Rrp47∆C-TAP tagged proteins and analysed by 
western blotting using the PAP antibody (Figure 3.10). Quantitative analysis from 
three independent biological replicas shows that the expression of Rrp47 proteins 
is not markedly altered in strains lacking Mpp6 or Rex1. Levels of Rrp47∆C are 
slightly reduced to 82% and 89% in mpp6∆ and rex1∆ mutants, respectively, in 
comparison to the expression of full length Rrp47.  
 
In conclusion, Rrp47 and Rrp47∆C proteins are stable in complex with the N-
terminal region of Rrp6 (Rrp6NT). Additionally; Rrp47∆C proteins are stable in the 
absence of Mpp6 or Rex1.  
 
3.2.8 Rrp47 and rrp47ΔC proteins retain function when separated 
from Rrp6-containing complexes.  
 
The separation of Rrp47 and Rrp6 using the DECOID method in mpp6Δ or rex1Δ 
mutants causes slow growth phenotypes, yet strains are viable (Garland et al., 
2013). In mpp6Δ rrp47ΔC and rex1Δ rrp47ΔC mutants, overexpression of the 
Rrp6NT domain causes a strong conditional block in growth. This suggests that the 
C-terminus of Rrp47 is required to function with Mpp6 or Rex1 when separated 
from Rrp6-containing complexes.  
 
To address if Rrp47∆C is functional when segregated from Rrp6, northern blot 
hybridisation analyses were carried out in rrp47∆C mutants upon GST-Rrp6NT 
induction. Yeast rrp47∆ strains harboring plasmids encoding either full length or 
C-terminally truncated Rrp47 proteins were transformed with plasmids encoding 
GAL-driven GST-Rrp6NT proteins. Total RNA was analysed in parallel with wildtype 
and rrp47∆ strains before and after induction of GST-Rrp6NT. Northern blot  
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Figure 3.11. Rrp47 and Rrp47ΔC proteins are functional when segregated from 
Rrp6. Northern analyses of Rrp6NT induction in wildtype, rrp47Δ and rrp47Δ 
strains transformed with plasmids encoding RRP47 or rrp47ΔC alleles.  Cells were 
harvested in during growth in raffinose (lanes labeled R) or galactose (lanes labeled 
G)-based medium. RNA was fractionated through an 8% denaturing acrylamide 
gel and analysed by Northern blot hybridisation using probes complementary to 
the RNAs indicated.  To compare relative levels of mature and 3’ extended forms 
of U14 snoRNA, two images are shown of the same hybridisation. Dispersed 
bands labeled I-pA and II-pA correspond with pre-snoRNAs that are 
polyadenylated at termination sites I or II respectively. SCR1 was used as a loading 
control. 
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hybridisation analyses of 5.8S rRNA revealed that both full length Rrp47 and 
truncated Rrp47∆C proteins retained function when segregated from Rrp6. A mild 
accumulation of 3’ extended 5.8S + 30 pre-rRNA species was observed in 
rrp47∆C ffmutants upon Rrp6NT induction. However, the levels of this processing 
intermediate were markedly less than those observed in the rrp47∆ mutants 
(Figure 3.11 compare lanes 8 with 3-4). Additionally, the rrp47∆C mutant showed 
a lower accumulation of 5’ external transcribed spacer (5’ETS) and 3’ extended 
snoRNAs when overexpressing GST-Rrp6NT in comparison to levels detected in 
the rrp47∆ mutant. In general, the rrp47∆C and RRP47 complemented strains 
showed comparably mild rrp47∆-phenotypes upon Rrp6NT expression. This 
suggests that both full length and C-terminally truncated Rrp47 proteins are 
functional when segregated from Rrp6 in otherwise wildtype cells.  
 
 
3.2.9. Expression of Rrp6NT is not suff icient to complement the rrp6Δ 
mpp6Δ or rrp6Δ rex1Δ synthetic lethal ity 
 
Expression levels of Rrp47 are dramatically reduced in the absence of Rrp6. It has 
previously been reported that the stability of Rrp47 is dependent upon its physical 
interaction with the N-terminus of Rrp6 (Feigenbutz et al., 2013b). Both rrp6Δ and 
rrp47Δ alleles are synthetic lethal in combination with mpp6Δ or rex1Δ mutants. 
One possibility for the basis of the synthetic lethality in rrp6Δ mpp6Δ and rrp6Δ 
rex1Δ mutants is that the protein levels of Rrp47 are reduced in the absence of 
Rrp6. Exogenous expression of the N-terminal domain of Rrp6 is sufficient to 
maintain stable expression of Rrp47 in vivo in the absence of Rrp6 (Section 3.2.7. 
and Feigenbutz et al. 2013). If the synthetic lethality of rrp6∆ mpp6∆ and rrp6∆ 
rex1∆ strains is due to the indirect loss of Rrp47 protein levels, expression of 
Rrp6NT should complement the double mutants.  
 
To address this, plasmid shuffle strains were generated to assay if overexpression 
of Rrp6NT could complement the synthetic lethality observed in rrp6∆ mpp6∆ and 
rrp6∆ rex1∆ strains. As shown in Figure 3.9, expression of the GST-Rrp6NT protein 
increases the levels of Rrp47 in rrp6∆ mutants. The N-terminal domain of Rrp6  
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Figure 3.12. Expression of Rrp6NT is not sufficient to complement the rrp6Δ mpp6Δ or 
rrp6Δ rex1Δ synthetic lethality. Plasmid shuffle assay to test complementation rrp6Δ 
mpp6Δ or rrp6Δ rex1Δ synthetic lethality by the rrp6-1 allele or expression of the 
Rrp6NT domain. (A) Plasmids encoding Rrp6 (p428), rrp6-1 (p430) and Rrp6NT (p432) 
were transformed into a rrp6Δ mpp6Δ strain harboring a wildtype RRP6 allele on a 
URA3 vector. A parallel transformation was carried out with an empty vector (pTL26). 
Strains were assayed for the ability to lose the URA3 maintenance plasmid by 
streaking onto minimal media containing 5’FOA. (B) Plasmids encoding Rrp6 (p428), 
rrp6-1 (p430) and Rrp6NT (p432) were transformed into a rrp6Δ rex1Δ strain harboring 
a wildtype RRP6 allele on a URA3 vector. A parallel transformation was carried out 
with an empty vector (pTL26). Strains were assayed for the ability to lose the URA3 
maintenance plasmid by streaking onto minimal media containing 5’FOA. 
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does not contain exonuclease or exosome-binding regions of Rrp6 and therefore 
is assumed to have no other function than to bind and stabilise Rrp47.   
 
Yeast rrp6∆ mpp6∆ and rrp6∆ rex1∆ strains were generated through targeting the 
kanMX4 disruption cassette to MPP6 and REX1 loci in an rrp6∆::TRP1 strain 
bearing a URA3 plasmid encoding zz-Rrp6. Genomic DNA was isolated from 
mpp6∆::kanMX4 and rex1∆::kanMX4 strains and PCR was used to amplify the 
disruption cassettes using outlying MPP6 and REX1 specific primers (o595 + 
o599 and o468 + o512 respectively). The amplicons were used to transform the 
rrp6∆ strain complemented by exogenous expression of zz-Rrp6. Disruption of 
MPP6 and REX1 loci was confirmed by PCR using outlying primers.  
 
Yeast rrp6∆ mpp6∆ and rrp6∆ rex1∆ plasmid shuffle strains were transformed 
with plasmids encoding zz-tagged Rrp6 constructs and assayed for growth on 
media containing 5’FOA to screen for complementation of synthetic lethality. 
Plasmids bearing wildtype RRP6 alleles allowed for complementation of the rrp6∆ 
mpp6∆ and rrp6∆ rex1∆ double mutants and were viable on media containing 
5’FOA (Figure 3.12. A-B) No complementation was observed upon transformation 
with a plasmid encoding the N-terminal domain of Rrp6 (Rrp6NT) in both mutants. 
Additionally, a plasmid encoding a catalytically inactive D238N Rrp6 mutant (rrp6-
1) was not sufficient to allow growth on 5’FOA in both mutants.  
 
These results show that the synthetic lethality observed in rrp6∆ mpp6∆ and rrp6∆ 
rex1∆ strains is not dependent on expression levels of Rrp47. Furthermore, the 
catalytic activity of Rrp6 is required in the absence of Mpp6 or Rex1.  
 
3.2.10. Analysis of Rrp6NT overexpression in mpp6Δrrp47ΔC and 
rex1Δrrp47ΔC mutants 
 
A block of growth was observed in conditional mpp6Δ rrp47ΔC and rex1Δ 
rrp47ΔC mutants by inducing overexpression of the N-terminus of Rrp6. To 
address the loss-of-growth phenotypes, changes in the levels of specific RNA 
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were analysed from the aforementioned strains upon transfer from permissive to 
non-permissive conditions by northern blot hybridisation.  
 
Exosome mutants, including rrp6Δ, rrp47Δ and mpp6Δ strains, have previously 
been shown to stabilise a subset of non coding RNAs known as cryptic unstable 
transcripts (CUTs) (Milligan et al., 2008; Wyers et al., 2005). CUTs are barely 
detectable by northern hybridisation analysis in wildtype strains due to rapid 
degradation aided by the Exosome. To aid detection of a model CUT, NEL025c, a 
2µ high-copy number plasmid encoding the NEL025c gene was transformed into 
the analysed strains. Plasmid-borne expression of the NEL025c gene has 
previously been shown to recapitulate the expression and degradation pattern of 
endogenous NEL025c transcript (Thiebaut et al., 2006). In Section 3.2.11, RNA 
analysis of wildtype cells overexpressing NEL025c shows that the transcript levels 
are still barely detectable.  
 
To investigate the basis for the conditional lethal growth phenotype, mpp6Δ 
rrp47ΔC and rex1Δ rrp47ΔC strains bearing plasmids encoding GAL-regulated 
GST or GST-Rrp6NT proteins were grown in synthetic raffinose-based media 
before shifting to galactose-based media. All analysed strains also bore a 2µ high-
copy number plasmid encoding NEL025c (p532). Cells were harvested during 
logarithmic growth in raffinose media and after every cell doubling in galactose 
media. The growth rate of both mutants expressing GST-Rrp6NT slowed 
considerably when shifted from permissive raffinose to non-permissive galactose 
based media in comparison to cells expressing GST (Figure 3.13. A-B). The 
mpp6Δ rrp47ΔC mutant showed a slowed growth rate before the fourth doubling 
after induction of the Rrp6NT domain in galactose-based media (Figure 3.13. A). 
Equivalent strains expressing the GST domain alone grew at a constant rate with 
a doubling time of ~ 4 hours. The rex1∆ rrp47∆C mutant showed a more rapid 
reduction in growth upon expression of the Rrp6NT domain with a strong growth 
defect observable before two doublings in galactose-based media (Figure 3.13. 
B). Strains lacking Rex1 grew considerably slower in galactose-based media as 
observed in previous analysis (Garland et al., 2013).  
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Figure 3.13. Growth rate of mpp6∆ rrp47∆C and rex1∆ rrp47∆C mutants upon 
Rrp6NT induction. Growth rate assays of (A) mpp6∆ rrp47∆C and (B) rex1∆ rrp47∆C 
strains after induction of GST or GST-Rrp6NT. Cultures were grown in raffinose-
based medium at 30°C to mid-log phase before shifting to galactose-based 
medium. Strains were kept in early exponential growth by dilution with pre-warmed 
media. The cumulative increase in OD600 is expressed as log2 values. 
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Figure 3.14. Induction of the GST-Rrp6NT protein in mpp6∆ rrp47∆C and rex1∆ rrp47∆C 
mutants. Western blot analysis of (A) mpp6∆ rrp47∆C and (B) rex1∆ rrp47∆C mutants upon 
induction of GST or GST-Rrp6NT. Cells were harvested during growth in raffinose based 
medium (R) and at each doubling of cell density after transfer to galactose based medium (G). 
Lysates were fractionated by SDS PAGE and analysed by western blot using an antibody 
against the GST domain (upper panel). An antiserum against Pgk1 was used as a loading 
control (lower panel).  
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Cells harvested from raffinose and galactose time points were assayed by western 
blot analysis to detect the induction of GST or GST-Rrp6NT proteins. Lysates from 
cells harvested pre- and post-induction of GAL-regulated proteins were 
fractionated by SDS PAGE and analysed by western blotting using the GST 
antibody (Figure 3.14. A-B). No detectable expression of GST or GST-Rrp6NT was 
observed in cells grown in raffinose-based synthetic media (Figure 3.14. A and B, 
lanes 1 and 3). Expression of GST-Rrp6NT is tolerated in mpp6∆ rrp47∆C strains 
and is relatively stable throughout the time course (Figure 3.14.A, lanes 4-9). The 
expression of GST-Rrp6NT decreases slightly after three cell doublings in the rex1∆ 
rrp47∆C mutant upon shifting to galactose-based media (Figure 3.14.B, lanes 4-
6). The stability of the fusion protein may decrease over time due to the long 
induction and doubling time of the rex1∆ rrp47∆C mutant. Nevertheless, the 
Rrp6NT protein is still highly overexpressed.  
 
Total RNA was isolated from cells harvested at every cell doubling timepoint and 
extensive northern blot hybridisation analyses were carried out to investigate the 
effects on the levels of known exosome target transcripts.   
In the absence of either Mpp6 or Rrp47, cells have previously been reported to 
accumulate cryptic unstable transcripts (CUTs) including NEL025c, a well 
characterised CUT transcript (Milligan et al., 2008). Hybridisation analysis of RNA 
extracted from the mpp6∆ rrp47∆C mutant revealed a striking accumulation of the 
NEL025c transcript from early time points upon Rrp6NT induction (Figure 3.15, 
lanes 5-10). This transcript was barely detectable in equivalent control samples 
expressing the GST domain (lane 2). NEL025c transcripts are heterogeneous due 
to 3’ polyadenylation and therefore appear as a smear upon northern blot 
hybridisation. The degree of heterogeneity of the NEL025c CUT observably 
decreases in the later time points of the time course, corresponding to slowed 
growth. A similar accumulation of the IGS1-R CUT (also known as NTS1) was 
observed in later time points in the mpp6∆ rrp47∆C mutant (Lanes 8-10). This 
non-coding RNA arises from pervasive transcription of intergenic regions between 
ribosomal DNA (rDNA) tandem repeats and has previously been characterised to 
have 3’ heterogeneity due to polyadenylation analogous to the NEL025c transcript 
(Houseley et al., 2007; Vasiljeva et al., 2008b) 
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Figure 3.15. Northern blot analysis of conditional mpp6 rrp47 and rex1 rrp47 mutants. 
Total RNA was isolated from mpp6∆ rrp47∆C and rex1∆ rrp47∆C mutants expressing 
GST-Rrp6NT from the GAL promoter. Cells were harvested during growth in raffinose 
based medium (R) and at each doubling of cell density after transfer to galactose based 
medium (G). RNA was also isolated from strains expressing GAL-regulated GST in 
raffinose and galactose- based medium (lanes 1, 2, 11 and 12). RNA was fractionated 
through 8% polyacrylamide gels containing 50% urea and analysed by northern blot 
hybridisation using oligonucleotide probes as indicated. Asterisks (*) denote truncated 
transcripts. 
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Figure 3.16.A. Model of transcriptional termination, polyadenylation and termination of 
snoRNAs.  The major pathway of snoRNA termination is at the Nrd1/Nab3-dependent site I. 
Released pre-snoRNAs undergo multiple rounds of polyadenylation by Trf4/5 and 
exonucleolytic digestion by Rrp6 to generate mature snoRNAs. Failsafe termination occurs 
at a distal site II by cleavage polyadenylation pathways. Site II-termination pre-snoRNAs are 
exclusively polyadenylated by Pab1 and undergo further processing or complete 
degradation by the exosome/Rrp6. Adapted from Grzechnik P et al (2008). 
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Figure 3.16.B Northern blot analysis of box C/D snoRNAs in conditional mpp6 rrp47 and 
rex1 rrp47 mutants. RNA isolated as described in Figure 3.15 was resolved through 
denaturing polyacrylamide gels and analysed by northern blot hybridisation using indicated 
probes. Dispersed bands labeled I-pA and II-pA correspond with pre-snoRNAs that are 
polyadenylated at termination sites I or II respectively. Asterisks (*) denote truncated 
transcripts. SCR1 was used as a loading control. 
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The mpp6 rrp47 conditional mutant showed a strong accumulation of the 
5’external transcribed spacer (5’ETS) region generated from AO cleavage of the 
35S pre-rRNA. The 5’ETS RNA is a byproduct of rRNA processing and undergoes 
rapid turnover in wildtype cells. Exosome mutants show defects in the turnover of 
5’ETS with stronger accumulations reported in cells depleted of core-exosome or 
TRAMP components (Allmang et al., 1999a; de la Cruz et al., 1998). Similarly, 
defects in the degradation of truncated fragments of 5S rRNA, U3 and snR13 
snoRNAs (5S*, U3* and snR13* respectively) are observed in the mpp6∆ rrp47∆C 
mutant upon Rrp6NT induction (Figure 3.15 and 3.16). The accumulation of these 
species will be discussed further below.  
 
The rex1Δ rrp47ΔC mutant exhibited less striking RNA phenotypes in comparison 
to the mpp6Δ rrp47ΔC mutant upon induction of the GST-Rrp6NT protein, yet 
growth was more rapidly impeded. There was no observable accumulation of the 
NEL025c or IGSR-1 CUTs throughout the time-course. A mild accumulation of 
5’ETS and truncated U3 (U3*) was observed in later time-points (Lanes 14-16), 
but the effect was not as pronounced as the mpp6Δ rrp47ΔC mutant. Previous 
analyses have shown Rex1 to be required for 3’ end maturation of 5S rRNA and 
rex1Δ mutants exhibit an ~3nt extended 5S species (Piper et al., 1983; van Hoof 
et al., 2000b). This 5S processing phenotype was observed in the rex1Δ rrp47ΔC 
mutant but induction of Rrp6NT had no further effect on the 5S rRNA. Both mpp6 
rrp47 and rex1 rrp47 conditional mutants exhibited an accumulation of the 5.8S + 
30 rRNA processing intermediate and corresponding decrease of mature 5.8S 
upon Rrp6NT induction consistent with a loss of Rrp47 function (Mitchell et al., 
2003) 
 
Hybridisation with probes against box C/D snoRNAs revealed distinct phenotypes 
in the mpp6∆ rrp47∆C and rex1∆ rrp47∆C mutants upon Rrp6NT induction (Figure 
3.16.B). The mpp6 mutant showed an accumulation of heter ogeneous 
extended forms of U14, snR38 and snR13 with no effect on mature snoRNAs 
(Lanes 4-10). However, the rex1 mutant showed an accumulation of shorter 
extended forms of U14, snR38 and snR13 with a corresponding loss of mature 
snoRNA (11-16). Transcriptional termination of snoRNAs is dependent on a 
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bipartite signal at the 3’ region of the alleles consisting of a proximal Nrd1/Nab3 
binding region (site I) and a more distal ‘failsafe’ cleavage/polyadenylation signal 
(site II) (Steinmetz and Brow, 2003) (Figure 3.16.A). Both termination events are 
followed by polyadenylation to target the transcript for either 3’ processing or 
degradation by the exosome respectively (Steinmetz et al., 2001). Nrd1-
dependent termination at site I, and subsequent Trf4-dependent polyadenylation 
results in productive 3’-end processing of snoRNAs. Termination events at site II 
are consistent with a loss of Nrd1-dependent termination and result in aberrant 
snoRNAs. Site II transcripts are suggested to be targeted by surveillance 
pathways for rapid degradation by the exosome to prevent transcriptional 
interference with adjacent downstream promoters (Steinmetz et al., 2001). 
Heterogeneous transcripts, polyadenylated at sites I and II (pA-I and pA-II, 
respectively), are accumulated in core-exosome, rrp6, TRAMP and NNS mutants 
(Allmang et al., 1999a; Mitchell et al., 2003; van Hoof et al., 2000a; Vasiljeva and 
Buratowski, 2006).  
 
The mpp6∆ rrp47∆C mutant accumulated site II terminated snoRNAs upon 
Rrp6NT expression. The accumulation of II-pA snoRNAs is consistent with a loss of 
degradation pathways and corroborates the accumulation of aberrant transcripts 
noted above. The levels of mature U14 and snR38 remain relatively unchanged in 
the mpp6 mutant yet the levels of snR13 appear to increase in later time points. 
This suggests that normal productive snoRNA processing pathways are present 
and do not require the function of Mpp6.  
 
A prominent depletion of mature snoRNAs coupled with an accumulation of 
extended heterogeneous snoRNAs was observed in the rex1Δ rrp47ΔC mutant 
upon induction of the Rrp6NT protein (Figure 3.16.B, lanes 11-16). The extended 
forms of U14, snR38 and snR13 correspond to transcripts terminated at the 
Nrd1-dependent site I (marked as I-pA) and have been previously characterised as 
3’ extended precursor transcripts that undergo 3’-end exonuclease processing to 
generate mature snoRNAs. This processing was previously attributed to Rrp6, yet 
these data suggests that the 3’-5’ exonuclease activity of Rex1 may also 
contribute to redundant 3’ processing pathways of snoRNAs.  The final step in 3’ 
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end processing of box C/D snoRNAs requires the catalytic activity of Rrp6 with 
the co-operation of Rrp47. Functional analysis of rrp47 mutants revealed that the 
C-terminus of the protein is required for this process. Cells expressing Rrp47∆C 
show the accumulation of short 3’ extensions of 1-6 nucleotides (Costello et al., 
2011; Mitchell et al., 2003). In the case of snR38, these can be resolved as 
mature snR38 and snR38 + 3 species on 8% polyacrylamide gels as observed in 
the mpp6∆ rrp47∆C mutant (Figure 3.16.B., lanes 1-10). However, expression of 
Rrp47∆C in a rex1∆ mutant shows an accumulation of short heterogeneous 
snoRNAs (Figure 3.16.B, lanes 11-12). These species are lost upon Rrp6NT 
induction in concordance with a block in a prior processing step.  
 
A number of truncated transcripts were identified from northern blot hybridisation 
analysis of the mpp6 rrp47 and rex1 rrp47 conditional mutants including U3*, 5S* 
and snR13*. Similar transcripts have previously been identified and characterised 
in exosome mutants with U3* and snR13* transcripts being truncated from the 5’ 
end and 5S* truncated from the 3’ end (Kadaba et al., 2006; Kufel et al., 2000; 
Rasmussen and Culbertson, 1998). To confirm these species, northern blot 
hybridisation was carried out using probes complementary to the 3’ ends of the 
transcripts (Figure 3.17). The U3* and snR13* transcripts were still detectable 
upon hybridisation with the 3’ end probes in the mpp6 rrp47 and rex1 rrp47 
conditional mutants, therefore these species are truncated at the 5’ end in 
agreement with previous studies. Additionally, the 5S* truncated species was not 
detectable upon hybridisation with a 3’ end probe showing that these transcripts 
are truncated at the 3’ end, also in concordance with previous observations in 
rrp6 and trf4 mutants(Kadaba et al., 2006). These transcripts are suggested to be 
aberrant RNA species that are targeted for rapid degradation by the exosome.  
 
These observations suggest a widespread loss of RNA surveillance and 
degradation pathways in the mpp6∆ rrp47∆C mutant upon Rrp6NT 
overexpression. This results in the accumulation of RNAs normally targeted for 
rapid degradation including CUTs, aberrant ncRNAs, read-through snoRNA 
transcripts and rRNA processing byproducts. The block in growth could be 
attributed to the inhibition of RNA surveillance and CUTs degradation. However, it  
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Figure 3.17. Northern blot analysis of truncated RNA species in conditional mpp6 
rrp47 and rex1 rrp47 mutants. RNA, prepared as described in Figure 3.15 was 
resolved through 8% polyacrylamide gels containing 50% urea and analysed by 
northern blot hybridisation using oligonucleotide probes as indicated. Probes were 
complementary to either the center or 3’ end region of (A) U3, (B) snR13 or (C) 5S 
transcripts as indicated on the schematics.  Asterisks (*) denote truncated transcripts. 
SCR1 was used as a loading control 
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Figure 3.18.A. The yeast pre-rRNA processing 
pathway. Summary of 35S processing including 
intermediate and aberrant pre-rRNA species. The 
18S, 5.8S and 25S rRNA are separated by internal 
transcribed spacers (ITS1, ITS2) and flanked by 
external transcribed spacers (5’ETS, 3’ETS). Sites 
complementary to probes used in this study are 
indicated. Endonucleolytic cleavage and 
exonucleolytic steps are indicated at processing 
sites. The aberrant 23S and 25S pre-rRNA species 
are generated by premature cleavage at site A3. 
The aberrant 17S’ species arises from 5’ 
degradation of pre-rRNA fragments generated as a 
result of a block in ITS1 processing. Adapted from 
Mitchell et al (2003). Sites within the 35S pre-rRNA 
complementary to oligonucleotide probes are 
indicated. 
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is not as clear as to why rex1∆ rrp47∆C strains stop growing upon Rrp6NT 
induction. The rex1 rrp47 conditional mutant showed a block in 3’-end processing 
of box C/D snoRNAs resulting in the accumulation of 3’-extended pre-snoRNAs 
and a corresponding loss of mature transcripts. The function of snoRNAs is 
important in the biogenesis of ribosomes by guiding modifications of pre-rRNA. A 
depletion of mature snoRNA may have a critical impact on the levels of mature 
rRNA. The conditional rex1 rrp47 mutant showed a depletion of U14, snR38 and 
snR50 box C/D snoRNAs which target sites in 18S and 25S rRNA (Li et al., 1990; 
Lowe and Eddy, 1999). To investigate the effects on larger pre-rRNA species in 
mpp6∆ rrp47∆C and rex1∆ rrp47∆C upon Rrp6NT induction, agarose gel northern 
analyses were carried out using RNA from the samples described above. Northern 
blots were analysed with probes complimentary to known pre-rRNA species 
(Figure 3.18.A). The mpp6 rrp47 mutant showed an accumulation of pre-rRNA 
species upon induction of Rrp6NT including 23S, 21S and 17S’ transcripts along 
with a number of smaller uncharacterised degradation intermediates (Figure 
3.18.B, lanes 1-9). These species were previously characterised in strains lacking 
Rrp6 (Allmang et al., 2000). Some of these effects were previously reported in 
RNA analysis of a conditional mpp6 rrp47 mutant albeit not as detailed (Milligan et 
al., 2008). The levels of mature 18S and 25S remain relatively unchanged in the 
mpp6∆ rrp47∆C samples (Figure 3.18 with the exception of lane 7 due to an error 
in loading. The accumulation of aberrant pre-rRNA species in the mpp6∆ rrp47∆C 
mutant upon Rrp6NT induction is consistent with previous observations described 
above.  
 
The rex1Δ rrp47ΔC mutant showed mild accumulation of pre-rRNA degradation 
intermediates upon expression of the Rrp6NT protein (lanes 10-15) but not to the 
extent of the mpp6 rrp47 mutant. Depletion of essential snoRNAs such as U3 or 
U14 results in a loss of 18S rRNA. However, no effect on mature 18S or 25S 
rRNA was observed in the rex1 rrp47 mutant.  
 
 
3.2.11 Comparing condit ional mpp6 rrp47 and rex1 rrp47 mutant 
phenotypes with RNA processing and degradation mutants 
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Northern blot hybridisation of the mpp6Δ rrp47ΔC mutant upon Rrp6NT 
overexpression exhibited a block in the degradation of RNA surveillance 
substrates including CUTs, aberrant 5S, snoRNAs and pre-rRNA species. These 
phenotypes have been extensively described previously in rrp6, nrd1 and TRAMP 
complex mutants (Allmang et al., 1999a; Briggs et al., 1998; LaCava et al., 2005; 
Thiebaut et al., 2006; van Hoof et al., 2000a). Similarly, species observed in the 
rex1∆ rrp47∆C mutant upon Rrp6NT induction have previously been identified in 
strains lacking Rrp6 (Allmang et al., 1999a). The levels of these RNA transcripts 
were compared in mpp6 rrp47 and rex1 rrp47 conditional double mutants with 
the corresponding single mutants. Additionally, these strains were compared with 
previously characterised RNA processing and degradation mutants including rrp6, 
TRAMP and NNS-complex mutants.   
 
In Section 3.2.10 the mpp6∆ rrp47∆C mutant showed a striking accumulation of 
the NEL025c CUT transcript upon induction of the Rrp6NT protein. Isogenic wild 
type, rrp47∆, mpp6∆ and rex1∆ strains were transformed with a multicopy 
plasmid encoding the NEL025c along with a second 2µ plasmid encoding for the 
GST-Rrp6NT protein under the control of the GAL1/10 promoter. Strains were 
grown in synthetic raffinose- and galactose-based minimal media. Cells grown in 
galactose media were pre-grown in raffinose and allowed to double 5 times in 
galactose before harvesting. This allowed a comparison the effects seen after 
equivalent cell doubling in the time-course experiment described in Section 
3.2.10. The mpp6∆ rrp47∆C and rex1∆ rrp47∆C strains were harvested 
equivalent to the end time points in the experiment in Section 3.2.10. Isogenic 
rrp6∆ and trf4∆ strains harboring a multicopy plasmid encoding the NEL025c 
gene were grown in minimal media and harvested at mid-log phase. Conditional 
GAL::NRD1 and GAL::NAB3 strains were used to analyse the loss of NNS 
complex components. Both Nrd1 and Nab3 are essential in yeast; therefore a 
conditional system is required. The aforementioned strains were transformed with 
the multicopy plasmid encoding NEL025c and pre-grown in permissive galactose-
based minimal media before shifting to non-permissive glucose-based media. 
Cells were harvested after 4 doublings in glucose-based medium. Total RNA was  
! 143!  
GET RID OF 
snR50? !
Shorten figure 
legend!
D"for"dextrose?"
1   2   3   4   5  6   7   8   9  10 11 12     13 14 15 16 17 18!
- NEL025cS!
- NEL025cL!
- 5’ETS!
- 5S!
- 5S*!
- snR13!
- snR13*!
- I-pA (snR13)!
- II-pA (snR13)!
- snR50!
- I-pA (snR50)!
- II-pA (snR50)!
- SCR1!
(o925)!
(o809)!
(o274)!
(o821)!
(o494)!
(o242)!
GST-Rrp6NT!
WT
!
rrp
47∆
!
mp
p6∆
!
rex
1∆
!
mp
p6∆
 rrp
47∆
C!
rex
1∆
 rrp
47∆
C!
R!G! rrp
6∆
!
trf
4∆
!
G!D!
GA
L::N
RD
1!
GA
L::N
AB
3!
R!G! R!G! R!G! R!G! R!G! G!D!
Figure 3.19. Conditional mpp6∆ rrp47∆ mutants show markedly strong RNA degradation 
phenotypes in comparison with RNA surveillance mutants. Northern blot analysis of 
isogenic WT, rrp47∆, mpp6∆, rex1∆, mpp6∆ rrp47∆C and rex1∆ rrp47∆C strains 
bearing a 2-micron plasmid encoding the GST-Rrp6NT fusion protein under the control of 
the GAL promoter. Cells were grown in raffinose(R)- and galactose(G)-based media and 
harvested after 6 doublings of cell density. Isogenic rrp6∆ and trf4∆ mutants were grown 
in glucose-based minimal medium. GAL::NRD1 and GAL::NAB3 strains were grown in 
permissive galactose(G)-and non-permissive glucose(D)-based minimal medium and 
harvested after 4 doublings of cell density. Total RNA was extracted from all samples and 
fractionated on 8% denaturing polyacrylamide gels and analysed by northern blot 
hybridisation using radiolabelled oligonucleotides as indicated. Asterisks (*) denote 
truncated transcripts. Dispersed bands labeled I-pA and II-pA correspond with pre-
snoRNAs that are polyadenylated at termination sites I or II respectively. SCR1 was used 
a loading control 
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fractionated by denaturing polyacrylamide gel electrophoresis and analysed by 
northern blot hybridisation using probes against RNA species that exhibited strong 
phenotypes in the analysis of mpp6∆ rrp47∆C and rex1∆ rrp47∆C mutants 
(Section 3.2.10).   
 
The initial identification and characterisation of cryptic unstable transcripts was 
previously carried out in yeast strains defective in nuclear exosome functions. As 
rrp6∆ strains are viable, these have proven to be a useful tool to analyse stabilised 
CUT transcripts such as NEL025c (Thiebaut et al., 2006; Wyers et al., 2005). 
Conditional mpp6 rrp47 mutants previously exhibited a strong accumulation of 
cryptic unstable transcripts. The levels of the NEL025c CUT in the mpp6∆ 
rrp47∆C mutant upon Rrp6NT induction showed a markedly higher accumulation in 
comparison to strains lacking Rrp6 or Trf4 (Figure 3.19 compare lane 10 with 13-
14). Quantitative analysis of heterogeneous transcripts is not entirely accurate but 
the level of NEL025c transcripts was roughly estimated at 5-fold higher in the 
mpp6 rrp47 conditional mutant in comparison to the rrp6∆ mutant (Figure 3.20. 
A). The TRAMP complex targets RNA surveillance substrates, including CUTs, to 
the nuclear exosome by Trf4/5-dependent polyadenylation (LaCava et al., 2005; 
Vanácová et al., 2005; Wyers et al., 2005). Strains lacking Trf4 accumulate 
NEL025c transcripts that are non-adenylated and appear as more distinct bands 
in comparison to the heterogeneous smear observed in rrp6∆ strains (Figure 3.19 
compare lanes 13 and 14). Some level of heterogeneity is observed in trf4∆ 
strains, most likely due to redundant polyadenylation activity by the major yeast 
nuclear poly(A) polymerase, Pap1. Transcriptional termination of CUTs is 
dependent on the activity of Nrd1 and Nab3 as part of the NNS complex (Arigo et 
al., 2006). Depletion of Nrd1 or Nab3 results in the accumulation of read-through 
transcripts that terminate at downstream terminator regions. In the initial 
characterisation of the NEL025c CUT, two forms of the transcript were reported; 
shorter, heterogeneous transcripts that undergo Nrd1-dependent termination 
(termed NEL025cS) and a longer homogenous species (NEL025cL) that terminates 
at a downstream terminator region. The mpp6 rrp47 conditional mutant shows a 
strong accumulation of the NEL025cS transcript consistent with a block in the 
rapid turnover of Nrd1-dependent termination products. In conditional nrd1 or  
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Figure 3.20. Quantification of 
accumulated transcripts from 
RNA surveillance mutants. 
Quantification of northern blot 
signals from strains analysed in 
Figure 3.19. Values of NEL025cS, 
5S*, 5’ETS and snR13* are given 
for each strain. Asterisks (*) 
denote truncated RNA species.  
Averages from two data sets are 
normalised to SCR1 levels and 
expressed relative to the signals 
from the wildtype (WT) strain. 
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Figure 3.21. Quantification of box C/D 
snoRNA phenotypes in RNA 
surveillance mutants. Quantification of 
northern blot signals from analysis of 
box C/D snoRNAs from strains 
analysed in Figure 3.19. Values of I-pA 
and II-pA snoRNAs are shown for 
each strain. Averages from two data 
sets are normalised to SCR1 levels 
and expressed relative to the signals 
from the wildtype (WT) strain. 
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nab3 mutants, the longer NEL025cL transcript is accumulated upon shifting to 
non-permissive conditions (Figure 3.19, lanes 15-18).    
 
The conditional mpp6 rrp47 mutant also showed a greater accumulation of RNA 
surveillance substrates such as the 5’ETS, 5S* and snR13* species in comparison 
to the rrp6Δ, trfΔ and conditional nrd1/nab3 mutants. In comparison to the rrp6∆ 
mutant, the mpp6∆ rrp47∆C strain expressing Rrp6NT showed a ~10 fold greater 
accumulation of the 5S* and 5’ETS species (Figure 3.19 compare lanes 10 and 
13, Figure 3.20. B-C). Additionally, the mpp6∆ rrp47∆C mutant shows a 4-fold 
accumulation of site II terminated snoRNAs on average in comparison to rrp6∆ 
strains (Figure 3.21. B,D). These results strongly corroborate the model that 
Rrp47/Rrp6 and Mpp6 function in redundant RNA surveillance pathways. The 
separation of Rrp47∆C from Rrp6-containing complexes in the absence of Mpp6 
results in disruption of both pathways resulting in a critical loss of RNA surveillance 
and accumulation of target transcripts.    
 
The rex1Δ rrp47ΔC showed a stronger depletion of mature snoRNAs compared to 
the single rex1Δ mutant upon Rrp6NT overexpression (Figure 3.19, compare lanes 
8 and 12). This, in turn, is matched by a stronger accumulation of I-pA extended 
snoRNAs suggesting a cumulative block in the 3’ end processing of pre-snoRNAs 
from the loss of Rex1 and functional Rrp47. This suggests that 3’-end processing 
of box C/D snoRNAs is primarily dependent on redundant pathways involving 
Rrp6/Rrp47 and Rex1. However, 3’-end processing may still be functional through 
the activity of other exonucleases such as Rrp44 or Rex2/3 proteins albeit less 
efficient.  
 
 
3.3 Discussion 
 
Rrp47 has previously been shown to function as an exosome-associated cofactor 
in RNA processing and surveillance pathways. The function and stability of Rrp47 
is dependent on the physical interaction with the Rrp6 exonuclease (Costello et 
al., 2011; Feigenbutz et al., 2013b; Mitchell et al., 2003; Stead et al., 2007). The 
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specific molecular function of Rrp47 still remains largely elusive although it has 
generally been proposed that Rrp47 acts to stimulate the activity of Rrp6 through 
RNA binding (Butler and Mitchell, 2011).  
 
In this chapter we set out to analyse the function of Rrp47 when physically 
separated from Rrp6. In the absence of Rrp6, Rrp47 is rapidly degraded by the 
proteasome and steady state expression levels of Rrp47 are reduced to below 
10% in comparison to wildtype cells (Feigenbutz et al., 2013b). Therefore, to 
overcome the issue of protein stability, a novel approach was developed to 
segregate the Rrp6/Rrp47 homodimer in vivo whilst maintaining the stability of 
Rrp47. The DECOID (decreased expression of complexes by overexpression of 
interacting domains) strategy was utilized to divorce Rrp47 from Rrp6 by 
overexpression the N-terminal interacting domain of Rrp6 (Rrp6NT). The use of 
GAL-inducible vector constructs allows a conditional system in which the 
expression of the interacting domain can be switched on.  Glycerol gradient 
ultracentrifugation and pulldown analyses reported that the segregation of the 
Rrp6/Rrp47 complex was ~96% effective (Garland et al., 2013). We cannot fully 
eliminate the possibility that a small fraction of residual Rrp47 remains bound to 
Rrp6. However, using DECOID on a truncated rrp47 mutant in resulted conditional 
lethal phenotypes in combination with mpp6∆ or rex1∆ alleles. This suggests that 
the rrp47 mutant is functional under permissive conditions and loses function 
upon segregation from Rrp6 by the induction of the Rrp6NT protein.  
 
RNA analysis of wildtype and rrp47∆C strains upon induction of the Rrp6NT protein 
revealed that the cells still have functional RNA processing and surveillance 
mechanisms upon separation of the Rrp47/Rrp6 complex. The loss of Rrp47 or 
Rrp6 function is synthetic lethal in combination with mpp6∆ or rex1∆ alleles. 
Overexpression of Rrp6NT in mpp6∆ and rex1∆ strains was tolerated yet induced 
slow growth phenotypes and mild RNA processing and degradation phenotypes. 
However, inducing Rrp6NT expression in mpp6∆ and rex1∆ mutants combined 
with a C-terminal truncation rrp47 mutant (rrp47∆C) resulted in a block in growth. 
This suggests that full length Rrp47 is functional when segregated from Rrp6-
containing complexes yet requires the C-terminal domain for sufficient function. 
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The C-terminus of Rrp47 contains a highly basic, lysine-rich region that is required 
for RNA binding in vitro. However, this property is not required for the function of 
Rrp47 in vivo as shown by the complementation of mpp6∆ rrp47∆ and rex1∆ 
rrp47∆ synthetic lethality (Costello et al., 2011). The C-terminus is suggested to 
provide substrate recognition for the Rrp47/Rrp6 complex through RNA binding. 
Additionally, the C-terminal domain is required for the physical interaction between 
snoRNP proteins Nop56 and Nop58 (Costello et al., 2011). Furthermore, an 
interaction between Rrp47 and the Nrd1/Nab3 (NNS) termination complex has 
been observed but is lost in rrp47∆C mutants (P. Mitchell, M. Feigenbutz, 
personal communication). This suggests that the C-terminus is required to 
function in the recognition of RNP substrates through both RNA and protein 
contacts (Figure 3.22) 
 
In the absence of a functional Rrp47/Rrp6 complex, cells require the activities of 
either Mpp6 or Rex1. Mpp6 is a nuclear exosome-associated RNA binding protein 
with many similarities to Rrp47, however the exact molecular function is yet to be 
determined. Previous analyses of conditional mpp6 rrp47 double mutants 
reported defects in the degradation of pre-rRNAs, cryptic unstable transcripts and 
aberrant mRNAs (Milligan et al., 2008). This suggests that Mpp6 functions in 
redundant RNA surveillance pathways, possibly through stimulation of the core-
exosome and Rrp44. The data in this chapter supports the conclusion that 
Rrp6/Rrp47 and Mpp6 function in redundant RNA surveillance pathways and 
extensive northern blot hybridisation analysis expands on RNA targets of these 
pathways. These conditional mpp6 rrp47 mutants show accumulations of CUTs, 
pre-rRNA processing byproducts, truncated forms of stable RNAs and site II-
terminated snoRNA transcripts. Analyses of rex1 rrp47 double mutants revealed 
distinct phenotypes from the mpp6 rrp47 mutants. The Rex1 exonuclease 
functions in 3’ end maturation of 5S rRNA and tRNAs (Copela et al., 2008; 
Ozanick et al., 2009; van Hoof et al., 2000b). Conditional rex1 rrp47 double 
mutants showed a strong accumulation of site I terminated pre-snoRNAs 
matched with a depletion of mature snoRNAs. These observations support a 
model that mature snoRNA transcripts are terminated at site I by Nrd1/Nab3  
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Figure 3.22. Model for substrate recognition by Rrp47. (A) Rrp47 is bound to Rrp6 in 
wildtype cells via an interaction between the Sas10/C1D and PMC2NT domains 
respectively. The C-terminus of Rrp47 (CTD) forms interactions with RNA and proteins 
and contribute to substrate recognition prior to Rrp6-dependent catalysis. (B) Rrp47 is 
functional when physically separated from Rrp6 using the DECOID method. The CTD of 
Rrp47 can still engage in RNA and protein interactions to recruit substrates. (C) The 
functional capability of Rrp47 is dependent on the CTD when physically segregated from 
Rrp6. Upon separation, Rrp47 is can no longer interact with substrates. When Rrp47/
Rrp6 pathways are blocked, the strain is dependent on redundant pathways involving 
Rex1 and Mpp6. 
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followed by polyadenylation (Grzechnik and Kufel, 2008) and that subsequent 3’ 
end processing requires redundant pathways involving a functional Rrp6/Rrp47 
complex or Rex1.  
 
A block in growth was observed in mpp6∆ rrp47∆C and rex1∆ rrp47∆C double 
mutants upon expression of the Rrp6NT protein. The significant accumulation of 
CUTs and aberrant RNAs may contribute to the growth defect in mpp6 rrp47 
mutants. Whilst the role of CUTs, if any, is generally unknown, previous studies 
have identified possible roles in transcriptional regulation (Camblong et al., 2007; 
Castelnuovo et al., 2013; Martens et al., 2004). With this in mind, a loss of cryptic 
transcription regulation may impact normal transcription of genes that are 
regulated by CUTs. Additionally, a loss in RNA surveillance pathways would result 
in the stabilisation of aberrant transcripts that incorporate into RNP complexes 
and cause adverse cellular effects. The possible basis of a block in growth in the 
rex1∆ rrp47∆C mutant upon Rrp6NT induction is less clear. Whilst cells showed a 
block in snoRNA processing and subsequent depletion of mature snoRNA 
transcripts, no adverse effects on the levels of mature ribosomal RNA were 
observed. Both mpp6 rrp47 and rex1 rrp47 conditional mutants showed a 
significant accumulation of polyadenylated snoRNAs and CUTs. The stabilisation 
of polyadenylated transcripts may result in the titration of poly(A)-binding proteins 
such as Pab1, Nab2 or the Nrd1/Nab3 termination complex and impact on 
normal gene expression profiles. The effects observed in northern blot 
hybridisation analysis are limited by the use of complementary probes for specific 
RNA transcripts. With the advent of high throughput next generation RNA 
sequencing methods, a transcriptome-wide analysis on RNA isolated from 
conditional mpp6 rrp47 and rex1 rrp47 mutants may reveal a more 
comprehensive understanding on the changes in transcription profiles upon loss 
of RNA surveillance or processing pathways.  
 
Transcriptome wide analysis of exosome targets and the identification of cryptic 
unstable transcripts has historically been performed on rrp6∆ strains. The loss of 
Rrp6 is tolerated by cells yet serves as a tool to stabilise pervasive transcripts and 
RNA surveillance targets. As described in Section 3.2.11, the levels of NEL025c 
CUTs are accumulated to a larger degree in the mpp6 rrp47 mutant in 
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comparison to levels in rrp6∆ or trf4∆ mutants. This effect is most likely due to a 
cumulative loss of redundant Rrp6/Rrp47 and Mpp6-dependent processes 
required for efficient RNA surveillance pathways. The mpp6∆ rrp47∆C GAL::GST-
rrp6NT mutant may provide an ideal conditional host strain to analyse CUT 
transcripts and could be used purify CUT RNPs from yeast.  
 
Mpp6 was previously identified as a nuclear exosome-associated cofactor and 
shown to be involved in RNA surveillance and quality control pathways (Milligan et 
al., 2008). This chapter expands on the molecular basis of the synthetic lethality of 
mpp6∆ rrp47∆ double mutants using a conditional system. However, the exact 
role of Mpp6 is still poorly understood. The work in Chapter 5 investigates Mpp6 
in further detail through mutational analysis.  
 
The use of DECOID allowed the successful segregation of Rrp47 from Rrp6-
containing complexes whilst maintaining the normal expression of Rrp47. The 
DECOID approach provides a simple method to determine if components of 
protein complexes are able to function when separated. Using the technique only 
requires knowledge of the interacting domain one of the protein components 
within a complex. The use of an inducible promoter allows conditional expression 
of the interacting domain. The stability of the induced protein would generally be 
aided by the use of a neutral N-terminal tag such as GST which would also allow 
for detection by western blot analysis using widely available antibodies. We have 
already begun work on physically separating other exosome-associated 
components using the DECOID method. The use of the technique can be applied 
to any protein complex with prior knowledge of interacting domain architecture.  
 
 
 
 
 
 
 
 
! 153!
 
Chapter 4: Analysis of functional and redundant 
relat ionships between Rrp6, Rrp47 and Mpp6.     
 
4.1. Introduction 
 
As described in Chapter 1, the function of Rrp6 is largely dependent on the 
physical and functional interaction with the small nuclear RNA binding protein 
Rrp47. It was recently shown that in the absence of Rrp6, the expression level of 
Rrp47 protein is dramatically reduced to ~15% in comparison to wild-type RRP6 
strains with no significant change to mRNA levels (Feigenbutz et al., 2013b). 
Previous reports have observed that Rrp6 protein expression levels are not 
sensitive to the loss of Rrp47 (Mitchell and Tollervey, 2003; Stead et al., 2007). 
However, these studies were carried out on strains grown in rich medium. Further 
studies have shown that Rrp6 protein levels are reduced in rrp47∆ strains grown 
in synthetic minimal media. The decrease in protein expression is due to both 
protein and RRP6 transcript stability. RRP6 mRNA levels are decreased to ~ 44% 
in rrp47∆ strains compared to RRP47 cells. Concurrently, the expression levels of 
Rrp6 protein are reduced to ~ 30% in rrp47∆ mutants (Feigenbutz et al., 2013a). 
Taken together, these results suggest that the stability of Rrp6 and Rrp47 are 
mutually dependent on their physical interaction with Rrp47 being more sensitive 
to the loss of Rrp6. This proposes that a function of Rrp47 is to maintain the 
normal expression levels of Rrp6 in vivo. It was subsequently shown that artificially 
increasing the expression of Rrp6 in rrp47∆ mutants was able to suppress RNA 
processing and turnover phenotypes observed from the lack of Rrp47 (Feigenbutz 
et al., 2013a).  
 
In this chapter it is observed that overexpression of Rrp6 is sufficient to 
complement the synthetic lethality of mpp6∆ rrp47∆ double mutants through 
genetic shuffling assays. Chapter 3 reported a loss of RNA surveillance and 
degradation pathways in conditional mpp6 rrp47 mutants. Consistent with these 
observations, northern blot analysis of complemented mpp6∆ rrp47∆ mutants 
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showed a strong accumulation of RNA surveillance targets. Increased expression 
of Rrp6 suppressed the severity of RNA phenotypes in the mpp6∆ rrp47∆. These 
results provide an insight into the molecular nature of the synthetic lethality of 
mpp6∆ and rrp47∆/rrp6∆ alleles and corroborates the proposal that Rrp6/Rrp47 
function in RNA turnover pathways redundant with Mpp6. A parallel study carried 
out by colleagues in the lab reported similar findings: RRP6 overexpression 
complements the rex1∆ rrp47∆ synthetic lethality and that increased levels of 
Rrp6 suppresses RNA processing phenotypes observed in conditional rex1 rrp47 
mutants (reported in Feigenbutz, Garland et al. 2013). The analysis of 
complemented rex1∆ rrp47∆ mutants corroborates the model that Rrp6/Rrp47 
and Rex1 have a redundant function in RNA processing pathways. These results 
complement the results observed in Chapter 3.  
 
Results in this chapter contribute to the work published in Feigenbutz et al (2013)b 
(Appendix IV).  
 
4.2. Results 
 
4.2.1. Increased RRP6 expression complements the mpp6Δ rrp47Δ 
synthetic lethal ity 
 
It has been previously reported that the stability of Rrp47 is strongly dependent on 
the physical interaction with the N-terminal PMC2NT domain of Rrp6 (Rrp6NT) in 
vivo (Feigenbutz et al., 2013b; Stead et al., 2007). Subsequent analyses have 
revealed that the levels of Rrp6 protein are also sensitive to the loss of Rrp47 in 
strains grown in minimal media. By artificially increasing levels of Rrp6 through 
exogenous plasmid-borne expression, RNA defects in rrp47∆ mutants are 
suppressed (Feigenbutz et al., 2013a). This suggests that a key function of Rrp47 
is to maintain the stable expression of Rrp6. However, increased expression of 
Rrp6 did not fully suppress rrp47∆ RNA processing defects to the extent of 
complementation with wildtype RRP47 therefore suggesting that Rrp47 has 
functions in addition to maintaining Rrp6 levels (Feigenbutz et al., 2013a).  
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Figure 4.1. Exogenous expression of Rrp6 complements the mpp6∆ rrp47∆ synthetic 
lethality. A plasmid shuffle assay. Centromeric plasmids encoding RRP47 (p425), zz-rrp6 
(p428), zz-rrp6-1 (p430), zz-rrp6NT (p432), zz-mpp6 (p599) and 2µ plasmids encoding zz-
rrp6 (p602) and zz-mpp6 (p603) were transformed into a mpp6∆ rrp47∆ yeast strain bearing 
a URA3-containing gene encoding for a wildtype copy of MPP6. Transformants were 
isolated on selective minimal media and assayed for viability on minimal media containing 
5’FOA. Plates were incubated at 30˚C for 3 days before photographing. The nature of each 
transformant is indicated on the right panel. 
Glucose! Glucose + 5’FOA!
mpp6Δ rrp47Δ!
zz-mpp6, URA3!
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Loss of function rrp47 alleles are synthetic lethal with mpp6∆ mutants. To 
determine if increased expression levels of Rrp6 can complement the dependency 
of RRP47 expression in an mpp6∆ mutant, an mpp6∆ rrp47∆ plasmid shuffle 
strain (previously described in Section 3.1.2) was transformed with single-copy 
centromeric (cen) and high-copy 2-micron (2µ) plasmids encoding rrp6 alleles 
under the control of the RRP4 promoter. Transformants were assayed for growth 
on minimal medium containing 5’FOA to counterselect against the URA3 plasmid 
bearing a wildtype copy of MPP6.  
 
Plasmid-borne expression of a tagged zz-Rrp6 fusion protein allowed for viability 
of the mpp6Δ rrp47Δ strain (Figure 4.1). Similarly, expression of the zz-rrp6 allele 
on a 2µ multicopy plasmid also complemented the mpp6Δ rrp47Δ double mutant. 
Interestingly, a catalytically inactive rrp6-1 (rrp6D238N) was able to complement the 
mpp6∆ rrp47∆ double mutant and grew comparable to strains complemented by 
exogenous expression of function zz-Rrp6. The catalytically inactive rrp6-1 allele 
(rrp6D238N) was unable to complement the synthetic lethality of rex1Δ rrp47Δ 
double mutants in a similar plasmid shuffle assay (Feigenbutz et al., 2013a). This 
suggests that Rrp6 has other roles important in strains lacking Mpp6 that do not 
require its exonuclease activity. A single copy plasmid encoding the N-terminal 
PMC2NT domain of Rrp6 (Rrp6NT) was unable to complement the mpp6Δ rrp47Δ 
synthetic lethality. Single copy plasmids encoding RRP47 and zz-MPP6 allowed 
for complemented viability of the plasmid shuffle strain whereas strains 
transformed with an empty vector (pTL26) were inviable on 5’FOA media.  
 
These results show that exogenous overexpression of Rrp6 can suppress the 
synthetic lethality of mpp6∆ rrp47∆ mutants and that complementation is not 
dependent on the catalytic activity of Rrp6.  
 
 
4.2.2. Slow growth rates are observed in Rrp6-complemented mpp6 
rrp47 mutants  
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Figure 4.2. Slow growth phenotypes are observed in mpp6∆ rrp47∆ mutants bearing 
exogenous rrp6 alleles. Spot growth assay of mpp6∆ rrp47∆ mutants transformed with 
centromeric plasmids encoding RRP47 (p425), zz-rrp6 (p428), zz-rrp6-1 (p430), zz-rrp6NT 
(p432), zz-mpp6 (p599) and 2µ plasmids encoding zz-rrp6 (p602) and zz-mpp6 (p603). 
Strains were grown in liquid selective minimal medium and normalised by optical density 
(A600nm) before spotting 10-fold serial dilutions onto selective solid medium. Plates were 
incubated for 3 days at 30˚C before photographing. 
Glucose!
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Increased expression of Rrp6 was shown to be able to complement the synthetic 
lethality of mpp6Δ rrp47Δ double mutants in a plasmid shuffle. Single colony 
isolates were recovered from 5’FOA media and assayed for growth on solid 
minimal medium by spot growth tests.  
 
A markedly decreased growth rate was observed in mpp6Δ rrp47Δ strains 
complemented with cen zz-rrp6, zz-rrp6-1 and 2µ zz-rrp6 plasmids in comparison 
to strains complemented by wildtype RRP47 or MPP6 alleles (Figure 4.2). 
Expression of the multicopy zz-rrp6 plasmid did not show any significant 
improvement in growth compared to the single-copy zz-rrp6 plasmid.  
 
These results show that artificially increasing the expression levels of Rrp6 in an 
mpp6Δ rrp47Δ mutant is able to complement the synthetic lethality. Strains are 
viable but show markedly slow growth phenotypes in comparison to strains 
complemented with wildtype RRP47 or MPP6 alleles. Interestingly, no significant 
growth defect was observed in rex1∆ rrp47∆ mutants complemented with either 
RRP6 or RRP47 alleles (Feigenbutz et al., 2013a). This suggests that mpp6∆ 
mutants are more sensitive to the loss of Rrp47 and corroborates the proposition 
that Mpp6 and Rrp6/Rrp47 function in redundant pathways.  
 
 
4.2.3. Rrp6 can be overexpressed in mpp6∆ rrp47∆ mutants 
 
Artificially increasing the copy number of RRP6 in an rrp47Δ mpp6Δ strain allows 
for cell viability and complemented the genetic synthetic lethality of the double 
mutant. This was assumed to be due to increased Rrp6 protein expression. It has 
been shown that expression levels of Rrp47 are dramatically decreased in strains 
lacking Rrp6 (Costello et al., 2011; Feigenbutz et al., 2013b). Likewise, it has been 
shown that Rrp6 transcript and protein expression levels are decreased in strains 
lacking Rrp47 when grown in minimal media. However, Rrp47 is more sensitive to 
the loss of Rrp6. By increasing Rrp6 levels through exogenous overexpression on 
plasmids, this could negate the requirement of Rrp47 for Rrp6 stability.  
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Expression of Rrp6 was assayed in mpp6Δ rrp47Δ strains complemented with 
RRP47, MPP6 and rrp6 alleles. Lysates were also prepared from isogenic 
wildtype, rrp47Δ and mpp6Δ strains and assayed in parallel by SDS PAGE and 
western blot analysis using an Rrp6-specific antibody (Figure 4.3). Levels of 
endogenous Rrp6 are decreased in the rrp47Δ strain and mpp6Δ rrp47Δ double 
mutant complemented with zz-Mpp6 in comparison to wildtype levels (Figure 4.3 
compare lanes 1,2 and 4). The loss of Mpp6 has no effect on the expression level 
of Rrp6 (compare lanes 1 and 3).  
 
Exogenous expression of zz-Rrp6 and zz-rrp6-1 fusion proteins from centromeric 
plasmids under the control of the RRP4 promoter were analysed in mpp6Δ rrp47Δ 
strains. Endogenous levels of Rrp6 remained comparable to rrp47 mutants 
whereas the tagged proteins showed a marked overexpression effect (Figure 4.3 
lanes 6 & 7). Greater levels of overexpression were observed in strains bearing a 
high copy number 2µ plasmid encoding zz-Rrp6 (Lane 8). Lower molecular weight 
bands observed in strains expressing zz-Rrp6 fusion proteins are due to C-
terminal degradation products and are typical of plasmid-borne Rrp6 expression. 
These degradation products are more distinct in lane 8 due to a greater 
expression level of the zz-Rrp6 protein. Due to the high level of degradation 
observed in samples expressing zz-Rrp6, these westerns could not be accurately 
quantified. 
 
Overexpression of zz-Mpp6 from a 2µ plasmid had no stabilizing effect on the 
levels of endogenous Rrp6 in the mpp6Δ rrp47Δ plasmid. This suggests that 
Mpp6 does not function to maintain normal expression levels of Rrp6.  
 
These results show that Rrp6 can be overexpressed in strains lacking Rrp47, with 
greater expression in strains bearing 2µ plasmids encoding for zz-Rrp6 fusion 
proteins. Exogenous overexpression of Rrp6 can therefore negate the requirement 
for Rrp47 in strains lacking Mpp6.  
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Figure 4.3. Rrp6 can be overexpressed in rrp47∆ mpp6∆ strains. Lysates prepared 
from mpp6∆ rrp47∆ strains bearing centromeric plasmids encoding zz-mpp6, 
RRP47, zz-rrp6, zz-rrp6-1 or 2µ plasmids encoding zz-rrp6 or zz-mpp6 were 
fractionated by SDS PAGE and analysed by western blotting. Lysates from isogenic 
wildtype, rrp47∆ and mpp6∆ strains were assayed in parallel. Rrp6 proteins were 
detected upon incubation with an Rrp6-specific antibody (upper panel). A second 
incubation using a Pgk1-specific antibody was used for a loading control (lower 
panel). 
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4.2.4 The stabi l i ty of Rrp6 is not dependent on Mpp6 or Rex1 
 
Rrp6 protein levels are reduced in yeast strains lacking Rrp47. Loss of function 
rrp47 alleles are synthetic lethal in with mpp6Δ or rex1Δ alleles (Milligan et al., 
2008; Peng et al., 2003). It could be proposed that the basis of synthetic lethality 
is due the cumulative destabilisation of Rrp6 due to additive loss of Mpp6 or Rex1 
in combination with rrp47∆ alleles. However, rrp6Δ strains are viable, therefore an 
additive loss of Rrp6 expression would not be the sole reason for synthetic 
lethality, but could be a contributing factor. An alternative proposition is that the 
expression levels of Rrp6 are increased in mpp6∆ or rex1∆ mutants to 
compensate for the lack of Mpp6- or Rex1-dependent pathways.  
 
MPP6 and REX1 loci were individually targeted for disruption by homologous 
recombination of a kanMX4 deletion cassette in an rrp6Δ strain bearing a 
centromeric plasmid encoding for a zz-Rrp6 fusion protein under the control of the 
RRP4 promoter. Transformants were selected on rich media containing G418 and 
candidates were screened by PCR for disruption of MPP6 and REX1 loci (Garland 
et al., 2013). The expression levels of zz-Rrp6 were assayed in the resulting 
mpp6Δ and rex1Δ strains grown in minimal medium by SDS PAGE and western 
blot analysis (Figure 4.4). Compared to MPP6 strains, there was no significant 
change in the relative zz-Rrp6 expression levels in the mpp6Δ mutant (Figure 
4.4A). The rex1Δ mutant showed a slight but not substantial increase in zz-Rrp6 
expression (Figure 4.4B).  
 
Therefore, Rrp6 stability is not significantly affected by the loss of Mpp6 or Rex1 
expression. Any loss of endogenous Rrp6 protein in mpp6 rrp47 mutants can be 
predominantly attributed to the loss of Rrp47.  
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Figure 4.4. Rrp6 expression levels are unchanged  in mpp6∆ or rex1∆ 
strains. Lysates were prepared from yeast strains expressing zz-Rrp6 
fusion proteins either carrying a wildtype or a deletion allele of the MPP6 
(A) or REX1(B) genes. Proteins were fractionated by SDS PAGE and 
analysed by western blotting using the PAP antibody (upper panel). Blots 
were incubated with a Pgk1-specific antibody as a loading control (lower 
panel). Expression levels of zz-Rrp6 in each strain are given below the 
figure and are the average of of three independent biological replicas. 
Values are expressed relative to the corresponding wildtype MPP6 or 
REX1 strains respectively. 
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4.2.5 RNA analysis of mpp6Δ rrp47Δ mutants 
 
Chapter 3 investigated RNA processing and degradation phenotypes in a 
conditional mpp6 rrp47 double mutant. This strain exhibited defects in surveillance 
and degradation of CUTs, pre-rRNA and other aberrant RNAs. Northern blot 
hybridisation was carried out on complemented mpp6Δ rrp47Δ strains to 
investigate if these phenotypes could be suppressed with increasing exogenous 
levels of Rrp6.  
 
Total cellular RNA was isolated from mpp6Δ rrp47Δ strains complemented with 
RRP47, MPP6 or rrp6 alleles. Strains were grown in minimal media and harvested 
during mid-log phase. Isogenic wildtype, rrp47Δ and mpp6Δ strains were 
analysed in parallel. Northern blot analyses were performed on total cellular RNA 
fractionated by denaturing polyacrylamide electrophoresis.  
 
A strong accumulation of cryptic unstable transcripts (CUTs) was exhibited in 
mpp6∆ rrp47∆ mutants complemented by single copy plasmids encoding zz-rrp6 
and zz-rrp6-1 alleles (Figure 4.5 lanes 6 and 7). The accumulation of NEL025c and 
IGS1-R CUTs was markedly increased in comparison to rrp47∆ and mpp6∆ single 
mutants (Figure 4.5 compare lanes 2-3, 6-7, Figure 4.6A-B). This is in 
concordance with previous observations in conditional mpp6 rrp47 mutants 
(Chapter 3 and Milligan et al. 2008). Additionally, mpp6∆ rrp47∆ mutants 
expressing the zz-Rrp6 and zz-rrp6-1 fusion proteins revealed defects in the 
degradation of RNA surveillance targets including truncated fragments of 5S 
rRNA, U3 and snR13 snoRNAs (Figures 4.6 and 4.8 lanes 6-7, denoted 5S*, U3* 
and snR13* respectively). These transcripts have previously been characterised as 
aberrant species in RNA surveillance mutants (Kadaba et al., 2006; Kufel et al., 
2000; Rasmussen and Culbertson, 1998). A similar accumulation of a truncated 
fragment of the U6 snRNA was also observed (data not shown).  
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Figure 4.5. Northern blot analysis of 
mpp6∆ rrp47∆ mutants. Total 
cellular RNA was isolated from 
isogenic wild-type (WT), rrp47∆ and 
mpp6∆ strains (lanes 1-3), and 
mpp6∆ rrp47∆ double mutants 
complemented with either 
centromeric (cen) plasmids encoding 
zz-mpp6, RRP47, zz-rrp6, zz-rrp6-1 
or 2-micron (2µ) plasmids encoding 
zz-rrp6 and zz-mpp6 (lanes 4-9). 
RNA was fractionated on 8% 
denaturing polyacrylamide gels and 
analysed by northern blot 
hybridisation using radiolabeled 
oligonucleotides as indicated. 
Detected RNA species are indicated 
to the right of each panel. Truncated 
RNA transcripts are indicated with 
an asterisk (*). SCR1 served as a 
loading control. 
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Figure 4.6. Quantification of RNA degradation phenotypes in mpp6∆ rrp47∆ mutants. 
Quantification of northern blot signals from analysis of mpp6∆ rrp47∆ mutants shown in 
Figure 4.5. Values from NEL025, IGS1-R, U3*, 5S*, 5’ETS and 5.8S + 30 species are shown 
for each strain. Averages from two data sets are normalised to SCR1 levels and expressed 
relative to the signals from the wildtype (WT) strain. 

A!
B!
C!
D!
E!
F!
Error"bars"
! 166!
 
As observed in conditional mpp6 rrp47 mutants (Chapter 3), the mpp6∆ rrp47∆ 
strains expressing zz-rrp6 and zz-rrp6-1 proteins revealed an accumulation of 3’ 
extended U14 and snR13 snoRNAs (Figure 4.7, lanes 6-7). The rrp47Δ strain 
displays two populations of extended U14 snoRNAs that are proposed to 
correspond to transcriptional termination at a proximal Nrd1-dependent site (site I) 
and a more distal cleavage/polyadenylation site (site II). Both termination events 
result in polyadenylation and appear as smears on northern blot hybridizations 
(Grzechnik and Kufel, 2008). The mpp6Δ rrp47Δ strains complemented by zz-rrp6 
and zz-rrp6-1 alleles show a stronger accumulation of site II polyadenylated 
transcripts (dubbed II-pA (U14) and II-pA (snR13)) in comparison to the rrp47∆ 
single mutant (Figure 4.7 compare lanes 2 with 6-7). These transcripts read 
through into distal alleles and are targeted for rapid degradation in wild type cells 
through RNA surveillance pathways (Allmang et al., 1999a; Steinmetz and Brow, 
2003). These results agree with previous analyses in Chapter 3 and show that 
degradation of RNA surveillance targets is impeded in the absence of Mpp6 and 
Rrp47.  
 
The final step in 3’ end processing of box C/D snoRNAs requires the catalytic 
activity of Rrp6 with the co-operation of Rrp47 (Costello et al., 2011; Mitchell et 
al., 2003). Short 3’ extensions of 1-6 nucleotides are present in the absence of 
Rrp6 and Rrp47. In the case of snR38, these can be resolved as mature snR38 
and snR38 + 3 species on 8% polyacrylamide gels as seen in the rrp47∆ mutant 
(Figure 4.7, lane 2).  The mpp6Δ rrp47Δ strain expressing zz-Rrp6 shows 
complementation of the snR38 + 3 phenotype when compared with the rrp47Δ 
single mutant (Figure 4.7, compare lanes 2 and 6). Interestingly, the strain 
expressing zz-rrp6-1 shows a stronger accumulation of the snR38+3 species and 
subsequent depletion of mature snR38. This shows the rrp6-1 mutant is unable to 
efficiently process short 3’-extended snoRNAs in comparison to strains 
complemented by functional Rrp6 (Figure 4.7, compare lanes 6 and 7).  
 
A suppression of all observed phenotypes was detected in the mpp6Δ rrp47Δ 
strain expressing zz-Rrp6 from a multicopy plasmid. Accumulation of CUTs,  
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Figure 4.7. Northern analysis of 
box C/D snoRNAs in mpp6∆ 
rrp47∆ mutants. RNA isolated as 
described in Figure 4.5 was 
fractionated on 8% denaturing 
polyacrylamide gels and analysed 
by northern blot hybridisation 
using radiolabeled probes as 
indicated. Dispersed bands 
labeled I-pA and II-pA 
correspond with pre-snoRNAs 
that are polyadenylated at 
termination sites I or II 
respectively. To compare the 
relative levels of mature and 
extended U14 transcripts, two 
images are shown from the same 
hybridisation. Asterisks (*) denote 
truncated transcripts. SCR1 
served as a loading control. 
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Figure 4.8. Quantification of box C/D 
snoRNA phenotypes in mpp6∆ rrp47∆ 
mutants. Quantification of northern 
blot signals from analysis of box C/D 
snoRNAs in mpp6∆ rrp47∆ mutants 
from Figure 4.7. Values of II-pA 
(snR13), snR13*, snR38 + 3 and II-
pA(U14) are shown for each strain . 
Averages from two data sets are 
normalised to SCR1 levels and 
expressed relative to the signals from 
the wildtype (WT) strain. 
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5’ETS, II-pA snoRNAs, truncated 5S*, U3* and snR13* transcripts are less severe 
in comparison to strains complemented with single copy plasmids encoding zz-
Rrp6 and zz-rrp6-1 (Figures 4.5 and 4.7, compare lanes 6-8). Quantitative analysis 
shows reduction of at least 50% of the aforementioned RNA species when 
comparing the 2µ zz-Rrp6 mutants with the cen zz-Rrp6 strain (Figures 4.6 and 
4.8). Strikingly, overexpression of Rrp6 showed almost complete suppression of 
the IGS1-R CUT transcript. However, CUTs have a very low expression level and 
any changes may seem more modest in comparison to more abundant 
transcripts.  
 
No substantial suppression of phenotypes was seen in mpp6∆ rrp47∆ double 
mutants expressing zz-Mpp6 from a multicopy vector (Figures 4.5 and 4.7, lane 
9). On average, accumulated RNA transcripts were comparable to strains 
expressing single copy zz-Mpp6 (Figures 4.6 and 4.8, compare lanes 4 and 9). 
Steady state protein analysis previously showed that overexpression of zz-Mpp6 
does not stabilise normal expression levels of Rrp6 in an rrp47∆ strain (Figure 4.3, 
lane 9). This suggests that Mpp6 does not function to maintain normal levels of 
Rrp6 and that increased levels of Mpp6 protein does not complement RNA 
phenotypes observed in rrp47∆ mutants.  
 
Strains assayed in the aforementioned RNA analyses were initially isolated by the 
plasmid shuffle method using 5’FOA to counter-select against a URA3 plasmid. 
Exposure to 5’FOA can be highly mutagenic to cells with some studies reporting 
large levels of chromosomal instability (Wellington and Rustchenko, 2005). To 
validate that the above results are not due to genetic instability from 5’FOA 
exposure, 4 sets of independent mpp6∆ rrp47∆ strains bearing RRP47, MPP6 
and rrp6 plasmids were isolated by the 5’FOA plasmid shuffle assay. 
Transformants were recovered from 5’FOA-containing media as soon as colonies 
were observable to minimize exposure. Total cellular RNA was isolated from 
independent isolates and analysed by acrylamide gel Northern analysis (Figure 
4.9). The phenotypes observed in Figures 4.7 and 4.9 were shown to be 
reproducible in independent isolates. The mpp6∆ rrp47∆ double mutants 
complemented by zz-Rrp6 and zz-rrp6-1 expressed from centromeric plasmids 
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showed consistent accumulations of 3’ extended snR13 transcripts and the 5S* 
truncated transcript in concordance with previous analyses (Figure 4.9 lanes 3-4, 
9-10, 15-16 and 21-22). Complementation of the double mutant with a 2µ 
plasmid encoding zz-Rrp6 showed a suppression of said phenotypes (lanes 5, 11, 
17 and 23).  This validates that the effects seen in mpp6∆ rrp47∆ mutants are 
reproducible and are not due to mutations through 5’FOA exposure.   
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Figure 4.9. RNA analyses from independent mpp6∆ rrp47∆ isolates. Northern blot 
hybridisation analysis of total cellular RNA independently isolated mpp6∆ rrp47∆ 
mutants complemented with either centromeric (cen) plasmids encoding zz-mpp6, 
RRP47, zz-rrp6, zz-rrp6-1 or 2-micron (2µ) plasmids encoding zz-rrp6 and zz-mpp6. 
RNA from four sets os isolates (labelled sets 1-4) was analysed by hybridisation using 
the probes as indicated. Truncated RNA transcripts are indicated with an asterisk (*). 
SCR1 served as a loading control. 
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4.3 Discussion  
 
The functional relationship between Rrp6 and Rrp47 has been widely 
characterized in a number of previous analyses (Costello et al., 2011; Feigenbutz 
et al., 2013b; Mitchell et al., 2003; Stead et al., 2007). The normal function of 
Rrp6 in RNA processing and surveillance pathways relies on the presence of 
Rrp47. In turn, the stability of Rrp47 is dependent on the physical interaction with 
Rrp6 through their respective N-terminal domains. More recently it has been 
shown that the stability of Rrp6 is also dependent on this interaction, albeit less 
sensitive (Feigenbutz et al., 2013a). Whilst the relationship with Rrp6 has been well 
studied, the exact molecular function of Rrp47 has remained largely unknown. 
From recent analyses, it has been proposed that one role of Rrp47 is to maintain 
stable expression of Rrp6. Here, it is shown that by artificially increasing the 
expression levels of Rrp6, the requirement of Rrp47 for normal Rrp6 stability is 
negated. This allowed the isolation and analysis of mpp6 rrp47 double mutants 
and supports previous observations in conditional mpp6 rrp47 double mutants as 
described in Chapter 3.  
 
Initially, it was found that plasmid-borne overexpression of Rrp6 was sufficient to 
complement the synthetic lethality of mpp6∆ rrp47∆ double mutants. This 
suggests that the requirement of Rrp47 for normal Rrp6 function could be 
circumvented. Loss of function mpp6 alleles are synthetic lethal in combination 
with rrp47∆ or rrp6∆ mutants. As it has been widely characterised that Rrp47 and 
Rrp6 work in concert, it has been proposed that Mpp6 functions in pathways 
redundant with the Rrp6/Rrp47 homodimer. Therefore, in the absence of Mpp6, a 
functional Rrp6 pathway is required to maintain cell viability. If one function of 
Rrp47 is to maintain the normal expression levels of Rrp6, the synthetic lethality 
observed in mpp6∆ rrp47∆ mutants could be a result of the decreased amounts 
of Rrp6 protein. By increasing Rrp6 levels in these mutants, it was possible to 
maintain cell viability.  
 
Interestingly, exogenous expression of a catalytically inactive rrp6-1 mutant was 
able to complement the synthetic lethality of mpp6∆ rrp47∆ mutants. In parallel 
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analyses, the rrp6-1 mutant was unable to complement the synthetic lethality of 
rex1∆ rrp47∆ mutants. This suggests that Rrp6 may have important non-catalytic 
roles in RNA surveillance pathways redundant with Mpp6-dependent pathways. 
One possibility, irrespective of catalytic function, is that the association of Rrp6 
with the exosome stimulates the activity of Rrp44. Recent analyses have 
suggested that Rrp6 allosterically promotes the activity of Rrp44 through physical 
interactions with the nuclear exosome (Makino et al., 2013a; Wasmuth and Lima, 
2012). Additionally, analysis of RNA substrates targeted by Rrp6- and Rrp44-
dependent pathways shows a large degree of overlap (Gudipati et al., 2012b; 
Schneider et al., 2012). Therefore, it may be possible that the overexpression of 
catalytically inactive Rrp6 proteins would function to stimulate the function of 
Rrp44 in RNA surveillance pathways that are redundant with Rrp6-dependent 
pathways. Furthermore, Rrp6 could contribute to the recruitment of other proteins 
or complexes through physical interaction. Nevertheless, catalytic activity of Rrp6 
is required for some processes in the absence of Mpp6 as mpp6∆ rrp6-1 mutants 
were previously shown to be inviable in Chapter 3 (Section 3.2.9).  
 
Increased expression of Rrp6 proteins allowed the isolation of mpp6∆ rrp47∆ 
double mutants. Strains complemented with centromeric (cen) or 2µ plasmids 
bearing rrp6 alleles showed slow growth phenotypes in comparison to equivalent 
strains complemented by RRP47 or MPP6 alleles. Growth was not markedly 
improved in strains expressing Rrp6 from a high copy number vector in 
comparison to a single copy plasmid, although western blot analysis shows that 
Rrp6 expression was clearly increased. Additionally, the absence of Mpp6 or Rex1 
did not have a negative effect on normal Rrp6 protein expression. This suggests 
that the growth rate limiting effect in complemented mpp6∆ rrp47∆ strains was 
not due to the amount of Rrp6 protein but due to the synergystic absence of 
Mpp6 and Rrp47.  
 
Northern blot analyses of complemented mpp6∆ rrp47∆ mutants corroborated 
previous observations described in Chapter 3 and provides an insight into the 
molecular basis of the synthetic lethal association between mpp6∆ and rrp47∆ 
alleles. Conditional mpp6 rrp47 mutants were extensively analysed in Chapter 3 
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and shown to accumulate a wide array of RNA transcripts that are normally 
degraded by the exosome complex in wildtype conditions. This was observed in 
mpp6∆ rrp47∆ mutants complemented by increased expression of Rrp6. Cells 
showed an accumulation of cryptic unstable transcripts (CUTs), truncated forms of 
stable RNAs, pre-rRNA processing byproducts and extended snoRNAs consistent 
with impaired RNA surveillance pathways. These phenotypes were partially 
suppressed upon increased expression of Rrp6 from a high copy number 
plasmid. This suggests that increased Rrp6 expression is able to maintain RNA 
surveillance pathways to an extent in the absence of Mpp6 and Rrp47. However, 
overexpression of Rrp6 was not able to fully suppress the observed phenotypes. 
This indicates that despite being required for normal Rrp6 expression, Rrp47 has 
other functions required for efficient RNA surveillance pathways. Interestingly, 
mpp6∆ rrp47∆ strains complemented by rrp6-1 alleles showed comparable RNA 
surveillance phenotypes to equivalent strains complemented by a wildtype RRP6 
gene. This indicates, as previously mentioned, that Rrp6 has non-catalytic roles in 
targeting aberrant RNAs and CUTs for rapid degradation.  
The functional redundancy between Rrp47/Rrp6- and Mpp6-dependent 
processes is supported by synthetic lethality observed in mpp6∆ rrp47∆ and 
mpp6∆ rrp6∆ mutants. In the absence of either pathway, cells are viable. 
However, as shown in Chapter 3, destabilisation of functional Rrp6/Rrp47 
complexes in mpp6∆ mutants results in a block in growth. This may be explained 
by the strong accumulation of aberrant ncRNA species and stabilisation of cryptic 
unstable transcripts consistent with a loss of RNA surveillance and quality control 
mechanisms. This also highlights the biological importance of RNA surveillance as 
a loss in these pathways results in a loss of cell viability.  
Functional redundancy is common in many biological systems and provides 
failsafe pathways in case one pathway is impaired. The results in this Chapter and 
Chapter 3 suggest a model where Rrp6/Rrp47 function in redundant RNA 
processing pathways with Rex1 (Figure 4.10.A) and in redundant discard 
pathways with Mpp6 (Figure 4.10.B).  
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Figure 4.10. Rrp6/Rrp47, Rex1 and Mpp6 function in redundant RNA processing and 
degradation pathways. Model for 3’-end processing or degradation of transcripts via 
alternative, redundant pathways. (A) Rrp6 and Rex1 are required for the 3’-end 
exonucleolytic trimming of pre-RNAs to form mature RNPs. Both pathways can function 
in the absence of the other. However, a cumulative loss of both pathways results in loss of 
viability. (B) RNA transcripts targeted for discard pathways require either Rrp6/Rrp47- or 
Mpp6-dependent pathways. It is assumed that Mpp6-dependent pathways target 
substrates for degradation by Rrp44. Disruption of either pathway is tolerated in vivo yet 
rrp6∆ mpp6∆ or rrp47∆ mpp6∆ double mutants are synthetic lethal. Proteins with 
exonuclease domains are marked with a cross. 
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Whist it has been shown that Mpp6 is required for redundant RNA surveillance 
pathways; the molecular basis of its function is not understood. Mpp6 has been 
shown to associate with the exosome core and given that Rrp6 and Rrp44 share 
a common set of substrates, it has been proposed that Mpp6 acts to stimulate 
the function of Rrp44 in pathways redundant with Rrp6 (Milligan et al., 2008). An 
alternative proposition is that Mpp6 functions with the TRAMP polyadenylation 
complex and Rrp6 to target RNA substrates to the exosome core. This is 
supported by observed physical interactions between human Mpp6, Rrp6 and 
Mtr4 homologues (MPP6, PM-Scl100 and hMtr4 respectively) (Butler and Mitchell, 
2011; Schilders et al., 2007). A more comprehensive characterisation of the Mpp6 
protein is described in Chapter 5.  
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Chapter 5: Mutagenesis and functional characterisat ion of 
Mpp6 
 
5.1 Introduction  
 
In Chapters 3 and 4, the physical and functional interactions between the nuclear 
exosome associated exonuclease Rrp6 and cofactor partner Rrp47 were 
investigated. The Rrp6/Rrp47 heterodimer functions in RNA processing and 
surveillance pathways in concert with the nuclear exosome and a number of 
associated proteins and complexes. Functional disruption of the Rrp6/Rrp47 
complex was shown to be synthetic lethal in combination with mpp6∆ and rex1∆ 
alleles. This is in agreement with previous studies that showed rrp6∆ or rrp47∆ 
mutants are synthetic lethal in combination with mpp6∆ or rex1∆ alleles (Milligan et 
al., 2008; Peng et al., 2003). RNA analyses of conditional mpp6 rrp47 showed a 
block in RNA surveillance and turnover pathways, while rex1 rrp47 mutants 
showed a specific defect in snoRNA maturation pathways (Chapter 1., Garland et 
al. 2013). These results support the conclusion that Mpp6 and Rex1 function in 
RNA surveillance and processing pathways redundant with the function of 
Rrp6/Rrp47.  
 
The small, nuclear protein Mpp6 was originally identified in yeast in a genome-
wide screen for synthetic lethal interactions with rrp47∆ mutants and subsequently 
shown to associate with the nuclear exosome. Additionally, mpp6∆ mutants were 
shown to be synthetic lethal in combination with rrp6∆ mutants or the loss of Air1, 
an RNA binding protein and part the TRAMP polyadenylation complex (Milligan et 
al., 2008). Mpp6 shows RNA binding activity in yeast and human homologues with 
a preference for pyrimidine-rich sequences (Milligan et al., 2008; Schilders et al., 
2005). However, Mpp6 is devoid of any characterised RNA binding motifs. Cells 
lacking Mpp6 show mild defects in RNA surveillance and degradation pathways 
including the accumulation of cryptic unstable transcripts (CUTs), pre-rRNA 
processing byproducts and aberrant forms of stable ncRNAs. These effects are 
exacerbated in combination with conditional rrp47 mutants (Feigenbutz et al., 
2013a; Garland et al., 2013; Milligan et al., 2008). Whilst is has been proposed 
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that Mpp6 functions in RNA surveillance pathways redundant with the function of 
the Rrp6/Rrp47 complex, the molecular basis of this is still not understood. One 
model is that Mpp6 functions to stimulate the activity of the core-exosome 
associated exonuclease Rrp44 (also known as Dis3) (Milligan et al., 2008). 
However, any possible stimulation may be indirect, as human MPP6 has been 
shown to associate with the exosome core in the absence of DIS3 (Chen et al., 
2001). An alternative proposal is that Mpp6 acts to promote the functional 
coupling between Rrp6 and the TRAMP complex. This is supported by the 
reported physical interaction between human homologues of Mpp6, Rrp6 and 
Mtr4 (MPP6, PM-Scl-100 and hMtr4, respectively) (Schilders et al., 2007).   
 
The amino acid sequence of Mpp6 contains no characterised domains that may 
hint to the function of the protein. Alignment of known Mpp6 homologues in 
model organisms identifies two regions of high conservation (Figure 5.1) (Milligan 
et al., 2008). In the yeast Mpp6 protein, these sequences map to an N-terminal 
motif I (residues L11 to F23) and a distal motif II (residues G111-S119). Using 
these sequences for consecutive PSI-blast searches only identifies other Mpp6 
homologues. The secondary structure of Mpp6 was predicted using the Phyre2 
web server (Kelley and Sternberg, 2009). These analyses predicted that 61% of 
the protein sequence is disordered (Figure 5.2). Additionally, predicted secondary 
structure features are modeled with a low confidence score (26%). The N-terminal 
conserved motif I (residues L11-F23) is predicted to form an alpha-helix structure 
with mid-high confidence scores. However, the reliability of such data is not ideal 
with such a low confidence score. The C-terminal region of Mpp6 contains a high 
proportion of lysine and arginine residues. A lysine-rich domain is also found in the 
C-terminus of Rrp47. This region was shown to be required for RNA binding in 
vitro but not for the function of the protein in vivo (Costello et al., 2011). The C-
terminal lysine-rich region is found in other yeast Mpp6 homologues (Appendix II) 
but not as conserved between homologues in higher eukaryotes (Appendix I). !!!
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Figure 5.1. Mpp6 contains two highly conserved motifs. Amino acid sequence alignment of 
Mpp6 homologues from model eukaryotes. Sequences from Saccharomyces cerevisiae, 
Homo sapiens, Mus musculus, Danio rerio, Drosophila melanogaster, Caenorhabditis 
elegans, Arabidopsis thaliana and Schizosaccharomyces pombe were aligned using Clustal 
Omega (Sievers et al. 2011) and edited using CLC Main Workbench 6 (CLC Bio, Aahus, 
Denmark). Residues with high conservation are highlighted in red. Yeast Mpp6 contains an 
N-terminal motif I between residues L11 and F23 (A) and a distal motif II between residues 
G111 and S119 (B). Amino acid numbers are according to residues in the yeast Mpp6 
sequence. A full alignment is found in Appendix I
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H. sapiens! MPHOSPH6! MAAER---KTRLSKNLLRMKFMQRG-! --LLYGRMSFRG!
M. musculus! Mphosph6! MASER---KTKLSKNLLRMKFMQRG! --LLYGRMSFRG!
D. melanogaster! CG920! MPSKS---KPRLSRGVLDMKFMQR-! --LIDGRLSFRG!
A. thaliana! F29A7.6! -MAKR-----EISSTLRNLKFMQRS! --ALLGRMSFQS!
S. pombe! UNK4.11c! -----------MSSKLLSMKFMQRAR! PNLVQGRASFGL!
D. rerio! mphosph6! MANDG---GAKLSKNLLRMKFMQRG! --LVYGRMSFKG!
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Figure 5.2. Secondary structure prediction of M
pp6. RAW
 output of the secondary structure prediction obtained for 
yeast M
pp6 using Phyre
2 web server. Three independent secondary structure predictions using PSIPRED, JNet and 
Sspro score each residue for structure and give a confidence value of 0 (low, blue) to 9 (high, red) which are 
averaged to form
 a consensus. Phyre also uses the DISOPRED server to prodive a prediction score for disordered 
(?) or ordered (-) residues. Two conserved m
otifs found in M
pp6 are also indicated. 
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In the absence of domain information or structural data for Mpp6, this Chapter 
describes a mutagenesis study to characterise functional regions of the protein. A 
random mutagenesis approach was employed to generate a library of mpp6 
mutants that were screened for function using an mpp6∆ rrp47∆ plasmid shuffle 
assay. Loss-of function mutations were identified in the N-terminal conserved 
region in addition to sites in areas of low conservation. The DECOID approach, 
described in Chapter 3, was used to analyse RNA phenotypes of conditional 
mpp6 rrp47 mutants and revealed regions in Mpp6 required for function in RNA 
surveillance and degradation pathways. Finally, possible links between Mpp6 and 
larger complexes was investigated in rrp6 and TRAMP complex mutants using 
glycerol gradient ultracentrifugation. Sedimentation analysis of Mpp6 mutants 
identifies critical residues required for complex association.   
 
 
5.1.1 Random mutagenesis methods for in vitro evolut ion 
 
Random mutagenesis is a powerful tool used to alter the chemical and physical 
properties of proteins. When combined with precise screening procedures to 
identify loss-of function mutations, this provides a viable method to map functional 
regions of a protein.  
 
With no identifiable domain features or structural data, a random mutagenesis 
approach seemed ideal to investigate the functional regions of Mpp6. A library of 
random mpp6 mutants could be screen could be screened for functionality by the 
ability to complement the mpp6∆ rrp47∆ synthetic lethality using a plasmid shuffle 
assay generated in Chapter 3.   
 
Various methods for generating random mutations in vitro have been well 
documented including the use of chemical mutagens, passing DNA through 
mutator strains or using error-prone PCR (EPPCR) (Labrou, 2010). Each method 
is effective depending on the application. Chemical mutagens such as nitrous acid 
(HNO2) or ethyl methanesulfonate (EMS) alter the chemical structure of nucleotides 
by deamination or alkylation respectively and promote base-pair substitutions 
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(Kaudewitz, 1959; Lai et al., 2004). Chemical mutagenesis can be used on DNA in 
vitro or on whole cells to introduce random mutations. Random mutations can be 
introduced into DNA by passaging plasmids through mutator strains lacking DNA 
repair mechanisms (Cox, 1976). The mutagenic E. coli strain XL1-Red (Stratagene) 
contains mutS, mutD and mutT mutations that disrupt primary DNA repair 
pathways. The rate of mutation of DNA is measured to be ~5000-fold higher than 
wildtype cells (Greener et al., 1996). This method has the advantage that a wide 
array of mutations can be incorporated including insertions, deletions and 
frameshifts. However, the drawback is that the bacterial strain becomes 
chromosomally unstable due to errors in replication of endogenous genes 
(Labrou, 2010). Finally, error-prone PCR methods promote random copying errors 
by imposing low-fidelity conditions to PCR reactions. PCR can be used to amplify 
the DNA of interest under mutagenic conditions to lower the fidelity of the DNA 
polymerase. Taq DNA polymerase is generally used due to its lack of 3’-5’ 
proofreading activity and exhibits a mutation rate of 2.2 x 10-5 errors per nt per 
cycle (Lundberg et al., 1991). Altering standard PCR conditions can increase the 
degree of mutagenesis. Increasing MgCl2 concentrations, the addition of MnCl2, 
using an unbalanced ratio of dNTPs and increasing the polymerase concentration 
are all methods of increasing the rate of mutation in PCR (Pritchard et al., 2005). 
An advantage to using PCR-based mutagenesis over other methods is that 
mutations can be specifically directed to the ORF of interest before cloning into 
plasmids for analysis. Whilst the cloning step may be rate limiting, this prevents 
mutations forming in regions of plasmids outside of the site of interest.   
 
For the purposes of this study, error-prone based PCR methods were employed 
to introduce random mutations into the MPP6 open reading frame. Libraries of 
mpp6 mutants were generating through consecutive rounds of standard PCR 
using Taq polymerase. For each round of PCR, a reaction volume of 100 µl was 
divided into 10 x 10 µl volumes before thermocycling and pooled at the end. This 
was to prevent the predominance of mutations arising early in PCR cycles and 
would allow a more heterogeneous population of unique mutations. DNA 
generated after the primary PCR round (1°) was used as a template for the 
secondary PCR round (2°) and so on for five rounds of PCR. This allowed the 
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generation of five libraries of mpp6 DNA fragments with increasing degrees of 
mutation that were subsequently cloned into plasmids using homologous 
recombination methods in yeast.  
 
 
5.2 Results 
 
5.2.1. Construction of a mutational l ibrary in MPP6 using error-prone 
PCR (EPPCR) 
 
PCR based random mutagenesis was employed to generate a library of mutants 
in the MPP6 open reading frame in order to determine functionally important 
regions of MPP6. Section 5.1.2. describes various methods of in vitro 
mutagenesis including pros, cons and mutational biases. However, this study 
utilized PCR-based mutagenesis using Taq DNA polymerase isolated from 
Thermus aquaticus. Taq polymerase is commonly used as a method to introduce 
random mutations due to its naturally high error rate from a lack of proofreading 
activity (Keohavong and Thilly, 1989). Mutational bias can be manipulated by 
modifications to the PCR protocol including using unequal ratios of dNTPs, 
increasing MgCl2 concentration or the addition of MnCl2 (Leung et al., 1989). This 
study employed consecutive rounds of standard PCR on the MPP6 ORF to create 
a library of PCR products with increasing degrees of mutagenicity. Products were 
cloned into plasmids through yeast recombinational cloning (Ma et al., 1987). An 
overview schematic describing the generation of the random mutant library is 
depicted in Figure 5.3.  
 
PCR was performed on a yeast centromeric plasmid encoding an epitope-tagged 
zz-MPP6 allele (p599) using a forward primer complementary to the T3 RNA 
polymerase promoter (o68) and a reverse primer complementary to downstream 
regions of the MPP6 ORF (o598). Standard PCR reaction mixes were prepared in 
100µl volumes before splitting into 10 x 10µl volumes prior to thermocycling and 
pooled after the procedure. This method was employed to prevent a bias of 
certain mutations that may arise during early cycles of PCR and increase the  
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RANDOM MUTAGENSIS EXP!
!
EPPCR !
!
CO-TRANSFORM INTO YEAST!
!
SELECT BY 5’FOA REPLICA PLATING!
!
CHECK FOR PROTEIN EXPRESSION !
!
SEQUENCING DATA!
zz! MPP6!
zz-MPP6!
LEU2!
zz! mpp6!** *  *** *  *  ** *** *   * *!
LEU2!
URA3!
zz-MPP6!
mpp6!
mpp6∆ rrp47∆!
zz!** *  *** *  !
SD-ura-leu! 5’FOA!
-GAGTCTCGCCATT-!
|  |  |  |  |  |  |  |  |  |  | !
*"
A!
B!
C!
D!
E!
F!
Figure 5.3. Generation of a library of random mutations 
in the MPP6 ORF and subsequent screening steps. A 
library of random mutations in the MPP6 ORF was 
created using error prone PCR and resulting 
transformants were selected for loss of function in a 
plasmid shuffle assay. (A) The zz-MPP6 ORF was 
amplified from plasmid p599 by PCR  to generate a 
wildtype template fragment. (B) in vitro evolution using 
error-prone PCR. Consecutive rounds of PCR were 
carried out on the template fragment using low fidelity 
Taq DNA polymerase to generate a library of mutant 
mpp6 ORF fragments. (C) Libraries of mutant mpp6 
ORFs were co-transformed along with a gapped LEU2 
plasmid into a rrp47∆ mpp6∆ plasmid shuffle strain 
bearing a URA3 plasmid encoding wildtype zz-Mpp6. 
Mutant mpp6 ORF fragments contained regions of 
homology with the gapped plasmid to allow for 
homologous recombination in yeast. (D) Transformants 
were selected for functionality by replica plating colonies 
from solid SD-ura-leu media to 5’FOA media. Colonies 
that were unable to grow on 5’FOA after 3 days at 30°C 
were recovered from the permissive plate for further 
analysis. (E) Strains that were non-viable on 5’FOA 
media were screened for expression of mutant zz-fusion 
proteins. The wildtype zz-MPP6, URA3 plasmid was 
purged from strains by transforming with a RRP47, HIS3 
plasmid (p425) and passaging over 5’FOA. Denatured 
lysates were fractioned by SDS PAGE and analysed by 
western blotting using the PAP antibody. (F) Screened 
mpp6 mutants were analysed by sequencing to 
determine mutation sites. Mutant mpp6 ORFs were 
amplified direct from yeast using colony PCR before 
analysis by Sanger sequencing. 
"
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heterogeneity of mutations. Following PCR, DNA products were analysed by 
agarose gel electrophoresis to validate the thermocycling reaction and determine 
DNA concentration (Figure 5.4. B). The PCR generated a 1650 nt fragment 
consisting of the coding regions for zz-tag, the MPP6 ORF plus flanking 
sequences. DNA was purified using a PCR cleanup kit before using 20ng as a 
template for the second PCR reaction. Five consecutive PCR reactions (termed 
1°- 5°) were carried out and products were confirmed by agarose gel 
electrophoresis (Figure 5.4. A-B).  
 
Yeast recombinational cloning can be used to insert DNA fragments into plasmids 
by exploiting the efficient homologous recombination machinery in S. cerevisiae 
(Oldenburg et al., 1997). By co-transforming a DNA fragment with a linearised 
plasmid bearing regions of sufficient homology, a ligated plasmid will be generated 
through homologous recombination in vivo.  
 
A yeast centromeric LEU2 plasmid encoding for zz-Mpp6 under the control of the 
RRP4 promoter (p599) was digested with NcoI and PshAI to remove the MPP6 
open reading frame sequence. This allows for 590 nt of homologous sequence 
with the EPPCR generated MPP6 fragment (Figure 5.5. A). Gapped plasmids were 
recovered by agarose gel electrophoresis and gel purified to remove the digested. 
Purified gapped plasmid was co-transformed into the mpp6∆ rrp47∆ plasmid 
shuffle strain (described in Section 3.2.2) along with PCR fragments from EPPCR 
libraries 1° through 5°. A parallel transformation was carried out with the gapped 
plasmid alone. Roughly ~7500 colonies were scored on plates with strains 
transformed with both gapped vector and insert DNA. The gapped-plasmid 
control transformation yielded ~ 1000 background colonies on average, most 
likely due to ligated plasmids generated through non-homologous end joining 
pathways in yeast (Daley et al., 2005). Primary transformants were washed off 
plates and stored in glycerol at -80°C. This allowed for re-plating of cells at 
suitable densities to distinguish single colonies.  
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Gapped plasmid vs. Gapped plasmid plus insert !
Example of protein expression screen 05.04.12!
26.04.12 example of colony PCR success!
GAPPED PLASMID IS CUT WITH Nco1 and PsHa1!
Primers'='o68'+'o598'
68'='T3''
zz! MPP6!
zz-MPP6!
LEU2!
PCR!
1°! 2°! 3°! 4°! 5°!
zz! mpp6!
Cumulative !
PCR!
*! *! *!
A!
B!
Increasing degree of mutagensis!
Figure 5.4. Generation of random mutant library using error-prone PCR. (A) Schematic of 
error prone PCR method. The zz-MPP6 allele and flanking regions was amplified from a 
plasmid construct (p599) by PCR using oligonucleotides o68 and o598 using Taq DNA 
polymerase. PCR products were purified before use in 5 sequential rounds of PCR to 
generate independent libraries of increasing mutagensis. (B) Validation of error-prone PCR 
products from each PCR step. A 1/50 volume of each PCR reaction was fractionated by 
agarose gel electrophoresis to confirm successful PCR products. Each round number of 
error-prone PCR is suffixed by the degrees symbol for the primary (1°) to quinary (5°) EPPCR 
cycling reaction. 
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zz! mpp6!
NcoI! PshAI!
LEU2!
A!
Glucose!
+! -!
Glucose + 5’FOA!
+! -!
C!
Glucose! Glucose + 5’FOA!B!
Figure 5.5. Cloning of mutant libraries by in vivo homologous recombination and screening 
by 5’FOA selection. (A) Schematic of recombination event to generate library of plasmids 
bearing mutant mpp6 alleles. A LEU2 plasmid encoding wildtype zz-Mpp6 (p599) was 
linearised by NcoI/PshAI digestion and co-transformed with insert DNA, generated by error-
prone PCR, into a mpp6∆ rrp47∆ plasmid shuffle strain bearing a URA3 plasmid encoding 
wildtype zz-Mpp6 (p593). Transformants were selected on synthetic glucose medium lacking 
uracil and leucine (SD-ura-leu). (B) Mpp6 mutants were assayed for function for 
complementation of the mpp6∆ rrp47∆ synthetic lethality. Strains harboring mpp6 mutants 
were grown on SD-ura-leu media at 30°C for 3 days before replica plating to minimal media 
containing 5’FOA and growing for a further 3 days. Non-viable strains on 5’FOA were 
recovered from the glucose plate for further screening. (C) Recovered mutants were 
confirmed for loss of viability on 5’FOA media. Candidate strains were grown to saturation in 
liquid SD-ura-leu medium before diluting 100 fold and spotting onto solid glucose- and  
glucose + 5’FOA media. The plasmid shuffle strain was transformed with a wildtype MPP6, 
LEU2 plasmid and an empty LEU2 vector as positive (+) and negative (-) controls. Plates 
were incubated at 30°C for 3 days before photographing. 
MAYBE 11pt? !
591$nt$of$homology$$
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5.2.2. Scoring mpp6 mutants for loss of function in a mpp6Δ rrp47Δ 
plasmid shuff le assay  
 
The mpp6Δ rrp47Δ plasmid shuffle assay (described in Section 3.2.2 and Figure 
3.1) was constructed in order to test MPP6 and RRP47 alleles for functionality.  In 
brief, a double mpp6Δ rrp47Δ strain bearing a wildtype MPP6 allele on a URA3 
plasmid is transformed with a second plasmid bearing mutated MPP6 alleles and 
a LEU2 marker. Transformants are tested for viability on media containing 5-
Fluoroorotic Acid (5’FOA), which counter-selects against strains expressing the 
URA3 gene.  If the second plasmid bears a functional MPP6 allele, the strain is 
able to lose the URA3 plasmid through mitotic destabilisation and is viable on 
5’FOA media. If the second plasmid bears a non-functional MPP6 allele, the URA3 
plasmid is not lost through segregation and the strain generates toxic 5-
flourouracil on 5’FOA media and loses viability.  
 
Section 5.2.1. describes the creation of a library of mutant mpp6 plasmids 
generated in the mpp6Δ rrp47Δ plasmid shuffle strain. In order to screen mutants 
for loss of function alleles, mutant libraries were assayed for growth on media 
containing 5’FOA. Cells from libraries produced from tertiary and quinary EPPCR 
DNA fragments (termed 3° and 5°), were plated onto selective media at suitable 
density to distinguish single colonies (~200-400 colonies per plate). Colonies 
formed after 3 days incubation at 30°C were replica plated onto minimal media 
containing 5’FOA and incubated at 30°C for a further 3 days. Strains unable to 
grow on 5’FOA were recovered from the original plate and stored for further 
analysis. Figure 5.5. B shows an example of mutant screening by 5’FOA selection. 
Roughly 8000 colonies per library were screened to cover the initial estimate of 
transformants on the primary plate. From the 3° and 5° libraries, 55 and 68 strains 
were scored as non-viable on 5’FOA media respectively. Loss of function mutants 
were validated by growing to saturation in liquid media before spotting onto solid 
glucose- and glucose + 5’FOA media (Figure 5.5. C). The proportion of mutants 
isolated from the 5° library was not significantly greater than that of the 3° library. 
In total, 123 non-functional mutants were scored from screening of ~14,000 
colonies, roughly a 1% hit-rate.  
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5.2.3 Screening loss of function mpp6 mutants for protein 
expression  
 
From initial screening, 123 strains bearing loss-of function mpp6 alleles were 
isolated by 5’FOA counterselection using the mpp6∆ rrp47∆ plasmid shuffle 
assay. Loss of function phenotypes can be attributed to a loss of protein 
expression through mutation. For the purposes of this investigation, such mutants 
are not useful for study. Additionally, a high background of transformants was 
observed in cells transformed with a gapped plasmid alone suggesting a 
significant proportion of re-ligated plasmids are formed through non-homologous 
end joining. Such plasmids would give false-positive results when screening for 
loss of function alleles by 5’FOA counterselection. Mutant plasmids generated by 
homologous recombination were constructed to encode epitope tagged zz-Mpp6 
fusion peptides in order to assay for protein expression using the PAP antibody. 
However, these plasmids were constructed in an mpp6∆ rrp47∆ plasmid shuffle 
strain complemented by a URA3 plasmid encoding zz-Mpp6. In order to assay for 
the expression of the mutant proteins, strains were cured of the URA3 
maintenance plasmid by genetic shuffling. A yeast centromeric plasmid encoding 
RRP47 and HIS3 alleles was transformed into yeast mpp6Δ rrp47Δ strains bearing 
plasmids encoding wildtype and mutant zz-Mpp6 fusion proteins on URA3 and 
LEU2 vectors respectively. An RRP47 allele would complement the synthetic 
lethality of mpp6Δ rrp47Δ and allow for loss of the URA3 plasmid encoding 
wildtype MPP6. Successful transformants were grown on media containing 5’FOA 
to purge the URA3 containing plasmid. Resulting mpp6Δ rrp47Δ strains contained 
LEU2 plasmids bearing mutant mpp6 alleles and a HIS3 plasmid encoding Rrp47.  
 
Lysates from strains expressing epitope tagged Mpp6 mutants were screened by 
SDS PAGE and western blotting using the PAP antibody. Parallel lysates from 
mpp6Δ rrp47Δ strains bearing either zz-Mpp6 encoding plasmids or an empty 
vector were used to compare relative expression of wildtype and mutant zz-Mpp6 
proteins. In addition, lysates from a strain encoding an endogenous C-terminal 
TAP tagged MPP6 allele was used to compare mutant protein expression to 
wildtype Mpp6 under the control of its endogenous promoter. As described in 
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Section 3.2.1, zz-Mpp6 fusion proteins under the control of the RRP4 promoter 
are expressed 3 fold greater than Mpp6-TAP fusion proteins under the control of 
the endogenous MPP6 promoter. Of the 123 strains isolated from the 5’FOA 
screen (Section 5.2.2), 66 (54%) expressed zz-Mpp6 fusion proteins detectable by 
western blot analyses using the PAP antibody.  
 
An example of screening by western blot analysis is shown in Figure 5.6. The 
western screen identified zz-Mpp6 proteins of variable size and expression level. 
Fusion proteins were categorized into sub-groups depending on size. In total, 
44% of strains screened expressed a full-length zz-Mpp6 protein (Figure 5.6. 
Lanes 7, 10, 12 and 14). The majority of proteins detected (48.5%) were truncated 
to varying sizes between 20 - 25 kDa as determined by comparison with 
molecular weight standards (Lanes 5-6, 9, 13, 15-17). Additionally, a small 
number of strains (7.5%) expressed zz-fusion proteins that migrated slower than 
wildtype zz-Mpp6 (Lane 8). Upon further analysis, described below, these 
extended proteins arise due to a mutation in the natural MPP6 stop codon 
resulting in translational read-through to the next available stop codon.  
 
This screen removed Mpp6 mutants that did not express detectable protein. A 
loss of expression could be attributed to mutations causing destabilisation of 
correct protein folding and are therefore targeted for rapid degradation. Another 
possibility is that a low percentage of gapped plasmids were re-circularised upon 
transformation in yeast by non-homologous end joining and did not contain 
EPPCR-generated insert DNA.  
 
A more comprehensive analysis of Mpp6 mutant protein expression is detailed in 
Section 5.2.8. 
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Full$length$=$14$(29)$
Trunca5on$=$13(32)$$
Extension$=$3$(5)$$
Protein type! Number of mutants isolated!
Percentage of 
non-functional 
mutants (%)!
Percentage of 
protein-expressing 
mutants (%) !
Full length! 29! 23.6! 44.0!
Truncation! 32! 26.0! 48.5!
Extension! 5! 4.1! 7.5!
No protein ! 57! 46.3! −!
123!
Mp
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Mp
p6!
vec
tor
!
zz-Mpp6 mutant candidates!
1     2     3      4      5      6      7     8      9    10    11    12    13   14    15   16    17  !
- Pgk1!
- Mpp6-TAP!
- zz-Mpp6!
mpp6∆ rrp47∆ RRP47"
50 - !
37 - !
25 - !
20 - !
(kDa)!
A!
B!
Figure 5.6. Screening mpp6 mutants by protein expression. (A) Western blot analysis of strains 
harbouring loss of function mpp6 alleles to screen for expression of a zz-Mpp6 protein. Lysates 
from strains expressing wildtype Mpp6-TAP and zz-Mpp6, under control of MPP6 and RRP4 
promoters respectively, were analysed in parallel. Denatured protein samples were fractionated on 
a 10% polyaderylamide gel and analysed by western blotting using the PAP antibody to detect 
tagged Mpp6 proteins (upper panel). An antiserum against Pgk1 was using as a loading control 
(lower panel). (B) Relative percentages of proteins identified by western blot analysis. Candidate 
strains were grouped by expression of either full length, truncated and extended zz-Mpp6 
proteins. Additionally, strains were identified that did not express detectable proteins.  
$
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26.04.12 example of colony PCR success!
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(o774 + o598)!
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Figure 5.7. Amplification of mpp6 alleles from yeast colonies. Colony PCR to amplify mpp6 
alleles from loss of function mutants. Fresh growing yeast colonies were added to PCR 
reactions directly and lysed during an extended initial heating step. A forward primer 
complementary to the zz-tag and a reverse primer complementary to downstream MPP6 
sequences were used to amplify zz-mpp6 alleles (1194 nt). PCR products were confirmed 
by agarose gel electrophoresis before sequencing. Unincorporated oligonucleotides are 
indicated
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5.2.4. Sequence analysis of mpp6 mutants  
 
In order to analyse the extent of mutation in the library of loss of function mpp6 
mutants, DNA sequences of mutagenised ORFs were analysed by Sanger 
sequencing. Initial attempts to recover plasmids bearing mutant mpp6 alleles from 
yeast were unsuccessful. Therefore a colony PCR-based method was employed 
to amplify the mpp6 ORF directly from yeast colonies. Primers complementary to 
sequences in the zz-tag (o774) and downstream of the MPP6 open reading frame 
(o598) were used to generate a DNA fragment of 1194 nt. The forward primer 
complementary to the zz-tag was used to prevent amplification of the 
endogenous mpp6∆::kanMX4 allele. PCR products were confirmed by agarose 
gel electrophoresis (Figure 5.7) and purified using spin columns before submission 
for sequencing analysis.  
 
Raw DNA sequences were translated into amino acid sequences in silico using 
the ExPASy Translate tool (Artimo et al., 2012) and aligned using Clustal Omega 
(Sievers et al., 2011). Mutants were sub-categorized and arranged into point 
mutations and frameshift mutations (Figure 5.8). In some cases, duplicate 
mutations arose from independent clones. Duplicated point mutants were 
included in the alignment. However, a frameshift mutation at residue I73 was 
found in 12 individual mutants and duplicated sequences were omitted from the 
alignment.  
 
Analysis of point mutant sequences identified two single point mutants: V15D and 
K145R. The V15D mutation lies in a highly conserved motif found in Mpp6 
homologues (Milligan et al., 2008) as shown in Figure 5.1 However, the K145R 
mutation resides in a previously un-characterised region of Mpp6. The C-terminal 
domain of Mpp6 has a large fraction of basic residues including K145. A highly 
basic C-terminus is also found in the nuclear exosome-associated RNA binding 
protein, Rrp47. A rrp47 mutant lacking the C-terminal domain (rrp47∆C) is unable 
to bind RNA in vitro yet is still functional in vivo (Costello et al., 2011).  
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Figure 5.8. Sequence analysis of non-functional m
pp6 m
utants. Am
ino acid alignm
ent of translated nucleotide 
sequences from
 isolated m
pp6 m
utants. M
utant m
pp6 alleles were sequenced by Source BioScience 
(Nottingham
., UK) using Sanger sequencing. Raw nucleotide sequences from
 trace files were obtained using 
FinchTV (Geospiza) and translated in silico using the ExPASy Translate tool (Artim
o et al. 2012) and aligned 
using Clustal Om
ega (Sievers et al. 2011). M
ultiple sequence alignm
ents were edited using CLC M
ain 
W
orkbench 6 (CLC Bio, Aahus, Denm
ark). Conserved regions found in M
pp6 hom
ologues are indicated 
above. Highlighted residues indicate sites of am
ino acid substitution in com
parison to wildtype M
pp6 protein 
sequence. Sequence absent from
 truncated proteins is indicateg by highlighting. 
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he sequencing data also identified multiple point mutants including 7 unique 
double mutants. Not surprisingly, a large proportion of amino acid substitutions 
were identified in the highly conserved domain in the N-terminus of Mpp6 
spanning roughly the first 30 amino acids. However, more interestingly, a number 
of mutations in non-conserved regions of the protein were identified. A S42P 
substitution was present as part of a S42P_Y66H double mutant. S42 was 
previously identified as a phosphorylated residue in two independent mass 
spectrometry analysis of phosphorylation sites in yeast (Gnad et al., 2009; Smolka 
et al., 2007) although it has not been directly shown. Bioinformatics analysis 
reveals that S42 is part of a casein kinase II motif (SXXE/D). Phosphorylation 
status may be of functional importance to Mpp6, which itself was initially identified 
as a phosphoprotein in humans (Matsumoto-Taniura et al., 1996). However, 
further investigation into Mpp6 phosphorylation was not explored in this study.  
 
Analysis of mpp6 mutant sequences also identified 8 unique mutations that 
encode truncated or extended proteins either through frameshift deletions or point 
mutations. Frameshift mutations including F115-fs, I73-fs and A60-fs are the result 
of single nucleotide deletions. The I73-fs mutation was found in 12 independently 
isolated mutants and results from a single adenine deletion in a stretch of 8 
consecutive adenine bases in the nucleotide sequence. This mutation causes a 
frameshift and the encoded protein terminates after a further 8 amino acids. A 
nonsense R88X mutation causes a CGA>TGA mutation resulting in a premature 
stop codon and encoding for just under 50% of the wildtype protein. Interestingly, 
nucleotide analysis of three mutants that encode extended proteins reveals three 
independent mutations of the natural MPP6 stop codon. Substitutions are found 
in all three nucleotides of the stop codon triplet (TAG>TGG, CAG and TAC), each 
encoding for different amino acids (X187W, X187Q and X187Y respectively). Stop 
codon mutants encode an additional 18 amino acids before termination. 
Interestingly, 2 out of 3 X187 mutants contain no other amino acid substitutions 
suggesting that the extension of 18 amino acids causes the loss of protein 
function.   
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In summary, sequence analysis of random mpp6 mutants identified 2 single point 
mutations (V15D, K145R) and 7 double point mutations that cause a loss of 
protein function in vivo. Additionally, 8 mutations were identified that encode for 
truncated or extended Mpp6 proteins. Whilst a number of amino acid 
substitutions arose in a highly conserved region in the N-terminal domain, 
mutations were found in other regions of the protein. 
 
 
5.2.5. Separating loss of function amino acid substitut ions in mpp6 
mutants.  
 
Sequence analysis of loss of function mpp6 alleles encoding full-length proteins 
identified 7 mutants with two single amino acid substitutions (Figure 5.8) Loss of 
function could be attributed to the effect of one single mutation or the combination 
of both. To investigate the nature of each substitution, site directed mutations 
were generated in a plasmid encoding zz-Mpp6 to separate identified double 
mutants. For these investigations, double mutants were chosen depending on 
their vicinity to each other in primary sequence. Without a 3D structure of Mpp6, it 
is impossible to know the relative spatial proximity of these residues. Double 
substitutions identified in close proximity, such as R14S_M16T and R127_F129I, 
were omitted from further analysis by separation. Single M18I, N33D, S42P, 
D43N, L63P, Y66H and E146K mutations (Figure 5.9) were generated through 
site-directed mutagenesis using oligonucleotide pairs o846/o847, o850/o851, 
o854/o855, o858/o859, o852/o853, o856/o857 and o848/o849 respectively. 
SDM was carried out as described in Section 2.2.7 using a LEU2 centromeric 
plasmid encoding a wildtype copy of zz-Mpp6 (p599). Candidate plasmids were 
screened by southern blot hybridisation before confirming mutations though 
sequencing analysis.  
 
Single point mutated mpp6 alleles were screened for functionality using the 
mpp6∆ rrp47∆ plasmid shuffle assay described in Section 3.1.2. Plasmids 
encoding zz-Mpp6 proteins harboring single amino acid substitutions were 
transformed into an mpp6∆ rrp47∆ strain complemented by a URA3 plasmid  
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MSANNGVTGKLSSRVMNMKFMKFGKTDDEESSNSNTPSNINSDVEPIEQKGKLFGL
DDSAWDLNSYKDDLKKISGKEKKKVKRVVYKKRPNLIISNVGYSELRKPEGVISGRKT
FGDNSDDSGSRKRKFDEGEQNEDEKRDAKDKEFTGSQDDGEDEYDLDKLFKDSIKK
KKTNHNGKNKNRNSKK!
M18I! N33D! S42P! D43N!
L63P! Y66H!
E146K!
A!
P1232 (mpp6Δ, rrp47Δ + pRS416[zz-mpp6])!
B!
 zz-mpp6"
vector!
 zz-mpp6_L63P"
 zz-mpp6_Y66H"
 zz-mpp6_E146K"
zz-mpp6"
vector!
 zz-mpp6_M18I"
 zz-mpp6_N33D"
 zz-mpp6_S42P"
 zz-mpp6_D43N"
Glucose! Glucose + 5’FOA!
m
pp
6∆
 rr
p4
7∆
 zz
-m
pp
6,
 U
RA
3"
Figure 5.9. Separation of non-functional mpp6 double mutants. (A) Schematic of mutation targets 
for amino acid subsitution. Double point mutations were identified in a random mutageneis 
approach and separated using SDM. A list of SDM primers for each mutation is detailed in Table 
2.10. (B) Plasmid shuffle assay to test for functionality of mutants. Plasmids generated through 
SDM were transformed into a mpp6∆ rrp47∆ plasmid shuffle strain and assayed for growth on 
medium containing 5’FOA. Strains were grown to saturation in selective medium and normalised by 
optical densitiy before spotting 10-fold serial dilutions onto solid glucose- and 5’FOA media. Plates 
were incubated 3 days at 30°C before photographing. 
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bearing a wildtype MPP6 allele. A LEU2 plasmid encoding wildtype zz-Mpp6 and 
an empty LEU2 vector were transformed in parallel. Transformants were screened 
for complementation of the mpp6∆ rrp47∆ synthetic lethality by assaying growth 
on media containing 5’FOA to counterselect against the URA3 maintenance 
plasmid bearing a wildtype MPP6 allele (Figure 5.9) All single point mutants 
complemented the mpp6∆ rrp47∆ synthetic lethality and were viable on media 
containing 5’FOA. Each complemented mutant grew comparable to the wildtype 
MPP6 complemented strain with the exception of the M18I mutant that showed a 
strong growth defect. The M18I mutation was originally identified as a non-
functional M18I_E146K double mutant. It is worth noting that an adjacent single 
K145R mutation was identified as non-functional, however the E146K single 
mutant showed no apparent growth defect in the plasmid shuffle strain. M18 is a 
highly conserved residue shared in Mpp6 homologues from model organisms 
(Milligan et al., 2008).  
 
Separating mpp6 double point mutations reveals that the loss of function 
phenotypes observed in the double point mutants are most likely due to a 
cumulative effects from each single point mutation. Whilst the majority of single 
point mutations show no apparent growth phenotype, the combined double 
mutations show a synergistic loss of function. The notable exception identified 
here is a single M18I amino acid substitution, which shows a strong growth defect 
combined with an rrp47∆ allele.  
 
5.2.6. Conserved regions of Mpp6 are functional ly important.  
 
Sequence analysis of mpp6 mutants generated by random mutagenesis showed 
that a high number of point mutations were found in a highly conserved N-terminal 
region of Mpp6. This region was initially identified in a previous analysis of Mpp6 
along with a second region closer to the C-terminus (Milligan et al., 2008). 
Appendices I and II shows the conservation of these regions from homologues 
found in model organisms and orthologs found in other Saccharomyces species. 
To investigate the importance of these regions in Mpp6, site directed mutagenesis  
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M
SANNGVTGKLSSRVM
NM
KFM
KFGKTDDEESSNSNTPSNINSDVEPIEQKGKLFGLDDSAW
DLNSYKDDLKKISG
KEKKKVKRVVYKKRPNLIISNVGYSELRKPEGVISGR
KTFGDNSDDSGSRKRKFDEGEQNEDEKRDAKDKEFTGSQ
DDGEDEYDLDKLFKDSIKKKKTNHNGKNK!
NRNSKK! L11A_S12A_V15A!
M
18A_K19A!
F20A_M
21A!
G111A_R112A_F115A!
A!
Mention oligos? !
B !
M
PP6
!
 
 1 MSANNGVTGKLSSRVMNMKFMKFGKTDDEESSNSNTPSNINSDVEPIEQK     50 
m
pp6
L11A_S12A_V15A
 1 MSANNGVTGKAASRAMNMKFMKFGKTDDEESSNSNTPSNINSDVEPIEQK     50 
m
pp6
M
18A_K19A
 
 1 MSANNGVTGKLSSRVMNAAFMKFGKTDDEESSNSNTPSNINSDVEPIEQK     50 
m
pp6
F20A_M
21A
!
 1 MSANNGVTGKLSSRVMNMKAAKFGKTDDEESSNSNTPSNINSDVEPIEQK     50 
m
pp6
G111A_R112A_F115A
 1 MSANNGVTGKLSSRVMNMKFMKFGKTDDEESSNSNTPSNINSDVEPIEQK     50 
!M
PP6
 
 
 51 GKLFGLDDSAWDLNSYKDDLKKISGKEKKKVKRVVYKKRPNLIISNVGYS    100 
m
pp6
L11A_S12A_V15A
 51 GKLFGLDDSAWDLNSYKDDLKKISGKEKKKVKRVVYKKRPNLIISNVGYS    100 
m
pp6
M
18A_K19A
 
 51 GKLFGLDDSAWDLNSYKDDLKKISGKEKKKVKRVVYKKRPNLIISNVGYS    100 
m
pp6
F20A_M
21A
!
 51 GKLFGLDDSAWDLNSYKDDLKKISGKEKKKVKRVVYKKRPNLIISNVGYS    100 
m
pp6
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was used to introduce alanine substitutions in conserved residues. Mutations were 
grouped together for initial characterisation of these regions (Figure 5.10 A)  
 
Mutations were introduced into the coding sequence of a zz-Mpp6 expression 
construct on a LEU2 plasmid (p599) using site directed mutagenesis. 
L11A_S12A_V15A, M18A_K19A, F20A_M21A and G111A_R112A_F115A  
 
mutations (Figure 5.10. A) were introduced using oligonucleotide pair’s 
o758/o759, o760/o761, o762/o763 and o764/o765 respectively. Mutant 
plasmids were screened by southern blot analysis and validated by sequencing.  
 
Plasmids harboring mpp6 mutants were transformed into the mpp6∆ rrp47∆ 
plasmid shuffle strain bearing a URA3 maintenance plasmid encoding wildtype zz-
Mpp6. Transformants were assayed for growth on medium containing 5’FOA to 
counterselect against the URA3 maintenance plasmid. Parallel strains transformed 
with a LEU2 plasmid encoding wildtype zz-Mpp6 and an empty vector were 
assayed in parallel as positive and negative controls respectively. Analysis of 
growth on 5’FOA revealed that all mutants were able to complement the mpp6∆ 
rrp47∆ synthetic lethality. However, resulting strains displayed reduced growth 
phenotypes with the strongest effect noted in the F20A_M21A mutant. This 
suggests that these regions are functionally important in Mpp6 and corroborates 
observations in loss of function mutations identified above.  
 
 
5.2.7. Short, C-terminal delet ions of Mpp6 are functional in vivo.  
 
Through random mutagenesis, four unique mpp6 mutants were isolated that 
encoded truncated proteins. Sequence analysis revealed that proteins containing 
the first 115 amino acids, or less, were not able to function in vivo. The C-terminus 
of Mpp6 contains a high abundance of basic residues including a 17 residue 
lysine-rich stretch. This basic region is reminiscent of the C-terminus of Rrp47 that 
also contains a lysine-rich peptide sequence. Short deletions in the C-terminus of 
Rrp47 abolished RNA binding in vitro. However, these mutants were shown to be  
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Figure 5.11. The C-terminal lysine-rich region is not required for Mpp6 function in vivo. (A) 
Schematic of truncated mpp6 mutants generated during this study. Highlighted residues 
mark the site of mutation. Red circles correspond to mutations that cause a loss of protein 
function. D130X and K169X mutations were introduced by SDM using oligonucleotide pairs 
o766/o767 and o844/o845 respectively. (B) A plasmid shuffle assay to test K169X and 
D130X mutations for function. Yeast expression constructs encoding zz-Mpp6 and K169X, 
D130X derivatives were transformed into a mpp6∆ rrp47∆ plasmid shuffle strain. An empty 
LEU2 vector was transformed in parallel. Strains were grown to saturation in liquid selective 
media before normalising by optical density and spotting 10-fold serial dilutions onto solid 
glucose- and 5’FOA-based media. Plates were incubated 3 days at 30°C before 
photographing. 
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functional in vivo through plasmid shuffle assays suggesting that RNA binding is 
not required for protein function (Costello et al., 2011).  
 
To investigate the requirement of the C-terminus of Mpp6 for protein function in 
vivo, two directed mutations were generated in a zz-Mpp6 expression construct 
and assayed for functionality using the mpp6∆ rrp47∆ plasmid shuffle assay. A 
K169X mutant was generated to remove the furthermost lysine-rich peptide region  
of the C-terminus. Furthermore, a D130X mutation was generated as an 
intermediate truncation between F115 and K169 sites. A schematic of mutation 
sites are shown in Figure 5.11 A.   
 
K169X and D130X mutations were introduced to the zz-Mpp6 expression 
construct (p599) by site-direction mutagenesis using oligonucleotide pairs 
o766/o767 and o844/o845 respectively. Candidate plasmids were screened by 
southern blot hybridisation and validated by sequencing before transforming into 
the mpp6∆ rrp47∆ plasmid shuffle strain. Transformants were screened for 
functionality by assaying for growth on media containing 5’FOA to counterselect 
against the URA3 plasmid bearing a wildtype MPP6 allele (Figure 5.11. B). Both 
K169X and D130X mutations complemented the mpp6∆ rrp47∆ synthetic lethality 
and were viable on media containing 5’FOA. Additionally, both strains grew 
comparably to an mpp6∆ rrp47∆ strain transformed with a wildtype zz-Mpp6 
expression construct. These results show that the last 56 residues of Mpp6, 
including a lysine-rich domain, are not required for protein function in vivo.  
 
5.2.8. Steady state expression levels of mpp6 mutants  
 
The library of mpp6 mutants was first screened for loss of function alleles in an 
mpp6Δ rrp47Δ plasmid shuffle assay followed by a second round of screening to 
confirm expression of a tagged zz-Mpp6 protein. The expression levels of Mpp6 
mutant proteins were assayed further to investigate the effects of specific 
mutations on protein stability. Loss of function phenotypes could be attributed to 
protein mis-folding as a result of amino acid substitutions, truncations or 
extensions. The library of mpp6 mutants was generated from a zz-Mpp6  
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Figure 5.12. Relative stability of Mpp6 proteins bearing single and double amino acid 
substitutions. (A) SDS PAGE and western blot analysis of full length zz-Mpp6 mutant proteins. 
Lysates were prepared from strains harbouring plasmids encoding mutant zz-Mpp6 proteins 
and wildtype zz-Mpp6 as a control. Additionally, lysates were prepared from a strain encoding 
a C-terminally TAP-tagged Mpp6 fusion promoter from the endogenous MPP6 locus. Fusion 
peptides were detected using the PAP antibody (upper panel). An antiserum against Pgk1 
was used as a loading control (lower panel). (B) Quantification of relative steady state levels of 
Mpp6 proteins. Data is representative of three independent experiments. Relative expression 
levels of Mpp6 proteins are normalised for Pgk1 expression values and standardised to levels 
in the Mpp6-TAP strain. Error bars represent the standard error of the mean for each set of 
values. 
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expression construct under the control of the RRP4 promoter. In a global analysis 
of yeast protein expression, it was reported that Rrp4 proteins are expressed 
roughly 3.5-fold greater than Mpp6 proteins (4830 molecular per cell compared to 
1350 respectively) (Ghaemmaghami et al., 2003). As shown in Section 3.2.1, zz-
Mpp6 fusion proteins are expressed roughly 3-fold greater than endogenous 
Mpp6 under the wildtype promoter. Therefore, mpp6 mutants are already 
overexpressed compared to endogenous MPP6.  
 
 
Lysates were prepared from strains harboring plasmids encoding loss of function 
zz-Mpp6 mutants and a wildtype RRP47 plasmid to complement the mpp6Δ 
rrp47Δ strain background. Proteins were fractionated by SDS PAGE and analysed 
by western blotting using the PAP antibody to detect zz-tagged fusion proteins. 
Lysates were also prepared from an endogenous C-terminal TAP tagged MPP6 
strain in parallel to compare relative steady state expression levels.  
 
Western blot analysis of mpp6 mutants encoding full-length proteins with amino 
acid substitutions revealed that the steady state expression profiles were generally 
similar to the wildtype zz-Mpp6 protein with a couple of exceptions (Figure 5.12. 
A). Quantitative analysis of independent samples showed that protein expression 
is reduced in some double mutants, including N33D_L63P and S42P_Y66H 
(Figure 5.12). However, these expression levels still remain greater in comparison 
to endogenous levels of Mpp6. (Figure 5.12. A,B compare lanes 1 with 2-18). 
These results suggest that loss of function phenotypes observed in mpp6 point 
mutants are not due to decreased stability of Mpp6 proteins. This implies that 
substitutions in residues critical for protein function are the basis of observed 
phenotypes.  
 
Steady state protein expression levels were analysed in mpp6 mutants expressing 
zz-Mpp6 proteins bearing alanine substitutions in conserved residues. These 
mutants were constructed through site directed mutagenesis and shown to 
complement the synthetic lethality of mpp6∆ rrp47∆ double mutants (Section 
5.2.6). Lysates were fractionated by SDS PAGE and analysed by western blotting 
along with samples from strains expressing wildtype Mpp6-TAP and zz-Mpp6  
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Figure 5.13. Mutations in conserved regions of Mpp6 do not affect protein stabiltiy. (A) Western 
blot analysis of strains harboring mpp6 mutants encoding zz-Mpp6 proteins bearing alanine 
substitutions in conserved motifs. Denatured lysates from strains expressing wildtype Mpp6-
TAP, zz-Mpp6 and mutant L11A_S12A_V15A, M18A_K19A, F20A_M21A and 
G111A_R112A_F115A proteins were analysed by SDS PAGE and western blotting using the 
PAP antibody to detect Mpp6 fusion proteins (upper panel). An antiserum against Pgk1 served 
as a loading control (lower panel). (B) Quantitative analysis of relative levels of Mpp6 proteins in 
each strain. Data is representative of three independent experiments. Relative expression levels 
of Mpp6 proteins are normalised for Pgk1 expression values and standardised to levels in the 
Mpp6-TAP strain. Error bars represent the standard error of the mean for each set of values. 
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Figure 5.14. Truncation and extension mutations generated in Mpp6. Relative comparison 
schematic of truncated or extended Mpp6 proteins generated in this study through random 
or directed mutagenesis. The nature of the mutation is indicated according to the amount of 
Mpp6 sequence expressed. Mpp6-peptide sequences are depicted in light grey and non-
Mpp6 peptide sequence as a result of frameshift is depicted in dark grey. Asterisks (*) 
denote non-function Mpp6 proteins. The scale indicates the relative length of each protein in 
amino acid residues. 
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proteins as previously described (Figure 5.13. A). Western blot analysis displayed 
that all conserved motif mutants expressed Mpp6 proteins comparable to the 
wildtype zz-Mpp6 protein that, in turn, is expressed roughly 2.5-3 fold higher than 
endogenously expressed Mpp6-TAP (Figure 5.13. B). This suggests that these 
conserved regions of Mpp6 are not required for normal protein stability. The slow 
growth phenotypes observed in Section 5.2.6 are therefore presumed to be due 
to the nature of the substitutions rather than a loss of normal protein expression. 
The random mutagenesis approach also generated frameshift mutations resulting 
from nucleotide deletions. Such mutations produce truncated or extended 
proteins, often with nonsense peptide sequences following the frameshift site. A 
scaled schematic of truncation and extension mutants generated during this study 
are depicted in Figure 5.14 including SDM generated K169X and D130X 
mutations.   
 
Western blot analysis of truncated proteins showed a general trend of decreased 
stability correlating with the length of Mpp6 proteins. Mutant strains expressing 
functional proteins (WT, K169 and D130X) showed relatively comparable 
expression levels at steady state (Figure 5.15. A, lanes 2-4). The F115-fs mutant 
shows a 2.5-fold decrease in expression level compared to wildtype zz-Mpp6 
proteins (compare lanes 2 and 5). However, the expression level is equivalent to 
levels of endogenous Mpp6 under the control of the wildtype promoter (Lanes 1 
and 5). It is worth reiterating that the F115-fs protein is longer than the D130X 
protein due to a 44 amino acid extension as a result of the frameshift. It can be 
inferred that this long nonsense peptide extension interferes with folding of the 
protein resulting in a loss of stability. The R88X mutant is produced from single 
nucleotide change resulting in a premature stop codon and therefore contains no 
peptide extension. As a result, this protein appears to be more stable than the 
F115-fs protein yet the expression level is lower in comparison to the wildtype zz-
Mpp6 (Compare lanes 2, 5-6). Finally, I73-fs and A60-fs mutations express 
proteins with short peptide extensions of ~10 amino acids. The resulting proteins 
are expressed considerably lower than wildtype zz-Mpp6 and have steady state 
levels of 81% and 28% in comparison to endogenous Mpp6 under the control of 
the wildtype promoter (compare lanes 1, 7-8).  
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Figure 5.15. C-terminal truncations of Mpp6 result in reduced protein expression. (A) 
Western blot analysis of truncated Mpp6 proteins. Lysates from strains harbouring 
plasmids encoding Mpp6 truncations depicted in Figure 5.14 were fractionated on 10% 
polyacrylamide gels and analysed by western blotting. Lysates from a Mpp6-TAP and 
wildtype zz-Mpp6 strain were analysed in parallel. TAP- and zz- fusion proteins were 
detected using the PAP antibody. An antiserum against Pgk1 served as a loading control. 
(B) Quantification of relative levels of Mpp6 protein expression from western blot analysis. 
Data is representative of three independent experiments. Values are standardised to levels 
in the Mpp6-TAP strain and expressed as relative quantities. Error bars represent the 
standard error of the mean for each set of values.  
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Figure 5.16. C-terminal peptide extensions in Mpp6 result in reduced protein expression. (A) 
Western blot analysis of extended Mpp6 proteins. Lysates from strains harboring plasmids 
encoding Mpp6 extensions depicted in Figure 5.14 were fractionated on 10% polyacrylamide gels 
and analysed by western blotting. Lysates from a Mpp6-TAP and wildtype zz-Mpp6 strain were 
analysed in parallel. TAP- and zz- fusion proteins were detected using the PAP antibody. An 
antiserum against Pgk1 served as a loading control. (B) Quantification of relative levels of Mpp6 
protein expression from western blot analysis. Data is representative of three independent 
experiments. Relative expression levels of Mpp6 proteins are normalised for Pgk1 expression 
values and standardised to levels in the Mpp6-TAP strain. Error bars represent the standard error 
of the mean for each set of values. 
! 212!
hree non-functional mpp6 mutants were identified from the random mutagenesis 
screen that encodes extended proteins. These arise from mutations in the natural 
stop codon and encode an additional peptide sequence of 18 amino acids. Each 
mutant differs in the nature of the stop-codon mutation (X187W, X187Q, X187Y) 
yet encodes the same 18 residue extension. The X187Y mutant was omitted from 
further investigation due to an additional F115S mutation in the sequence.  
Western blot analysis of strains expressing extended Mpp6 proteins reveals a 
considerable loss of protein expression in comparison to wildtype zz-Mpp6 levels 
(Figure 5.16. A, compare lanes 2 and 3-4). Expression levels of X187W and 
X187Q proteins are reduced to 29% and 6% respectively in comparison to 
wildtype zz-Mpp6. These expression levels are also below steady state levels of 
endogenous Mpp6 (compare lanes 1 and 3-4). It is interesting to note that the 
X187Q mutation causes a stronger destabilisation of protein expression in 
comparison to the X187W mutant. These values were consistent in independently 
prepared samples. These data suggest that short C-terminal extensions 
destabilise Mpp6 proteins resulting in reduced expression levels. It is unsure if 
loss-of function phenotypes are observed due to the reduced protein expression 
or that the peptide extension interferes with protein function. Curiously, strains 
bearing C-terminally tagged Mpp6 alleles produce functional proteins. In Section 
5.2.11 the endogenous RRP6 allele is disrupted in an MPP6-TAP strain and the 
resulting transformant is viable. As rrp6∆ mpp6∆ double mutants are synthetic 
lethal, taken together this shows that the C-terminally TAP-tagged Mpp6 protein is 
functional in vivo. Therefore, loss of function in the X187W and X187Q mutants 
can be attributed to either a reduced protein expression or the specific nature of 
the 18-residue extension.  
 
Taken together, analysis of steady state protein expression in mpp6 mutants 
shows that single amino acid substitutions do not significantly affect stable protein 
expression. As zz-Mpp6 mutant proteins are overexpressed in comparison to 
endogenous Mpp6 levels, it can be assumed that loss of function phenotypes are 
not due to reduced protein levels but due to a loss of essential protein function. 
Additionally, truncated and extended non-functional proteins show decreased 
expression levels in comparison to wildtype zz-Mpp6. Loss of function in C-
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terminal truncation mutants is likely due to the absence of regions critical to 
protein function. Additionally, a loss of normal peptide sequence may result in 
protein mis-folding and prevent possible interactions with either RNA or proteins. 
Curiously, short C-terminal peptide extensions results in destabilisation of Mpp6 
proteins. This indicates that the distal C-terminal region is required for the stability 
of the protein either by cis-interactions to maintain tertiary conformation or trans-
interactions with other proteins to form quaternary structure.  
 
5.2.9. Using the DECOID approach to analyse mpp6 mutants.  
 
Loss-of function mpp6 mutants were generated through a random mutagenesis 
approach to identify regions of Mpp6 that are critical to function. Sequencing data 
revealed the nature of mutations and protein analyses showed that most mutants 
encoded in zz-Mpp6 fusion constructs are expressed equal or greater than levels 
of endogenous Mpp6 proteins. In Chapters 3 and 4, it was identified that Mpp6 
and the Rrp6/Rrp47 complex function in redundant RNA surveillance pathways. 
Loss of function mpp6 alleles are synthetic lethal with rrp6∆ or rrp47∆ alleles. A 
conditional system was used to investigate the effects of mpp6 mutations on RNA 
surveillance pathways. Initially, a GAL-regulated Mpp6 expression construct was 
generated to make a conditional GAL::mpp6 rrp47∆ double mutant. However, 
control of Mpp6 expression could not be tightly regulated and strains were viable 
in non-permissive glucose- based media (data not shown). Chapter 3 described a 
novel method of separating protein complexes in vivo by the overexpression of 
one of the interacting domains of either protein. This novel method is called 
DECOID (decreased expression of complexes by overexpression of interacting 
domains). Rrp6 and Rrp47 interact physically via their respective N-terminal 
PMC2NT and Sas10/C1D domains. Overexpression of the N-terminal PMC2NT 
domain of Rrp6 (Rrp6NT) allowed the successful segregation of the Rrp6/Rrp47 
complex in vivo by titrating Rrp47 from Rrp6 (Garland et al., 2013). Segregation of 
Rrp47 from Rrp6 was tolerated in mpp6∆ strains suggesting that Rrp47 retained 
function when divorced from the exonuclease and exosome-binding domains of 
Rrp6. Separation of a Rrp47∆C protein, expressing the N-terminal Sas10/C1D 
domain, from Rrp6 was not tolerated in mpp6∆ strains resulting in a block to cell 
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growth. RNA analyses of conditional mpp6 rrp47 mutants show a global loss of 
RNA surveillance pathways resulting in the accumulation of RNA degradation 
targets including CUTs, pre-rRNA processing byproducts and aberrant forms of 
stable ncRNAs. The DECOID approach was used as a conditional system to 
induce loss of Rrp6/Rrp47 function in strains harboring mpp6 mutants to analyse 
their phenotypic effects on RNA surveillance.  
 
Plasmids were recovered from strains bearing mpp6 mutations originally identified 
in the 5’FOA screen described in Section 5.2.1. However, these strains harbored 
LEU2 plasmids encoding mpp6 mutant alleles and an URA3 maintenance plasmid 
bearing a wildtype MPP6 allele. The maintenance plasmid was required for 
complementation of the mpp6∆ rrp47∆ synthetic lethal genetic background. 
Normal plasmid extraction from yeast involves DNA isolation followed by recovery 
of plasmid DNA using E. coli (Robzyk and Kassir, 1992). However, initial attempts 
proved to be unsuccessful and DNA preps were unable to transform competent 
E. coli cells. This procedure was vastly improved upon the use of a commercial kit 
to isolate plasmid DNA from yeast cells (Section 2.2.20) and plasmids were 
successfully recovered in E. coli. However, recovered DNA was a mixture of LEU2 
plasmids encoding mpp6 mutants and URA3 plasmids encoding a wildtype MPP6 
allele and required time-consuming downstream screening to isolate the LEU2 
plasmids. To overcome this issue, heterogeneous plasmid DNA isolated from 
yeast strains was used to transform competent KC8 E. coli cells (Clontech). The 
KC8 strain bears leuB, trpC, pryR and hisB auxotrophic mutations that can be 
complemented by LEU2, TRP1, URA3 and HIS3 yeast alleles (Struhl et al., 1979). 
Transformed KC8 E. coli cells were selected for growth on M9 minimal media 
plates lacking leucine to only select for cells harboring LEU2 plasmids. This only 
allowed the isolation of LEU2 plasmids bearing mutated mpp6 alleles and 
prevented contamination by the URA3 maintenance plasmid.  
 
Centromeric yeast plasmids bearing mpp6 alleles were transformed into an 
mpp6∆ rrp47∆ strain complemented by a HIS3 plasmid bearing an rrp47∆C allele. 
As shown in Section 3.2.3 and 3.2.7, the rrp47∆C allele is sufficient for 
complementation of the mpp6∆ rrp47∆ synthetic lethality and Rrp47∆C proteins  
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are stable in the absence of Mpp6. Resulting transformants were transformed with 
a 2µ plasmid that encodes a GAL-inducible GST-Rrp6NT fusion protein (Stead et 
al., 2007). Conditional overexpression of Rrp6NT allows the segregation of 
Rrp47∆C from Rrp6. Combined with loss of function mpp6 mutations; this 
induces synthetic lethality and results in a strong growth defect. Strains were 
assayed for growth on glucose and galactose plates to validate the assay (Figure 
5.17). Mutations causing loss of function showed slow growth phenotypes upon 
induction of the GST-Rrp6NT protein equivalent to strains transformed with an 
empty vector. Yeast cells bearing functional copies of Mpp6 such as E146K, 
N33D and L63P, permitted growth on galactose media comparable to strains 
bearing wildtype MPP6 alleles.  
 
Strains bearing mpp6 truncation and extensions mutations showed similar effects 
on growth upon induction of the Rrp6NT protein (Figure 5.18). K169X and D130X 
mutations were previously shown to be functional in a plasmid shuffle assay 
(Section 5.2.7) and permitted growth on galactose medium comparable to the 
wildtype MPP6 complemented strain. All non-functional truncation and extension 
mutants showed slow growth phenotypes upon Rrp6NT induction. The F115-fs 
mutant showed slightly improved growth compared to other non-functional 
mutants, yet was much slower compared to K169X and D130X mutants (Figure 
5.18).  
 
DECOID growth analysis of strains bearing mutations in conserved regions of 
Mpp6 showed an equivalent growth pattern observed in the functionality assay 
(Section 5.2.6. Figure 5.10) All conserved motif mutants showed slow growth 
phenotypes upon induction of Rrp6NT with the F20_M21 mutant displaying the 
strongest effect (Figure 5.19)  
 
These results corroborate previous growth analyses and are consistent with loss 
of growth phenotypes observed in mpp6∆ rrp47∆C mutants upon GST-Rrp6NT 
expression. The DECOID technique to separate Rrp47∆C proteins from Rrp6 
complexes successfully works as a conditional system to induce loss of functional 
Rrp6/Rrp47 complexes in vivo.  
! 219!
5.2.10. RNA analyses of mpp6 mutants 
 
The DECOID approach allows a conditional system to induce destabilisation of 
functional Rrp6/Rrp47 complexes in vivo. In wildtype cells, separation of Rrp47 
and Rrp47∆C proteins from Rrp6 is tolerated and mild RNA processing and 
surveillance phenotypes are observed. Segregation of Rrp47∆C proteins in strains 
lacking Mpp6 results in a block in growth and cells exhibit a widespread loss of 
RNA surveillance. This suggests that Rrp6/Rrp47 and Mpp6 function in redundant 
RNA surveillance pathways and loss of both mechanisms results in loss-of growth 
phenotypes. Using this technique in strains harboring mpp6 mutants allows 
characterisation of specific mutations in order to map functional regions of the 
protein.  
 
Yeast mpp6∆ rrp47∆C GAL::GST-rrp6NT strains harboring plasmids encoding 
mpp6 mutants (as described in Section 5.2.9) were harvested in selective 
raffinose- based minimal media and after five doublings of cell density following 
transfer to galactose- based minimal media. In parallel, cells from GAL::GST-rrp6NT 
and mpp6∆ rrp47∆C GAL::GST-rrp6NT strains transformed with a wildtype zz-
Mpp6 construct or an empty vector were harvested as described above. Samples 
of 5µg total RNA were fractionated through denaturing acrylamide gels and 
analysed by northern blot hybridisation. Blots were probed for RNAs shown to 
accumulate in conditional mpp6 rrp47 mutants including NEL025c cryptic 
unstable transcripts (CUTs), the 5’ external transcribed spacer (5’ETS), truncated 
fragments of 5S rRNA U3 snoRNA and site II extended snoRNAs (II-pA). 
Hybridisation of NEL025c CUTs appears as a homogenous smear on blots 
transferred from an 8% polyacrylamide gel and cross-hybridises with high 
molecular weight RNAs. To aid the detection of CUTs, separate acrylamide gels 
were loaded with 10 µg RNA and fractionated for 1.5 x longer than normal before 
analysis by northern blot hybridisation. Under non-permissive conditions, upon 
Rrp6NT induction, mpp6∆ rrp47∆C GAL::GST-rrp6NT strains transformed with an 
empty vector show strong RNA surveillance phenotypes as described in detail in 
Chapter 3 (Figure 5.20. A-C lane 4). However, equivalent strains bearing a plasmid 
encoding wildtype zz-Mpp6 show virtually no phenotype upon Rrp6NT induction  
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(Figures 5.20. A-C lane 6). These control samples act as standards for either 
complete loss of function or no loss of function respectively. This allows a 
comparable measure to determine if mpp6 mutations cause phenotypes 
equivalent to a total loss of Mpp6 function or show milder effects.  
 
RNA analysis of mpp6 mutants bearing single or double amino acid substitutions 
were grouped together to examine if the phenotypes of double mutants are the 
result of one single mutation or have a cumulative effect (Figures 5.20 A-B) 
M18_E146K and N33D_L63P double mutants showed a strong accumulation of 
NEL025c, 5’ETS, U3*, 5S* and II-pA (U14) upon induction of Rrp6NT comparable 
to the null mpp6 mutant (Figure 5.20. A. compare lanes 4 with 12 and 18). 
Analyzing the separated point mutations shows mild phenotypes in M18I and 
N33D mutants and weaker phenotypes in E146K and L63P mutants. This 
suggests that M18I and N33D mutations are the main contributors to loss of 
function in their respective double mutants but their effects are exacerbated in 
combination with E146K and L63P substitutions respectively. Interestingly some 
mutants displayed specific phenotypes: The N33D mutant showed a strong 
accumulation of site II terminated snoRNAs comparable to the null mutant (Figure 
5.20 A compare lanes 4 and 14). However, this mutant showed a relatively weak 
CUTs phenotype and almost undetectable levels of the aberrant truncated U3* 
snoRNA. All mutants in Figure 5.20 showed a detectable amount of 5’ETS and 
5S* transcripts upon Rrp6NT induction. However, as these species are derived 
from pre-rRNA and 5S rRNA species respectively, their relative abundance will be 
much greater in comparison to other analysed transcripts.  
Hybridisation analysis of the S42P_Y66H double mutant and separated single 
mutants shows that the Y66H mutation has the greater effect in the pair. 
Curiously, the Y66H single mutation shows a stronger accumulation of NEL025c 
CUTs, aberrant U3* and snR13* transcripts in comparison to the double mutant 
(Figure 5.20 B compare lanes 10 and 12).  Y66 is mildly conserved in fungal Mpp6 
homologs (Appendix II) and not conserved in homologues in model organisms 
(Appendix I) however; these results suggest the residue is important for Mpp6 
function in vivo. The D43N mutant shows relatively weak RNA surveillance 
phenotypes upon Rrp6NT expression in comparison to a N5D_D43N double 
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mutant (Figure 5.20 B compare lanes 14 and 16). The N5D mutation was not 
separated by SDM because it was assumed be causing loss-of function 
phenotypes due to the proximity to the N-terminal conserved motif in Mpp6. In 
hindsight, it would be interesting to investigate this mutant in isolation.  
V15D and K145R were identified as single amino acid substitutions that cause a 
loss of function. RNA analyses show comparable phenotypes upon Rrp6NT 
induction in comparison to the mpp6∆ mutant (Figure 5.20 C compare lanes 8 
and 10 with 4). Specifically, the K145 mutant shows comparable accumulations of 
NEL025c CUTs, 5’ETS, U3* and II-pA (U14) whereas the V15D mutant shows 
slightly milder phenotypes with the possible exception of 5S*. As mentioned 
previously, due to the higher levels of 5S rRNA, the 5S* phenotype may appear to 
be more distinct in comparison to transcripts that are weakly expressed.  
R14S_M16T and V15A_N118S double mutants show comparable CUT and 
aberrant ncRNA accumulations. These mutants share substitutions in a highly 
conserved N-terminal domain motif in Mpp6 that appears to be a critical region for 
protein function.  
 
Taken together, analysis of mpp6 mutants encoding full-length proteins identifies 
critical regions for protein function. Firstly, mutations in a highly conserved N-
terminal motif cause loss of function or slow growth phenotypes in combination 
with rrp47 mutants. RNA analyses show that this region is important for the 
function of Mpp6 in RNA surveillance pathways. Loss of function proteins show an 
accumulation of RNA substrates normally targeted for degradation in wildtype 
cells. Mutational analysis has also identified residues between N33 and Y66 that 
also seem important for Mpp6 function in vivo. This region is not conserved in 
Mpp6 homologues found in model organisms. However, N33, S42, D43 and L63 
residues are relatively well conserved when comparing fungal homologues 
suggesting that this region may be functionally important in other yeast species.  
 
RNA analysis using DECOID was carried out in strains harboring mpp6 mutants 
bearing alanine substitutions in conserved residues. These analyses corroborate 
results described above. Mutations in the highly conserved N-terminal motif were 
previously shown to cause slow growth phenotypes in combination with rrp47∆  
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alleles. Northern blot hybridisation analysis revealed that these strains accumulate 
RNA surveillance targets including CUTs, 5’ETS and aberrant ncRNAs  (Figure 
5.21 lanes 8-12). Additionally, a triple mutant bearing substitutions in a second 
conserved motif revealed similar phenotypes suggesting that both regions are 
important for normal Mpp6 function (Figure 5.21 lane 14). Mutations in the N-
terminal motif but not the second, more distal motif were identified in loss-of 
function mutants isolated by random mutagenesis.  
 
Finally, mpp6 mutants encoding truncated or extended Mpp6 proteins were 
analysed using DECOID as a tool to induce Rrp6/Rrp47 destabilisation as 
described above. In Section 5.2.7,  Mpp6 proteins bearing K169X and D130X 
mutations were shown to be functional in vivo using a plasmid shuffle assay and 
were also included in this RNA analysis. All mutants bearing C-terminal truncations 
or extensions showed an accumulation of the 5’ external transcribed spacer 
region (5’ETS) (Figure 5.22). This fragment is a byproduct of 35S pre-rRNA 
maturation and is usually degraded by the exosome in wildtype cells. The 
accumulation of 5’ETS in all truncated and extended mutants suggests that the C-
terminus of Mpp6 is important in normal 5’ETS turnover. Mutants encoding Mpp6 
proteins truncated at D130 and shorter showed a strong accumulation of 
NEL025c cryptic unstable transcripts comparable to conditional mpp6∆ rrp47 
strains (Figure 5.22 compare lanes 4 with 10-18). Additionally, X187W-fs and 
X187Q-fs mutations, encoding extended Mpp6 proteins showed an accumulation 
of CUTs with X187Q-fs mutant displaying a stronger phenotype (Figure 5.22 
Lanes 19-22). Accumulations of aberrant ncRNA species were observed in 
truncation and extension mutants including U3* and 5S* truncated transcripts. 
Consistent with previous observations, an accumulation of box C/D snoRNAs 
terminated at the failsafe site-II (Grzechnik and Kufel, 2008) was detected in non-
functional mpp6 mutants. A mild accumulation of II-pA (U14) was observed in 
K169X and D130X mutants but not to the extent of loss-of function mutants 
(Compare lanes 7-10 with 11-18).  
 
Consistent with conditional mpp6∆ rrp47 mutant strains explored in Chapter 3, 
loss-of function mpp6 mutants display a block in RNA surveillance pathways when  
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Figure 5.22. RNA analysis of mpp6 truncation and extension mutants using DECOID. Northern blot 
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Total RNA was fractionated on denaturing polyacrylamide gels and analysed by northern blot 
hybridisation using radiolabelled oligonucleotide probes as indicated (left of panels). Asterisks (*) 
denote truncated transcripts. Dispersed bands labeled I-pA and II-pA correspond with pre-snoRNAs 
that are polyadenylated at termination sites I or II respectively. SCR1 was used a loading control. 
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combined with conditional rrp47 mutants. Cells accumulate transcripts that 
usually undergo rapid turnover in wildtype cells such as CUTs and aberrant 
ncRNAs. This study has characterised a number of loss-of function mpp6 mutants 
and identified functionally important regions of the Mpp6 protein (Summarised in 
Figures 5.23). However, it is still not known how Mpp6 functions with the nuclear 
exosome in RNA surveillance pathways and what proteins/complexes it may 
contact.  
 
5.2.11. Mpp6 expression is decreased in the absence of Rrp6 or Trf4 
 
Mutational studies and RNA analysis have shown that Mpp6 is required for RNA 
surveillance and degradation pathways involving the nuclear exosome. 
Additionally, functional pathways involving Mpp6 are redundant with pathways 
requiring functional Rrp6 and Rrp47. In the absence of both pathways, cells 
accumulate a wide range of aberrant RNA species and stabilise cryptic unstable 
transcripts (CUTs). Many of the RNA species shown to accumulate in conditional 
rrp47 mpp6 mutants have been previously characterised in exosome mutants. 
Specifically, nuclear exosome surveillance pathways have been shown to require 
the function of the Trf4/Air2/Mtr4 polyadenylation (TRAMP) complex (Houseley et 
al., 2006; Wolin et al., 2012). The TRAMP complex targets RNAs for degradation 
by the nuclear exosome by the addition of short poly(A) tails (~ 4-5 nt) which are 
suggested to enhance the activity of the exosome by providing a more favorable 
single stranded RNA substrate. The complex is typically composed of a non-
canonical poly(A) polymerase Trf4 or Trf5, a zinc-knuckle RNA binding protein Air1 
or Air2 and the ATP-dependent 3’-5’ helicase Mtr4. The helicase action of Mtr4 is 
predicted to function in unwinding of structured RNA substrates, such as 5’ETS, 
to aid in recognition by the exosome. Many RNA surveillance targets detected in 
northern hybridisation analysis of mpp6 mutants are known substrates for the 
TRAMP complex. Transcriptional termination of CUTs is dependent on the activity 
of the Nrd1/Nab3/Sen1 (NNS) complex that recruits the TRAMP complex for 
subsequent polyadenylation prior to rapid degradation by the nuclear exosome 
(Wolin et al., 2012). Yeast trf4∆ cells accumulate non-polyadenylated CUTs (Wyers 
et al., 2005). Additionally, truncated forms of stable ncRNAs such as a 5’-
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truncated form of 5S rRNA (5S*) have been shown to accumulate in trf4 mutants 
(Kadaba et al., 2006).  
 
Mpp6 has previously been proposed to function by stimulating the activity of 
Rrp44, possibly by substrate recognition/recruitment through RNA binding activity 
(Milligan et al., 2008). This was inferred as mpp6∆ mutations are synthetic lethal 
with rrp47∆ or rrp6∆ alleles, suggesting that Mpp6 and Rrp47 do not both 
function to target substrates to Rrp6. An alternative model is that Mpp6 promotes 
functional coupling between Rrp6 and the TRAMP complex (Butler and Mitchell, 
2011). This is supported by a physical interaction observed between human 
homologs of Mpp6, Rrp6 and Mtr4 (MPP6, PM-Scl100 and hMtr4 respectively) 
(Schilders et al., 2007). Additionally, mpp6∆ mutations are synthetic lethal with 
air1∆ alleles (Milligan et al., 2008).  
 
To investigate possible functional and/or physical interactions between Mpp6 and 
TRAMP components, a C-terminal TAP-tagged MPP6 allele was transposed into 
isogenic strains lacking TRAMP components or Rrp6. Previous analysis of the 
Rrp6/Rrp47 heterodimer revealed that the stability of either protein was 
dependent on their physical interaction, with Rrp47 more sensitive to the loss of 
Rrp6 (Feigenbutz et al., 2013a, 2013b). Deletions in TRAMP components and 
Rrp6 were used as a method to possibly identify proteins that interact physically 
with Mpp6 and are required for protein stability in vivo.  
 
A C-terminally TAP tagged MPP6 allele was amplified from yeast genomic DNA by 
PCR using outlying primers (o595 + o598). PCR products were validated by 
agarose gel electrophoresis and purified using commercial PCR clean up kits. The 
MPP6-TAP cassette fragment contains sufficient regions of homology to target to 
MPP6 loci and also included a HIS3 selectable marker (Ghaemmaghami et al., 
2003). Isogenic rrp6∆, trf4∆, trf5∆ and air1∆ strains were transformed with purified 
MPP6-TAP, HIS3 DNA and selected on minimal medium lacking histidine. 
Transformants were screened for successful integration by PCR using outlying 
MPP6 primers (o595 + o598). Lysates were prepared from isogenic wildtype,  
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Figure 5.24. Stable expression of Mpp6 is dependent on Rrp6 or Trf4. Western blot analysis 
of Mpp6-TAP expression in rrp6 and TRAMP mutants. The MPP6-TAP allele was transposed 
into isogenic wildtype (WT), rrp6∆, trf4∆, trf5∆ and air1∆ strains. (A) Lysates were fractionated 
by SDS PAGE and the expression of Mpp6 proteins were analysed by western blot using the 
PAP antibody (upper panel). An antiserum against Pgk1 was used as a loading control (lower 
panel). (B) Quantitative analysis of of relative Mpp6-TAP protein expression. Data is 
representative of three independent experiments. Values were normalised against Pgk1 levels 
and standardised to the amount of protein in wild-type cells. Error bars represent the 
standard error of the mean for each set of values. 
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rrp6∆, trf4∆, trf5∆ and air1∆ strains bearing MPP6-TAP alleles and analysed by 
SDS PAGE and western blot analysis using the PAP antibody (Figure 5.24. A).  
 
Steady state expression levels of Mpp6 were decreased to 34 % and 32 % in 
rrp6∆ and trf4∆ strains in comparison to wildtype cells (compare lanes 1-3). These 
values were consistent upon independent analysis of biological replicas. 
Interestingly, levels of Mpp6 were unchanged in cells lacking Trf5 or Air1 in 
comparison to wildtype levels (compare lanes 1 with 4-5). This suggests that both 
Rrp6 and Trf4 are required for stable expression of Mpp6.  
 
The non-canonical poly(A) polymerases Trf4 and Trf5 form distinct TRAMP 
complexes (TRAMP4 and TRAMP5 respectively) which have been reported to 
target distinct groups of RNAs for degradation with some functional overlap 
(Egecioglu et al., 2006; San Paolo et al., 2009). TRAMP4 complexes contain either 
Air1 or Air2 proteins whereas TRAMP5 complexes exclusively contain Air1 
(Houseley and Tollervey, 2006; LaCava et al., 2005). These results suggest a 
possible functional and/or physical link between Mpp6, Rrp6 and the TRAMP 
complex, specifically TRAMP4.  
 
Mpp6 has previously been reported to physically associate with the nuclear 
exosome through pull-down analyses and shown to cosediment with core-
exosome components in glycerol gradient ultracentrifugation experiments (Milligan 
et al., 2008). However, the physical contacts between Mpp6 and the core-
exosome complex are unknown. Interactions could either be direct or via another 
associated protein. To investigate interactions with exosome-containing 
complexes, the sedimentation of Mpp6 proteins were analysed in rrp6∆ and 
TRAMP mutants described above.  
 
Native cell lysates prepared from isogenic wildtype, rrp6∆, trf4∆, trf5∆ and air1∆ 
strains expressing Mpp6-TAP proteins were fractionated by ultracentrifugation 
through glycerol gradients and the sedimentation behavior of Mpp6 was visualised 
by western blot analysis (Figure 5.25. A). Colloidal staining of fractions separated 
by SDS PAGE was used to validate the distribution of total cellular protein profiles 
and were comparable in each gradient (Figure 5.25. B). Additionally, lysates from  
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Figure 5.25. The association of Mpp6 with larger complexes is destabilised in the 
absence of Rrp6. Glycerol gradient ultracentrifugation analysis of Mpp6-TAP proteins 
expressed in rrp6 and TRAMP mutants. Lysates from isogenic wildtype, rrp6∆, trf4∆, 
trf5∆ and air1∆ strains expressing Mpp6-TAP proteins were sedimented through 10 – 
30% glycerol gradients. Lysate from a Rrp44-TAP strain was sedimented in parallel. (A) 
Gradient fractions 1-18 were resolved by SDS PAGE and analysed by (A) western 
blotting using the PAP antibody and (B) coomassie staining (overleaf). 
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cells expressing C-terminally TAP tagged Rrp44 were fractionated in parallel as a 
marker for the sedimentation profile of nuclear exosome complexes. The 
sedimentation behavior of Mpp6 in wildtype cells clearly displays that the protein is 
found in large complexes. The distribution of sedimentation showed a peak in 
fractions 15-17 and exhibited clear overlaps with the sedimentation profile of 
Rrp44. This corroborates previous analyses in which Mpp6 showed 
cosedimentation with the core-exosome subunit Rrp43 (Milligan et al., 2008). 
Analysis of the sedimentation of Mpp6 in rrp6∆ strains reveals that the distribution 
of Mpp6-TAP is shifted further to the top of the gradient. Additionally, the protein 
shows a high degree of degradation in fractions 6-12. This pattern was 
reproducible upon repeat glycerol gradient analyses. The shift in sedimentation 
distribution suggests that Rrp6 is partly required for the association of Mpp6 with 
larger complexes. As the protein is still present in fractions 14-18, this implies that 
Mpp6 may form other contacts with the exosome independent of Rrp6. The 
increased degradation pattern of Mpp6 suggests that the protein is less stable in 
the absence of Rrp6. This agrees with the observable decrease in steady state 
protein expression of Mpp6 in rrp6∆ cells.  
Analysis of the sedimentation behavior of Mpp6 in cells lacking Trf4 shows that the 
protein sedimentation retains a similar distribution pattern to the wildtype in 
fractions 12-18 (Figure 5.25). However, no protein is observed in upper fractions 
(4-10). This may be due to relative signal intensities as Mpp6 expression is 
decreased to ~30% in trf4∆ cells. However, another possibility is that the fraction 
of Mpp6 proteins represented in fractions 4-10 corresponds to sub-exosome 
complexes composed of TRAMP complexes associated with Mpp6, specifically 
TRAMP4 complexes. In trf5∆ and air1∆ samples, Mpp6 shows a normal 
distribution profile comparable to wildtype cells.  
 
These results suggest the possibility that Mpp6 is found in two distinct 
subcomplexes and that the connection between these complexes is partially 
dependent on Rrp6. In the absence of Rrp6, Mpp6 expression is decreased to 
~30% of normal steady state levels. Glycerol gradient analysis shows that the 
distribution of Mpp6 sedimentation shifts from larger complexes to moderately 
sized complexes where the protein appears to be less stable. In the absence of 
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Trf4, Mpp6 expression is also decreased to ~30% compared to wildtype cells. 
Glycerol gradient sedimentation shows that Mpp6 is still found in larger complexes 
but is not detected in fractions corresponding to smaller complexes. This 
suggests that Mpp6 may contribute to connections between the TRAMP complex 
and the nuclear exosome. Additionally, Rrp6 may be partially required for the 
association of Mpp6 with the exosome complex that also maintains normal protein 
stability of Mpp6. Interestingly; this interaction appears to be specific for TRAMP4 
complexes as no effect is observed in cells lacking Trf5 or Air1.   
 
 
5.2.12. Glycerol gradient ultracentr i fugation analysis of Mpp6 
mutants.  
 
Section 5.2.11 identified possible connections that mediate the interaction of 
Mpp6 with larger complexes using glycerol gradient ultracentrifugation analyses to 
analyse the sedimentation pattern of tagged-Mpp6 proteins. Additionally, a library 
of mpp6 mutants has been generated through either random or directed 
mutagenesis methods. Using glycerol gradient ultracentrifugation methods, the 
sedimentation behavior of Mpp6 proteins was analysed in mpp6 mutants in order 
to characterise regions of the protein that may be required for interactions with 
larger complexes.  
 
A number of mpp6 mutants identified in the random mutagenesis screen were 
shown to contain amino acid substitutions in a highly conserved motif at the N-
terminus of the protein. Using site directed mutagenesis methods, four mutants 
were previously constructed with alanine substitutions in conserved regions of 
Mpp6 including the N-terminal motif (L11A_S12A_V15A, M18A_K19A and 
F20A_M21A) and a second, more distal motif (G111A_R112A_F115A). Mutations 
were generated in a N-terminal zz-tagged Mpp6 expression construct under the 
control of the RRP4 promoter. Glycerol gradient ultracentrifugation analysis of the 
wildtype zz-Mpp6 construct showed a slightly different distribution profile to that 
observed in cells expressing a C-terminal TAP-tagged Mpp6 protein under the 
control of the endogenous MPP6 promoter (Figure 5.26) In addition to  
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sedimentation in larger complexes in fractions 8-18, a large pool of zz-Mpp6 
protein is found in fractions 1-6. As proteins found in these fractions are generally  
 
not incorporated in complexes, it is inferred that this distribution represents a 
population of Mpp6 proteins that are not part of larger complexes. Due to the 
nature of the zz-Mpp6 construct, these proteins are overexpressed in comparison 
to endogenous Mpp6-TAP proteins under the control of the MPP6 promoter. It is 
presumed that overexpressing Mpp6 generates an excess of the protein that is 
not incorporated into larger complexes.  
 
Lysates prepared from yeast mpp6∆ rrp47∆ strains harboring LEU2 plasmids 
encoding mpp6 mutants and a HIS3 plasmid encoding RRP47 were fractionated 
by ultracentrifugation and the relative distribution of Mpp6 proteins was compared 
using western blot analysis. The mpp6 mutant encoding zz-Mpp6 with 
M18A_K19A substitutions showed a striking loss of sedimentation with larger 
complexes (Figure 5.26) The majority of M18A_K19A proteins were observed in 
fractions from the top of the glycerol gradient corresponding to proteins not 
incorporated into complexes. Upon longer exposures of M18A_K19A western 
blots, trace amounts of proteins are observed in larger fractions yet the majority of 
signal was found in fractions 1-5. Interestingly, alanine substitutions in adjoining 
F20_M21 residues did not have an effect on the distribution of Mpp6 
sedimentation and was comparable to the profile of the wildtype zz-Mpp6 protein. 
This suggests that M18 and/or K19 residues are specifically required for the 
interaction of Mpp6 with larger complexes.  
The profiles of L11A_S12A_V15A and G111A_R112A_F115A mutants show 
weaker signals for larger complexes in fractions 10-18 and a corresponding 
stronger signal in fractions 5-8. This effect is difficult to analyse due to the excess 
of free zz-Mpp6 protein in fractions 1-5. An interpretation could be that M18 
and/or K19 are required for the interaction with larger complexes and these 
interactions are stabilised by residues in L11-V15 and G111-F115 motifs.  
 
In the screen for loss-of function mpp6 mutants, substitutions at the M18 residue 
were observed in a M18I_E146K mutant. Generation of a single M18I mutant was 
shown to complement the mpp6∆ rrp47∆ synthetic lethality yet cells showed a  
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strong growth defect (Section 5.2.5) The sedimentation profiles of single M18I and 
double M18I_E146K mutants were analysed using glycerol gradient 
ultracentrifugation to determine if M18I mutations cause a loss of cosedimentation 
with larger complexes (Figure 5.27) Interestingly both single and double mutants 
showed Mpp6 protein distributions comparable to the wildtype zz-Mpp6 protein 
profile. This suggests that the K19A substitution in M18A_K19A double mutants 
causes the loss of interaction with complexes. Alternatively, the nature of the 
mutation may be responsible for this effect. Methionine and isoleucine residues 
are hydrophobic whereas alanine is generally considered to be a neutral amino 
acid. The differences in amino acid properties may contribute differential effects 
upon substitutions in the same residue.  
The vast majority of mpp6 mutants isolated showed no significant change in 
sedimentation profiles in comparison to the wildtype zz-Mpp6 protein (data not 
shown). However, the distribution of a N33D_L63P double mutant showed a shift 
of sedimentation from larger complexes to moderately sized complexes (Figure 
5.27) This mutant was isolated as non-functional in the random mutagenesis 
screen and sequence analysis showed that amino acid substitutions were found in 
regions of Mpp6 with low conservation. This observation suggests that N33D, 
L63P substitutions or the combined double mutant causes destabilisation of the 
interaction of Mpp6 with larger complexes.  
 
Finally, the sedimentation profile of truncated and extended Mpp6 proteins were 
analysed by glycerol gradient ultracentrifugation. Previous analysis in Section 5.2.7 
showed that K169X and D130X truncations were functional in vivo whereas 
proteins encoding the first 115 residues of Mpp6 or shorter were identified as non-
functional. Glycerol gradient and western blot analyses showed that K169X and 
D130X proteins maintained a similar sedimentation profile as the wildtype protein 
(Figure 5.28) Proteins truncated at residue 88 or shorter (R88X, I73-fs and A60-fs 
mutations) showed a loss of incorporation into larger complexes and were 
predominantly found in fractions 1-5 consistent with un-complexed protein 
distributions. The F115-fs mutant showed protein sedimentation corresponding to 
complex proteins (Fractions 10-18) yet did not have a pool of excess protein in 
lower fraction numbers. The relative expression level of the F115-fs protein is  
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Figure 5.28. C-terminal truncations inhibit the association of Mpp6 with larger complexes. 
Glycerol gradient ultracentrifugation analysis of (A) truncated and (B) extended Mpp6 proteins. 
Strains expressing either wildtype zz-Mpp6 or C-terminal truncation and extension mutants were 
lysed and fractionated through 10 – 30% glycerol gradients. Fractions 1-18 were separated by 
SDS PAGE and analysed by western blotting using the PAP antibody to detect zz-tagged 
proteins. 
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comparable to the levels of endogenously expressed Mpp6-TAP under control of 
the wildtype promoter (Figure 5.15) and protein distribution through glycerol 
gradients matches this accordingly as in Figure 5.25. These results show that the 
first 115 residues of Mpp6 are sufficient for incorporation into larger complexes 
whereas proteins truncated at R88 and shorter remain unincorporated. Loss of 
sedimentation with larger complexes could be attributed to a loss of accessible 
domain features due to misfolding. This is increasingly likely in truncated proteins 
that may be stably expressed but lack structural features found in the 
conformation of full-length proteins. Assuming that Mpp6 is functional in larger 
complexes, loss of function could be due to the loss of incorporation into 
complexes. Analysis of a G111A_R112A_F115A mutant showed a reduced 
distribution of Mpp6 proteins in larger complexes. This agrees with a loss of 
complex incorporation in the R88X mutant that lacks G111-F115 residues. 
Analysis of mutants expressing Mpp6 proteins with short C-terminal extensions 
(X187W-fs and X187Q-fs) revealed distributions in higher fractions (13-18) 
consistent with proteins associated with larger complexes (Figure 5.28 B). This 
suggests that the short peptide extensions do not interfere with normal 
association in larger complexes. Due to the low expression of these mutants, the 
full distribution through gradient fractions was difficult to detect.  
 
These results identify sites within Mpp6 that may contribute to interactions with 
larger protein complexes. The M18A_K19A mutation in a highly conserved region 
of Mpp6 showed a striking loss of sedimentation with larger complexes. Analysis 
of different M18 mutations showed that this effect may be dependent on the 
nature of amino acid substitution or is solely due to the K19A mutation. Isolation of 
K19 mutants would characterise this region more critically. Additionally, mutations 
in a second region of conservation (G111-F115) showed a reduced sedimentation 
of Mpp6 proteins with larger complexes suggesting that this region is also 
important for protein-protein contacts. Finally, mutations in a region of poor 
conservation (N33D_L63P) displayed a shift in Mpp6 sedimentation from larger 
complexes to moderately sized complexes.  
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5.3 Discussion 
 
The exosome complex requires a wide range of auxiliary factors to modulate the 
recognition and fate of transcripts from all known classes of RNA. In the nucleus 
the exosome associates with the small, basic, RNA-binding protein Mpp6. Whilst 
Mpp6 is not essential in yeast, mpp6∆ mutants are synthetic lethal with the loss of 
Rrp6 or Rrp47. Functional redundancy is an inherent feature common to many 
biological systems where multiple pathways exist to perform overlapping 
functions. This ‘genetic buffering’ would provide cells with failsafe mechanisms in 
the failure of one pathway. It was proposed that Mpp6 functions in pathways 
redundant with Rrp6/Rrp47-dependent processes. Consistent with previous 
analyses (Milligan et al., 2008), destabilisation of the Rrp6/Rrp47 complex in mpp6 
mutants resulted in a widespread loss of RNA surveillance and degradation 
pathways (Chapter 3 and Garland et al. 2013). Conditional mpp6 rrp47 mutants 
accumulate a wide range of RNA surveillance targets including cryptic unstable 
transcripts (CUTs), pre-rRNA processing byproducts and aberrant forms of stable 
RNAs.  
 
Although it has been shown that Mpp6 functions in surveillance pathways, little is 
known about the protein itself and what interactions it forms within the network of 
the nuclear exosome complex and associated proteins. Mpp6 lacks any 
characterised domains that are associated with nucleic acid- or protein-binding 
activity. A previous report described two highly conserved motifs found in Mpp6 
homologues in higher eukaryotes (Milligan et al., 2008) but was not investigated. 
Here, a random mutagenesis approach was used to isolate loss-of function mpp6 
mutants in order to map the functional regions of the protein.  
 
A library of mpp6 mutants was generated through in vitro error-prone PCR based 
mutagenesis. Loss of function mutants were initially screened using an mpp6∆ 
rrp47∆ plasmid shuffle assay before analyzing protein expression. The 
mutagenesis screen identified 66 strains bearing non-functional mpp6 alleles. 
Sequence analysis revealed two mpp6 mutants bearing single amino acid 
substitutions (V15D and K145R) along with a larger fraction of mutants with 
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multiple point substitutions. Furthermore, a number of mpp6 mutants bearing 
frameshift mutations were shown to encode truncated and extended proteins.  
 
A high proportion of amino acid substitutions in mpp6 mutants were found in an 
N-terminal region that is highly conversed in Mpp6 homologues. Alanine-scanning 
mutagenesis of conserved motifs showed that these regions are functionally 
important. Glycerol gradient analyses suggest that these regions may be required 
for protein-protein interactions. Specifically, the sedimentation of a M18A_K19A 
mutant showed a striking loss of association with larger complexes in comparison 
to the wildtype protein. Interestingly, an M18I single mutant did not show this 
effect suggesting that either the K19A mutation is critical for complex formation or 
the effect is specific to the amino acid substitution. Isolation of separated M18A 
and K19A single mutations would be interesting to expand these observations.  
 
Sequence analysis of mpp6 mutants revealed a number of mutants encoding 
proteins with double substitutions in residues with weak conservation in 
homologues. To determine the effects of each individual substitution, single point 
mutants were isolated by SDM and were tested for functionality using the mpp6∆ 
rrp47∆ plasmid shuffle assay. Separated point mutations were revealed to be 
functional in vivo suggesting that the action of double mutants had synergistically 
lethal effects on protein function. This was substantiated by RNA analyses of 
single and double mutants.  
 
A loss of RNA surveillance is observed in conditional mpp6 rrp47 mutants 
(Garland et al., 2013; Milligan et al., 2008). The DECOID approach, described in 
Chapter 3, was used as a conditional system to destabilise the Rrp6/Rrp47 
complex by the overexpression of the interacting domain of Rrp6 (Rrp6NT). This 
method was used in mpp6 mutants to analyse levels of RNA surveillance targets. 
Consistent with a loss of Mpp6, using DECOID in cells encoding loss of function 
mpp6 mutations resulted in a strong accumulation of CUTs, aberrant ncRNAs and 
pre-rRNA processing byproducts. All mpp6 mutants displayed phenotypes 
comparable or weaker than those observed in the null mutant. No specific 
phenotypes were attributed to isolated mutants. This suggests that Mpp6 
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functions as a general factor in RNA surveillance pathways rather than in the 
recognition of specific substrates.   
 
The random mutagenesis approach generated a number of mpp6 mutants 
encoding proteins truncated or extended at the C-terminus. Additional mutations 
generated by SDM showed that truncations to D130 were functional in vivo. An 
mpp6 mutant expressing the first 115 residues of Mpp6 was identified as non-
functional. However, the protein also encoded a further 44 amino acids due to a 
frameshift mutation. Therefore, the loss of function may be due to the additional 
foreign peptide sequence. Nevertheless, a R88X mutant was also shown to be 
non-functional which suggests a cut-off point exists between R88 and D130 in 
which the protein no longer functions. This region, which includes a stretch of 
highly conserved residues (G111 - S119), may be required for interactions with 
larger complexes. Cosedimentation analysis showed that the F115-fs mutant was 
found in larger complexes whereas a R88X mutant lost this association. Directed 
alanine substitution mutations in conserved residues in this region (G111-F115) 
resulted in reduced cosedimentation with larger complexes. These proteins were 
still identified in higher complexes suggesting that this conserved region may only 
stabilise more critical interactions from other parts of the protein. Systematic 
directed mutational analysis may help to define this region.  
Curiously, short C-terminal peptide extensions resulting from mutations in the 
natural MPP6 stop codon resulted in a loss of function. Western blot analysis 
showed that these proteins are relatively unstable which suggests that the C-
terminus is crucial for normal protein stability. Interestingly, the destabilisation 
appears to be specific to the nature of the sequence. A strain encoding a C-
terminally tagged Mpp6 protein has been used extensively in other experiments. 
Successful isolation of rrp6∆ MPP6-TAP strains demonstrates that the Mpp6-TAP 
protein is functional in vivo as mpp6∆ rrp6∆ double mutants are synthetic lethal.  
 
The library of mpp6 mutants was generated from a zz-tagged Mpp6 expression 
construct under the control of the RRP4 promoter. As shown in Section 3.2.1, zz-
Mpp6 is expressed ~3-fold higher than endogenous Mpp6-TAP under the control 
of the natural MPP6 promoter. This system has both advantages and limitations 
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for the purposes of these studies. With no Mpp6-specific antibody available, using 
a tagged expression construct allows detection of the fusion protein in western 
blot analyses using commercial antibodies. Additionally, using an overexpression 
system allowed the detection of mpp6 mutants that exhibited reduced levels of 
zz-Mpp6 protein at steady state. However, this system does not represent 
endogenous Mpp6 expression conditions due to the use of a different promoter 
and addition of a stabilising tag. Additionally, the zz-tag may interfere with possible 
protein-protein interactions at the N-terminus of Mpp6. The zz-Mpp6 expression 
construct was able to complement an mpp6∆ rrp47∆ double mutant and is 
therefore functional. However, this does not account for non-essential functions of 
Mpp6 including protein-protein interactions. Furthermore, overexpression of 
mutant Mpp6 proteins may suppress more distinct phenotypes due to increased 
expression. For a more precise analysis of the effects of mpp6 mutations in vivo, it 
would be interesting to integrate isolated mutants into the chromosomal MPP6 
locus. This would allow endogenous expression from the natural promoter and 
may give stronger phenotypes when combined with conditional rrp47 mutations.  
 
In analyzing RNA phenotypes in conditional mpp6 rrp47 mutants, it was noted 
that a large number of accumulated transcripts were also targets of Rrp6 and the 
TRAMP complex. It has previously been proposed that Mpp6 may be involved in 
the functional coupling between Rrp6 and the TRAMP complex (Butler and 
Mitchell, 2011). This is supported by observed physical interactions between the 
human MPP6 protein and PM-Scl100 and hMtr4 (Rrp6 and Mtr4 in yeast) 
(Schilders et al., 2007). By analyzing relative steady state levels of Mpp6 proteins 
in rrp6∆ and TRAMP mutants it was shown that Mpp6 expression is reduced to 
~30% in the absence of Rrp6 or Trf4. Protein stability is often dependent on 
physical interactions with other proteins. For example, the mutual stability of Rrp6 
and Rrp47 is dependent on the physical interaction between their respective N-
terminal domains (Feigenbutz et al., 2013a, 2013b; Stead et al., 2007). Glycerol 
gradient analysis of Mpp6 proteins in rrp6∆ mutants showed a shift in distribution 
from larger complexes to moderately sized complexes with increased amounts of 
protein degradation. In the absence of Trf4, Mpp6 does not co-sediment with 
moderately sized complexes. These results  
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(%)!
RNA surveillance 
phenotype !
(s=strong, m=weak, 
n=none)!
!
!
Association in larger 
complexes!
(✓=yes, ✗ = no, ? = partial, n/a= 
not tested) !
!
!
V15D*! ✗! 82! S! ✓!
M18I*! ✓! 103! W! ✓!
N33D! ✓! 103! W! ✓!
S42P! ✓! 97! W! n/a!
D43N! ✓! 66! N! n/a!
L63P! ✓! 88! W! n/a!
Y66H! ✓! 75! S! n/a!
K145R! ✗! 53! S! ✓!
E146K! ✓! 101! W!
N5D_D43N! ✗! 86! S! n/a!
R14S*_M16T*! ✗! 78! S! ✓!
V15A*_N118S! ✗! 46! W! n/a!
M18I*_E146K! ✗! 98! S! ✓!
N33D_L63P! ✗! 60! S! ?!
S42P_Y66H! ✗! 43! S! n/a!
R127G_F129I! ✗! 63! W! ✓!
L11A*_S12A*_V15A*! ✓! 90! W/S! ?!
M18A*_K19A*! ✓! 92! W/S! ✗!
F20A*_M21A*! ✓! 95! W/S! ✓!
G111A*_R112A*_F115A*! ✓! 98! W/S! ?!
K169X! ✓! 91! N! ✓!
D130X! ✓! 109! W! ✓!
F115-fs! ✗! 43! W/S! ✓!
R88X! ✗! 62! S! ✗!
I73-fs! ✗! 35! S! ✗!
A60-fs! ✗! 12! S! ✗!
X187W! ✗! 28! S! ✓!
X187Q! ✗! 6! S! ✓!
Figure 5.29. Summary of mpp6 mutants and corresponding phenotypes. Mutations are 
separated into groups of single amino acid substitutions, double amino acid substitutions, 
alanine substitutions in conserved motifs and C-terminal truncation and extensions 
according to the schematic in Figure 5.28. Relative protein expression is the average of 
three independent values. RNA surveillance phenotypes are compared to phenotypes 
observed in equivalent mpp6∆ strains. 
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suggest that Mpp6 may associate physically with both the TRAMP complex and 
the exosome and that these interactions are partially mediated through Trf4 and 
Rrp6 respectively. Mpp6 is still found in larger complexes in the absence of Rrp6 
but the association appears to be less stable. This suggests that other factors 
may be involved in this recruitment or that Rrp6 has a more indirect role. It has not 
been possible to observe a direct interaction between Rrp6 and Mpp6 using 
recombinant proteins (data not shown). This suggests that other factors are 
employed.  
 
With a library of functional and non-functional mutants (summarised in Figures 
5.23 and 5.29) it may be possible to identify the regions of Mpp6 that contribute 
to RNA binding. Both yeast and human Mpp6 proteins have been shown to bind 
pyrimidine-rich RNA sequences yet have no characterised nucleic-acid binding 
domains (Milligan et al., 2008; Schilders et al., 2005). Furthermore, it would be 
interesting to see if RNA binding is required for the function of Mpp6 in vivo or if 
Mpp6 simply serves as a bridging protein for various complexes. Analogously, the 
RNA binding properties of Rrp47 are not required for protein function in vivo 
(Costello et al., 2011).  
 
Finally, after initial observations it would be interesting to further analyse the 
interactions between Mpp6, Rrp6 and the TRAMP complex. Mpp6 shows a 
specific sensitivity to the loss of Trf4 over Trf5 that form analogous TRAMP4 and 
TRAMP5 complexes respectively and have been shown to have a specific set of 
RNA targets (San Paolo et al., 2009; Schmidt and Butler, 2013). Mpp6 may 
function in quality control pathways to recruit TRAMP4/Rrp6 complexes to the 
exosome and stimulate the degradation of RNA surveillance targets including 
cryptic unstable transcripts and aberrant ncRNAs.  
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Chapter 6: Conclusions and future studies 
 
This study has focused on the function of the exosome associated co-factors 
Rrp6, Rrp47 and Mpp6, which are involved in RNA processing and degradation 
activities in the nucleus. Whilst these proteins are non-essential, they appear to 
share redundant essential processes. This is highlighted by the synthetic lethality 
observed in double rrp47∆ mpp6∆ and rrp6∆ mpp6∆ mutants. The exosome 
requires a high level of modulation to recognise all known classes of RNA and 
target transcripts for processing or degradation in both the nucleus and 
cytoplasm. It is believed that co-factors play important roles in forming specific 
pathways for RNAs and associated proteins to interact with the exosome. The 
details of how these proteins provide specificity is yet to be elucidated and 
remains a rich source of investigation.   
 
The relationship between Rrp6 and Rrp47 was investigated in Chapters 3 and 4. 
Whilst the catalytic activity and function of Rrp6 has been widely characterised, 
the exact molecular function of Rrp47 has remained elusive. Using the DECOID 
technique to separate Rrp47 from Rrp6, it appears that Rrp47 can function 
independently from Rrp6. However, this Rrp6-independent function requires the 
C-terminus of Rrp47. The results in Chapter 3 support the model that Rrp47 
functions as a substrate adaptor, recognising substrates prior to Rrp6-dependent 
catalysis. This role is dependent on the C-terminus of the Rrp47 that has been 
reported to mediate interactions with RNA and snoRNP proteins Nop56/58 
(Costello et al., 2011). In addition, an interaction between Rrp47 and the NNS 
complex has been observed that is lost upon deletion of the C-terminal domain 
(M. Feigenbutz, P. Mitchell, personal communication). The C-terminus of Rrp47 
requires further investigation to understand how the protein specifically recruits 
substrates prior to Rrp6-dependent catalysis. Previous attempts at identifying in 
vivo RNA targets using the CRAC (cross-linking and analysis of cDNAs) technique 
(Granneman et al., 2009) have been unsuccessful using full length Rrp47 (P. 
Mitchell, personal communication). As RNA binding is not essential to the function 
of Rrp47, it may be of more interest to further investigate protein interactions such 
as Nrd1.  
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Furthermore, the results in Chapter 4 and (Feigenbutz et al., 2013a) suggest that 
Rrp47 functions to maintain normal expression levels of Rrp6. Artificially increasing 
the copy number of Rrp6 was able to suppress the synthetic lethality of rrp47 
mpp6 and rrp47 rex1 double mutants and partially suppress RNA processing and 
degradation phenotypes. Whilst Rrp47 has a key impact on the expression levels 
of Rrp6, it must also perform additional functions as part of the Rrp6/Rrp47 
complex. Overexpressing Rrp6 in rrp47∆ mutants does not fully suppress RNA 
phenotypes consistent with impaired processing and degradation pathways 
(Feigenbutz et al., 2013a). This complements the model that Rrp47 aids in 
substrate recognition and may bridge contacts with other proteins.  
 
The DECOID technique provides a simple method to determine whether proteins 
are functional when physically separated from interactions in complexes. This 
method can be widely applied as a tool to dissect complexes with minimum 
knowledge of the interacting domain within only one of the protein partners. With 
an every increasing wealth of structural biology data, this technique can be used 
to complement in vivo investigations of protein complexes. However, the 
limitations must also be considered. This method relies inducing the expression of 
a ‘decoy’ interaction domain to outcompete the natural interaction between two 
partner proteins. Using a GAL-regulated promoter to overexpress the interaction 
domain will increase the equilibrium in favour of disrupting the intended targets. 
However, the possibility of residual proteins left unaffected cannot be eliminated 
and must be considered. It was shown that ~4% of Rrp47 remained bound to 
Rrp6 upon Rrp6NT induction in pulldown experiments. This shows that the titration 
is efficient but not absolute. The stability of the decoy protein must be considered 
as this process relies on its overexpression.  
Additionally, when investigating the consequences of separating protein 
complexes using the DECOID technique, the possibility of off-target effects must 
be considered. It can be possible that overexpression of a decoy protein may 
interact with or disrupt non-intended targets. In this work, the N-terminal PMC2NT 
domain of Rrp6 (Rrp6NT) has no known role other than to interact with Rrp47. 
Overexpressing GST-Rrp6NT in an rrp47∆ strain showed no effect on growth 
compared to the overexpression of a GST control and RNA analyses showed no 
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discernable effect to processing and degradation phenotypes. Controls as such 
must be introduced to confirm off-target effects of overexpressing decoy proteins.  
 
The DECOID approach can be utilized to disrupt characterised interactions 
between proteins known to associate with the exosome complex. It would be 
interesting to investigate the effects of disrupting EXO9 associated proteins and 
analyse the effects of divorced complexes. Notably Rrp44, Rrp6 and Ski7 all 
interact with the core-exosome complex and have characterised binding domains. 
In the case of Rrp44, it would be of interest to investigate whether the protein can 
function independent of the exosome. It has been proposed that Rrp44 requires 
threading of substrates through the exosome for some processes but can also 
degrade substrates more direct. Disruption of Rrp44 from EXO9 using DECOID 
and subsequent RNA analyses may reveal subsets of transcript targets that 
specifically require exosome-threading.  
A previous study has shown that Rrp6 can function independently from the EXO9 
but used a C-terminal deletion that lacks a characterised exosome-interacting 
region (Callahan and Butler, 2008). However, this may have a negative impact on 
the activity of Rrp44 as it has been shown that Rrp6 interaction with EXO9 
allosterically promotes the catalytic activity of Rrp44 (Wasmuth and Lima, 2012). 
By overexpressing the C-terminus of Rrp6 (Rrp6CT), this should disrupt Rrp6 from 
the core-exosome whilst maintaining any allosteric effects of Rrp6CT binding to 
EXO9.  
Further studies using the DECOID method will develop the technique whilst 
addressing key experimental questions involving the exosome and associated 
proteins.  
 
RNA analyses of conditional rrp47 mpp6 and rrp47 rex1 mutants have revealed 
distinct phenotypes that hint the basis of synthetic lethality of the double mutants. 
In Chapters 3-5 and previous studies, Mpp6 and the Rrp6/Rrp47 complex 
function in redundant RNA degradation pathways to remove transcripts targeted 
for discard. Extensive RNA analysis was carried out using northern blot 
hybridisation. However this technique is restricted to analyzing RNAs with 
complementary probes available in the lab. With the advent of next generation 
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sequencing technologies, RNA-seq transcriptome analyses can be used to 
investigate a more global dataset. It would be of interest to analyse the RNA from 
the conditional mutants used in Chapter 3. Comparing the data from mpp6 
rrp47∆C and rex1∆ rrp47∆C after GST or GST-Rrp6NT induction would reveal RNA 
substrates that are inefficiently degraded or processed due to the loss of 
functional redundant pathways. More interestingly, a global RNA analysis may 
reveal the basis of synthetic lethality in rrp47 rex1 mutants, as this was not 
obvious from the northern analyses in this study.  
 
Chapter 5 employed a mutagenesis strategy to define the functional regions of the 
exosome-associated co-factor Mpp6. It is accepted that Mpp6 functions in RNA 
degradation pathways that are redundant with Rrp6/Rrp47, the molecular basis of 
this function is still unknown. With a library of non-functional mutants, this will aid 
further analyses of Mpp6.  
Previous studies reported that Mpp6 can bind RNA with a preference for 
unstructured RNAs such as poly(U) (Milligan et al., 2008). The RNA binding activity 
of Mpp6 was not thoroughly investigated during this study but would be of interest 
to see if it was required for protein function. Mpp6 shares many features with 
Rrp47 as both proteins are small, basic and have a lysine-rich C-terminus. 
Interestingly, the RNA binding activity of Rrp47 is not essential to protein function 
(Costello et al., 2011). The ability of Mpp6 mutants to bind RNA could be assayed 
in a recombinant protein system using poly(U)-agarose affinity resins. Initial studies 
have shown that recombinant GB1-tagged Mpp6 is able to bind poly(U)-agarose 
whereas a GB1 control could not (data not shown). An alternative method would 
be to use an in vitro transcription/translation system to generate radiolabelled 
protein from PCR-generated DNA and assay for the ability to bind poly(U) RNA-
agarose resin.  
 
Mpp6 has been identified as associated to the nuclear exosome by mass 
spectrometry of purified exosome complexes and through biochemical 
cosedimentation analyses (Milligan et al., 2008). However, the specific physical 
interactions have yet to be shown. Analyses of rrp47 mpp6 mutants show that the 
majority of RNAs that accumulate are known targets of the TRAMP complex. This 
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suggests possible physical interactions between Mpp6, TRAMP and the exosome. 
This is also indicated by the reduced stability of Mpp6 in rrp6∆ and trf4∆ strains 
(Section 5.2.11). The loss of function of mpp6 mutants generated in this study 
may be due to impaired interactions between either TRAMP and/or the exosome. 
This was initially investigated using glycerol gradient ultracentrifugation (Section 
5.2.12) which identified some Mpp6 mutants that no longer co-sedimented with 
larger complexes. These mutations could be combined with tagged exosome or 
TRAMP components and assayed for detection in a pulldown assay.  
 
The library of Mpp6 mutations was created in a zz-Mpp6 expression construct 
under the control of the RRP4 promoter. By using an overexpression system it 
was possible to detect mutant proteins that may otherwise not be detectable by 
western blot analysis. The downside of this method is that the mutants are not 
under the control of the MPP6 promoter and subsequent functional analyses may 
not be indicative of endogenous conditions. For a more comprehensive analysis of 
the effects of mpp6 mutants in vivo, it would be of worth to integrate the alleles 
generated during this study at the MPP6 chromosomal loci. It would also be 
advantageous to integrate these alleles into a C-terminally tagged Mpp6 strain 
(Mpp6-TAP) in order to analyse relative protein expression and for use in pulldown 
experiments.  
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Appendix I. Amino acid sequence alignment of Mpp6 homologues from model 
organisms. Sequences of Mpp6 proteins from Saccharomyces cerevisiae, Homo 
sapiens, Mus musculus, Danio rerio, Drosophila melanogaster, Caenorhabditis elegans, 
Arabidopsis thaliana and Schizosaccharomyces pombe were aligned using Clustal 
Omega (Sievers et al. 2011) and edited using CLC Main Workbench 6 (CLC Bio, Aahus, 
Denmark). Conserved residues are highlighted in red. 


MSANNG - V TG KLSSRVMNMK FMKFG - - - - - - - - K TDDEES SNSNTPSN I N
MAAER - - - K T R LSKNL LRMK FMQRG - - - - - - - LDSE TKKQ LEEEEKK I I S
MASER - - - K T K LSKNL LRMK FMQRG - - - - - - - LDSE TKKQ LEEEERKM I S
MANDG - - - GA K LSKNL LRMK FMQRG - - - - - - - LDAEVKKQ LDEEEKR I I S
MPSKS - - - KP R LSRGV LDMK FMQRT - - - - - - - - KVKVEKE ADDEQSRALY
MTASERVVVK E LSSS L LDMK FMLKKKKQ - - I E TKAAKKKE AKLDQL I TEK
- - - - - - MAKR E I SS T LRNLK FMQRSS - - - - - - LKVEKKKA DEEEP - - - - -
- - - - - - - - - - - MSSK L LSMK FMQRARG I DP KQAEEE LSKN I V TDEHWS LA
SDVEP I EQKG KL FGLDDSAW DLNSYKDDLK K I SGKEKKKV KRVVYK - KRP
EEHWY LDLPE LKEKES F - - - - - I I EEQS F L LCE - - - D L LY GRMS FRGFNP
DEHWY LDLPE LKEKES F - - - - - I VEEQS FS LCE - - - D L LY GRMS FRGFNP
DEHWF LDLPE LKAKENH - - - - - I I EERS FV PCE - - - D LVY GRMS FKGFNP
SN - - E I NQKM LNS TSNF - - - - - V - VESSYS I CA - - - GL I D GRLS FRGMNP
EAEATCS TE I LKSSEPK - - - - - L E I CYDYA KLE - - - N LK F GRLS FGGFNK
- - - - NGS FPS LGTVAKK - - - - - CVV I TDWD PQP - - - GA L L GRMS FQS FNP
GKVDF LPQKM TRNVEYESGY GGL I EENDLE SHSNEPNLVQ GRAS FGL FNK
NL I I SNVGYS E LRKPEGV I S GRK - - - - - - T FGDNSDDSGS RKRKFDEGEQ
EVEKLMLQMN AKHKAEEV - E D - - - - - - - - E TVE LDVSDEE MARRYE T LVG
EVEKLMLQMN SKNRAEAAEE D - - - - - - - - E TVEVDVSDEE MARRYE T LVG
DVEKLML LMN APREEEDEEE EDESM - - - - N KME TD I TDEE MAKRYQS LVE
E LE L LMEQDL AEKQGRTRPE QPK - - - - - - E VSDQDMVKAY YANKAP TVSG
EVE L LMEYYE KLQNGMLSDS DDDGM - - - - D VDDEEMAKS L GGQKLAALDK
S I EK LHEEA I NGGNPSSSSS NGGKK - - - - S FSEPESSKVE PSGE TDGDLK
E LGEENVDEK DVSKNEEVDV NGTK I TD TSE L TERERRKQE LVSKKAEASR
NEDEKRDAKD KE F TGSQDDG EDEYDLDKL F KDS I KKKKTN HNGKNKNRNS
T I GKKFARKR DHANYEEDEN GD I - - - - - - - - - - - - - - T P I KAKKMF LKPQ
T I GKKFVKKR DRANYEEDEN GT I - - - - - - - - - - - - - - KA I KPKKMF LKPQ
SMRKKFAKKR DRSAVSNKED VNC - - - - - - - - - - - NV TDD I RPKRAFMKPQ
SMSKKFNTKK DFKRKQ I GGD SDS - - - - - - - - - - - - - - PHA MKKQY FKKPR
KSQSKRERRQ QNERNEE T TG GRRFN I KD I R KRFAADDVAD APERKFMKPA
RKQSEVVSEE QNRPNKSPRS FDKPSPSNKK GNGFKKPKSK KVDWSV LRPP
KMEVKAPAKE SKKRKVNE LS QDV I S LHSP - - - - - KESNAR KTKKNKNKKK
KK - - -
D - - - -
D - - - -
D - - - -
SGDE -
EDC - -
KPQTK
KKRN -
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Appendix II. Amino acid sequence alignment of Mpp6 orthologs in other 
Saccharomyces species. Sequences of predicted Mpp6 proteins from 
Saccharomyces cerevisiae, Saccharomyces paradoxus, Saccharomyces 
mikatae, Saccharomyces bayanus and Saccharomyces castellii were aligned 
using Clustal Omega (Sievers et al. 2011) and edited using CLC Main 
Workbench 6 (CLC Bio, Aahus, Denmark). Conserved residues are 
highlighted in red. 
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MSANNGV TGK LSSRVMNMKF MKFGKTDDEE SSNSNTPSN I NSDVEP I EQK GKL FGLDDSA
MS TNNGV TGK LSSRVMNMKF MKFGKTDDEE SSNSNTPS I I NSDVESNEQR EKL FGRDNSA
MSANNGV TGK LSSRVMNMKF MKFGRTDDDE SSNSNTPSNT NSDVES TEQK RKL FGRDNSE
MSSNNGV TGK LSSRVMNMKF MKFMKNDDDE SSNSNT TSNA NSDTES TEQK RKQFGRDKSE
M - - - - - - - - - - - - - - - - - K F SRNNNNNDEE NTSDSRESS I NNNDE TSN - - - KN F - RDNSE
WDLNSYKDDL KK I SGKEKKK VKRVVYKKRP NL I I SNVGYS E LRKP - EGV I SGRKT FGDNS
WDLNSYSDDV KK I SGKQKKK MRKVVYKKRP HL I I SNVGYS E LRKP - EGVM NGRKV FGDNP
WDLNNYNDDV KQ I LGKEKKK VKKV I YKKRH HL I VSNVGYS E LRKS - DGV I SGRKT FGDDT
WDLNSCNDDV KGDTGKEKKK VKKL I YKKRP HP I VSNVGYS E LRKS - EGL I TGRKT FGSSA
WKLEPNT TP I K - - - GKKV I R I KKKNQLRSH PNV I QDVG I T Y I QSN LNNA I MGRQT I RDDK
DDSGSRKRKF DEGEQNEDEK RDAKD - - - - K E F TGSQDDGE DEYDLDKL FK DS I KKKKTNH
ND I GSRKRKL EESEQNEEGK SDAKD - - - - K E F TGSQEEGE DEYDLDKL FK DS I KKKKT TH
GDTNSKKRKL EENEQDEEER SDV - - - - - - - - - TGNQDKGE DEYDLDKL FK NSNKKRKNTQ
DEANPKKRKL EEGEQEEEGE EEGKGYKSKN EAAGKQDEGE DDYDLDKL FK DS TKKKMTNQ
E TENEKDNKE NENENQEHTK RP - - - - - - - - - - - - RDDEPE DDYDLDK I FK ESMSKNKHNN
NGKNKNRNSK K
NTKNKNGNSK Q
NSKNKNKN - K K
VKKPKKKKSK Q
KKQKKNKYKN K
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Rrp47 functions in RNA surveillance and stable RNA
processing when divorced from the exoribonuclease
and exosome-binding domains of Rrp6
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ABSTRACT
The eukaryotic exosome exoribonuclease Rrp6 forms a complex with Rrp47 that functions in nuclear RNA quality control
mechanisms, the degradation of cryptic unstable transcripts (CUTs), and in the 3′ end maturation of stable RNAs. Stable
expression of Rrp47 is dependent upon its interaction with the N-terminal domain of Rrp6 (Rrp6NT). To address the function of
Rrp47 independently of Rrp6, we developed a DECOID (decreased expression of complexes by overexpression of interacting
domains) strategy to resolve the Rrp6/Rrp47 complex in vivo and employed mpp6Δ and rex1Δ mutants that are synthetic lethal
with loss-of-function rrp47 mutants. Strikingly, Rrp47 was able to function in mpp6Δ and rex1Δ mutants when separated from
the catalytic and exosome-binding domains of Rrp6, whereas a truncated Rrp47 protein lacking its C-terminal region caused a
block in cell growth. Northern analyses of the conditional mutants revealed a specific block in the 3′ maturation of box C/D
snoRNAs in the rex1 rrp47 mutant and widespread inhibition of Rrp6-mediated RNA surveillance processes in the mpp6 rrp47
mutant. In contrast, growth analyses and RNA northern blot hybridization analyses showed no effect on the rrp47Δ mutant
upon overexpression of the Rrp6NT domain. These findings demonstrate that Rrp47 and Rrp6 have resolvable functions in
Rrp6-mediated RNA surveillance and processing pathways. In addition, this study reveals a redundant requirement for Rrp6 or
Rex1 in snoRNA maturation and demonstrates the effective use of the DECOID strategy for the resolution and functional
analysis of protein complexes.
Keywords: RNA surveillance; RNA processing; yeast; synthetic lethality; protein overexpression; exosome
INTRODUCTION
The degradation of RNA is a fundamentally important bio-
logical process. Firstly, cellular RNAs are typically generated
by the accurate, limited degradation of larger precursor mol-
ecules. RNA fragments released through such processing re-
actions are also subjected to degradation. In addition, mRNA
transcripts have defined functional lifetimes and are degrad-
ed in a temporally controlled manner. Furthermore, both
mRNAs and noncoding RNAs are subjected to quality con-
trol systems that eliminate incorrectly processed transcripts
or misassembled ribonucleoprotein particles (Houseley and
Tollervey 2009; Wolin et al. 2012). A significant proportion
of transcripts are degraded by such “RNA surveillance” pro-
cesses, even in normally growing, healthy cells (Gudipati et al.
2012). Finally, low level antisense and inter-genic transcrip-
tion generates a large number of noncoding RNAs, many
of which are subjected to rapid degradation (Wyers et al.
2005).
A major source of 3′→5′ ribonucleolytic activity in eukary-
otic cells is the exosome ribonuclease complex (Mitchell et al.
1997; Allmang et al. 1999b). The exosome functions in both
the limited trimming of RNA precursors in RNA processing
pathways and in the complete destruction of RNAs as part of
RNA surveillance mechanisms, the removal of RNA frag-
ments generated during RNA processing, and the elimination
of transiently expressed, cryptic unstable transcripts (CUTs)
(Chlebowski et al. 2013). The core of the eukaryotic exosome
is itself catalytically inert, ribonuclease activity being provid-
ed by two additional associated proteins; Rrp44 (also known
as Dis3) is bound to the base of the core, while Rrp6 is asso-
ciated with the cap region (Bonneau et al. 2009; Makino et al.
2013). Rrp44 is a member of the RNase II family of exoribo-
nucleases that also has an N-terminal PIN domain with asso-
ciated endonucleolytic activity and is found tightly associated
with the core exosome in both the nucleus and cytoplasmic
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regions. Rrp6 is an RNase D-related 3′→5′ exoribonuclease
(Burkard and Butler 2000) that contains an N-terminal
PMC2NT domain, a “DEDD” catalytic domain, an HRDC
domain, and a C-terminal region that is required for interac-
tion with the exosome complex. A C-terminal truncation of
Rrp6 that prevents its stable association with the exosome
does not inhibit Rrp6-dependent processes (Callahan and
Butler 2008), suggesting that Rrp6 can function largely inde-
pendently of its association with the exosome.
The activity of the nuclear exosome is dependent upon ad-
ditional proteins or complexes, including the Trf/Air/Mtr4
polyadenylation complex TRAMP, the Nrd1/Nab3/Sen1
complex, and the nuclear RNA-binding proteins Rrp47
(also known as Lrp1) and Mpp6 (Chlebowski et al. 2013).
The Nrd1/Nab3/Sen1 complex functions in the transcrip-
tion termination of short RNA polymerase II transcripts
(Steinmetz et al. 2001), copurifies together with RNA poly-
merase II and exosomes in large transcription/processing
complexes, and promotes exosome-mediated degradation
of transcripts containing Nrd1/Nab3 binding sites (Vasiljeva
and Buratowski 2006). TRAMP promotes Nrd1/Nab3-de-
pendent transcription termination of snoRNAs (Grzechnik
and Kufel 2008) and adds poly(A) tails onto RNA substrates,
which promotes their subsequent degradation (LaCava et al.
2005; Vanacova et al. 2005;Wyers et al. 2005). Rrp47 interacts
directly with Rrp6 and functions specifically to promote
Rrp6-mediated processes (Mitchell et al. 2003; Peng et al.
2003). In contrast, the exosome-associated protein Mpp6
has been proposed to function as an Rrp44-specific cofactor
(Milligan et al. 2008).
Functional redundancy is a common feature of biological
systems. Yeast rrp6 and rrp44mutants have synergistic pheno-
types, and both Rrp6 and Rrp44 function in the processing of
stable RNAs, in RNA surveillance pathways, and in the degra-
dation of CUTs (Gudipati et al. 2012; Schneider et al. 2012).
Redundancy between Rrp6 and an Mpp6-stimulated activity,
presumably that of Rrp44, is supported by the synthetic lethal-
ity observed for rrp6Δmpp6Δ and rrp47Δmpp6Δ double mu-
tants (Milligan et al. 2008). Yeast rrp6Δ and rrp47Δ mutants
are also synthetic lethal with loss-of-function mutations in
REX1/RNA82 (van Hoof et al. 2000a; Peng et al. 2003), a
gene that encodes another RNase D-related 3′→5′ exoribo-
nuclease (Ozanick et al. 2009) that is not physically associat-
ed with the exosome. Like rrp6 mutants, rex1 strains are
defective in the 3′ end maturation of stable RNAs and accu-
mulate polyadenylated RNAs (Piper et al. 1983; van Hoof
et al. 2000a).
Rrp6 and Rrp47 interact directly through their N-terminal
PMC2NT and Sas10/C1D domains, respectively, and normal
Rrp47 expression levels are strongly dependent upon this
interaction. In contrast, Rrp6 expression and nuclear localiza-
tion are not significantly affected in the rrp47Δmutant (Stead
et al. 2007; Feigenbutz et al. 2013). Both Rrp47 and the ho-
mologous human protein C1D show nucleic acid binding
activity in vitro, with a specificity for structured substrates
(Schilders et al. 2007; Stead et al. 2007). Notably, purified
recombinant Rrp6 exonuclease shows poor processivity
through structured RNA (Burkard and Butler 2000; Liu
et al. 2006). This led to the proposal that Rrp47 may promote
the Rrp6-mediated degradation of structured RNA. However,
Rrp6 lacking the PMC2NT domain shows comparable exo-
nucleolytic activity to the full-length protein on the substrates
tested in vitro (Assenholt et al. 2008; Wasmuth and Lima
2012). Furthermore, the N-terminal Sas10/C1D domain is
able to complement the synthetic lethality of an rrp47Δ
rex1Δmutant but is itself insufficient for the RNA-binding ac-
tivity of Rrp47 (Costello et al. 2011).
In these studies, we sought to address whether the physi-
cal association of Rrp47 with the Rrp6 exonuclease is criti-
cal for its function in RNA processing and degradation.
Demonstration that Rrp6 and Rrp47 can function when the
proteins are divorced would provide prima facie evidence
that Rrp47 functions in substrate recognition or activation,
before catalysis. Rrp47 stability is dependent upon its interac-
tion with the Rrp6NT domain (Feigenbutz et al. 2013). We
therefore used an overexpression system to induce expres-
sion of the Rrp6NT domain and titrate Rrp47 out of Rrp6
complexes. We refer to this approach as DECOID (decreased
expression of complexes by overexpression of interacting
domains).
Our results reveal that Rrp47 is functional as a full-length
protein when separated from the catalytic and exosome-
binding domains of Rrp6 but that its ability to function is
lost upon deletion of the C-terminal region of the protein.
This region of Rrp47 has previously been shown to be re-
quired for its interaction with the snoRNP proteins Nop56
and Nop58 and for binding to RNA (Costello et al. 2011).
Genetic assays and Northern analyses show that the resolved
Rrp6/Rrp47 complex functions in the processing or degrada-
tion of all Rrp6 substrates tested. Intriguingly, conditional
rrp47 rex1 mutants showed a specific defect in snoRNA pro-
duction, while rrp47 mpp6 mutants were blocked in RNA
turnover pathways. These findings are consistent with a func-
tion for Rrp47 in the recognition of most, if not all, substrates
prior to RNA processing or degradation by Rrp6.
RESULTS AND DISCUSSION
Overexpression of the Rrp6NT domain segregates
Rrp47 from full-length Rrp6
To determine whether Rrp47 could be titrated out of com-
plexes containing full-length Rrp6 by overexpression of the
Rrp6NT domain, a yeast strain expressing an Rrp47-GFP fu-
sion protein from its own promoter (Feigenbutz et al.
2013) was transformed with plasmids that encode either a
GAL-inducible GST-Rrp6NT fusion protein or just the GST
domain. Lysates from cells grown in galactose-based medium
were fractionated by ultracentrifugation through glycerol gra-
dients, and the sedimentation behavior of Rrp47 was
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compared to the total cellular protein profiles and to protein
markers that were resolved in parallel gradients.
In control cells expressing GST, Rrp47 sedimented as part
of a moderately sized complex with a sedimentation coeffi-
cient between that of BSA (4.6 S) and catalase (11.3 S) (Fig.
1A). A similar distribution of Rrp47, with a peak in fraction
7, was observed in lysates from nontransformed cells grown
in glucose-based minimal medium (data not shown). GST
sedimented in a distinct region of the gradient from Rrp47-
GFP, being observed in fractions 3 and 4. Upon overexpres-
sion of GST-Rrp6NT, Rrp47 exhibited a slower sedimentation
rate, and the two proteins showed a clear overlap, with a peak
in fraction 5 (Fig. 1A). The observed shift in sedimentation
profile for Rrp47 upon induction of GST-Rrp6NT was sup-
ported by completely reproducible protein patterns of these
gradient fractions upon SDS-PAGE analyses.
To determine whether the observed cosedimentation of
GST-Rrp6NT and Rrp47 reflects an interaction between these
two proteins, GST pull-down assays were performed on ly-
sates from strains expressing an Rrp47-zz fusion protein
from its own promoter (Mitchell et al. 2003) after induction
of GST-Rrp6NT overexpression. Parallel assays were also per-
formed on strains expressing C-terminal TAP-tagged fusion
proteins of Rrp6 or the core exosome subunit Csl4, both ex-
pressed from their own promoter. The pull-down data shown
in Figure 1B clearly demonstrate that Rrp47, but not full-
length Rrp6 or Csl4, is associated with the induced GST-
Rrp6NT protein (Fig. 1B). We have previously shown that
no interaction is observed between Rrp47-zz and GST (see
also Fig. 1A; Stead et al. 2007). Depletion of Rrp47-zz and
GST-Rrp6NT from the cell lysates upon incubation with glu-
tathione sepharose beads occurred at comparable efficiencies
(cf. the band intensities for Rrp47-zz and GST-Rrp6NT in Fig.
1B, lanes 1–3), suggesting that the majority of Rrp47 is asso-
ciated with the GST fusion protein.
We then determined whether Rrp47 could still be detected
in complexeswith Rrp6 upon overexpression ofGST-Rrp6NT.
GSTor theGST-Rrp6NT proteinwas induced in an rrp47-GFP
rrp6Δ strain expressing a plasmid-encoded zz-Rrp6 fusion
protein, and Rrp6 complexes were captured in IgG pull-
down assays. We have previously shown that the zz-Rrp6
fusion protein, which is expressed from the RRP4 pro-
moter in this construct (Allmang et al. 1999b), is expressed
at a level comparable to that of the Rrp6-TAP fusion protein
(Stead et al. 2007). To reduce the degree of Rrp6 proteolysis
observed during pull-down reactions, Rrp6 complexes were
initially enriched from whole cell lysates by ion exchange
chromatography using SP-sepharose beads (Allmang et al.
1999b). IgG pull-down assays were performed on both the
flow-through and eluate fractions obtained by ion exchange
chromatography, and Western analyses were performed
on equivalent aliquots of the cell extracts, flow-through, and
eluate fractions.
Western analyses revealed that Rrp47 efficiently copurified
with Rrp6 from lysates of strains overexpressing the GST pro-
tein (Fig. 1C; cf. “nonbound” lanes 2 and 3 with “bound”
lanes 4 and 5), demonstrating that Rrp47 and Rrp6 remained
stably associated under the experimental conditions used in
the pull-down assay. In contrast, the interaction between
Rrp47 and endogenous Rrp6was barely detectable upon over-
expression of the GST-Rrp6NT fusion protein (Fig. 1C; cf.
lanes 7 and 8 with 9 and 10). A significantly higher level of
FIGURE 1. Rrp6NT induction leads to disruption of the Rrp6/Rrp47
complex. (A) Glycerol gradient analyses of extracts from strains express-
ing epitope-tagged Rrp47-GFP after induction of GST-Rrp6NT or GST.
Gradient fractions 1–18 were resolved by SDS-PAGE and analyzed by
Western blotting. Bovine serum albumin (BSA), ovalbumin (OVA),
and catalase (CA) markers were resolved in a parallel gradient and frac-
tions analyzed by SDS-PAGE; molecular weight markers (masses
indicated in kDa) are resolved in lane M. (B) Pull-down analysis of
Rrp47-zz, Rrp6-TAP, and Csl4-TAP fusion proteins with GST-
Rrp6NT. The upper panel shows a Western analysis of Rrp47-zz, Rrp6-
TAP, and Csl4-TAP proteins in equivalent aliquots of the cell extract, su-
pernatant, and pull-down fractions. The lower panel shows a subsequent
Western analysis of the same blot using a GST antibody. Asterisks indi-
cate bands due to residual signal from the initial Western. (C) Pull-
down analysis of Rrp47-GFP binding to zz-Rrp6 upon induction of
either GST or GST-Rrp6NT. Cell extracts were initially resolved into
“flow-through” and “eluate” fractions by SP sepharose chromatography.
Both fractions were then incubated with IgG-sepharose beads, giving
“bound” and “nonbound” fractions. Equivalent aliquots of each fraction
were then analyzed by Western blotting for the presence of Rrp47-GFP
(upper panel), Pgk1 (center panel), and zz-Rrp6 (lower panel). Asterisks
in the center panel indicate bands due to residual signal from the Rrp47-
GFP Western.
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expression of Rrp47-GFP was observed in the cells expressing
GST-Rrp6NT, presumably because the increased availability of
this domain serves to stabilize Rrp47 (Feigenbutz et al. 2013).
Comparison of the amount of Rrp47 present in the Rrp6 pull-
down samples upon induction of GST or GST-Rrp6NT was
therefore standardized to the expression level of Pgk1 in the
cell extracts. Pgk1 is clearly visible as the major band in the
cell extract and the SP sepharose flow-through fractions in
the center panel of Figure 1C and is absent from the upper
panel. Quantitative analyses revealed that the amount of
Rrp47 associated with Rrp6 upon overexpression of GST-
Rrp6NT was ∼4% of that observed upon overexpression of
GST. Comparable amounts of Rrp6 protein were observed
in the pull-downs in both samples (Fig. 1C, lower panel; cf.
lanes 4 and 5 with 9 and 10). Taken together, the data from
glycerol gradient analyses and pull-down experiments dem-
onstrate that Rrp47 is effectively titrated out of full-length
Rrp6-containing complexes upon overexpression of the
Rrp6NT “decoy” domain.
Rrp47 is functional when physically segregated from
the catalytic and exosome-binding domains of Rrp6
To test genetically whether Rrp47 can function when physi-
cally separated from full-length Rrp6, mpp6Δ and rex1Δmu-
tants were transformed with plasmids expressing either GST
or GST-Rrp6NT from the GAL promoter, and the resultant
transformants were assayed for growth on glucose- and galac-
tose-based media. Isogenic wild-type and rrp47Δ strains were
also transformed with the same plasmids and assayed in par-
allel. Strikingly, transformants of bothmpp6Δ and rex1Δmu-
tants expressing GST-Rrp6NT were viable on galactose-based
medium. We then compared the growth rates of transform-
ants expressing either GST or GST-Rrp6NT during incubation
in galactose-based medium. There was only a very slight
decrease in growth rate seen in the wild-type strain upon in-
duction of the GST-Rrp6NT protein. In contrast, mpp6Δ
and rex1Δ strains overexpressing GST-Rrp6NT clearly grew
slower than transformants overexpressing the GST domain
(Fig. 2A).No detectable differencewas observed in the growth
rate of transformants of the rrp47Δ mutant, demonstrating
that induction of the GST-Rrp6NT domain does not elicit an
Rrp47-independent dominant negative growth phenotype.
Plasmid shuffle assays showed that overexpression of GST-
Rrp6NT in itself did not suppress the synthetic lethality of
the mpp6Δ rrp47Δ double mutant (data not shown). These
analyses demonstrate that the function of Rrp47 is impaired,
but nevertheless not blocked, when Rrp47 is segregated from
full-length Rrp6.
To address the nature of the slow growth phenotypes in
mpp6Δ and rex1Δ strains observed upon induction of GST-
Rrp6NT expression, Northern analyses were performed on
RNA isolated from transformants of a wild-type strain and
from rrp47Δ, mpp6Δ, or rex1Δ mutants (Fig. 2B). RNA pro-
cessing and degradation phenotypes were observed upon in-
duction of GST-Rrp6NT in the wild-type strain that are
similar in nature to those observed in rrp47Δ mutants
(Mitchell et al. 2003; Costello et al. 2011) but considerably
weaker, consistent with a mild inhibition of Rrp47 function
in wild-type cells upon segregation of Rrp47 from full-length
Rrp6 (Fig. 2B; cf. lanes 1–3). Specifically, induction of GST-
Rrp6NT in the wild-type strain led to a detectable accumula-
tion of the “5.8S + 30” rRNA processing intermediate and 3′
extended forms of the snoRNA snR38, a modest accumula-
tion of the excised RNA polymerase I 5′ external transcribed
spacer (5′ ETS) fragment, and the accumulation of extended
FIGURE 2. Growth rate and RNA analyses of mpp6Δ and rex1Δ mu-
tants upon Rrp6NT induction. (A) Growth rate analyses of wild-type,
rrp47Δ, mpp6Δ, and rex1Δ strains after induction of GST or GST-
Rrp6NT. Cultures were grown in galactose-based minimal medium at
30°C and maintained in early exponential growth by dilution with
pre-warmed medium. The increase in OD600 is expressed as log2 values.
All plotted lines of best fit have Rf values greater than 0.98. (B) Lanes 1–
8, acrylamide gel Northern analyses of RNA from wild-type, rrp47Δ,
mpp6Δ, or rex1Δ strains expressing either GST (−) or GST-Rrp6NT
(+). RNA was isolated from cultures grown in selective galatose-based
medium. Lanes 9–12, Northern analyses of RNA from a rex1Δ mutant
and from a rex1Δ rrp47Δ mutant expressing either the full-length
RRP47 gene, the rrp47ΔC allele, or the rrp47I162X allele. RNA was isolat-
ed from cultures grown in glucose-based selective minimal medium.
The blot was successively hybridized with probes complementary to
the RNA species indicated. Identical hybridizations and exposure times
are shown for lanes 1–8 and 9–12.
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forms and shorter degradation intermediates of U6 snRNA
(the degradation product is denoted U6∗ in Fig. 2B). A dis-
crete, truncated 5S rRNA fragment was observed (also labeled
with an asterisk in Fig. 2B) that was not detected with a probe
complementary to the 3′ terminus and, hence, is shortened
from the 3′ end; a similarly sized, 3′ truncated 5S rRNA deg-
radation fragment has previously been reported in rrp44,
rrp6Δ, and trf4mutants and is proposed to reflect anRNA sur-
veillance substrate (Kadaba et al. 2006; Callahan and Butler
2008).
In contrast to the wild-type strain, induction of GST-
Rrp6NT expression in the rrp47Δ strain had no significant dis-
cernible effect. Thus, GST-Rrp6NT expression induced no
detectable Rrp47-independent “off-target” effects in either
growth rate or the RNA processing and degradation pathways
analyzed.
Notably, induction of GST-Rrp6NT in the mpp6Δ mutant
caused a greater accumulation of the truncated 5S rRNA
and the 5′ ETS fragment than was observed in the rrp47Δmu-
tant, while the 3′ end maturation of 5.8S rRNA was only
modestly affected (Fig. 2B; cf. lanes 4–6). This strain also ac-
cumulated the U6 snRNA degradation fragments seen in the
rrp47Δ mutant. Furthermore, hybridization with a probe
against the box C/D snoRNA snR38 revealed a specific accu-
mulation of the longest extended forms seen in the rrp47Δ
mutant. Overexpression of GST-Rrp6NT in the rex1Δmutant
largely caused the modest defects observed in the wild-type
strain. However, there was a specific accumulation of extend-
ed snR38 and snR50 RNAs (Fig. 2B; data not shown).
The data shown in Figures 1 and 2 strongly supports the
conclusion that Rrp47 is able to function effectively in Rrp6-
dependent RNA processing and degradation pathways when
the two proteins are physically uncoupled from one another.
We cannot formally eliminate the possibility that the small
fraction of Rrp47 that remains associated with full-length
Rrp6 upon GST-Rrp6NT induction is sufficient for Rrp47
function. However, further analyses with an rrp47mutant de-
tailed belowprovide additional support forour interpretation.
These data also suggest that Rrp47 and Mpp6 function in re-
dundant pathways that largely target RNA for degradation,
while Rex1 and Rrp47 are required for redundant pathways
that mediate productive processing of snoRNA.
The C-terminal region of Rrp47 is critical for its function
when segregated from the catalytic and exosome-
binding domains of Rrp6
As noted above, expression of the N-terminal Sas10/C1D
domain of Rrp47 complements the synthetic lethality of
rex1Δ rrp47Δ strains (Costello et al. 2011). We performed
Northern analyses on RNA from a rex1Δ rrp47ΔC strain,
which encodes essentially only the Sas10/C1D domain of
Rrp47, and from a rex1Δ rrp47I162X mutant, which encodes
a mutant Rrp47 protein lacking a cluster of basic residues at
theC terminus of the protein that is required for RNAbinding
activity in vitro (Costello et al. 2011). The rex1Δ rrp47ΔC dou-
ble mutant, but not the rex1Δ rrp47I162X double mutant or
either rex1Δ or rrp47Δ single mutants, showed a strong accu-
mulation of a heterogeneous population of snR38 molecules
with short 3′ extensions (Fig. 2B, lane 11). Again, similar re-
sults were observed for snR50 (data not shown). Thus, either
FIGURE 3. (Legend on next page)
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segregation of Rrp47 from full-length Rrp6 or deletion of the
C-terminal region of Rrp47 causes a specific defect in snoRNA
3′ end maturation in the rex1Δ mutant.
The observation that similar snoRNA processing defects
are observed in rex1Δmutants expressing the rrp47ΔCmutant
or upon GST-Rrp6NT induction suggested that the C-termi-
nal region of Rrp47 may be important for the function of
the protein when it is segregated from full-length Rrp6. To
test this hypothesis, a rex1Δ rrp47ΔC double mutant was
transformed with plasmids encoding GAL-regulated GST or
GST-Rrp6NT, and the transformants were assayed for growth
on glucose- and galactose-based medium. Strikingly, induc-
tion of GST-Rrp6NT in the rex1Δ rrp47ΔC mutant caused a
strong block in growth, while a transformant harboring plas-
mids encoding GAL-regulated GST grew on both glucose-
and galactose-based medium (Fig. 3C). A plasmid shuffle as-
say demonstrated that the rrp47ΔC allele also complements
the synthetic lethality of the mpp6Δ rrp47Δ double mutant
(Fig. 3A). Similarly, mpp6Δ rrp47ΔC mutants transformed
with a plasmid encodingGAL-regulatedGST-Rrp6NT showed
growth inhibition on galactose-based medium, while the
transformant expressing GST grew on both glucose- and ga-
lactose-based medium (Fig. 3B).
Since the Rrp47ΔC protein is functional when expressed in
a complex with Rrp6 (Costello et al. 2011), these data argue
against the interpretation that the residual Rrp47/Rrp6 com-
plex upon GST-Rrp6NT induction is sufficient for growth.
Based on previous work (Costello et al. 2011), we envisage
that the C-terminal region of Rrp47 engages with RNP
substrates of Rrp6 through contacts with protein and/or
RNA and promotes their subsequent processing or degrada-
tion, even when Rrp47 is divorced from catalytically active
Rrp6.
A caveat to this model is that the truncated Rrp47ΔC pro-
tein is stably expressed when associated with the GST-Rrp6NT
protein. We generated TAP-tagged alleles of full-length
Rrp47 and the C-terminal truncated mutant and compared
their expression levels in rrp6Δ mutants before and after in-
duction of GST-Rrp6NT protein or the GST control (Fig.
3F). As previously observed (Feigenbutz et al. 2013), expres-
sion of full-length Rrp47 was increased in the rrp6Δ mutant
upon expression of the Rrp6NT fusion protein. In contrast, no
difference in the Rrp47 expression level was observed upon
induction of GST. Importantly, expression of the Rrp47ΔC
mutant was increased upon expression of GST-Rrp6NT pro-
tein in a comparable manner to that observed for the full-
length protein.
Since rrp6Δ mutants express very low levels of Rrp47
(Feigenbutz et al. 2013), it is formally possible that the synthet-
ic lethality observed in rrp6Δmpp6Δ and rrp6Δ rex1Δmutants
is due to the lack of Rrp47 protein rather than a requirement
for Rrp6. We, therefore, tested whether expression of the
Rrp6NTdomainwas sufficient to complement the synthetic le-
thality ofmpp6Δ rrp6Δ and rex1Δ rrp6Δmutants, using a plas-
mid shuffle assay. No complementation was observed upon
transformation with a plasmid encoding only the N-terminal
region of Rrp6 (Fig. 3, panels D and E). Moreover, the rrp6-1
mutation also failed to allow growth of the plasmid shuffle
strain on 5-FOAmedium, whereas complementation was ob-
served for the wild-type RRP6 gene. Thus, separable activities
provided by both Rrp47 and Rrp6 are required in the absence
of Mpp6 or Rex1.
Processing and degradation defects in rrp47 mpp6
and rrp47 rex1 mutants
To determine the basis of the loss-of-growth phenotypes
upon induction of GST-Rrp6NT in the mpp6Δ rrp47ΔC and
rex1Δ rrp47ΔC mutants, changes in the levels of specific
RNAs upon transfer from raffinose-based medium to galac-
tose-based medium were assayed by Northern blot hybrid-
ization. The analyzed strains also harbored a high-copy-
number plasmid encoding the well-characterized NEL025c
gene (Wyers et al. 2005; Arigo et al. 2006b); a previous study
has shown that plasmid-based expression of the NEL025c
gene recapitulates the expression and degradation pattern
of the chromosomal transcripts (Thiebaut et al. 2006). Con-
trol strains expressing GST were harvested during growth
in raffinose- and galactose-based medium and analyzed in
parallel.
Thempp6Δ rrp47ΔCmutant showed slowed growth before
the fourth doubling after induction of the Rrp6NT domain.
Northern hybridization analyses revealed a dramatic accumu-
lation of the NEL025c CUT well before this time-point, with
the length of the CUT becoming less heterogeneous and
shorter after the onset of slow growth (Fig. 4, lanes 4–10).
The IGS1-R CUT from the inter-genic region of the rDNA re-
peat (Houseley et al. 2007; Vasiljeva et al. 2008) also accumu-
lated upon transfer to galactose-based medium, with a strong
increase at later time-points. Thempp6Δ rrp47ΔCmutant also
FIGURE 3. Full-length Rrp47, but not the Rrp47ΔC mutant, is func-
tional when divorced from the catalytic and exosome-binding domains
of Rrp6. (A–E) Plate growth assays of yeast strains on permissive glu-
cose-based medium (Glc, left-hand side) and on galactose-based medi-
um (Gal) or medium containing 5-FOA (Glc + FOA) (right-hand
side). Relevant genotypes of the yeast strains are indicated on the right.
(A) Plasmid shuffle assay for complementation of the mpp6Δ rrp47Δ
strain by the rrp47ΔC allele. (B) Growth of the mpp6Δ rrp47ΔC strain
bearing a plasmid encoding either GAL-regulated GST or GST-
Rrp6NT. (C) Growth of the rex1Δ rrp47ΔC strain bearing a plasmid en-
coding either GAL-regulated GST or GST-Rrp6NT. (D) Plasmid shuffle
assay for complementation of thempp6Δ rrp6Δmutant by the rrp6-1 al-
lele or expression of Rrp6NT domain. (E) Plasmid shuffle assay for com-
plementation of the rex1Δ rrp6Δmutant by the rrp6-1 allele or expression
of Rrp6NT domain. (F) Western analysis of Rrp47 and Rrp47ΔC protein
expression. Yeast rrp6Δ rrp47Δ strains harboring plasmids expressing C-
terminal TAP-tagged fusion proteins of wild-type Rrp47, or the C-termi-
nal truncationmutant and the galactose-inducible GST, or GST-Rrp6NT
proteins were lysed under denaturing conditions and analyzed by SDS-
PAGE/Western blotting. Rrp47 and Rrp47ΔC fusion proteins were de-
tected with the PAP antibody (upper panel). An antiserum against
Sba1 was used as a loading control on the same blot (lower panel).
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showed defects in the degradation of the 5′ ETS fragment and
truncated fragments of 5S, snR13, U3, and U6 at early time-
points (Fig. 4; data not shown; truncated 5S and snR13 species
are denoted with asterisks in Fig. 4).
Transcription termination of snoRNA genes occurs at a
proximal Nrd1-dependent site I and a more distal, “fail-
safe” mRNA 3′ processing site II (Steinmetz and Brow 2003;
Steinmetz et al. 2006). In rrp6Δ mutants, heterogeneous 3′
extended forms of snR13, U14, and snR50 accumulate due
to polyadenylation after termination at both sites I and II
(Allmang et al. 1999a; van Hoof et al. 2000b; Grzechnik and
Kufel 2008), denoted I-pA and II-pA. Hybridization with
probes complementary to the snoRNAs U14, snR13, and
snR50 revealed that the mpp6Δ rrp47ΔC mutant specifically
accumulated snoRNAs before inhibition of growth that corre-
spond in length to transcripts terminating at the distal site II
(Fig. 4; data not shown; denoted II-pA in Fig. 4). The level of
mature snoRNAwas not affected. Aweak accumulation of the
5.8S + 30 fragment equivalent to that seen upon induction in
the presence of full-length Rrp47 was also observed (cf. Figs.
2B and 4). Agarose gelNorthern analyses of thempp6 rrp47ΔC
mutant revealed the accumulation of a range of apparent pre-
rRNA degradation intermediates of diverse sizes upon induc-
tion of the Rrp6NT domain that are not seen in rrp47Δ or
rrp6Δmutants (data not shown). In sum, these data are con-
sistent with the loss of redundant RNA surveillance pathways
upon inactivation of both Rrp47 and Mpp6 (Milligan et al.
2008).
The rex1Δ rrp47ΔC mutant was impeded in growth more
rapidly upon induction of the Rrp6NT domain than the
mpp6Δ rrp47ΔC mutant, with a clear effect within less than
two doublings after transfer to galactose-based medium.
There was no clear defect in the degradation of CUTs or trun-
cated stable RNAs in this mutant, and the defects in the pro-
cessing of the 5.8S + 30 species, U6 processing, or the
degradation of the 5′ ETS fragment were equivalent to those
seen upon induction of the Rrp6NT domain in the rex1Δmu-
tant expressing full-length Rrp47 (see Fig. 2B). In contrast,
there was a striking, rapid depletion of U14, snR13, snR38,
and snR50 snoRNAs and an associated accumulation of
longer, heterogeneous species corresponding in length to
transcripts that are terminated at site I and subsequently poly-
adenylated (Fig. 4, lanes 13–16; data not shown; denoted I-pA
in Fig. 4). These data support the model that normal produc-
tive snoRNA synthesis is mediated by termination at site I fol-
lowed by polyadenylation (Grzechnik and Kufel 2008) and
requires either Rrp6 or Rex1 activity for snoRNA 3′ end mat-
uration. In contrast, fail-safe termination at site II generates
RNAs that can apparently be targeted to exosome-mediated
RNA surveillance by either Rrp6 or an Mpp6-dependent ac-
tivity. The 5S rRNA and dimeric tRNAArg-tRNAAsp process-
ing defects of rex1Δ mutants (Piper et al. 1983; van Hoof
et al. 2000a) were not exacerbated (Fig. 4; data not shown).
Widespread inhibition of the degradation of CUTs and
RNA surveillance substrates may well significantly contribute
to the block in cell growth. In contrast, it is less obvious how
the depletion of snoRNAs could cause rapid growth inhibi-
tion. A small number of snoRNAs are essential for viability
in yeast and function in pre-rRNA processing (Watkins and
Bohnsack 2011). However, agarose gel Northern blot analyses
did not reveal a pre-rRNA processing defect upon Rrp6NT in-
duction in the rex1Δ rrp47ΔC strain, and conditional ribo-
some synthesis mutants are slow-acting because the pre-
FIGURE 4. Northern analyses of conditional rrp47 mpp6 and rrp47
rex1 mutants. RNA was isolated from mpp6Δ rrp47ΔC and rex1Δ
rrp47ΔC mutants expressing GST-Rrp6NT from the GAL promoter.
Cells were harvested during growth in raffinose-basedmedium (lanes la-
beled R) and at each doubling of cell density after transfer to galactose-
based medium (lanes labeled Gal). RNA was also isolated from cells ex-
pressing GAL-regulated GST during growth in raffinose- or galactose-
based medium (lanes 1,2,11, and 12; labeled R or G, respectively).
RNA was resolved through denaturing acrylamide gels and analyzed
by Northern blot hybridization, using probes complementary to the
RNAs indicated. Lanes 1–10, RNA isolated from the mpp6Δ rrp47ΔC
mutant. Lanes 11–16, RNA from the rex1Δ rrp47ΔC mutant. Asterisks
denote truncated fragments of the full-length, mature 5S rRNA, and
snR13. Dispersed bands labeled I-pA and II-pA denote snoRNA precur-
sors that are polyadenylated at termination sites I or II, respectively.
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existing pool of ribosomes must be depleted through growth.
We envisage that a significant accumulation of polyadenylated
snoRNAs or CUTs could lead to the depletion of the free pool
of nuclear poly(A)-binding proteins such as Pab1 and Nab2,
or theNrd1/Nab3 termination complex, and havewidespread
effects on gene expression profiles.
Our data are consistent with the model that Rrp47 func-
tions in the recognition of Rrp6 substrates, prior to RNA
degradation or processing. Rrp47, Rrp6, and the TRAMP
component Trf4 have been proposed to promote Nrd1/
Nab3-dependent transcription termination (Arigo et al.
2006a; Grzechnik and Kufel 2008; Castelnuovo et al. 2013),
in addition to subsequent RNA hydrolysis. We envisage that
the Rrp47/Rrp6NT complex, perhaps in combination with
TRAMP, retains the ability to recognizeNrd1/Nab3-mediated
termination events when separated from full-length Rrp6.
Deletion of the C-terminal region of Rrp47, which is known
to mediate interactions with RNA and RNA-bound proteins
(Costello et al. 2011), would be predicted toweaken this activ-
ity and thereby impede subsequent recognition of RNP sub-
strates by Rrp6. In strains expressing the truncated Rrp47
protein bound to full-length Rrp6, substrate recognition
may be more effective due to contacts between the TRAMP
complex and both Nrd1/Nab3 (Arigo et al. 2006a) and Rrp6
(Callahan and Butler 2010).
TheDECOID approach provides a simplemethod to deter-
mine whether proteins that are normally expressed within a
complex are able to functionwhen resolved fromone another.
Most proteins function as part of larger complexes, and the
majority of proteins are predicted to be significantly overex-
pressed when placed under the control of the GAL promoter.
Use of a neutral N-terminal tag such as GST would general-
ly allow stable expression of individual protein domains.
Application of the technique requires only knowledge of the
interacting domain within one of the partner proteins. It is
of note that we were able to obtain far tighter conditional
growth phenotypes using the DECOID strategy than we ob-
served with GAL::rrp47 rex1Δ and GAL::mpp6 rrp47Δ mu-
tants. Given the accelerating wealth of detailed structural
biology data, DECOID could provide a widely applicable, ad-
ditional approach for the functional dissection of protein
complexes.
MATERIALS AND METHODS
Plasmids
The URA3marker gene in the GAL::rrp6NT construct (p280) (Stead
et al. 2007) was inactivated by restriction digestion with ApaI and
StuI, treatment with Klenow fragment, and religation. Selection of
the resultant plasmid (p601) in yeast was dependent upon the
leu2-dmarker. TheNEL025c genewas amplified fromwild-type yeast
genomic DNA using primers o636 (catggatccatatgctgtctttaagcc) and
o637 (catgtcgacgaacgtaacgacttttcc) and cloned into the 2μURA3 vec-
tor pRS426 (Christianson et al. 1992) after digestionwithBamHI and
SalI, giving p532. TheMPP6ORFanddownstream∼500 ntwere am-
plified from wild-type yeast genomic DNA using primers o597 (acg-
gaattcaatgagtgctaacaatgg) and o598 (cgcaagcttggcgtgcatgagacg) and
cloned in-frame into p44 (Mitchell et al. 1996) by digestion with
EcoRI and HindIII. The resultant plasmid (p593) encodes an N-ter-
minal Mpp6 protein fusion bearing two copies of the z domain of
proteinA from Staphylococcus aureus that is expressed under the con-
trol of the RRP4 promoter and also bears the URA3 marker.
Analogous constructs expressing a functional N-terminal full-length
Rrp6 fusion protein (zz-Rrp6, p263) or rrp6 mutants expressing
only the N-terminal 196 aa residues (Rrp6NT, p287) or expressing
the catalytically inactive D238N mutant (Burkard and Butler 2000)
(p389) have been described (Allmang et al. 1999b; Feigenbutz
et al. 2013). Constructs encoding the full-length Rrp47 protein
(p262) or a C-terminally truncated mutant that encodes the first
120 aa (denoted Rrp47ΔC) (p293) have also been described previ-
ously (Costello et al. 2011). For plasmid shuffle assays, inserts from
RRP6 or RRP47 constructs were transposed into pRS313 (Sikorski
and Hieter 1989), which contains the HIS3 marker. Plasmids ex-
pressing C-terminal TAP-tagged fusion proteins of full-length
Rrp47 or the first 120 aa were generated by homologous recombina-
tion in yeast, as follows. The pRS313-based RRP47 genomic clone
p425 was linearized downstream from the RRP47 ORF by digestion
with SalI and transformed into an rrp6Δ rrp47Δ strain, together with
amplicons generated from pBS1479 (Puig et al. 2001) that comprise
the TAP tag and the downstream TRP1marker into an rrp6Δ rrp47Δ
strain harboring theGAL::rrp6NT construct. PCR was performed us-
ing the reverse primer o879 (tataagcatttttgcatttgtgctctcacatcacctttaatc
tacgactcactataggg) and the forward primer o878 (aaaagtaaaagattgg
ataaagttggaaaaaagaaaggagggaagaagtccatggaaaagagaag) or o877 (cagg
cagagcaagaaaaagctaagaatatcatttccaatgttttggactccatggaaaagagaag) for
the full-length clone (p670) or truncated clone (p671), respectively.
Transformants were isolated on selective medium and screened for
expression of the zz fusion protein by Western analyses. Positive
cloneswere recovered fromyeast and confirmed by sequence analysis
of the ORF/TAP tag junction.
Strains
Strains were grown at 30°C in selective medium comprising 2% glu-
cose, raffinose, or galactose, 0.5% ammonium sulphate, and 0.17%
yeast nitrogen base, supplemented with appropriate amino acids
and bases. Isogenic wild-type, rrp47Δ::kanMX4, rex1Δ::kanMX4,
and mpp6Δ::kanMX4 strains were obtained from Euroscarf
(University of Frankfurt, Germany). The rrp47Δ::kanMX4 disrup-
tion allele was converted to an rrp47Δ::hphMX4 allele by PCR-medi-
ated homologous recombination of the rrp47Δ::kanMX4 recipient
strain, using the hygromycin B resistance gene in plasmid pAG32
(Goldstein and McCusker 1999). An mpp6 rrp47 plasmid shuffle
strain was generated by transforming the mpp6Δ::kanMX4 strain
with the MPP6 expression construct p593 and disruption of the
RRP47 gene by transposing the rrp47Δ::hphMX4 allele. The mpp6Δ
rrp6Δ and rex1Δ rrp6Δ shuffle strains were made by targeting the
kanMX4 cassette to theMPP6orREX1 locus in an rrp6Δ::TRP1 strain
bearing the plasmid p263, which encodes the zz-Rrp6 fusion protein
and the URA3 gene (Allmang et al. 1999b). The rrp6Δ::kanMX4
rrp47Δ::hphMX4 strain was generated by PCR-mediated gene dis-
ruption of the RRP6 locus in the rrp47Δ::hphMX4 strain. Csl4-TAP
and Rrp6-TAP strains were obtained from Open Biosystems. The
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rrp47-zz, rrp47-GFP, and rrp47-GFP::HIS3 rrp6Δ::kanMX4 strains
have been described (Mitchell et al. 2003; Feigenbutz et al. 2013).
The chromosomally encoded Csl4-TAP, Rrp6-TAP, Rrp47-zz, and
Rrp47-GFP fusion protein and the plasmid-encoded Rrp47-TAP fu-
sion proteins were expressed from their homologous promoters.
Expression of the plasmid-encoded zz-Rrp6 fusion protein, which
is driven from the RRP4 promoter, is comparable to that of the
Rrp6-TAP fusion protein (Stead et al. 2007).
RNA analyses
For Rrp6NT induction analyses, cultures were harvested during
growth in permissive, raffinose-based medium and upon every dou-
bling of OD600 after transfer to medium containing 2% galactose.
RNA was isolated by glass bead extraction in the presence of phenol
and guanidinium isothiocyanate (Tollervey and Mattaj 1987). Total
cellular RNAwas resolved through 8% polyacrylamide gels contain-
ing 50% urea or 1.2% agarose gels and transferred to Hybond-
N+ (GE Healthcare) for hybridization analyses. The sequences of
the oligonucleotide probes used were as follows: 5.8S, gcgttgttcatc
gatgc; 5S, ctactcggtcaggctc; 5′ ETS, cgctgctcaccaatgg; U6, atctctgtatt
gtttcaaattgaccaa; snR38, gagaggttacctattattacccattcagacagggataactg;
NEL025c, ggcttctacagaacaagttgtatcgaaatgattgttggcgac; IGS1-R, gatg
taagagacaagtgaacagtgaacagtgaacagtggggaca; U14, tcactcagacatcctagg;
snR13 3′, ggtcagataaaagtaaaaaaaggtagc; SCR1, aaggacccagaactaccttg.
Hybridized blots were placed under phosphor storage screens, ana-
lyzed using a Personal Molecular Imager FX machine (BioRad), and
nonsaturated images were obtained using the ImageJ64 package
(NIH).
Protein analyses
Yeast cell extracts for gradient centrifugation analyses and pull-down
assays were made by glass bead disruption in TMN150 buffer (10
mM Tris, pH 7.6, 150 mM NaCl, 5 mM MgCl2, 1 mM PMSF)
(Mitchell et al. 1996), while the protein expression analyses in
Figure 3 were done on alkaline denatured cell lysates (Motley et al.
2012). Samples were analyzed by Western blotting, using the perox-
idase-antiperoxidase conjugate (PAP, Sigma), mouse anti-GFP
(Roche), mouse anti-Pgk1 (Invitrogen), rabbit anti-GST (Sigma),
and rabbit anti-Sba1 (Mollapour and Piper 2012) primary antibod-
ies, and HRP-conjugated goat anti-mouse (BioRad) or anti-rabbit
(Sigma) secondary antibodies. Proteinswere detected by ECL and vi-
sualized using a G:Box iChemi XL system running GeneSnap and
GeneTools software packages (Syngene).
For sedimentation analyses, the rrp47-GFP strain was trans-
formed with plasmids encoding either GST or GST-Rrp6NT under
the control of the GAL promoter. Strains were grown in galactose-
based medium, and cell lysates were resolved through 12 mL
10%–30% glycerol gradients in TMN150 buffer at 36,000 rpm for
24 h using an SW40 rotor (Beckman Coulter). 0.65 mL fractions
were collected and analyzed by Western blotting. Protein markers
(BSA, 4.6 S; chicken ovalbumin, 3.6 S; bovine catalase, 11.3 S)
(Erickson 2009) were resolved in parallel gradients. Protein profiles
of glycerol gradients were routinely assessed by SDS-PAGE analysis
of the fractions and staining with InstantBlue colloidal Coomassie
Blue stain (Expedion).
For Rrp6NT pull-down experiments, yeast strains expressing
Rrp47-zz, Rrp6-TAP, or Csl4-TAP fusion proteins were trans-
formed with a plasmid expressing GAL-driven GST-Rrp6NT and
grown in galactose-based medium. Clarified lysates were passed
over glutathione beads, and retained protein was eluted with lysis
buffer containing 25 mM glutathione. For the Rrp6 pull-down ex-
periments, the rrp47-GFP::HIS3 rrp6Δ::kanMX4 strain was trans-
formed with plasmids encoding zz-Rrp6 and either GAL-driven
GST or GST-Rrp6NT. Cell extracts were initially fractionated by
binding with SP sepharose beads; retained protein was eluted with
buffer containing 500 mM NaCl. After adding NaCl to the flow-
though fraction to a final concentration of 500 mM, both flow-
through and eluate fractions were incubated with IgG sepharose
beads (GE Healthcare) to trap Rrp6 complexes. The beads were
washed with buffer containing 500 mM NaCl, and retained protein
was recovered by elution with 0.5 M acetic acid and lyophilized.
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Abstract
Rrp6 is a conserved catalytic subunit of the eukaryotic nuclear exosome ribonuclease complex that functions in the
productive 3’ end maturation of stable RNAs, the degradation of transiently expressed noncoding transcripts and in
discard pathways that eradicate the cell of incorrectly processed or assembled RNAs. The function of Rrp6 in these
pathways is at least partially dependent upon its interaction with a small nuclear protein called Rrp47/Lrp1, but the
underlying mechanism(s) by which Rrp47 functions in concert with Rrp6 are not established. Previous work on yeast
grown in rich medium has suggested that Rrp6 expression is not markedly reduced in strains lacking Rrp47. Here we
show that Rrp6 expression in rrp47∆ mutants is substantially reduced during growth in minimal medium through
effects on both transcript levels and protein stability. Exogenous expression of Rrp6 enables normal levels to be
attained in rrp47∆ mutants. Strikingly, exogenous expression of Rrp6 suppresses many, but not all, of the RNA
processing and maturation defects observed in an rrp47∆ mutant and complements the synthetic lethality of rrp47∆
mpp6∆ and rrp47∆ rex1∆ double mutants. Increased Rrp6 expression in the resultant rrp47∆ rex1∆ double mutant
suppresses the defect in the 3’ maturation of box C/D snoRNAs. In contrast, increased Rrp6 expression in the rrp47∆
mpp6∆ double mutant diminishes the block in the turnover of CUTs and in the degradation of the substrates of RNA
discard pathways. These results demonstrate that a principal function of Rrp47 is to facilitate appropriate expression
levels of Rrp6 and support the conclusion that the Rrp6/Rrp47 complex and Rex1 provide redundant exonuclease
activities for the 3’ end maturation of box C/D snoRNAs.
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Introduction
Ribonucleases are of fundamental importance for the
expression of both coding and non-coding RNA in all cells. All
characterised RNA transcripts are generated from longer
precursor molecules through processing reactions involving the
nuclease activities of exo- and/or endonucleases. Furthermore,
the large amount of RNA fragments that are released as by-
products of such processing reactions, such as pre-mRNA
introns, must be degraded. The ultimate degradation of mRNA
in the cytoplasm is also an essential biological process,
individual mRNAs being degraded at transcript-specific rates
that contribute to the expression levels of each gene [1].
Furthermore, both coding and non-coding RNAs are subjected
to quality control systems that degrade incorrectly processed or
assembled ribonucleoprotein (RNP) particles [2]. There is a
substantial flux through such RNA surveillance pathways, even
in normal healthy cells [3,4].
A major source of 3’ →5’ exoribonuclease activity in
eukaryotic cells is the exosome RNase complex, which plays
key roles in both the productive 3’ end processing of precursor
transcripts to their mature RNAs, and in the complete
degradation of RNAs that are targeted to RNA discard
pathways [5]. The exosome was initially identified as a
nuclease complex that functions in the 3’ end maturation of
5.8S rRNA, snoRNAs and snRNAs [6,7] and subsequently
shown to function in cytoplasmic mRNA turnover, and in
nuclear and cytoplasmic RNA surveillance pathways for both
coding and non-coding RNAs. In addition, the analysis of RNA
from yeast strains compromised in exosome activity allowed
the discovery of a new class of low abundance RNAs known as
cryptic unstable transcripts (CUTs) [8-10].
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The exosome has two associated catalytic subunits, Rrp44
(also known as Dis3) and Rrp6. Yeast and mammalian Rrp44
is found exclusively associated with the exosome complex
[11,12]. Rrp44 belongs to the RNase R/RNase II family of
exoribonucleases [13] but is restricted to eukaryotes and
contains an additional N-terminal PIN domain that has
endonuclease activity [14-16]. Rrp44 has a highly processive
hydrolytic exonuclease activity when expressed as a
recombinant protein [6] but shows a largely reduced activity
when associated with the exosome core complex [17].
Interaction with the exosome is through the N-terminal PIN
domain of Rrp44 and the exosome core subunits Rrp41 and
Rrp45 [16,18]. The core of the exosome structure functions to
channel the RNA substrate to the active site of the Rrp44
exonuclease [19]. Rrp6 is related to the RNase D family of
exonucleases [20] that have a “DEDD” catalytic domain named
after four highly conserved acidic residues that coordinate the
binding of two metal cations required for catalysis [21,22]. The
RRP6 gene was originally cloned by complementation of a
catalytically inactive allele (rrp6-1) that contains an asparagine
in place of the conserved D238 residue [23,24]. In addition to
the catalytic domain, Rrp6 also has an N-terminal PMC2NT
domain, a central HRDC domain and a C-terminal region that is
required for its association with the exosome. Loss of
interaction with the exosome has little effect on the ability of
Rrp6 to function in RNA processing or RNA degradation
pathways [25]. However, association of Rrp6 with the exosome
allosterically stimulates the activity of Rrp44 [19,26].
RNA analyses have revealed that most Rrp6-mediated RNA
processing and degradation pathways are impeded in strains
lacking the nuclear RNA-binding protein Rrp47 (also known as
Lrp1) [11]. Rrp47 directly interacts with the PMC2NT domain of
Rrp6 through its N-terminal Sas10/C1D domain, while the C-
terminal region of the protein is required for RNA binding
activity and contributes to substrate recognition [27,28].
Another RNA-binding protein, Mpp6, interacts with exosome
complexes and has been proposed to stimulate the activity of
Rrp44 [29] or to promote the functional coupling between Rrp6
and the TRAMP/exosome complexes [30]. Strains lacking Rrp6
or Rrp47 are synthetic lethal with mpp6∆ mutants, probably
reflecting a degree of functional redundancy between the Rrp6
and Rrp44 enzymes [3,31]. Similarly, rrp6∆ and rrp47∆ mutants
are also synthetic lethal with mutants lacking Rex1, another
RNase D-related 3’→5’ exoribonuclease [32,33].
Cellular ribonucleases represent effective modulators of
changes in gene expression profiles. However, little data is
available concerning how these enzymes might be regulated in
response to changes in physiological conditions or as a result
of developmental programmes. Rrp6 expression in diploid
yeast is decreased upon shift from fermentation to respiration,
and further depleted upon entry into meiosis. This fluctuation of
Rrp6 expression occurs without a significant alteration in RRP6
mRNA levels, indicative of a post-transcriptional mode of
regulation [34]. Furthermore, both the RRP6 and RRP47 genes
are potentially regulated by transcription factors that modulate
gene expression in response to nutrient availability or stress
[35-37]. In prokaryotes, the 3’→5’ exoribonucleases RNase II
and RNase R are both regulated in response to nutrient
availability at the level of protein stability. Notably, RNase II
protein levels are decreased upon shift from rich medium to
minimal medium in a manner dependent upon the protein Gmr
[38]. In contrast, RNase R is a highly unstable protein during
growth in rich medium and its expression is induced by protein
stabilisation upon entry into the stationary phase or upon cold
shock [39]. RNase R instability during rapid growth is mediated
by acetylation and involves its interaction with the SmpB/
tmRNA trans-translation complex [40,41]. The SmpB mRNA
accumulates in the absence of RNase R, indicative of a
mutually dependent regulation of expression [42].
We have recently reported that the absence of Rrp6 has a
profound effect on the stability of its associated protein Rrp47,
without a substantial change in transcript levels [43]. Previous
studies on cultures in rich medium suggested Rrp6 expression
levels are not markedly affected in strains lacking Rrp47
[11,27]. Here we report that Rrp6 levels are decreased
substantially in the absence of Rrp47 during growth in minimal
medium, reflecting both a decrease in protein stability and
RRP6 transcript abundance. Overexpression of Rrp6
suppressed RNA processing and degradation defects observed
in the rrp47∆ mutant and complemented the synthetic lethality
of rrp47∆ mpp6∆ and rrp47∆ rex1∆ double mutants.
Furthermore, analyses of RNA from the rrp47∆ mpp6∆ and
rrp47∆ rex1∆ double mutants are consistent with studies
proposing that either the Rrp6/Rrp47 complex or an Mpp6-
dependent activity is required for RNA surveillance pathways
and the degradation of CUTs, while the Rrp6/Rrp47 complex
and Rex1 provide redundant activities for the 3’ maturation of
box C/D snoRNAs [29,44].
Materials and Methods
Plasmids
The plasmid expressing an N-terminal Rrp6 fusion protein
(zz-Rrp6) with two copies of the z domain of protein A from
Staphylococcus aureus (p263) has been described previously
[45]. This construct expresses the Rrp6 fusion protein from the
RRP4 promoter. An analogous MPP6 construct has been
recently reported [44]. Mutant variants of the RRP6 construct
that express the catalytically inactive rrp6-1 (D238N) derivative
(p389) [24] or just the N-terminal domain truncation (L197X)
(p287) were generated by site directed mutagenesis with
appropriate primers [43]. A genomic clone of the RRP6 gene
encompassing approximately 400 nucleotides up- and
downstream of the ORF (p436) was constructed by
amplification of the RRP6 locus from wild-type genomic DNA
by PCR using Vent DNA polymerase and primers o457
(cagtctagacttcgagatgagcttg) and o458
(gctgggcccacctcagtattacagc), and cloning into pRS416 (URA3
marker) as an XbaI-EcoRI fragment [46] (the EcoRI site is
genomically encoded). The RRP6 promoter region contains the
CEN element of chromosome 15. To prevent recombination of
plasmids containing the genomic RRP6 sequence during
growth in yeast due to the presence of two CEN elements, the
CEN6 element within the vector backbone was deleted by site-
directed mutagenesis. HpaI sites were introduced either side of
the CEN6 element using the sense primers o839
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(gttggcgatccccctagagtcgttaacatcttcggaaaacaaaaactat) and
o841 (aattatttttatagcacgtgatgttaacgacccaggtggcacttttcgg) and
the intervening sequence was deleted by restriction digestion
and religation. A genomic clone of the RRP47 gene [28] was
generated by PCR amplification of wild-type genomic DNA
using the primers o191 (aaactcgaggaactgactactga) and o192
(aaagagctcaaactttcgctgg), and the product was cloned into
pRS416 as a XhoI-SacI fragment. High copy number
derivatives of these plasmids were generated by subcloning
the inserts into the 2 micron plasmids pRS424 (TRP1 marker),
pRS425 (LEU2 marker) and pRS426 (URA3 marker) [47] using
appropriate restriction enzymes. RRP6 and RRP47 alleles
were also subcloned into pRS314 (TRP1 marker) for plasmid
shuffle assays in the rex1∆ rrp47∆ strain, and into pRS313
(HIS3 marker) or pRS415 (LEU2 marker) for plasmid shuffle
assays in the mpp6∆ rrp47∆ strain.
Strains
Strains were grown at 30 ° C in YPD medium (2 % glucose,
2 % bactopeptone, 1 % yeast extract) or in selective minimal
growth medium, comprising 2 % glucose, 0.5 % ammonium
sulphate, 0.17 % yeast nitrogen base and the appropriate
amino acids and bases. Plasmid shuffle assays were
performed on complete minimal medium containing 50 µg/ml
uracil and 1 mg/ml 5-flouro-orotic acid (5 FOA) (Melford
Laboratories). Colonies recovered from 5 FOA plates were
streaked out on appropriate selective solid medium and shown
to be cured of the parental RRP47 or MPP6 plasmids by lack of
growth on SD medium lacking uracil.
For spot growth assays, precultures were diluted to a
standard OD at 600 nm and then 10-fold serially diluted with
fresh medium. Aliquots were applied to the surface of minimal
medium plates and incubated at 30 °C for 3 days. Cells were
harvested from liquid medium cultures at OD at 600 nm of less
than 1.0 for protein analyses, or less than 0.5 for RNA
analyses.
Strains expressing the C-terminal Rrp47-zz fusion protein,
with or without the rrp6∆::TRP1 allele, have been described
previously [11]. Yeast rrp47∆::KANMX4, mpp6∆::KANMX4 and
rex1∆::KANMX4 deletion strains were obtained from Euroscarf
(University of Frankfurt, Germany). The rrp47∆::KANMX4 allele
was introduced into the rrp6-TAP::HIS3 strain (Thermo Fisher
Scientific) by PCR-mediated homologous recombination, as
described [43]. The mpp6∆::KANMX4 rrp47::hphMX4 double
mutant was made by converting the KANMX4 marker in the
rrp47::KANMX4 strain to the hphMX4 marker, using the
plasmid pAG32 [48], and then targeting the RRP47 locus of the
mpp6∆ strain by PCR-mediated integration after transformation
with a plasmid encoding a functional MPP6 gene. The
rex1∆::KANMX4 rrp47∆::KANMX4 double mutant strain has
been described previously [28] and was made by crossing
rex1∆ and rrp47∆ single mutants, transforming the diploid
strain with a plasmid encoding a wild-type copy of the RRP47
gene, and isolating meiotic progeny bearing both null alleles.
Strains expressing the plasmid-borne zz-Rrp6 fusion protein as
the sole form of the protein and lacking either the MPP6 or
REX1 gene have been recently reported [44].
Protein Analyses
Cell extracts were prepared under alkaline denaturing
conditions to minimise protein degradation [49]. Translational
shut-off experiments were performed by addition of
cycloheximide to a final concentration of 100 µg/ml and aliquots
of the culture were harvested at 10 minute intervals thereafter.
Lysates were resolved by SDS-PAGE and the proteins
transferred to Hybond C membranes (GE Healthcare) for
western analyses. An Rrp6-specific polyclonal antiserum was
kindly provided by David Tollervey [11]. Pgk1 was used as a
loading control and was detected with a mouse monoclonal
antibody (clone 22C5D8, Life Technologies). TAP-tagged and
zz fusion proteins were detected using the PAP antibody
(P1291, Sigma). For the analysis of non-tagged proteins, blots
were incubated with either goat anti-rabbit (A4914, Sigma) or
goat anti-mouse (1706516, BioRad) HRP-conjugated
secondary antibodies. ECL images were captured and
quantified using a G:Box iChemi XL system (Syngene).
Expression levels of Rrp6 and Rrp47 proteins were determined
relative to the amount of Pgk1 detected on the identical blot for
a minimum of 4 independent biological replicates.
RNA analyses
Total cellular RNA was isolated from cell pellets by glass
bead extraction in the presence of phenol and guanidinium
isothiocyanate solution, followed by phenol/chloroform
extraction and ethanol precipitation [50]. RNA was resolved
through 8 % polyacrylamide gels containing 50 % urea and
transferred to Hybond N+ membranes (GE Healthcare).
Northern blots were hybridised at 37 °C with 5’ 32P-labelled
oligonucleotide probes in 6 x SSPE buffer, 5 x Denhardt’s
solution and 0.2 % SDS. The sequences of the oligonucleotide
probes used were as follows: U14, tcactcagacatcctagg (o238);
snR38, gagaggttacctattattacccattcagacagggataactg (o272);
snR13, caccgttactgatttggc (o240); SCR1,
aaggacccagaactaccttg (o242); U6, atctctgtattgtttcaaattgaccaa
(o517); U3, ttcggtttctcactctggggtac (o443); 5.8S,
gcgttgttcatcgatgc (o221); NEL025c,
ggcttctacagaacaagttgtatcgaaatgattgttggcgac (o809); 5S,
ctactcggtcaggctc (o925); IGS1-R,
gatgtaagagacaagtgaacagtgaacagtgaacagtggggaca (o815).
Hybridised blots were placed under phosphor storage screens
and analysed using a personal molecular imager FX scanner
(Biorad). Figures were generated from nonsaturated images
using ImageJ64 (NIH, Bethesda).
For cDNA synthesis reactions, RNA samples were cleaned
up using RNeasy miniprep kits (Qiagen) and their integrity
confirmed by analysis on glyoxal agarose gels. Reverse
transcription reactions were performed on DNase I treated
RNA, using random hexamer primers with the Tetro cDNA
synthesis kit (BioLine). Quantitative real time PCR (qPCR)
primers were designed using Primer3Plus software [51] and
their specificity confirmed by melt curve analyses and analytical
PCR reactions. The qPCR primers used in this study were as
follows: RRP6(+), tggcttcagcgagatttagg (o650); RRP6(-),
gcggtcttatacgccagtca (o651); SCR1(+), gagagtccgttctgaagtgtcc
(o654); SCR1(-), cctaaggacccagaactaccttg (o655). Triplicate
qPCR reactions were performed on 4 biological replicates in a
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Corbett Rotor-Gene cycler (Qiagen) using SensiMix SYBR kits
(Bioline). Assays were analysed using RotorGene 6000
software and RRP6 mRNA levels were normalized to the SCR1
reference transcript using the comparative CT method [52].
Results
Rrp6 expression levels are decreased in rrp47∆ strains
We recently showed that the expression of Rrp47 is strongly
dependent upon its ability to interact with Rrp6 and form the
Rrp6/Rrp47 complex [43]. Previous work had shown that the
lack of Rrp47 does not have a significant impact on the
expression level of Rrp6 [11,27] but these earlier studies were
nonquantitative and limited to analyses of cultures in rich YPD
medium. We therefore reanalysed the relative expression level
of Rrp6 in wild-type strains and rrp47∆ mutants by quantitative
western blotting during growth in rich medium (YPD) and in
complete minimal medium (SD). Cell lysates were prepared
under alkaline denaturing conditions to minimise protein
degradation in vitro [49].
As previously reported [43], the expression level of the
Rrp47-zz fusion protein was considerably less in the rrp6∆
mutant than in the wild-type strain (Figure 1A). In the reciprocal
experiment, Rrp6-TAP expression levels in the rrp47∆ mutant
were ~ 80 % of that observed in the wild-type strain during
growth in YPD medium (Figure 1B) but were reduced more
than two-fold during growth in minimal medium (Figure 1B).
The reduction in Rrp6 expression levels in the rrp47∆ mutant
was independent of the TAP tag fusion, since comparable
reductions in Rrp6 levels were observed for the Rrp6-TAP
fusion protein and for non-tagged, wild-type Rrp6 protein
(Figure 1B and C). These data clearly demonstrate that Rrp6
levels are reduced in the absence of Rrp47, and that this effect
is responsive to alterations in growth medium. The expression
levels of Rrp6 and Rrp47 are mutually dependent, with Rrp47
being more sensitive than Rrp6 to the absence of its partner
protein.
The reduction in Rrp47 observed in an rrp6∆ mutant is
principally due to a decrease in protein stability when Rrp6 is
not available for interaction [43]. To determine whether Rrp6 is
less stable in the absence of Rrp47, cultures of isogenic wild-
type and rrp47∆ strains were treated with the translation
inhibitor cycloheximide and the depletion of non-tagged, wild-
type Rrp6 was followed by western analyses of cell extracts.
Rrp6 levels showed a clear decrease through the 80 minute
time-course in the rrp47∆ mutant, compared to the wild-type
strain (Figure 2A,B). Quantitative analyses show that after 60
minutes incubation the Rrp6 levels were reduced by ~ 25 % in
the wild-type strain, whereas the reduction was nearly 10-fold
in the rrp47∆ mutant (Figure 2C). The half-life of the Rrp6
protein was estimated to be ~ 25 minutes in the rrp47∆ mutant
and greater than 80 minutes in the wild-type strain (Figure S1).
The stability of Rrp6 in the rrp47∆ mutant relative to the wild-
type strain was not further decreased when the cultures were
grown in minimal medium (Figures 2 and S1). These results
show that Rrp6 is more rapidly degraded in the absence of
Rrp47, and suggest that an additional mechanism is
responsible for the exacerbated decrease in Rrp6 steady state
levels during growth in minimal medium. Quantitative real time
PCR (qPCR) analyses revealed that the expression level of
RRP6 mRNA in the rrp47∆ mutant was reduced to ~ 60% of
the level observed in wild-type cells during growth in minimal
medium (62.5 %, SEM=3.6 %, n=4), while a slight increase in
RRP6 mRNA levels was observed in the rrp47∆ mutant during
growth in rich medium (114 %, SEM=8.7 %, n=4) (Figure 3).
Taken together with the western blotting data, these results are
consistent with a decrease in Rrp6 levels in the rrp47∆ mutant
due to a general decrease in Rrp6 protein stability that is
augmented by a decrease in RRP6 mRNA levels during growth
in minimal medium.
To determine whether the expression level of Rrp6 can be
increased in the rrp47∆ mutant by exogenous expression of
RRP6, isogenic wild-type and rrp47∆ strains were transformed
with low copy, centromeric (cen) or high copy, 2 micron (2µ)
plasmids encoding the wild-type RRP6 gene (see Materials
and Methods) and cell extracts from cultures grown in selective
minimal medium were analysed by western blotting using an
Rrp6-specific antibody [11]. Rrp6 levels were clearly increased
in both the wild-type strain and the rrp47∆ mutant upon
transformation with a high copy number plasmid encoding the
RRP6 gene (Figure 4, compare lanes 1-4), with higher
expression levels achieved in the rrp47∆ mutant than are seen
in wild-type cells transformed with the vector alone.
We also analysed the relative expression levels of an N-
terminal zz-Rrp6 fusion protein [45] expressed from the RRP4
promoter within either a centromeric or 2µ plasmid. Expression
of the zz-Rrp6 fusion protein from a 2µ plasmid was greater
than from a centromeric plasmid in both wild-type and rrp47∆
strains. Thus, although normal Rrp6 expression levels are
dependent upon Rrp47 it is nevertheless possible to
overexpress Rrp6 in the rrp47∆ mutant. The lower molecular
weight bands observed in Figure 4 upon overexpression of the
zz-Rrp6 fusion protein are C-terminal degradation products.
These polypeptide fragments are also visible upon expression
of the zz-Rrp6 fusion protein from a centromeric plasmid
(Figure 4, lane 5) or upon overexpression of non-tagged Rrp6
(Figure 4, lane 4), although at a much reduced level.
RRP6 overexpression suppresses RNA defects in
rrp47∆ mutants
To address whether the RNA processing and degradation
defects observed in the rrp47∆ mutant can be ascribed to an
indirect effect of decreased expression of Rrp6, rather than the
absence of Rrp47 protein, we performed acrylamide gel
northern blot analyses on RNA isolated from rrp47∆ strains that
harboured centromeric and 2µ plasmids expressing Rrp6. It
has previously been shown that rrp6∆ and rrp47∆ mutants
accumulate 3’ extended, polyadenylated forms of snoRNAs
[7,11,53]. These extended snoRNA transcripts are thought to
arise due to transcription termination at either the downstream
proximal site I or the more distal site II, followed by
polyadenylation [54]. Exogenous expression of the RRP6 gene
from the 2µ vector substantially reduced the levels of U14,
snR38 and snR13 box C/D snoRNAs that are 3’ extended to
site I and site II (Figure 5A-C,J) in the rrp47∆ mutant.
Expression of the RRP6 gene in the rrp47∆ mutant from a
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Figure 1.  The Expression of Rrp6 and Rrp47 is mutually dependent.  Isogenic wild-type and rrp6∆ or rrp47∆ strains were grown
in selective minimal medium (SD) or in nonselective rich medium (YPD) and extracts were prepared under alkaline denaturing
conditions. Extracts were resolved by SDS-PAGE and western blots were incubated with PAP antibody (Panels A and B) to detect
fusion proteins, or with an Rrp6-specific antibody (Panel C). Blots were also incubated with an antibody specific to detect Pgk1,
which serves as a loading control. (A) Western analysis of Rrp47-zz in isogenic wild-type RRP6 and rrp6∆ strains. (B) Western
analysis of Rrp6-TAP in isogenic wild-type RRP47 and rrp47∆ strains. (C) Western analysis of non-tagged Rrp6 in isogenic wild-
type RRP47 and rrp47∆ strains. Relative expression levels of Rrp6 or Rrp47, indicated as percentages under each panel, are
normalised for Pgk1 expression levels and standardised to the amount of protein in the wild-type strain grown in YPD. Values are
the mean of at least 4 independent experiments.
doi: 10.1371/journal.pone.0080752.g001
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Figure 2.  Rrp6 protein stability is decreased in the rrp47∆ mutant.  Isogenic wild-type and rrp47∆ strains were harvested during
growth in selective minimal medium (SD) or rich medium (YPD) and at time-points after addition of the translation inhibitor
cycloheximide (CHX), as indicated. Extracts were prepared under denaturing conditions and identical western blots were incubated
with antiserum specific to Rrp6 and the loading control Pgk1. (A) Translational shut-off experiment in YPD medium. (B) Translational
shut-off experiment in SD medium. (C) Quantitative analysis of the amount of Rrp6 in extracts from wild-type and rrp47∆ strains
before addition of cycloheximide (“0” lanes) and 60 minutes after treatment (“60” lanes). The relative amount of Rrp6, normalised to
Pgk1 expression levels and standardised to the level observed in the wild-type strain during growth in YPD medium (average of 2
experiments), is given below each lane.
doi: 10.1371/journal.pone.0080752.g002
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centromeric vector also had a clear effect but the suppression
was less marked than when RRP6 was expressed from the
multicopy plasmid (Figure 5A-C, compare lanes 2-5). This
suppression in the absence of a clear increase in Rrp6 steady
state levels (see Figure 4) may reflect a differential nuclear
localization of Rrp6 or an increase in the effective
concentration of Rrp6/TRAMP and/or Rrp6/exosome
complexes. The accumulation of extended forms of U6 snRNA,
truncated forms of U3 and snR13 snoRNAs (denoted as U3*
and snR13* in Figure 5) and the NEL025c CUT observed in the
rrp47∆ mutant was also suppressed (Figure 5C,E,F,H,J).
Notably, some RNAs that accumulate in the rrp47∆ mutant,
such as the “+30” 3’ extended form of 5.8S rRNA were not
clearly reduced upon Rrp6 overexpression (Figure 5G,J). This
difference may reflect either the extensive degree of secondary
structure found at the 3’ end of the 3’ extended 5.8S rRNA [55],
its nucleolar localisation or the large degree of flux through the
pre-rRNA processing pathway [56]. Increased expression of
Rrp6 in the rrp47∆ mutant did not suppress the RNA
processing defects to the extent seen upon transformation with
a plasmid bearing the wild-type RRP47 gene (Figure 5A-G,
compare lanes 5 and 6), indicating that Rrp47 has functions in
RNA processing and degradation in addition to ensuring
adequate expression levels of Rrp6. Overexpression of Rrp6
per se is not detrimental to the cell, since no alteration in
phenotype was detected upon Rrp6 overexpression in a wild-
type strain (unpublished data). These data suggest that the
requirement for Rrp47 in box C/D snoRNA maturation, the
degradation of CUTs and in RNA surveillance pathways
mediated by Rrp6 can be partially attributed to its indirect effect
on Rrp6 expression.
RRP6 overexpression suppresses the genetic
requirement for RRP47 expression
Yeast rrp47∆ rex1∆ and rrp47∆ mpp6∆ double mutants are
synthetic lethal [29,33]. To determine whether normal wild-type
Figure 3.  RRP6 mRNA levels are decreased in the rrp47∆ mutant.  Relative expression levels of RRP6 mRNA in wild-type and
rrp47∆ mutants during growth in either selective minimal medium (SD) or rich medium (YPD). Expression levels, indicated as
percentages, are standardised to the amount in wild-type cells grown in YPD medium. RRP6 mRNA levels were determined by
qRT-PCR and normalised to the SCR1 RNA. Expression levels of non-tagged Rrp6 protein, determined as in Figure 1, are shown
for comparison. Error bars indicate the positive range of the standard error of the mean for each set of values.
doi: 10.1371/journal.pone.0080752.g003
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Figure 4.  Rrp6 can be overexpressed in wild-type and rrp47∆ strains.  Western analyses of Rrp6 in isogenic wild-type and
rrp47∆ strains that are transformed with RRP6 expression constructs. Strains were transformed with either the 2 micron (2µ) vector
pRS426 (lane 1), the centromeric (cen) plasmid pRS416 (lane 2), an RRP6 genomic clone in pRS416 (lane 3) or in pRS426 (lane
4), as well as constructs expressing an N-terminal zz fusion of Rrp6 from the RRP4 promoter in pRS416 (lane 5) or pRS426 (lane
6). Identical blots were analysed for Rrp6 levels using an Rrp6-specific antiserum, followed by analysis of the loading control Pgk1.
doi: 10.1371/journal.pone.0080752.g004
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Figure 5.  Rrp6 overexpression suppresses RNA phenotypes in rrp47∆ mutants.  Northern analyses of total cellular RNA
isolated from a wild-type strain, an isogenic rrp47∆ mutant and from rrp47∆ mutants expressing exogenous Rrp6 or Rrp47 from
either centromeric (cen) plasmids or 2 micron-based (2µ) constructs. RNA was resolved through 8% denaturing acrylamide gels,
transferred to nylon membranes and hybridised with probes complementary to specific RNAs, as follows: (A) U14; (B) snR38; (C)
snR13; (D) SCR1; (E) U6; (F) U3; (G) 5.8S; (H) NEL025c; (I) SCR1. Blots shown in A-G and H-I are from distinct gels. Dispersed
bands labelled I-pA and II-pA in panels A-C represent snoRNAs that are polyadenylated after termination at sites I and II,
respectively. The bands labelled snR13* and U3* are 5’ truncated forms of snR13 and U3. (J) Quantification of signals for the 3’
extended forms of U14, snR38, snR13, U6 and 5.8S, the truncated U3 RNA and the NEL025c mRNA are shown for each strain.
Average values of two data sets are normalised to SCR1 loading controls and expressed relative to the level of the RNA observed
in the wild-type strain.
doi: 10.1371/journal.pone.0080752.g005
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expression levels of Rrp6 can alleviate the requirement for
RRP47 expression in rex1∆ or mpp6∆ mutants, centromeric
and 2µ plasmids encoding rrp6 alleles were transformed into
rrp47∆ rex1∆ and rrp47∆ mpp6∆ plasmid shuffle strains and
the resulting transformants were assayed for growth on
medium containing 5 FOA. Isolates were obtained for the
rrp47∆ rex1∆ transformants expressing either wild-type Rrp6 or
the zz-Rrp6 fusion protein from both centromeric and 2µ
vectors, but not from the vector control, growth being most
readily observed upon transformation with the 2µ plasmid
encoding the Rrp6 fusion protein (Figure 6A,B). In contrast, no
growth was observed upon transformation with constructs
encoding the catalytically inactive rrp6D238N mutant (Figure 6B)
or just the N-terminal PMC2NT domain of Rrp6 (rrp6NT) (Figure
6C). These data demonstrate that exogenous expression of
Rrp6 suppresses the synthetic lethality of rrp47∆ rex1∆
mutants, and that the suppression is dependent upon the
expression of catalytically active Rrp6. Exogenous expression
of the zz-Rrp6 fusion protein also allowed growth of the rrp47∆
mpp6∆ mutant (Figure 6D). Notably, the rrp47∆ mpp6∆ double
mutant was complemented by expression of the rrp6D238N
mutant. This suggests that Rrp6 has an important noncatalytic
function in cells lacking Mpp6.
Isolates were recovered from the 5 FOA plates and assayed
for growth on solid minimal medium. The growth rates of all the
complemented rrp47∆ rex1∆ double mutants were comparable,
whether the plasmids encoded the RRP6 gene or the RRP47
gene (Figure 7). In contrast, rrp47∆ mpp6∆ transformants
expressing an increased amount of Rrp6 showed a markedly
slow growth phenotype relative to transformants that were
complemented by copies of the RRP47 or MPP6 gene. This
suggests that the mpp6∆ mutant shows a higher degree of
dependence upon expression of the Rrp47 protein for optimal
growth than the rex1∆ mutant.
Northern analyses of rrp47∆ rex1∆ and rrp47∆ mpp6∆
mutants
Northern blot analyses were performed on total cellular RNA
isolated from the complemented rrp47∆ rex1∆ and
rrp47∆ mpp6∆ double mutants during growth in minimal
medium and compared to RNA from a wild-type strain and from
the rrp47∆, rex1∆ and mpp6∆ single mutants. The amount of
the shorter 3’ extended forms of U14, snR13 and snR38 was
dramatically increased in the rrp47∆ rex1∆ mutant
complemented by expression of the RRP6 gene from the
centromeric plasmid, compared to the rrp47∆ single mutant
(labelled I-pA in Figure 8A-C, compare lanes 3 and 5).
Complementation of the rrp47∆ rex1∆ mutant with cen or 2µ
plasmids encoding the zz-Rrp6 fusion protein caused a weaker
defect in snoRNA 3’ maturation (Figure 8A, lanes 7 and 8).
Northern analyses of RNA from multiple rrp47∆ rex1∆ isolates
showed that this effect was reproducible (Figure S2). The
milder phenotypes observed in the rrp47∆ rex1∆ strain
expressing the zz-Rrp6 fusion protein presumably reflect the
increased expression of this form of Rrp6 (Figure 4). We
conclude that the accumulation of 3’ extended snoRNAs in the
rrp47∆ rex1∆ mutants can be alleviated by increased
expression of Rrp6. As in the case of the rrp47∆ single mutant
(Figure 5), the extended forms of U6 snRNA were depleted in
the rrp47∆ rex1∆ double mutant upon overexpression of Rrp6
(Figure 8E) and there was no suppression of the 5.8S rRNA
processing defect (Figure 8D).
Conditional rrp47 mpp6 double mutants exhibit defects in the
degradation of CUTs and in discard pathways that degrade
defective nuclear pre-mRNAs and pre-rRNA fragments [29].
Consistent with this earlier study, northern analyses of RNA
from the rrp47∆ mpp6∆ mutants expressing the zz-Rrp6 fusion
protein from a centromeric plasmid revealed defects in the
degradation of truncated fragments of 5S rRNA and snR13
(denoted as 5S* and snR13* in Figure 8G and H, respectively)
that are presumably targeted to discard pathways [11,57], as
well as the accumulation of the NEL025c and IGS1-R CUTs
(Figure 8J,K). In all cases, these RNAs accumulated
substantially more in the rrp47∆ mpp6∆ double mutant
expressing zz-Rrp6 from a centromeric plasmid than in the
rrp47∆ or mpp6∆ single mutants (Figure 8G-K, compare lanes
2,3 and 6). Northern analyses using probes complementary to
box C/D snoRNAs revealed that the rrp47∆ mpp6∆ mutant
expressing zz-Rrp6 from a centromeric plasmid also
accumulated 3’ extended U14 and snR13 RNAs (Figure 8H,L).
In contrast to the rrp47∆ rex1∆ mutants, however, the longer
forms of snR13 and U14 detected in the rrp47∆ mpp6∆ mutant
were extended to site II (labelled II-pA in Figure 8).
The severity of the phenotypes observed in the rrp47∆
mpp6∆ double mutant expressing exogenously supplied zz-
Rrp6 was suppressed upon expression of the protein from a
multicopy plasmid (Figure 8G-N, compare lanes 6 and 8). The
analysis of RNA from multiple independent isolates showed
that this effect is reproducible (Figure S3). Taken together, the
data shown in Figure 8 supports a role for Rrp6, directly or
indirectly, in the processing or degradation of RNAs that
accumulate in the rrp47∆ rex1∆ or rrp47∆ mpp6∆ mutants.
Yeast snoRNA maturation is dependent upon the exonuclease
activity of Rrp6 in the case of the rrp47∆ rex1∆ mutant, since
no complementation was observed for the catalytically inactive
rrp6D238N mutant (Figure 6B). In contrast, the rrp47∆ mpp6∆
mutant could be complemented by expression of the rrp6D238N
mutant and the severity and nature of the RNA phenotypes
seen upon complementation were generally indistinguishable
to that seen upon expression of the wild-type protein (Figure
8G-N, compare lanes 6 and 7). These observations provide
support for an important non-catalytic role of Rrp6 in RNA
surveillance and degradation pathways that has been noted in
previous studies [58]. The rrp6D238N mutant was not, however,
able to process the short 3’ extensions of snoRNAs (resolved
from the mature RNA well in the case of snR38 in Figure 8I,
compare lanes 6 and 7) that arise through the addition of short
oligoadenylate tails [54].
Given that the exonuclease activity of Rrp6 is redundant with
activities dependent upon either Mpp6 or Rex1 [44](Figure 6),
we hypothesised that the expression of Rrp6 may be increased
when Mpp6- or Rex1-dependent pathways are blocked. To
address this, we determined the relative levels of Rrp6 in
extracts of isogenic strains that carry either a wild-type or null
allele of the MPP6 or REX1 gene. Western analyses of cultures
grown in minimal medium showed that Rrp6 expression levels
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Figure 6.  Exogenous expression of Rrp6 complements the synthetic lethality of rrp47∆ rex1∆ and rrp47∆ mpp6∆
mutants.  Yeast rrp47∆ rex1∆ and rrp47∆ mpp6∆ double mutants bearing plasmids with a URA3 marker and a wild-type copy of
either the RRP47 (panels A-C) or MPP6 gene (panel D) were transformed with RRP6 constructs. Transformants were isolated on
selective minimal medium and tested for growth in parallel on permissive minimal medium (left panel) and on medium containing 5
FOA (right panel). Plates were incubated at 30 °C for 3 days. The nature of the expression construct is indicated for each segment
on the right.
doi: 10.1371/journal.pone.0080752.g006
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are not markedly altered in the presence or absence of Mpp6
or Rex1 (Figure 9). Thus, Rrp6 expression levels are
responsive to the availability of its interacting protein Rrp47 but
not the status of redundant Mpp6- or Rex1-dependent
processing or degradation pathways.
Discussion
The yeast protein Rrp47 was identified 10 years ago as an
exosome-associated protein that is functionally linked to the
Rrp6 exonuclease [11,33,59]. The exact molecular function(s)
of this protein has, however, remained largely elusive. We have
recently shown that the stability of Rrp47 is drastically reduced
in the absence of Rrp6 [43]. Here we demonstrate that Rrp6
protein levels are reduced in the absence of Rrp47, and that
this effect is reinforced when strains are grown in minimal
medium rather than rich medium. Down-regulation of Rrp6
expression occurs both at the level of protein stability and at
the RRP6 transcript level. Strikingly, restoration of Rrp6
expression in an rrp47∆ mutant to wild-type levels is largely
sufficient to compensate for the lack of Rrp47, suppressing
RNA processing and turnover defects observed in the rrp47∆
Figure 7.  Growth assays of rrp47∆ rex1∆ and rrp47∆ mpp6∆ mutants.  Spot growth assays of rrp47∆ mpp6∆ (upper panel) and
rrp47∆ rex1∆ (lower panel) double mutant isolates. The complementing construct is indicated on the left. 10-fold serial dilutions of
standardised precultures were spotted on to selective solid medium and the plates were incubated at 30 °C. Plates were
photographed after incubation for 3 days.
doi: 10.1371/journal.pone.0080752.g007
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Figure 8.  Northern analyses of rrp47∆ rex1∆ and rrp47∆ mpp6∆ mutants.  Total cellular RNA was isolated from isogenic wild-
type, rex1∆, rrp47∆ and mpp6∆ strains, and from rrp47∆ rex1∆ rrp47∆ or rrp47∆ mpp6∆ double mutants that are complemented by
centromeric (cen) or 2 micron (2µ) plasmids expressing RRP47, MPP6 or RRP6 alleles. RRP6 constructs encoded either non-
tagged or zz-tagged fusion proteins. RNA was resolved through 8% denaturing polyacrylamide gels and northern blot analyses
performed, using probes complementary to the RNAs indicated on the right of each panel. (A-F) Analysis of rrp47∆ rex1∆ mutants.
(G-N) Analysis of rrp47∆ mpp6∆ mutants. To compare the relative levels of both mature and 3’ extended forms of snoRNAs in the
different strains in panels A-C, two images are shown from the same hybridisation. Dispersed bands labelled I-pA and II-pA
represent snoRNAs that are polyadenylated after termination at sites I or II, respectively. Bands labelled 5S* and snR13* represent
truncated RNAs.
doi: 10.1371/journal.pone.0080752.g008
Rrp47 Is Critical for Normal Expression of Rrp6
PLOS ONE | www.plosone.org 13 November 2013 | Volume 8 | Issue 11 | e80752
 mutant and complementing the synthetic lethal growth
phenotypes of rrp47∆ rex1∆ and rrp47∆ mpp6∆ double
mutants. This demonstrates that an important function of Rrp47
is to facilitate a critical expression level of Rrp6. Similar findings
have been independently reported recently [60]. In contrast to
the study by Stuparevic et al., we did not observe a complete
depletion of Rrp6 in the absence of Rrp47. Our findings are
more consistent with observed differences in the growth
phenotypes and genetic interactions of rrp47∆ and rrp6∆
mutants [11].
The Rrp6 and Rrp47 proteins interact directly with one
another [27]. The mutual stabilisation of two interacting proteins
has the consequence of limiting the expression of the
constituent proteins to functional, assembled complexes and
suppressing the potential titration of substrates or factors by
the one or other subunit. In the case of Rrp47 and Rrp6, this
would limit the expression of the proteins to their site of
assembly and functional location in the cell nucleus [43].
Consistent with a key function of Rrp47 being its ability to
facilitate normal Rrp6 expression levels, the Sas10/C1D
domain of Rrp47 that is required for the interaction with Rrp6 is
sufficient for the function of the protein in vivo [28].
Notwithstanding this impact of Rrp47 on Rrp6 expression
levels, Rrp47 performs additional functions as part of the Rrp6/
Rrp47 complex that contribute to RNA processing and
degradation and which involve the C-terminal region of the
protein [28,44]. This is underlined by the observation that
expression of exogenous Rrp6 protein restored Rrp6 levels but
did not suppress the defects in RNA processing and
degradation in the rrp47∆ single mutant or either double mutant
as efficiently as expression of the RRP47 gene.
The ability of increased Rrp6 expression to suppress the
requirement for Rrp47 facilitated the isolation of viable rrp47∆
rex1∆ and rrp47∆ mpp6∆ strains, and the analyses of the
complemented strains provided some insight into the molecular
basis of the synthetic lethal relationship between rrp47∆
mutations and rex1∆ or mpp6∆ alleles. Northern analyses of
the RRP6-complemented rrp47∆ rex1∆ double mutants
revealed an accumulation of 3’ extended box C/D snoRNAs
that was suppressed upon increased expression of Rrp6.
Furthermore, the exonuclease activity of Rrp6 is required for
complementation of the rrp47∆ rex1∆ mutant. We recently
reported that segregation of Rrp47 from catalytically active
form of Rrp6 in the rex1∆ mutant causes a block in the 3’ end
maturation of box C/D snoRNAs [44]. This strongly suggests
that Rrp6 and Rex1 have a redundant function in snoRNA
processing that cannot be carried out by other cellular
exonucleases. There are no additional detectable snoRNA
processing intermediates in the rrp47∆ mutant upon loss of
Rex1, suggesting that the redundancy between Rrp6 and Rex1
does not stem from a cooperative pathway. This is further
supported by the lack of data supporting a physical interaction
Figure 9.  Rrp6 levels are not altered in mpp6∆ or rex1∆ mutants.  Western analyses were performed on extracts from strains
that either carry a wild-type or a deletion allele of the MPP6 or REX1 gene and that express the zz-Rrp6 fusion protein. Blots were
successively incubated with the PAP antibody and antibody specific to the Pgk1 protein. Expression levels of zz-Rrp6 in the mpp6∆
and rex1∆ mutants, relative to the level observed in the corresponding wild-type strain, are given at the bottom of the figure and are
the average of three independent biological replicates.
doi: 10.1371/journal.pone.0080752.g009
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between these two proteins or with a mutual partner. Rather,
the redundancy of processing activities in snoRNA maturation
appears to reflect genetic buffering. Rex1 is a member of a
family of related exonucleases in yeast that remain relatively
poorly characterised [32,61]. It will be of interest to address
whether the substrate specificity or availability of Rex1 is
regulated by an associated protein in a manner similar to the
effect of Rrp47 on Rrp6.
In contrast to the specific snoRNA processing defect
observed in the rrp47∆ rex1∆ mutant, a set of RNAs
accumulated in the rrp47∆ mpp6∆ mutant that are normally
destined for rapid degradation. These phenotypes were also
suppressed upon increased expression of Rrp6, indicative of a
functional redundancy between the Rrp6/Rrp47 complex and
an Mpp6-dependent activity in RNA discard pathways and the
degradation of CUTs [29]. Interestingly, exogenous expression
of either the rrp6-1 allele or the wild-type RRP6 gene had
comparable effects on the growth of the rrp47∆ mpp6∆ double
mutant and the viable transformants were compromised to a
similar degree in their ability to degrade truncated stable RNAs,
CUTs or extended snoRNA transcripts. These observations are
consistent with a previous study proposing that Rrp6 has an
important noncatalytic role in RNA surveillance [58]. One
noncatalytic mechanism by which Rrp6 might promote RNA
surveillance is through its interaction with the exosome
complex, which promotes channelling of RNA substrates
through the core to Rrp44 [19,26]. However, rrp6-1 mpp6∆
double mutants are nonviable [44], suggesting that at least one
essential biological process is dependent upon the catalytic
activity of either Rrp6 or an Mpp6-dependent activity. This most
likely reflects the substrate overlap observed for Rrp6 and
Rrp44 [3,31]. The molecular function of Mpp6 remains unclear.
The human Mpp6 protein physically interacts with homologues
of Mtr4 and the Rrp47/Rrp6 complex [62] and contacts the
exosome independently of Rrp44 [63], while yeast
mpp6∆ mutants show strong genetic interactions with mutants
lacking the TRAMP component Air1 [29,64], as well as
mutations of the Rrp6/Rrp47 complex. One possibility is that
Mpp6 might act to functionally couple the TRAMP and Rrp6/
exosome complexes [30].
Studies on the prokaryotic exoribonucleases RNase R and
RNase II have revealed changes in the expression levels of
these enzymes upon changes in nutrient availability or other
forms of stress [38,39]. The wide-ranging impact on diverse
aspects of RNA metabolism that are seen for mutants of the
exosome complex, or the 5’→3’ exoribonucleases Xrn1 and
Rat1, suggests that modulation of the expression of eukaryotic
exoribonucleases may orchestrate similar changes in the
transcriptome associated with cellular responses to
physiological signals. More detailed analyses of the expression
levels of eukaryotic ribonucleases in response to altered
growth conditions may be a fruitful area of future research.
Supporting Information
Figure S1.  Rrp6 stability is decreased in rrp47∆ mutants.
Western analyses were performed on cell extracts from wild-
type strains and rrp47∆ mutants during growth in rich medium
(YPD) or minimal medium (SD) following treatment with
cycloheximide (CHX) for the times indicated. The amount of
Rrp6 detected was normalised to the level of endogenous Pgk1
protein and expressed as a percentage of the protein present
in the cell lysates as a function of time.
(TIF)
Figure S2.  RNA analyses of independent rrp47∆ rex1∆
isolates. Acrylamide gel Northern analyses were performed on
total cellular RNA from independent isolates of the rrp47∆
rex1∆ mutant that harbor either the centromeric RRP6 plasmid
(lanes 1-3), the 2µ RRP6 plasmid (lanes 4-6), a centromeric
plasmid encoding the zz-Rrp6 fusion protein (lanes 7-9) or a 2µ
plasmid encoding zz-Rrp6 (lanes 10-12). The blot was
successively hybridised with probes complementary to snR13,
U14, 5.8S rRNA and SCR1.
(TIF)
Figure S3.  RNA analyses of independent rrp47∆ mpp6∆
isolates. Acrylamide gel Northern analyses of total cellular
RNA from independent isolates of the rrp47∆ mpp6∆ mutant
harbouring centromeric plasmids encoding Rrp47 (cen
RRP47), the zz-Mpp6 fusion (cen zz-mpp6), the zz-Rrp6 fusion
(cen zz-rrp6) or the catalytically inactive rrp6 mutant (cen zz-
rrp6D238N), or 2µ plasmids encoding the zz-Rrp6 fusion (2µ zz-
rrp6) or the zz-Mpp6 fusion (2µ zz-mpp6). RNA from four sets
of isolates (labelled sets 1-4: lanes 1-6, 7-12, 13-18 and 19-24,
respectively) was analysed by hybridisation using probes
complementary to the RNAs indicated on the right.
(TIF)
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